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The research herein presents an approach to stabilising reactive materials by engineering 
and designing strategies for forming multi-component materials containing the reactive 
molecules by use of their non-covalent intermolecular interactions.  These interactions may 
be utilised as part of a design approach to create new materials of more beneficial physical 
and chemical properties for the desired application. 
The reactive materials focussed on in this research are organic peroxyacids, in particular 
peroxyacetic acid, meta-chloroperbenzoic acid and 6-phthalimidoperoxyhexanoic acid.  The 
stabilities of these target materials under different conditions are probed to find a suitable 
environment for crystallisation experiments.  Crystal structures of the materials were 
isolated and characterised and the peroxyacids were subsequently cocrystallised with 
materials chosen to interact with the target molecules to form new molecular complexes, 
including carboxylic acids, π stacking materials and metal salts. 
A hosting approach was also employed to form multi-component systems containing these 
materials, crystallising them with larger, stable, structure-generating compounds with the 
aim of intercalating the reactive molecules in their stable structure.  To this end, urea 
based compounds, cyclodextrins and Montmorillonite clay were investigated as hosting 
materials.  Candidate multi-component materials were synthesised which successfully 
retain peroxyacid reactivity. 
A second set of materials studied was agrichemicals, which also frequently have reactive 
character, in which a change in physical properties was pursued by the method of forming 
new crystalline complexes.  Five new crystalline agrochemical molecular complexes were 
synthesised and tested for thermal stability in comparison to the original materials to 
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The outline of the research presented in this thesis is to assess the feasibility of using 
crystal engineering approaches and techniques to directly target reactive materials of 
commercial interest with an aim to altering their physical or chemical properties in such a 
manner as to enhance or modify the stability of the material in the solid state, with 
potential implications also for the solution state stability.  The approach adopted in this 
work has primarily focused on solid state methods for product characterisation, 
predominantly using X-ray crystallography, in order to assess the impact of induced 
hydrogen bonding on the target materials by full structure elucidation and evaluation of 
products from synthesis by medium to high throughput X-ray powder diffraction screening 
methods, providing rapid indications of whether new materials have formed through solid 
state interactions, or by chemical reaction. 
1.2 What is a reactive material? 
The reactive materials described in this research, refer to selected organic chemicals of 
commercial interest which react readily under relatively mild reaction conditions to affect a 
desired function.  In such circumstances, the reactivity of the material is inherently 
important in the reaction and often forms the rate determining step in a process.  As a 
result, these materials can often prove difficult to work with safely or difficult to store for 
extended periods and can thus be less than practical in their normal state required for their 
function as a reagent in their proposed reaction.  This research has primarily focussed on 
peroxyacids, also called peracids, and in particular a subset of these functional materials, 
the organic peroxyacids (or organic peracids).  These materials are of great commercial 
relevance and interest as oxidizing agents in synthetic1-3 and household applications4, 5 
reaching from cosmetics6 to industrial bleaching7.  Another set of reactive materials studied 
in this work are agrichemicals, particularly chlorophenoxyacetic acids, widely used as 
herbicides in which solubility over time is important as a time-release mechanism in the 
soil8.  These agrichemicals can be highly affected by sudden rainfall, resulting in dissolution 
and loss of the material to the environment and thus reacting in higher concentrations than 
is needed.  In this case, this research is focussed on changing the physical properties of 
these materials to attempt to make the solubility more suited to the application. 
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1.3 Working with reactive materials and stability 
The instability inherent to reactive molecules is beneficial to their usefulness and activity.  
Although the reactivity is highly desirable at one point of the reaction, it can cause 
difficulties, for example in its preparation, storage, or dispersal9, 10.  Working with peroxides 
in particular can potentially be hazardous as the highly energetic materials become 
unstable at elevated temperatures leading to explosions, and thus great care must be taken 
when working with them and their synergistic products11.  The goal of modifying their 
physical properties to increase their stability is therefore useful for their application as well 
as for their potential safety and storage. 
1.3.1 Organic peroxides 
Organic peroxides are a well-known class of materials.  They are highly energetic materials 
that are potentially very dangerous with a characteristic unpleasant sharp smell, however 
they have a wide range of potential uses.  Synthetic methodologies regularly take 
advantage of their reactive attributes in the synthesis of polymers12, utilising their ability to 
generate free radicals as initiators13; however their main use by far is by the consumer 
industry in the application of their reactivity by formulation of peroxides into cleaning 
agents and detergents.  It is their oxidising power that is key to their usefulness in this 
application, chemically oxidising unsaturated fats, oils and colour from fabrics during the 
cleaning process4. 
The most reactive and hence unstable of all organic peroxides is the organic peroxyacid.  
They are commercially available and readily employed as a result of their ease of use12 and 
within the field of consumer detergents, of particular interest, is the potential for organic 
peroxy acids to work as low temperature laundry bleaches14.  Unsurprisingly, the 
application of this goal has proved problematic for the industry and the main problem lies 
in the inability to control the reactive peroxyacid effectively.  Decomposition of the 
peroxyacid in the formulation renders the detergent less effective over time as the 
peroxide activity is lost, leaving only the parent acid without the oxidizing ability of the 
reactive material10.  This has the result of greatly limiting shelf life of any mixture 
containing the peroxide compound9.  The strong oxidising ability also poses compatibility 
issues between the reactive component and the other materials present, such as 
perfumes15 and enzymes, leading to a need to seek a medium for storage of the oxidising 
material separate of the other components, or by only selecting components in the 
formulation that the reactive material will not readily oxidise.  These issues have yet to be 
overcome in any reliable or commercially viable way and it is therefore within that area 
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that this research on these particular reactive materials is focussed.  Three different 
peroxyacids have been studied:  peroxyacetic acid, meta-chloroperbenzoic acid and 6-
phtalimidoperoxyhexanoic acid (Figure 1).  These peroxyacids are all very reactive, but have 

















Figure 1 - Peroxyacetic acid, m-chloroperbenzoic acid and 6-phthalimidoperoxyhexanoic acid. 
Organic peroxy acids can be generalised by the notation R(CO3H)n where R can be 
substituted with an alkyl, aryl, cycloalkyl or heterocycle and n is 1 or 2 (Figure 2).  They are 
normally named after their parent acid prefixed by either “peroxy” or “per”, denoting that 






Figure 2 - Generic peroxyacid molecular formula. 
The simplest peroxyacids may be synthesised by the reaction of the parent carboxylic acid 
with 30%-98% hydrogen peroxide with an acid catalyst in a reversible reaction between the 











Figure 3 - Reaction scheme for oxidation of acetic acid to form peroxyacetic acid 
As this is an equilibrium reaction, the concentration and proportion of the hydrogen 
peroxide has an important role to play in the eventual concentration of peroxyacid.  It is 
therefore necessary during synthesis to maintain a high concentration of hydrogen 
peroxide to ensure sufficiently high conversion of the parent acid.  Upon creation of the 
peroxyacids, they are typically purified by distillation and fractional freezing, obviously 
taking great care to avoid thermal decomposition and potential explosions.  Larger parent 
acids are less soluble in aqueous hydrogen peroxide, and can instead be prepared by the 
same reaction, but using sulphuric acid, or the more powerful acid catalyst methane 
sulfonic acid, as a solvent to aid dissolution and accelerate conversion.  Other preparation 
methods, in which diacyl peroxides have a risk of forming, may be employed using sodium 
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peroxide whilst chilling the reaction under strictly controlled stoichiometric conditions.  
Preparations of peroxybenzoic acids are relatively simple and commercially attractive, as 
they follow the same reaction as a small chain aliphatic peroxyacid, with only the addition 
of hydrogen peroxide required, which may be further catalysed by stimulating the radical 
reaction initiation with ultraviolet light, various metals or salts11, 12. 
The equilibrating nature of the synthesis of peroxyacids means that during storage and 
decomposition of the peroxyacid, the reaction is reversed.  Water, present from 
environmental sources, aids in pushing the equilibrium in the reverse direction, towards 
the formation of the parent acid and thus affecting the yield of peroxyacid (Figure 4).  
During synthesis this is combatted by the use of water azeotroping solvents, a factor key to 
the crystallisation of these materials.  Prevention of the decomposition is a significant 
element in the development of these materials, not only for storage, but for their likely use 











Figure 4 - Reversed reaction of formation of a peroxyacid, emphasising the role of the “decomposition 
reaction” in the presence of excess H2O. 
1.3.1.1 The chemical activity of peroxyacids 
Peroxyacids by nature are very good oxidising agents and react with a large range of 
materials.  They are used for a wide range of reactions and are commonly used for 
epoxidations and hydroxylations of many organic compounds including, but not limited to 
acetates, amines, nitroso compounds, oximes, imines, azo compounds, aldehydes, azines, 
hydrazones, phenols, esters, ketones and ketoacids.  A common example in which this 


















Figure 5 - The Baeyer-Villiger reaction mechanism. 
Analysis of this reaction indicates the potential for the terminal oxygen of the peroxyacid 
molecule to act as an electron donor, nucleophilically attacking the carbonyl at the carbon 
position, disrupting the double bond1.  The nucleophilicity of the terminal oxygen is the 
driving force of the oxidation and hence the reactivity of the peroxyacid family of 
molecules.   
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A second common reaction of peroxyacids is the Prilezhaev epoxidation reaction, the 


















Figure 6 - Prilezhaev epoxidation of cyclohexene by meta-chloroperbenzoic acid. 
In the Prilezhaev reaction, an intramolecular hydrogen bond forms within the peroxyacid 
group in solution, resulting in a high degree of polarisation of the group, leading to the 
generation of a highly electrophilic terminal oxygen atom that attaches through the shown 
“butterfly” transition state across a double bond.  The peroxyacid will attack any double 
bond, however the more substituted the bond is, the more stable it will be with the 
peroxyacid.  It is important to note that oxidation by peroxyacids is not considered to be a 
radical driven reaction due to the high activation energies required for homolytic cleavage 
of the peroxide bonds which does not support the kinetics of observed oxidation 
reactions1.  Again it is shown that the basicity of the terminal oxygen is crucial in the 
reaction, and as thus was an obvious target for stabilisation of the peroxyacids. 
Solvent is also known to have an important role to play in the reaction of peroxyacids.  
With respect to the present work, the peroxy group has been shown in many cases to be 
assisted by altering the polarisation of the terminal oxygen by a polar solvent molecule, 
with the solvent molecule itself being an integral part of the transition state of the 











Figure 7  - Transition state in oxidation of an aromatic amine by a peroxyacid showing solvent (water) 
involvement. 
The mechanism confirms that this is not a radical oxidation, as when radical inhibitors are 
added, no effect is observed and the reaction proceeds unhindered.  A similar effect is 
observed with alcohols.  The hydroxyl group on the alcohol in the oxidation of a sulphide 
acts similarly to the water molecule in the transition state shown in Figure 7, with the 
oxygen and the hydrogen of the alcohol hydrogen bonding to the non-terminal oxygen and 











Figure 8 - Ring transition state present upon oxidation of a sulfide with an alcohol solvent environment. 
In basic solvents, such as dioxane and DMF, an open chain intermolecular hydrogen bond 
intermediate is formed, with the basic oxygen bonded to the acidic hydrogen of the peroxy 







Figure 9 - Open chain intermolecular hydrogen bond intermediate comprising of a generic peroxyacid and 
1,4-dioxane. 
The hydrogen bonding to a basic solvent reduces the rate of the reaction, showing that the 
reactivity is decreased by the inclusion of basic solvents2, 17. 
These observations indicate that not only will the choice of solvent be crucial in working 
with these reactive materials, but also that they may be modified by interaction of the 
functional group through hydrogen bonding.  These arrangements observed in these 
mechanisms in the solution phase, show which possible hydrogen bonding motifs may be 
reinforced or created in the solid phase in order to target reducing the reactivity of this 
family of molecules. 
1.3.2 Agrochemicals 
The second family of materials studied in this research is agrochemicals, or active 
agrochemical ingredients, AAI’s.  The term agrochemical can literally mean any chemical 
that is used in agriculture but within the context of this research, it refers solely to the 
subcategory of pesticides, herbicides and fungicides.  The field of AAI’s is a closely 
scrutinised one, that over recent years has come under a great deal of public and resulting 
legislative pressure to regulate and control the chemicals being deployed, to ensure they 
are used effectively, safely and conveniently.  This entails having knowledge of, and being 
able to predict accurately the bioactivity, solubility and dispersibility of the materials being 
used.  With the delivery method for these materials generally spraying over exposed land, 
environmental factors such as the weather and rainfall have a dramatic effect upon the 
dosage and permeability of the materials into the soil and surrounding environment8.  
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Heavy rainfall in particular can remove the compounds completely from the target location, 
allowing water soluble materials to seep rapidly into groundwater, eliminating their 
effectiveness and contaminating other areas and waterways within a matter of hours18.  
The usefulness of any given agrochemical is therefore a complex balance between several 
factors, chiefly the solubility, the bioavailability, the physical stability, safety and of course 
cost8. 
Many attempts have been made over the years to ensure these goals are achieved, with 
varying degrees of success.  These have included granulation, microencapsulation, and use 
of concentrates, emulsions, wettable powders and suspensions8.  All of these, however, 
have dealt with altering the formulation of the material and not the physical properties at 
the molecular level.  Much of the research outlined here focusses upon modification of the 
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Figure 10 - 2,4-Dichlorophenoxyacetic acid (2,4-D). 
The chosen family of materials for study in this research is that of the phenoxyacetic acid 
herbicide family.  This includes the material 2,4-dichlorophenoxyacetic acid (2,4-D; Auxin) 
(Figure 10).  This material is by far the most commonly used herbicide and was the first in 
the family of phenoxyacetic acids to be synthesised, from a reaction of chloroacetic acid 
and 2,4-dichlorophenol.  It is a synthetic plant hormone which regulates growth by 
absorption through the leaves of a broad leaf plant such as a weed.  The environmental 
properties of 2,4-D are well known and it is recorded to have a half-life of 10 days upon 
application in a controlled environment.  However, it is water soluble and this has led to it 






Figure 11 - 3,4-Dichlorophenoxyacetic acid (3,4-D). 
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The second material in this family studied is that of 3,4-Dichlorophenoxyacetic acid (3,4-D) 
(Figure 11).  3,4-D is an isomer of 2,4-D and is less commonly used.  It is a less water soluble 
analogue and is typically used as a replacement in areas where rainfall is high due to its 
similar chemistry yet higher stability. 
One particular methodology that has not been widely applied to these materials is that of 
modification of the reactivity or stability by crystal engineering methods, in the solid form 
before formulation methods have been applied.  Alteration of the melting point of these 
materials has a direct effect upon the water solubility, so modification of the chemical 
structure will in turn affect the water solubilities of the materials19.  This research into 
these materials is largely focussed upon this methodology.  Crystal engineering techniques 
are employed through medium throughput crystallisation to modify the crystal form of the 
material in a way that will affect the melting point (and hence solubility) in a favourable 
way, also assessing any outcomes the structural motifs have upon the stability of the 
molecules.   
1.4 Achieving control of reactive materials via structural modification 
The stability of a material in the solid state is not only dependent upon the chemical 
characteristics (functionality and reactivity) of the molecule, but also upon its interaction 
with other molecules of the same type, or of different molecules present.  Intermolecular 
interactions can have a dramatic effect upon the stability and physical properties of a 
material.  Implementing this observation in a practical methodology is thus a theoretically 
plausible concept for altering the physical properties of any given target material, providing 
an understanding of the preferred interactions of the target molecule, allowing these to be 
predicted and adequately understood.  A target material could potentially be matched with 
any secondary material with favourable interactions, and in particular in the solid 
crystalline form, could form a new intermolecularly stabilised complex with distinct 
physical characteristics, whilst retaining the chemical character (and effectiveness) of the 
individual molecules. 
Intermolecular interactions are normally relatively weak in comparison to covalent 
bonding, and could be seen as “temporary molecular binding” for a reactive material, 
stabilising its physical properties in the solid state, yet upon dissolution releasing the target 
molecule.  This would essentially offer the capability to switch on and off the modification 
of the material, and hence its modified reactivity.  It was the aim of this research to use this 
approach, as has become more commonplace in the pharmaceutical industry, to target the 
given reactive materials to form complexes using intermolecular interactions. 
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There are of course many types intermolecular interactions, however the ones used for 
design within the context of this research are outlined here and can be considered tools in 
a molecular solid state crystal designing toolbox for the creation of new crystalline 
materials with modified properties. 
1.4.1 Hydrogen bonding 
Although much weaker than a covalent bond, the hydrogen bond is considered the 
strongest of the intermolecular interactions20 and thus the most important structure 
directing factor in molecular solids.  It is also highly directional, allowing not only for 
molecular recognition in design, but also orientation prediction of the assembled forms20. 
Hydrogen bonding is a donor-acceptor interaction that has similarities to the characteristics 
of a Brønsted-Lewis  acid, through the presence of a proton donor (D) and a proton 
acceptor (A)21.  The interaction originates from a difference in electronegativity of the 
donor atom and a bonded hydrogen.  The difference in electronegativity creates a 
withdrawing of electron density from the hydrogen to the donor, resulting in a partial de-
shielding of the hydrogen atom creating a dipole.  The partially unshielded hydrogen atom 
is then susceptible to interaction with the acceptor atom, which may be any atom with 
available lone pairs of electrons or polarisable π electrons.  This leads to the formation of 
an attractive bond between the donor and acceptor atoms with a hydrogen atom 
positioned between the two (denoted DHA), at a point that may be influenced by 
several factors.  Very strong hydrogen bonds (HBs) share some characteristics of covalent 
bonds, but HBs can also be as weak as van der Waals forces; the majority of hydrogen 
bonding interactions lie between these extremes21.  They may exist as intermolecular or 
intramolecular HBs and are competitive, i.e. a stronger, more geometrically favourable, 
hydrogen bond interaction will prevail over a weaker one, in the absence of other 
structural considerations.  In general hydrogen bonds are predominantly linear and the 
DA distance should be less than the sum of the van der Waals radii for the donor and the 
acceptor. 
Hydrogen bonds are generally classified into three categories – strong, medium and weak, 
however in reality, it is a continuum with no real physical boundaries between the 
categories.  The categories defined by Jeffrey21 however are generally a useful descriptor 




Table 1 - Properties of strong medium and weak hydrogen bonds
21
 
Bond category Strong Medium Weak 
D-H···A characteristic Mostly covalent Mostly electrostatic Electrostatic 
Bond lengths D-H ≈ H···A D-H ˂ H···A D-H ˂˂ H···A 
    H···A (Å) 1.2-1.5 1.5-2.2 2.2-3.2 
    D···A (Å) 2.2-2.5 2.5-3.2 3.2-4.0 
Bond angles (°) 175-180 130-180 90-150 
Bond energy (kcal mol-1) 14-40 4-15 ˂4 
 
A strong hydrogen bond may be formed (with typical DA distances of less than 2.5 Å for 
OO and less than 2.55 Å for NO) by donors with a deficiency in electron density or an 
acceptor with a particularly high electron density, such as –Oδ--Hδ+ and O--P.  The large 
amount of electronegativity on the donor atom de-shields the hydrogen atom effectively 
giving it a greater δ+ charge which is attracted to the negative charge on the acceptor atom.  
They may also be the result of a “forced strong hydrogen bond” where the conformation 
pushes the donor and acceptor closer together than would be expected for the types of 
donor and acceptor included21. 
A moderate strength hydrogen bond is much more common, with donor – acceptor 
distances of between around 2.5 Å and 3.2 Å they are considered a softer interaction, 
generally occurring between neutral donor and acceptor atoms, such as –O-H···O=C, where 
the acceptor has free electron pairs which are able to assist in the bond interaction. 
A weak hydrogen bond is the result of a smaller difference of electronegativity between the 
covalently bonded hydrogen and the donor atom.  An example of this would be a -C-H 
donor.  It may be the case that no lone pair is available as acceptor, and in such instances a 
polarisable π electron orbital, such as in an aromatic ring or a double bond may be the 
acceptor.  Weak HB distances fall into the region of 3.2 Å to 4.0 Å and are directional, 
distinguishing them from van der Waals interactions of similar strength21. 
The distinction between these three classes allows for a description of a bond which gives a 
primary indication of strength of the intermolecular interactions.  Hydrogen bonded 
molecules with stronger interactions are more tightly bound and it follows that they are 
more stable, although designing a structure with stronger interactions is more complicated 
than merely choosing the strongest donors and acceptors. 
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HB geometry is not always a single DHA interaction, for example in bifurcated hydrogen 












Figure 12 - A generalised example of a single donor-double acceptor bifurcated bond and a double donor-
single acceptor bifurcated bond. 
In a bifurcated single donor hydrogen bond the hydrogen atom is shared between the two 
acceptors, lying is a position closest to the stronger of the two acceptors, on a plane 
between the two, assuming there are no other external influences upon the bond.  In a 
particularly strong bifurcated hydrogen bond of this type, the position of the hydrogen 
atom may be spread between the two acceptors in the plane of the donor and acceptor 
atoms.  Alternatively, the hydrogen atom may be positionally disordered over two sites.  In 
a double donor-single acceptor bond, two hydrogen atoms on the same donor atom may 
interact with a single acceptor atom22.  This is recognised by a D-H angle that is different to 
that which would be expected by VSEPR theory, i.e. the D-H bonds are bent towards the 
acceptor. 
In order to describe the often complex hydrogen bonding patterns and motifs present in a 
3D crystal structure, a simple method of presenting these can be employed.  The method 
used within the crystallographic community is known as graph set notation.  The graph set 
notation effectively defines the morphology of hydrogen bonded arrays within the 
structure as well as their constituent donors and acceptors23.  The motif is identified and 
one repeating unit is used to generate the notation. 
 For intermolecular hydrogen bonds, the designator (X) C, R or D is assigned, 
corresponding to either a chain, ring or dimer morphology respectively. 
 For an intramolecular hydrogen bond, an S designation is given. 
 The number of hydrogen bond donors (d) and acceptors (a) is assessed and 
recorded as superscripts and subscripts, respectively 




Figure 13 - A sample of example motifs and their corresponding graph set notations
23
. 
Thus the eventual graph set is recorded in the form Xda(Y) (Figure 13).  An example of this is 
the common motif displayed by a carboxylic acid dimer (Figure 13, lower left), which would 
be defined as a R22(8) motif, being a ring morphology with two hydrogen bonding donors, 
two hydrogen bonding acceptors and eight atoms in total forming the ring. 
1.4.2 Π interactions 
Molecules with π electrons, either in a delocalised π cloud or in the π orbital lobes of a 
multiple bond may interact with each other.  Although significantly weaker than hydrogen 
bonding, these π electron interactions, or π-π bonds, are significant and useful for 
molecular stacking.  They π electrons of two neighbouring molecules, such as aromatic 
rings may interact with each other even in the presence of hydrogen bonding to the σ 
bonds of the system.  The molecules of a π-π bonded material approach each other such as 
to maximise this interaction within the allowances of stronger interactions and steric 
obstacles.  Given free rein, the molecules would tend to stack indirectly over each other so 
that the π orbitals would interlock most effectively – in the case of benzene, this would 
mean the rings would stack directly on top of each other (Figure 14, left) however when 




Figure 14 - Illustration of π-π stacking interactions and a perpendicular π-σ interactions of aromatic rings
24
. 
Depending on detailed electron distributions, aside from stacking planar to each other, the 
planes may be skewed (Figure 14, centre) or somewhat perpendicular (Figure 14, right), 
allowing for edge to face π-σ interactions24, 25.  Where π-π stacking is involved in a parallel 
arrangement, the accepted distance limits for a significant interaction are 3.3 Å - 3.8 Å, 
limited by the attractive nature of the π – σ charge band and the Pauli repulsion of the π-π 
negative charged fields (Figure 15), with an average bond energy of approximately 
2 kJ mol1. 
 
Figure 15 - Pauli attraction and repulsion effects in stacked aromatic rings
24
. 
In molecules where there is a large amount of aromatic character, the π-π stacking 
interactions may dominate over weaker or less abundant hydrogen bonding, becoming the 
primary driving force in the structural arrangement of the crystal. 
1.4.3 Halogen interactions 
One final type of significant intermolecular interaction found in the materials studied here, 
is that of halogen interactions.  Halogen to halogen interatomic distances in crystalline 
materials are often significantly less than the sum of the van der Waals radii for the two 
halogen atoms.  As a result of this they are regarded a “close contact”.  This interaction 
may merely be a result of the greater strength interactions directing the packing, but the 
halogen interactions are known to have a smaller, though not insignificant directing 
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influence upon the crystal structure.  These may exist between symmetrical pairings of 
interacting halogens, such a Cl···Cl, I···I or  Br···Br, or an unsymmetrical interactions 
between two different halogen types such as Cl···Br.  These interactions are categorised 















Figure 16 - Illustration of halogen-halogen interaction types. 
By the definition given by Desiraju 26, type 1 describes an interaction between two halogen 
atoms where the angle between the carbon-halogen bond and the halogen-halogen 
contact, θ, is equal for both molecules: θ1=θ2.  It is generally accepted that a type 1 contact 
is a consequence of crystallographic symmetry, with the halogen atom interaction across 
an inversion centre.  Type 2 is the description given to an arrangement where one of the 
angles θ is approximately equal to 180° and the other is approximately equal to 90°; the 
example of θ1≈180°, θ2≈90° is shown in Figure 16.  Type 2 halogen bonding results from a 
polarisation of adjacent halogen atoms from anisotropic non-spherical flattening of the 
electron density causing attraction; these can be regarded as donor-acceptor interactions27. 
Also to be considered are more classical donor-acceptor interactions involving halogens.  In 
such instances a covalently bonded halogen (X) may interact with an electron rich donor (D) 
in the form D···X-Y, where Y is the atom covalently bonded to the halogen.  This, similarly to 
hydrogen bonding, is a result of the differences in electronegativity between the two 
covalently bonded atoms, resulting in formation of a dipole, creating an electropositive 
halogen, attracted to the donor site.  Such an interaction can have varying strengths 
depending upon the atom types and differences in electronegativities.  They thus span a 
large bond energy range (5-180 kJ mol-1) 28.  
1.5 Crystal engineering 
A field that has potential for changing the physical properties of the given target materials 
in order to alter the reactivity is Crystal Engineering.  The aim is to design rationally the 
solid state crystal structure of the target materials by influencing available intermolecular 
interactions with the introduction of secondary materials to incorporate into the lattice.  
This method of engineering crystals has had much success over recent years, particularly in 
the pharmaceutical industry29, 30-35, in modifying solid forms of active ingredients in order to 
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tune physical properties to those beneficial for the desired application and is becoming 
commonplace in the process of producing new, efficient, stable forms of active 
components.  The field of crystal engineering was defined by Desiraju to have three facets, 
that of studying intermolecular interactions, the study of packing modes with the aim of 
defining a strategy and the study of crystal properties and how they may be fine-tuned 
corresponding to modifications in the packing20. 
Integration of a secondary component into a crystal structure is known to have a wide 
array of physicochemical effects and is thus suited well to the research detailed within this 
thesis.  Physicochemical properties known to be influenced by modification of the crystal 
structure include solubility31, 36, bioavailability31, 37, density, refractive index, conductivity 
(both thermal and electrical), melting points32, and, influencing some of these, free 
energy27, 31, chemical potential and thermal stability35, 38.  The reduction of reactivity has 
been achieved with other materials within the literature through solid state modification 
by crystal engineering methods however it is by no means commonly adopted.  Co-
crystallisation in particular has be used to quench reactivity of photodecarbonylation 
reactions39, and the use of halogen bonding in combination with π-π stacking has been 
used in an attempt to control the reactivity in the solid state40. 
This approach addresses the way molecular building blocks are arranged in a designed 
optimal superstructure, and as such it is a semi-synthetic methodology that identifies 
molecular building blocks of favourable molecular properties and intermolecular 
interaction capability which can be combined with a chosen primary material in a directed 
self-assembly of a new, designed, crystalline product41.  Aside from the legal ramifications 
of designing “new materials” that may be patented from older materials, hence giving 
them a new lease of life33, 35, crystal engineering is well suited as a method of providing a 
delivery method for a primary active component as the process does not necessitate the 
breaking of covalent bonds, hence no chemical changes are imposed upon a primary 
material, therefore retaining its intrinsic activity as an individual component whilst 
changing its solid state properties33.  Of course an influencing factor in the design of a new 
material by crystal engineering is that of reversibility; the gained stability of a reactive 
material, once achieved, must be able to be reversed.  The methods chosen here must 
facilitate such an easy return to the reactive state upon application.  In most cases this 
would be a dissolution process, releasing the reactive material from the intermolecular 




The primary driving force in the design of supramolecular structures is usually hydrogen 
bonding.  Although other interactions are significant, it is to be expected when an attempt 
is made to predict a final outcome of a crystallisation, that the strongest interactions will 
have the greatest influence over the final structural arrangement.  The empirical 
observation of predictable robust hydrogen bonding motifs has led to the creation of a 
guiding set of rules for supramolecular structure prediction that were outlined by Etter in 
199023.  The Etter rules for self-assembly of molecules containing hydrogen bonding sites 
are as follows: 
1. All good proton donors and acceptors are used for hydrogen bonding; 
2. Six membered ring intramolecular hydrogen bonds form in preference to 
intermolecular hydrogen bonds; 
3. The best proton donors and acceptors remaining after intramolecular hydrogen 
bonds are formed will form intermolecular hydrogen bonds to one another. 
These are augmented with additional rules for specific interactions23.  Those rules are easily 
explained and make sense: for the first rule, it makes logical sense that no interaction 
potential should remain unused; for the second rule, an intramolecular bond would be 
formed first, as the molecule need no seek for an intermolecular interaction, when a 
geometrically favourable one within the same molecule is available; the third rule follows 
from the first. 
The concept of a molecular synthon42 is a useful one within this context and describes an 
arrangement of molecular components of which the molecular interactions are known and 
reliably form a bonding pattern between them.  The synthon may be between the active 
material and another material present in the crystallisation and as such is a building tool in 
the larger crystal structure.  Depending upon the available bonding sites upon the 
molecules, the interactions may self-assemble in the presence of each other in a way as to 
maximise the use of the interactions, forming one large crystalline material containing 
more than one component.  As such when designing a molecular arrangement, the choice 
of the secondary synthons is one of, if not the most important step.  A secondary 
molecule’s interacting sites must be matched to the primary material in order to express 
favourable interactions and generate a synthon.  A crystallisation of two molecules may 
have multiple possible synthons as the hydrogen bonding may have unexpected 
preferential attraction or hindering features that prevent or drive the desired structure 























































Figure 17  - An example of two molecules generating multiple synthons. (a) Component 1 self dimerised, (b) a 
ring generated by the dimerisation of components 1 and 2, (c) component 1 recrystallising to form a pure 
component 1 chain, (d) components 1 and 2 alternating to form a multi component catemeric chain 
The interaction between components with favourable hydrogen bonding potential 
however is a competitive process.  This can have the effect of either helping or hindering 
formation of a designed material.  If the available hydrogen bonding pattern of a particular 
molecule in its pure state allows it to favourably hydrogen bond to itself, such as in a 
carboxylic acid where reliable dimerisation is observed43,44 (Figure 17), the relative 
energetic facility for it to do so may be greater than for it to hydrogen bond to another 
molecule, hence the material would recrystallise on its own without any inclusion of a 
secondary material at all, following the most energetically efficient route.  For this reason, 
molecules are chosen that exhibit a degree of complementarity, levelling the energetic 
playing field to allow crystallisation of the materials together, or if possible, making them 
more energetically favourable to co-form than to recrystallise in a pure state45.  
This necessitates matching the hydrogen bond donor and acceptor sites in the primary and 
secondary components, aiming to introduce partners for molecular recognition through 
these in the solution state where the self-assembly process is taking place, leading to pre 
association and coalescence in the solid state20.  Predicting likely interactions may be aided 
by the use of preliminary crystallisations of a material and observation of the outcomes.  
However, for statistical analysis and collation of similarly featured materials and crystal 
structures, it is becoming increasingly more efficient and reliable to assess likely 
interactions of a given material computationally.  The Cambridge Structural Database46 has 
thus been widely utilised here, and has proved valuable in assessing which types of 
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interactions a given material is likely to prefer, by assessing all recorded interactions of that 
material known and optionally including those similar to the target material47.  This field is 
now entering a point where prediction of new materials that are resultant from a crystal 
engineering experiment is becoming a real possibility48. 
The arrangement of the synthons defined by the crystal engineering technique may result 
in the formation of several different types of final structure, the most common of which are 
illustrated in Figure 18. 
 
Figure 18 - Illustration of various engineered crystal structure outcomes. 
Figure 18 (a) and (b) represent recrystallisations of a single material.  As is represented by 
the motifs, there may be more than one possible arrangement of the material: polymorphs.  
A polymorphic material expresses itself in more than one arrangement of the crystal 
structure and bonding motifs resulting in different molecular arrangements and 
conformations, designated as distinctly different phases49.  This is equally true of single 
component materials and multi component materials.  As a result of different molecular 
interactions, they have different physical properties and are energetically different, 
representing minima in a potential energy landscape where they are separated by a 
activation energy50.  Interconversion between polymorphs is possible and without a 
complete polymorph screening, it is impossible to definitively know whether an observed 
phase of a material is the most stable form, or meta-stable51.  It is suggested, although not 
confirmed, that “every compound has different polymorphic forms and that, in general, the 
number of forms known for a given compound is proportional to the time and money spent 
in research on that compound”52.  Although this comment is speculative, a lack of 
understanding of the polymorphic nature of materials has led to financially disastrous 
consequences for pharmaceutical companies53, with polymorphic transformations 
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occurring out-with the control of the manufacturers, leading to a change in physical 
properties of a crystalline product to those that were ultimately undesirable54. 
Figure 18 (c) and (d) show inclusion of solvent within a crystal structure, a common 
occurrence in both single and multi-component crystallisations.  This may occur in several 
different ways.  The solvent may be included in a solvate as part of the hydrogen bonded 
network, and as such would be included in any graph set notation describing the hydrogen 
bonding motifs (Figure 18(d)).  This may occur with inclusion of the crystallisation solvent, 
or in those crystallisations which involve the use of hygroscopic solvents, it is not 
uncommon for water to be absorbed from the atmosphere and incorporated into the 
structure.  Water molecules readily incorporate themselves into a crystal structure because 
of their versatile hydrogen bonding capabilities and their small size.  Incorporation of other 
solvents is also regularly observed, however it is only about 10% as prevalent55.  The 
presence of a strongly hydrogen bonding solvent within the structure often becomes an 
integral part of the hydrogen bonded structure as a whole56-58 and may prove vital to its 
stability, bonding itself strongly to the molecular components, preventing its loss by 
heating or causing structural collapse with its loss from the structure58.  In the second type 
of solvent inclusion within a crystal structure, a solvent molecule becomes incorporated 
within a pore or void in the structure (Figure 18c)59.  A structure may assemble around a 
solvent and be porous on the molecular scale allowing disordered solvent molecules to be 
located within multiple positions or to occur freely throughout a pore, channel or void 
without any strong HB interactions identified in the crystal structure.  In such a material it is 
usually easier to remove a solvent from a void by heating a sample, promoting escape and 
in some cases displacement of one solvent within a material with another.  The inclusion of 
large amounts of loosely bound water within the crystalline structure is fairly common in 
large biological molecules.  The large amount of solvent water present and its disordered 
nature in these structures often prevents complete assignment of all solvent electron 
density to precise coordinates, a fact equally true of non-biological structures60, 61. 
Figure 18 (e), (f) and (g) represent molecular complexes corresponding to a co-crystal, a 
charged ionic material or a salt, and an inclusion complex respectively.  These will be 
discussed in greater depth as a result of their extensive use within this research. 
1.5.1 Co-crystals, Cocrystallisations and Molecular-Complexes 
Co-crystallisation, represented by schematic (Figure 18(e)) is defined as the deliberate 
bringing together of two different molecules into a single crystalline solid “without making 
or breaking covalent bonds”62.  The result of such an experiment, if successful, is the 
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creation of a crystalline material that may be referred to under certain conditions as a “co-
crystal”, however this term is somewhat ambiguous and there is much debate as to 
whether “co-crystal”, despite its popularity, is the correct term at all63.  The ambiguity 
stems from the fact that the term co-crystal has and may refer to several different 
phenomenon within the literature: a composite-crystal64 consisting of two discrete crystal 
forms, connected at the molecular level, or a crystal structure of two separate materials to 
form one multi-component crystal structure in which the two co-formers are 
intermolecularly bonded to each other within the lattice throughout one domain.  A second 
definition also requires that the co-molecules must originate as solid at ambient 
conditions57 and thus excludes solvates and hydrates as well as charged materials and 
metal ions44.  As an attempt to avoid this ambiguity, within the course of this research the 
terms “multi-component crystal” and “molecular complex” will be used to describe such a 
material, with the addition of the word “solvate” or “hydrate” as required.  The use of the 
term co-crystal, if used, will only apply in the event that the structure being defined 
consists of neutral molecules where there has been no proton transfer and the molecules 
remain unchanged in their new intermolecular arrangement with each other. 
The term co-crystallisation however, is less ambiguous and is used extensively to describe 
the multi-component synthesis of a solid crystalline material containing both (or all) 
components, for example an active pharmaceutical ingredient and stabilising co-
molecule(s).  It is considered a softer synthesis methodology as there is no intentional 
breaking of covalent bonds in the selection of the crystallisation conditions.  However, as 
has been observed, bond breaking reactions can occur, leading to the formation of entirely 
new materials which may or may not end up forming molecular complexes. 
A co-crystallisation may be carried out by different methods, the most typical of which is by 
evaporation, the method primarily employed within this research (described in detail in 
Chapter 2).  The concentration of a solution containing two co-molecules is gradually 
reduced by loss of solvent to the atmosphere, causing supersaturation, nucleation and 
subsequent co-crystallisation.  Other methods include dry solid grinding and solvent drop 
grinding (a solvent catalysed variant of mechanochemical grinding), where mechanical 
energy is used to crystallise the two components together65, sonochemical co-crystal 
formation66 and simply melting the two components together34.  The resulting properties of 
the formed materials can be very different from those of the original components.  and the 
solid mechanochemical co-crystallisation method has been seen as a greener route to co-
crystals of interest as a result of the minimised or eliminated use of expensive solvents67 
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Co-crystallisation has had particular success in the pharmaceutical industry as it is ideally 
suited to the preferred solid dosage form of the consumer distribution of active 
pharmaceuticals, whilst the dissolution and dissociation of the co-molecules within the 
human body allows release of the API in un-modified form, allowing its function to be 
completed.  The technique has been utilised to alter aqueous solubility in many cases as 
well as melting behaviour in anti-cancer medication68, anti HIV drugs69 and aspirin70.  Co-
crystallisation has also been used as a separation tool for purifying materials and selectively 
removing synthons from reactions, thus controlling concentrations71 including the 
decaffeination of coffee72.   In the agrochemical industry, there has been new interest in 
the use of co-crystals over recent years, with patents taken out on new co-crystals of active 
agrochemical ingredients73 where more favourable modified physical properties have been 
achieved.  As such the creation of molecular complexes, or specifically co-crystals of 
agrochemicals and reactive materials seems well suited to the aims of this work. 
Of particular relevance to highly reactive materials, the use of co-crystallisation has been 
applied to explosives, propellants, pyrotechnics and other energetic materials with 
stabilising effects74  including the use of one highly reactive material to stabilise another.  It 
follows that this method could therefore be used for the crystal engineering of highly 
reactive peroxyacids if the correct co-component with sufficient complementarity can be 
found. 
1.5.2 Salt formation 
The difference between a salt (Figure 18(f)) and a co-crystal is that of charge.  Although 
both material types are multi component molecular complexes and are overall charge 
neutral, upon co-crystallisation a material may be formed in which both components are 
oppositely charged.  The materials may have originated as charged species in solution, a 
neutral solid salt, or two neutral molecules, however upon solid crystallisation a charge 
assisted network is formed.  Not all molecules within the molecular complex may be ions; 
materials may exist where there are charged and neutral components present throughout 
the structure, however overall charge neutrality is always maintained.  An organic material 
balancing a positively charged ion may typically deprotonate, particularly with carboxylic 
acids, to form a RCOO- anion. 
Two neutral organic materials may also become an ionised molecular complex as a result of 
a proton transfer effect from one material to the other, the degree of which varies creating 
a “salt-co-crystal continuum” of ionisation with co-crystals with no proton transfer at one 
extreme and complete proton transfer at the other, creating a salt75.  The probability of a 
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co-crystallisation resulting in a co-crystal or a salt can be predicted to a limited extent by 
analysis of the difference between the pKa values (∆pKa) of the two co-components.   
Equation 1 - Calculation of the difference in pKa in a given cocrystallisation experiment 
        [               ]     [    ] 
The difference in pKa as shown in Equation 1 when applied to a cocrystallisation experiment 
containing two materials, one which will act as a base and one which will act as an acid, will 
give a primary numerical assessment of the strength of the proton transferring ability of 
the pairing.  If this number is greater than 2 or 3, from empirical observations, it is 
predicted that a salt complex will form75, 76.  The closer the value is to zero or below, the 
more likely the cocrystallisation is to form a non-ionic co-crystal.  However, the pKa is not 
the only deciding factor.  For ∆pKa values between 0 and 3 the continuum type nature is 
truly observed where there is a large overlap in cocrystallisations forming a co-crystal or a 
salt.  This can be seen in the analysis by Cruz-Cabeza76 where a survey of 6465 crystal 
structures from the CSD46 were assessed for their ∆pKa and whether proton transfer had 
occurred (Figure 19). 
 
Figure 19 - Plot of 6465 co-crystals and salts from the CSD and their corresponding ∆pKa 
76
. 
In Figure 19, zone 1, representing ∆pKa of less than -1, there is a 99.1% probability of a co-
crystal forming exclusively.  In zone 3, corresponding to a ∆pKa greater than 4, there is a 
99.2% chance of a salt forming exclusively, with an approximate 40/60 % probability of a 
co-crystal/salt forming, respectively, in the range of ∆pKa between -1 and 4 inclusive
77. 
There are of course factors to consider other than pKa and it must be noted that pKa is an 
(aqueous) solution, not solid-state, parameter.  As can be expected, steric parameters78 as 
well as thermal conditions must have an influence on the hydrogen transfer ability.  
Hydrogen bonds, like any other bonds, upon increasing temperature exhibit thermal 
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vibrations.  The increase in temperature produces a spreading out of the hydrogen position 
along the axis of the bond, leading to ambiguity in its definitive position and distance from 
donor and acceptor.  In general this can be clarified by cooling to low temperatures (20K) 
during collection of a crystal structure.  This reduces the thermal motion, allowing for a 
more accurate position to be defined.  There have been examples however, such as in the 
complex pentachlorophenol and 4-methylpyridine in which a proton is observed to exhibit 
transfer at low temperatures but not at temperatures above 90K, leading to a lack of 
definition of whether the complex is entirely a co-crystal or a salt75.  Problems also arise 
from molecular complexes with different stoichiometric ratios.  In such cases, only some of 
the synthons may exhibit proton transfer, such as in the 2:1 complex of fumaric acid and 
anilinium79 where there is incomplete deprotonation of the fumaric acid molecules 
resulting in overall charge balance, but with the complex having the character of both a co-
crystal and a salt.  In some definitions this would still be called a salt however, as a “pair of 
molecules are ionised”80. 
The characteristics of changing the physical properties of a material by salt formation has 
long been used and parallels that of co-crystallisation, and in particular the pharmaceutical 
industry have used it for controlling formulations in distribution81.  Its use as a crystal 
engineering tool is as valid as that of the aim of creating co-crystals, providing 
deprotonation of a target or primary material does not compromise its efficacy 
permanently or permanently change the chemical behaviour of the material upon 
application. 
1.5.3 Inclusion complex (hosting) 
Figure 18(g) represents a hosted complex.  This is a generalised term covering many 
different situations.  The first of these is a molecular inclusion approach.  Co-crystallisation 
of a smaller target molecule with a secondary co-molecule which includes a large empty 
volume within its molecular structure can physically encapsulate the target material within 
this space, assuming the interior wall of the volume is compatible with the target material, 
i.e. the intermolecular interactions of the target material are attracted to those on the 
inside of the void.  There are several families of large molecules that are ideal for this type 
of co-crystallisation and are commonly used.  These include, but are not limited to,  
cyclodextrins60, 82, modified cyclodextrins83, crown ethers84, 85 and cucurbiturils86.  They are 
termed inclusion complexes as the larger material forms the majority of the structure.  The 
included component may alter the overall structure somewhat, but the main interactions 




Figure 20 - Unmodified α, β and γ – cyclodextrins. 
In the cyclodextrin family (Figure 20), it is typical for the ring shaped molecule to stack with 
other cyclodextrin molecules in opposite directions forming a barrel structure.  Depending 
on the type of cyclodextrin used, the size of the barrel may be chosen to best suit the 
molecule being hosted.  The included material is hosted within the hydrophobic void 
generated by this stacking and as such is locked in and protected from external influence 
(Figure 21). 
 




Not only does hosting a material within a guest molecule protect the included material by 
physically encapsulating it within the void in the sold state, but as with other co-crystals the 
physical properties are modified with respect to the hosting material. 
The second type of complex is that of urea inclusion compounds.  For many years urea and 
its related family of molecules have been noted for their ability to form tubular channelled 
structures in which secondary materials can be hosted.  In contrast to the hosting 
molecules noted above, the urea series are small molecules, forming extended open 
architectures by exploiting the strong hydrogen bonding potential for interaction with each 
other.  The urea type compounds are known to form a predictable hexagonal hydrogen 
bonded tubular structure (Figure 22), similar to a honeycomb design, with a cross surface 
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revealing a tunnel type void with an inner wall diameter (defined by the van der Waals 
surface) of between 5.5 and 5.8 Å 87. 
 
Figure 22 - Crystal structure of Urea revealing the tubular void. 
The void is sufficiently large for aromatic molecules to be incorporated into the channel, 
such as with glipizide87, without disrupting the crystal structure, which maintains its original 
parameters with small distortions resulting from bulky guests88.  They are particularly well 
suited to molecules resembling large aliphatic chains which may rotate their orientation 
within the void forming a disordered  or periodic arrangement, aligning the chain with the 
channel89.  Inclusion is not favoured, however, for non-chain molecules or those with bulky 
side groups.  Their preference for inclusion of long chain molecules is so strong that these 
complexes have been used for separation of linear alkanes from mixtures90.  The inclusion 
compounds based upon urea form the crystalline tunnels around the molecules during the 
crystallisation phase, the hosted material aiding in the structural integrity of the urea 
channels.  A typical synthesis of such a structure would employ slow evaporation of a 
solvent, or alternatively slow cooling of methanolic solutions containing urea (approx. 2M), 
and the desired guest, provides well-formed hexagonal needles, prisms or plates.  The 
crystals however tend to contain substantial amounts of methanol within the channels, as a 
result of its ability to flow freely through the comparatively larger diameter channel91.  This 
is not the case for larger solvent molecules such as DMSO, DMF and propanol.  An 
alternative method, described later, is to use solvent drop grinding methods, with 
methanol as a catalytic amount of solvent, for liquid guests and low volatility solids91. 
It has been shown that upon removal of the material from inside the void, the structure 
collapses and recrystallises in its pure crystalline phase90.  Thiourea, closely related to urea, 
also forms the same host type channelled structure, but due to the larger size of the 
molecule, the guest materials that can be incorporated are larger.  Thiourea channels have 
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been observed to host molecules as large as ferrocenes, cyclohexanes and other 
organometallics as well as easily incorporating benzene90;  the channel size can thus be 
tuned to suit the intended guest material.  Another feature of thiourea inclusion materials 
is the divergence from the strictly tunnelled structure, with the channels incorporating a 
slight bulge which constricts the channels.  The structure could thus be considered as an 
arrangement of smaller cages, increasing stability of the guest material by reducing 
disorder90. 
This method has been used previously to host diacyl-peroxides, where the structure of the 
included material within the host material was mediated by hydrogen bonding within the 
inner wall of the urea complex, regulating guest-guest interaction91.  Photolysis has been 
known to occur in such situations, generating radicals within the channels which may not 
escape to further the reaction, allowing their study92. 
The limiting size of urea inclusion structures, however, poses potential problems and 
adaptations have been attempted to allow for larger guest intercalation, for example using 
bis-urea macrocycles (Figure 23).  The connection of two urea molecules by an organic 
substrate forming a cyclic ring results in the crystallisation of a macrocyclic tubular stack, 
producing hosting channels with an internal diameter between urea molecules, aided by π 
stacking at a distance which may be altered depending on the size of the organic substrate 
used 93, 94. 
 
Figure 23 - Bis-urea macrocyclic molecule producing a channelled structure upon stacking
93
. 
One further extension of this is to link such generated stacks and nanotubes together with 
a further strongly bonded parameter, to form the material into a fully three dimensionally 
coordinated framework or “molecular scaffold” (Figure 18(g)).  As with the other void 
creating methodologies, the adaptability of these materials, resulting from the ability to 
customise produced voids by selecting constructing molecules of desirable functionalities, 
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making voids more or less attractive to the intercalated material, is the key to their use and 
popularity. The most commonly known type of these materials, achieving great interest in 
the last decade is the field of metal-organic frameworks, or MOFs for convenience, also 
termed coordination polymers and hybrid organic-inorganic materials.  Within these 
structures, the strong bonding network provides robustness and a pre-assembled well 
defined highly crystalline structure which like the other clathrate types, lends such stability 
to the included material.  Like previously described materials, they are generally assembled 
in situ around the material to be intercalated, often under solvothermal conditions aided 
by the directionality and rigidity of bonding of the framework forming materials,  These 
materials are generally favoured for their porosity, which only applies if the material can 
allow the intercalate to enter and then leave the network without the destruction of the 
network itself95. 
 
Figure 24 - Illustration of consecutively larger organic substrates incorporated into the molecular framework 
creating a larger intermolecular void (represented by yellow spheres)
95
. 
One such material of particular interest due to its adaptability, ease of construction and 
benign nature is that of the somewhat recently published edible MOFs, a family of 




Figure 25 - Non-toxic edible MOFs from gamma-cyclodextrins and eight coordinate K
+
 ions. 
These materials are attractive as MOFs as they use smaller non-toxic metals that are more 
abundant and renewable organic materials produced by natural methods, such as 
potassium and cyclodextrins, are utilised to form the superstructure.  As is seen in Figure 
25 (a) a large spherical superstructure is generated by linking the hydroxyl groups (d) on 
the primary (smaller) face of the cyclodextrin rings as well as glycosidic ring oxygen atoms 
by ionic association with the potassium ions.   The potassium ions further coordinate to the 
secondary outer faces resulting in eight oxygen coordination (e).  This produces cages with 
inner voids (c) of a diameter of 0.9nm with pores of 0.78nm and 0.42nm in which small 
neutral molecules may be stored96. 
1.6 Structural analysis of targeted materials 
Choosing the correct methodology for stabilisation of the target material with all cases 
relies upon an in depth understanding of the interactions involved and how they will affect 
outcomes of crystallisation experiments with these materials. 
1.6.1 Peroxyacids 
The structural chemistry of peroxyacids has not been widely studied, with only 16 known 
crystal structures held in the CSD, many of which lack the important hydrogen positions on 
the vital peroxide group.  Nonetheless, several structure determinations of pure peroxy 








Figure 26 - Peroxypelargonic acid. 
As an example of the confusing collection of data available, the active site of the molecule, 
the CO3H, was thought by Swern
12 to exhibit evidence of dimerisation similar to that 
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Figure 27 - (left) hydrogen bonded peroxyacid dimers - (right) carboxylic acid dimerisation. 
The assumed dimerisation would give weight to a methodology of hydrogen bonding to 
induce stability, by promoting  self-supporting peroxyacid units in a way similar to the well-
used carboxylic acid dimerisation98, a commonly utilised crystal engineering strategy, 
providing a predictable hydrogen bonding motif for intermolecular association.  Upon 
closer investigation of the interaction observed in the supporting data however, it can be 
observed that this is not the case.  Instead, as seen in Figure 28, the crystal structure of 
peroxypelargonic acid collected in 1965 by Jeffrey97, it can almost be understood how when 
viewed from a certain orientation, the mistake of assuming that molecules exist as dimers 
could be made, however when rotated to view from other angles, it becomes clear that this 
simply is not the case. 
 
 
Figure 28 - Hydrogen bonded "Dimer" observed from the b axis in the crystal structure of peroxypelargonic 




Figure 29 - Peroxypelargonic acid viewed along c-axis highlighting the true hydrogen bonding network. 
The literature defines the carbonyl as being involved in an intermolecular hydrogen bond 
to the terminal hydrogen of the peroxyacid functional group of a neighbouring molecule.  
Since the hydrogen atom is not modelled in the supplementary data for the structure, the 
distance measured from the carbonyl to the neighbouring basic oxygen, with the hydrogen 
atom present somewhere between the two, presumably on the side of the basic oxygen, of 
2.746Å – a moderate strength hydrogen bond.  The endmost single bonded oxygen, the 
basic oxygen as described earlier, participates in an intramolecular hydrogen bond to the 
terminal hydrogen of the dimerised peroxy acid.  Dipole moment data also indicates that 
the peroxy acids are approximately coplanar to each other, with the terminal hydrogen 
sitting out of the plane97.  It is not possible to confirm this from the crystal structure (Figure 
29), as the terminal hydrogen position is undetermined.  The peroxy acid component of the 
molecule forms a hydrogen bonded spiralling chain around the screw axis, with a moderate 
strength HB between the basic oxygen and the acidic oxygen of a neighbouring group, with 
O1 – O1 distance of 2.875Å, also considered a moderate strength hydrogen bond, showing 
indication that the hydrogen may be directed towards it also forming a bifurcated 
hydrogen bond (Figure 30).  The hydrocarbon chains lie parallel to each other and show no 




Figure 30 - Hydrogen bond distances between two neighbouring peroxypelagonic acid molecules. 
The interactions observed of the terminal hydrogen, are examined in the study of the 
crystal structures of four p-amidoperbenzoic acids99, following the general structure 
outlined in Figure 31 for the cases where n=1-4.  In each of these it is observed that the 
dimerisation present in peroxypelargonic acid is not observed and instead all four examples 










Figure 31 - General formula of p-Amidoperbenzoic acid family 
The first in the family, p-acetamidoperbenzoic acid has a moderate strength hydrogen 
bond, with an O-O distance (O1···H6-O4) of 2.574Å, from the carbonyl at the start of the 
aliphatic chain to the terminal hydrogen of a neighbouring group.  This is further verified by 
the presence of the terminal peroxy hydrogen within the plane of the hydrogen bond.  The 
hydrogen bonding motif is then completed as a chain by the weaker yet still moderate 
strength hydrogen bond with a N-O (N1-H1···O2) distance of 2.937Å between the carbonyl 




Figure 32 - Hydrogen bonded chain motif of p-acetamidoperbenzoic acid. 
These features are observed in all recorded structures of this family in the CSD, with π-π 
stacking along the a-axis and steric manipulation of the orientation of the molecules by the 
increasing aliphatic chain length, affecting the packing within the solid state.  The cases 
where n=1 and n=2 exhibit similar packing (Figure 33), where the molecules align 
themselves in an alternating 90° orientation to each other whilst maintaining the chain 
structure perpendicular to the plane generated by this feature.  For n=3 and n=4, this 
packing is no longer present, with the n=3 case exhibiting a sandwich structure, with the 
molecules in their entirety forming parallel sheets, as shown in (Figure 34) supported by π-
π stacking at a distance of 3.440Å, within the accepted range of such interactions, and the 
n=4 case stacked in alternating directions with a skewed, stacked scissor like arrangement. 
 
Figure 33 - Crystal structures viewed along the c-axis showing similar packing for p-acetamidoperbenzoic acid 




Figure 34 - Crystal structure of p-butanamidoperbenzoic acid viewed along a-axis. 
For the nitroperoxybenzoic acids, only the ortho-nitro and para-nitro structures are 
reported.  o-nitroperoxybenzoic acid shows a similar motif as the peroxyacids above.  Once 
again a chain is formed by the hydrogen bond generated between the terminal hydrogen of 
the peroxyacid and the carbonyl of the peroxyacid group of the neighbouring molecule 
(Figure 35).   
 
Figure 35 - Hydrogen bonded chain motif observed in o-nitroperbenzoic acid. 
The measured distance from O1 to O3 is 2.731Å, again a moderate strength hydrogen 
bond.  The nitro group does not interact with the peroxyacid and only forms interactions in 




Figure 36 - Close contact interactions present between nitro group and aromatic hydrogens as viewed along 
the c-axis of o-nitroperbenzoic acid. 
The crystal structure of p-nitroperbenzoic acid has a different hydrogen bonding 
arrangement.  The motif observed is very similar to that observed in peroxypelargonic acid, 
described earlier.  The primary interaction of the chain motif is a hydrogen bond between 
the peroxyacid carbonyl and the terminal peroxy hydrogen of the next molecule.  This 
interaction is again of moderate strength with an O1O3 distance of 2.740Å (Figure 37). 
 
Figure 37 - Primary hydrogen bonding motif observed along the c-axis of p-nitroperoxybenzoic acid. 
This primary peroxyacid interaction is supplemented within the structure by weaker 
interactions between nitro groups in a herringbone fashion with a close contact from the 




Figure 38 - p-nitroperbenzoic acid viewed along the b-axis showing the herringbone arrangement of the nitro 
groups. 
One of the final families of peroxyacids characterised and present in the CSD are the 3-oxo-
1,2-benzisothiazole-2-peroxycarboxylic acid 1,1-dioxides which have the general molecular 











Figure 39 - General formula of the 3-oxo-1,2-benzisothiazole-2-peroxycarboxylic acid 1,1-dioxides. 
A series of three of these compounds have been studied by single crystal X-ray diffraction, 
the smallest of which is 3-oxo-1,2-benzisothiazole-2(3H)-perethanoic acid 1,1-dioxide (n=1). 
 
Figure 40 - 2-Saccharinperacetic acid monohydrate viewed along the c-axis. 
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In this case, the chain arranged hydrogen bonding motif is distinctly different in the 
inclusion of a bond bridging water molecule between the peroxyacid carbonyl and the 
terminal peroxy oxygen (the terminal peroxy hydrogen position has not been determined) 
depicted in Figure 40.  The water molecule has the effect of bridging a gap between the 
“normal” position of the peroxyacid regular hydrogen bond donor/acceptor motif O7···O5.  
As a result of other bulky packing effects, this distance is increased to 4.772Å – beyond the 
range of even weak hydrogen bonds, instead forming two hydrogen bonds, one from 
O5···O3 (2.838Å) and one from O3···O7 (2.599Å) and joining the two molecules with two 
moderate strength hydrogen bonds.  As the hydrogens have not been accurately 
determined, the directionality of the bonds cannot be confirmed.  Another possibility is 
that the terminal hydrogen of the peroxyacid group could be directed towards the non-
basic peroxide oxygen of the neighbouring peracid.  The water molecule also exhibits a 
close contact with the aliphatic C-H on a third molecule, further stabilising its position.  The 
S=O groups also point towards both another aliphatic C-H and the carboxylic carbon on a 
peroxy group, creating infinite chains. 
The second in the family, n=2, exhibits an entirely different motif, presumably resulting 
from the increased aliphatic chain length allowing a more efficient packing arrangement.  In 
this case (Figure 41) it can be seen that the peroxyacid functional group does not interact 
with any other peracid oxygens, unlike all other structures observed.  The terminal peroxy 
hydrogen is then definitively directed and thus hydrogen bonded to the carbonyl upon the 
3-oxo-benzothiazole part of the next molecule with an O2···O5 distance of 2.618Å. 
 
Figure 41 - Crystal structure of N-Saccharinperpropanoic acid showing primary hydrogen bonding motif. 
This shows that not only will the peroxyacid hydrogen bond with other peroxyacid 
functional groups, but also with any sufficiently electronegative carbonyls.  The carbonyl 
oxygen in the peroxyacid group exhibits a close contact with an aromatic C-H of a 
neighbouring molecule.  The molecular structure, with the exception of the sulphur oxygen 
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bonds, is planar creating hydrogen bonded planes with only π-π stacking interactions 
between the planes.  There is also symmetrical disorder present in the aliphatic chain, 
however it has no effect upon the position or orientation of the functional parts of the 
molecule.  
 
Figure 42 – Antiparrallel dimers of N-Saccharinperpentanoic acid as viewed along a-axis. 
In the third of this family whose structure is known (n=4; 3-oxo-1,2-benzisothiazole-2(3H)-
perpentanoic acid 1,1-dioxide), the peroxyacid functional group does not play a prominent 
role in the structural architecture.  Figure 42 shows how the molecules are aligned 
alongside each other stacked anti-parallel to one another.  This allows close contact 
interactions between the non-terminal peroxyacid oxygen and an aromatic C-H at either 
end of the rotated molecule forming dimers which are reinforced by the carbonyl on the 
five-membered ring interacting with an aliphatic C-H.  On the other side of the molecules, 
the peroxyacid carbonyl also interacts with an aromatic C-H, forming chains, and also with 
an aliphatic C-H out of the plane.  As before, π-π stacking is also present in the structure.  
There are no specific interactions with the terminal peroxide OH group in this example. 
In the known crystal structures of such materials, the primary interaction of the peroxyacid 
functionality thus appears almost invariably to be moderate strength hydrogen bonds 
between the terminal basic oxygen of the peroxyacid group to either a neighbouring 
peroxyacid carbonyl, or other electronegative carbonyl within the structure.  The exception 
to this is for cases where the steric interactions of the remainder of the molecules 
dominates, preventing such interactions taking place. 
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1.6.1.1 Compounds of interest 
The peroxyacid compounds to be studied are outlined here.  The primary material targeted 
for stabilisation is 6-phthamilidoperoxyhexanoic acid.  Of particular interest for its 
utilisation as a potential low temperature laundry bleach, its crystal structure was collected 
along with three other members of the same phthalimidoaliphatic peroxyacids by Feeder 
and Jones in 199614.  The molecular formula of 6-phtalimidoperoxyhexanoic acid (Figure 43) 
shows the features of the family of molecules – a peroxyacid head, a phthalimido tail and 
an aliphatic hydrocarbon backbone of varying length – with the 6-
phthalimidoperoxyheaxanoic acid being the six-membered aliphatic chain example.  The 
steric characteristics will play a role in assembly of these molecules, as well as π stacking 
effects, alongside the predicted peroxyacid interaction behaviour as highlighted by the 
other materials surveyed above.  The material is a white solid at room temperature with a 








Figure 43 - Molecular structure of 6-phthalimidoperoxyhexanoic acid. 
The second material under study is meta-chloroperbenzoic acid (Figure 44).  MCPBA is a 
common oxidising agent, routinely used in organic synthesis.  In contrast to its frequency of 
use, the study of its solid state properties is limited, with no crystal structure reported in 
the CSD.  Again the peroxyacid group should be the most significant interaction of this 
molecule, however the presence of the aromatic ring and the chlorine atom opens the 
molecule to the possibilities of π stacking interaction and halogen interactions.  At room 
temperature it exists as a white solid that is quick to draw water from the air to give it a 
sticky texture, thus working with it can prove difficult.  These difficulties may be overcome 
by aiming to develop a method of co-crystallisation with a secondary material that can be 
used for the phthalimidoperoxyacids in general. 
 






The third and final peroxyacid under study is that of the simplest of all peroxyacids, 
peroxyacetic acid.  Peroxyacetic acid is a liquid at room temperature, typically supplied in 
equilibrium with acetic acid, and thus technically any material formed by a cocrystallisation 
containing it would be a solvate of the presumably solid co-former.  Any stabilisation of the 
peroxyacid functional group would potentially apply to all peroxyacids, no matter their 
secondary functionalities.  The material therefore gives us the ability to study the 
peroxyacid group itself, unhindered by secondary interactions, relying only upon the motifs 
generated by the peroxyacid group.  As it is a liquid at ambient conditions, no 







Figure 45 - Peroxyacetic acid. 
1.6.1.2 Known crystal structures containing the target materials 
In order to fully understand and be able to predict the interactions of 6-
phthalimidoperoxyhexanoic acid, the family of molecules of which it is a member have 
been examined.  In the reported structures of the family of molecules, none of the terminal 
peroxy hydrogens are reported.  In 3-phthalimidoperoxyhexanoic acid, hydrogen bonding 
at the peroxyacid end of the molecule is observed between the terminal basic oxygen of 
the peroxyacid group and the carbonyl of the phthalimido group with an O···O distance of 
2.779Å (Figure 46) with the hydrogen assumed to be located between the two atoms, on 
the peroxyacid side.  The peroxycacid carbonyl is not the HB acceptor in this structure as 




Figure 46 - 3-phthalimidoperoxypropanoic acid viewed along a-axis showing hydrogen bond between 
phthalimido O1 and basic peroxyacid O5. 
This motif is also observed in the next molecule in the series, 4-phthalimidoperoxybutanoic 
acid, but in this case the molecules are aligned in a parallel arrangement (Figure 47) as 
opposed to the alternating direction seen in the previous member of the series.  The 
hydrogen bond distance in this example is 2.753Å, again a moderate strength interaction. 
 
Figure 47 - 4-phthalimidoperoxybutanoic acid showing O2···O5 hydrogen bond distance. 
As the chain backbone length increases within the series from four carbons to five, the 
peroxyacid bonding motif changes to the more common motif seen in peroxyacids.  The 
primary hydrogen bond is located between carbonyl O3 of a neighbouring molecule and 
terminal peroxyacid oxygen O5 with a O···O bond distance of 2.715Å, a moderate strength 
hydrogen bond.  The terminal peroxyacid oxygen is also within moderate to weak hydrogen 
bonding distance of 3.002Å to the non-terminal acidic oxygen of the neighbouring 
peroxyacid in the opposite direction, resulting in ambiguity as to whether the peroxy 
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hydrogen is located in this interaction O5-H···O4 or in the predicted carbonyl interaction 
O5-H···O3 (Figure 48).  It is assumed that the hydrogen is in fact directed towards the more 
electronegative carbonyl however the ambiguity can only be eliminated by a determination 
of the proton position.  The assembly of the structure is further aided by steric factors and 
by interaction of the π-π stacking phthalimido groups which fall within accepted π stacking 
distances, at 3.602Å. 
 
Figure 48 - 5-phthalimidoperoxypentanoic acid as seen along the a-axis showing the hydrogen bonded chain 
motif aided by π-π stacking. 
The larger backbone of the molecule also lends itself to this packing arrangement, with the 
aliphatic chains separating the channels of hydrogen bonding interactions generated by the 
peroxyacid groups from the channels of phthalimido π-π stacking. 
The final molecule in this family studied is the target molecule itself,  
6-phthalimidoperoxyhexanoic acid.  The existing structure in the CSD, like the rest of the 
family, does not determine the terminal peroxyacid hydrogen position.  As such the full 
structure of this molecule was studied as part of this research.  The main features of the 




Figure 49 - 6-phtalimidoperoxyhexanoic acid as viewed along the a-axis showing hydrogen bonding channels. 
The structure is very similar to that of the previous member in the family, with the terminal 
basic oxygen of the peroxyacid group forming a moderate strength hydrogen bond that is 
closer in distance to the carbonyl of a neighbouring peroxyacid group (Figure 49).  The 
O5···O3 bond distance is 2.717Å and is likely the direction in which the hydrogen atom is 
located.  The other possible hydrogen bond orientation has a larger bond distance between 
O5···O4 of 2.972Å and therefore is the weaker of the interactions.  Also similarly to the 
previous member of the series, the aliphatic chain orients the molecules to allow a channel 
of hydrogen bonding to be formed, and π-π interactions that lie within the accepted π-π 
stacking range.  Unlike the previous member of the series however, the phthalimido groups 
are angled in the opposite direction, resulting from the increased carbon atom in the 
aliphatic chain. 
All of the molecules within the phthalimidoperoxyaliphatic acid family have the 
characteristic phtalimido group, which is in itself relatively well studied and the interactions 
it is likely to have may be assessed more statistically.  The phthalimido group presents 
significant intermolecular interaction potential which could be exploited for crystal 




Figure 50 – Collated atomic short contacts of a phtalimido group as shown in isoStar, with red spheres 
representing close oxygen contacts and white spheres representing hydrogen atom positions from recorded 
crystal structures in the CSD. 
As can be seen in Figure 50, an isoStar plot of non-bonded interactions as collated from the 
CSD100, the interactions around the phthalimido group are of two general types.  Aside from 
the red oxygen interactions around the aromatic hydrogens on the 6-membered ring in 
which the hydrogens are acting merely as hydrogen bond donors to another molecule, the 
predominant interactions are those that are primarily hydrogen bond-like in nature, around 
the carbonyls at the head of the group.  These interactions (Figure 51) mainly originate 
from standard hydrogen bond donors N-H···O, O-H···O but also a few C-H···O interactions. 
 
Figure 51 - Interactions of phthalimido group directed towards the carbonyls. 
It may be taken from this evidence and from the hydrogen bonding density distribution 
map of these interactions (Figure 52) that the carbonyls are obviously the main area of 
interaction for the phthalimido molecule, as expected from their high electronegativity, 
and is likely increased by the aromatic nature of the group and the delocalisation of the 




Figure 52 - Hydrogen bonding density distribution map representing close contacts around phtalimido 
functional groups for all known CSD structures. 
Secondary to the hydrogen bonding interactions in terms of influence is the aromatic 
character of the phtalimido group itself. 
 
Figure 53 - C-H interaction density plots for the phtalimido functional group. 
From the plots of interaction density (Figure 53), where red regions show the highest 
density of C-H interactions with the phthalimido groups, it can be observed that the most 
focussed areas of these types of short contacts are situated above and below the planes of 
the rings, most likely originating from π-π stacking.  This is therefore an important 
interaction that must be considered with these molecules, as has been noted with the 
phthalimidoperoxyaliphatic acids in their pure structures. 
There is no solid state crystal structure on record for meta-chloroperbenzoic acid, and so 
one of the aims in studying this material was to determine this structure.  Leading from the 
observation of the hydrogen bonding motifs in all other peroxyacids recorded in the CSD, it 
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can be predicted that the crystal structure of MCPBA should exhibit similar characteristics.  
In particular it could be expected that the terminal peroxyacid hydrogen will be hydrogen 
bonded to the carbonyl of a neighbouring molecule, likely forming a catemeric chain that 
would be assisted by π-π stacking originating from the aromatic ring.  It is unclear at this 
point what effect the chlorine atom substituted on the aromatic ring will have upon the 
structure other than obvious steric effects resulting from its larger atomic radius. 
 




The closest resembling material to MCPBA within the CSD is that of 2-carboxylato-
monoperoxy benzoic acid, which is known to form a 2:1 structure with magnesium 
hexahydrate101 (Figure 54).  Unfortunately the atomic coordinates and atom parameters 
are not available for a more complete evaluation.  It appears, however, that the main 
interaction within the association to the magnesium complex is only via the carboxylate 
group, but interaction between the peroxyacid groups must be expected. 
Peroxyacetic acid, being a liquid, has no crystal structure known, and it was not expected 
that it would be possible to collect this within this research due to its volatile nature. 
No known structures containing any of these three target materials as a component in a 
multi component crystallisation are known to exist.  However, it can be  assumed that any 
material to be used as a co-former in a multi-component experiment should contain either 
a carbonyl for interaction with the terminal peroxyacid hydrogen, or in the cases of the 
phtalimidoperoxyaliphatic acids and meta-chloroperbenzoic acid, have a delocalised π 
electron character available for interaction with the phthalimido and the aromatic groups 
respectively.  With the 6-phtalimidoperoxyhexanoic acid, it was predicted that any co-
forming molecule will not only be competing with the carbonyl-terminal hydrogen 
peroxyacid functional group interactions, but also the phthalimido carbonyls present within 
the target material structure.  Secondary components that may be utilised in attempts to 
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form new multi-component materials may include those with either of these characteristics 
or a combination of both, including, but not limited to, carboxylic acids, ketones, and 
quinones. 
1.6.2 Agrochemicals 
As mentioned above two agrochemical compounds are studied as target materials within 
this research.  They are both structurally very similar, being isomers of each other.  The 
materials being targeted for stabilisation by cocrystallisation are 2,4-dichlorophenoxyacetic 
acid (2,4-D; Figure 10 and 3,4-dichlorophenoxyacetic acid Figure 11). 
The main points of interaction can be easily identified as being the hydrogen bond 
donor/acceptor group of the carboxylic acid, the electronegative lone pairs on the aromatic 
oxygen substituent and of course the aromatic chlorine atoms as well as the π-π stacking 
potential originating from the benzene ring.  It is easily predicted that the carboxylic acid 
will be the dominant hydrogen bonding interaction in a like-for-like multi-component 
crystallisation, likely forming the familiar R22(8) ring motif with another carboxylic acid 
molecule. It would be sensible therefore to attempt co-crystallisation experiments with 
other carboxylic acids. 
Analysis of the pure materials, aided by study of their known structure in the CSD102 shows 
this to be the case.  With 2,4-D it can be observed (Figure 55) that dimers are formed via a 
double moderate strength hydrogen bonded ring between the carboxylic acid groups, with 
the R22(8) motif and O-H···O bond distances of 2.633Å.   
 
Figure 55 - Hydrogen bonding motif in 2,4dichlorophenoxyacetic acid as viewed along c-axis. 
The carboxylic acid carbonyl also makes a short contact to the aromatic C-H between the 
two chlorine atoms of a neighbouring dimer of C-H···O distance 3.433 Å, a weak interaction.  
The dimers are arranged in a stacked interlocking pattern, held in place by π-π stacking 




Figure 56 - 2,4-dichlorophenoxyacetic acid highlighting angle of carboxylic acid group from the plane of the 
benzene ring. 
In the crystal structure, the chain angle is 112.12° , as would be expected for such a bond 
but with the rotation around the oxygen resulting in the plane of the benzene rings being 
perpendicular to each other in the dimer unit whilst allowing for the primary hydrogen 
bonding interactions (Figure 56). 
The structure of pure 3,4-D103 has both similarities and distinct differences to that of 2,4-D.  
The main interaction is again the R22(8) hydrogen bonding motif between two carboxylic 
acid groups as would be expected, with a moderate strength  O-H···O HB with a bond 
distance of 2.636Å, creating dimer units as before. 
 
Figure 57 - Crystal structure and primary interactions with measured distances in 3,4-dichlorophenoxyacetic 
acid. 
The R22(8) dimer motifs are sandwiched by a dimer above and below, parallel to the 
direction of the hydrogen bonding, allowing alignment of the alkoxy oxygen with the 
carboxylic carbon producing a packing motif of parallel stacked dimers at a distance of 
3.114Å, slightly stronger than the accepted π-π stacking interactions but of a comparable 




Figure 58 - 3,4-dichlorophenoxyacetic acid in the pure crystalline state with a plane generated through the 
benzene ring. 
The structure is more two dimensional in nature than that of 2,4-D (Figure 58).  The entire 
molecule lies in plane with the benzene ring and follows through the hydrogen bonding 
motif to the entire dimer and the structure as a whole.  This structure lacks the acidic 
hydrogen atom determination, however with the motif observed, it can be certain that the 
hydrogen is in plane with the rest of molecule on the hydrogen bond. 
1.6.2.1 Known crystal structures containing the target materials 
These two target materials, 2,4-D and 3,4-D are known to have been included in multi 
component molecular complexes in both their protonated and unprotonated form.  2,4-D 
has been shown to form discrete ionised salts with six materials recorded in the CSD, where 
the charged 2,4-D is molecularly separate and not chelated to the secondary material.  
These materials are a hydrated potassium salt, a benzimidazolium salt, an ammonium salt, 
a 3-hydroxypyridinium salt, and a salt with dicyclohexylammonium104, 105, 106, 107.  The final 
complex in which the molecule exists as a discrete ion is one in which a second ion of the 
molecule is also coordinated to a compound containing two charged manganese centres.  
In all of these instances, with the exception of the hydrated ammonium salt where it is 
planar like pure 3,4-D, the molecule retains its bent conformation in the final structure. 
In its protonated form, 2,4-D has been shown to form six multi-component molecular 
complexes, two of which are substituted β-cyclodextrin hosted materials in which the 2,4-D 
is located within the barrel of the much larger β-cyclodextrin molecule whilst maintaining 
its twisted conformation108.  It is also observed to have formed complexes with 2-
aminopyrimidine109, 4,4-bipyridine110, 4-aminobenzoic acid and triphenylphosphine oxide104 
of which only the 4,4-bipyridine and the 4-aminobenzic acid force planar geometry upon 
the 2,4-D molecule.  There are also 14 structures of 2,4-D in the CSD in which it is 
deprotonated and coordinated to a metal centre.  Of these structures, four of the metal 
centres are copper, three are cobalt, two are zinc, two are nickel, with one example of each 
of vanadium, silver and tin. 
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3,4-D in comparison has fewer known molecular complexes on record.  There are two 
known molecular complexes in which 3,4-D remains protonated, one of which is 
triphenylphosphine oxide111 and the other 2-aminopyrimidine109.  In the triphenylphospine 
oxide, the molecular attraction is via a short moderate strength hydrogen bond of O-H···O 
distance 2.597Å between the phosphine oxygen and the acidic hydrogen of the 3,4-D.  The 
molecular complex with 2-amidopyrimidine has a more complicated hydrogen bonding 
interaction network: there is a an R22(8) hydrogen bonding motif present between the two 
synthons with an O-H···N short hydrogen bond of length 2.540Å and a longer, moderate 
strength N-H···O bond of 2.893Å forming a dimer between the two molecules.  Two dimers 
are then further connected by a weak hydrogen bond of 3.390Å between the remaining 
unbounded amino hydrogen and the alkoxy oxygen of two neighbouring dimers forming a 
block of four molecules whose only further interactions are chlorine-chlorine interactions 
and π-π stacking from all four of the molecules (Figure 59). 
 
Figure 59 - 3,4-D 2-Aminopyrimidine molecular complex showing hydrogen bond distances of primary 
interactions. 
There is only one example in which 3,4-D exists as a discrete deprotonated material, in a 
complex with zoxazolamine112.  The deprotonation is the result of a proton transfer in the 
plane of a short strong hydrogen bond (2.546Å) in the observed R22(8) motif that is once 
again observed with the carboxylic acid functional group.  The second hydrogen bond in the 




Figure 60 - Zoxazolamine 2-(3,4-dichlorophenoxy)acetate showing primary intermolecular interactions. 
The dimers (Figure 60) are again interconnected in pairs by weaker hydrogen bonding 
interactions present between amino hydrogens and alkoxy oxygens (3.176Å) and aromatic 
hydrogens to the secondary oxygen in the 5 membered ring of the zoxazolamine (3.380Å).  
3,4-D is known to coordinate to only one metal centre, manganese. 
In summary, both 2,4-D and 3,4-D are quite versatile molecules with much potential for 
intermolecular interaction with a variety of materials including acids, amines, amides and 
both transition group and alkali metals.  Given that both molecules have the potential to be 
deprotonated, one particular area of interest that was therefore studied was that of 
interaction with proton sponge materials, which primarily use nitrogen lone pair 
interactions to form short strong hydrogen bonds to the acidic hydrogen of carboxylic acid 
molecules to the point in which the hydrogen is transferred to the proton sponge molecule 




2. Analytical Theory 
A range of techniques have been employed to characterise the products from the 
experimental work carried out in this work.  With the expected diversity of materials 
produced, medium to high throughput techniques to study the large number of samples 
were needed, highlighting the more relevant and interesting products for further study.  
Materials which were highlighted as previously unknown or those which gave information 
on the behaviour and reactivity of the materials under study were then further 
characterised fully by X-ray diffraction techniques, along with other supporting analytical 
methods. 
2.1 Crystallography 
The crystalline nature of the products in a large proportion of the samples provides a 
method of precise analysis through crystallographic methods.  A crystalline structure is one 
that is defined as having a distinct motif of atoms repeated in three dimensions throughout 
the material in its solid state forming a lattice.  When represented in its smallest volume, 
the dimensions of this repeating motif in the x, y and z directions can be represented by the 
basis vectors a, b and c and the angles between these, α, β and γ (Figure 61).  These vectors 
can operated any point in the lattice to translate to the next equivalent position or lattice 
point in the extended structure113.   
 
Figure 61 - A unit cell showing vectors a, b and c with corresponding angles α, β and γ, forming a box in the x, 
y and z axes. 
The physical volume described by these vectors is referred to as the unit cell, the building 
block which through translation creates the extended lattice.  The contents of the unit cell 
can thus be described in relation to the vectors a, b and c in fractional coordinates (x,y,z) of 
those vectors.  An atom described in a unit cell with these fractional coordinates will be at 
the same fractional coordinates throughout the entire crystal. 
Symmetry present within the lattice gives rise to seven possible crystal systems which in 
turn express themselves in the shape of the unit cell, as shown for the seven unit cells in 
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Figure 62, and the geometry of the external faces of crystal itself114.  The seven crystal 
systems exhibit restrictions on their cell dimensions and angles to allow for the various 
symmetry elements ( 
Table 2).  Convention states that aside from symmetry considerations, all dimensions 
should be as small, and angles as close to 90°, as possible. 
Crystal System Essential Symmetry Restrictions on Unit 
Cell Dimensions 




Triclinic None a ≠ b ≠ c α ≠ β ≠ γ ≠ 90° P 
Monoclinic One two-fold rotation and/or 
mirror 
a ≠ b ≠ c α = γ = 90° P, C (I) 
Orthorhombic Three two-fold rotation 
and/or mirror 
a ≠ b ≠ c α = β = γ = 90° P, C (A), F, I 
Tetragonal One four-fold rotation a = b ≠ c α = β = γ = 90° P, I 
Rhombohedral One three-fold rotation a = b = c α = β = γ ≠ 90° P (R) 
Hexagonal One six-fold rotation a = b ≠ c α = β = 90°; γ = 120° P 
Cubic Four three-fold rotation axes a = b = c α = β = γ = 90° P, I, F 
 
Table 2 - The seven possible crystal systems and their restrictions on the unit cell dimensions along with their 




    
      Triclinic  Monoclinic  Orthorhombic 
     
  Tetragonal  Rhombohedral     Hexagonal   Cubic 
Figure 62 – Primitive unit cell shapes imposed by restrictions generated from symmetry. 
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In some cases, a primitive unit cell lattice (P) may not fully address the symmetry present.  
In these, further lattice points may be added into the cell description by increase of 
volume, adding to the six primitive lattices, an additional eight centred lattices to produce 
the fourteen Bravais Lattices.  The lattices are described to be A, B or C centred if a lattice 
point is present on the a, b or c faces respectively and F centred if a there is a lattice point 
on all faces.  If the lattice point is at its (body) centre, it is I centred113.  Any further 
symmetry in a crystal structure is within the cell itself.   
Although the unit cell may be the smallest translating volume within the structure, it is in 
the majority of cases not the smallest unique part of the structure.  The asymmetric unit is 
the smallest unique part of the crystal structure which, through symmetry operations, can 
generate the unit cell and through translation, the structure as a whole.  The presence of 
rotation, reflection and inversion, along with combined rotations and translations – screw 
axes – and reflections and translations – glide planes (Figure 63), leads to the subdivision of 
the lattice types to 230 possible unique space groups 116, defining all possible arrangements 
of an asymmetric unit 117. 
 
Figure 63 - Representation of possible symmetry elements present within the unit cell (a) reflection, (b) glide 
plane - reflection and translation, (c) rotation, (d) screw axis - rotation and translation, (e) inversion centre. 
The nature of the crystallinity in organic, inorganic and metallic materials is such that the 
unit cell generated by the lattices under observation is of the size (3-40 Å113) comparable to 
the wavelength of X-ray radiation.  As a result, the lattice can act as a three dimensional 
diffraction grating causing constructive and destructive interference effects on a coherent 
X-ray beam and hence can be studied by X-ray diffraction. 
2.2 X-ray Diffraction 
In laboratory based experiments, monochromatic X-rays are typically generated using a 
sealed X-ray vacuum tube in which a high voltage (30-60 kV) is passed through a metal 
anode (Figure 64).   
(a) 
a) 




Figure 64 - Cutaway of a standard high vacuum X-ray tube with Cu anode and plot of wavelength against 
intensity showing characteristic K peaks 
113
. 
The type of metal anode chosen for a particular experiment is dependent on the 
wavelength of radiation required.  Commonly for small molecule experiments, a 
molybdenum or copper target is used, with different characteristic wavelengths depending 
on the energy difference between the electron shells in the target material (Table 3).  In 
order to achieve an intense monochromated beam of X-rays, the radiation is tuned either 
using a filter, or more commonly a single crystal of graphite or other suitable material 
orientated to the beam such that only the more intense Kα radiation wavelength meets the 








K ̅ (Å) 
Molybdenum 0.70926 0.713543 0.71069 
Copper 1.54051 1.54433 1.54178 
Iron 1.93597 1.93991 1.93728 
Table 3 - Kα wavelengths of commonly used X-ray tube sources, along with averaged 2:1 weighted Kα 
113
. 
The two X-ray diffraction techniques used in this work, single crystal X-ray diffraction and 
powder X-ray diffraction, rely upon the same initial principle.  An X-ray beam incident on a 
crystal interacts with the regular array of concentrations of electron density in the lattice, 
notably around atoms and in covalent bonds.  The degree to which the beam of X-rays 
interacts is dependent on the relative abundance of electron density and thus is 
proportional to the atomic number.  Materials with heavier elements, for example 
containing heavier metals, therefore diffract X-rays better than those which have fewer 
electrons, such as organic materials with only carbon, hydrogen and oxygen.  Scattering 
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from the regular planes of a crystal results in constructive and destructive interference 
patterns as shown by the Bragg condition, Figure 65. 
 
Figure 65 - Illustration of the Bragg construction for diffraction from a set of crystal planes. 
For constructive interference to occur, coherent X-rays incident on the parallel planes of 
spacing d at an angle θ to the plane are diffracted (reflected) with a path difference of 
2dsinθ between parallel planes; for constructive interference to occur, this must equal an 
integral number of wavelengths (Equation 2).    
Equation 2 – The Bragg equation for constructive interference 
                            ) 
Equation 3 – Rearrangement of the Bragg equation, to give the scattering angle at which diffraction from 
particular lattice spacings will be observed 





    
 
In three dimensions, these planes can be labelled with the Miller indices h, k and l, and 
results in discrete reflections satisfying the Bragg equation: nλ=2dhklsinθ for a particular set 
of (hkl) planes.  A regular pattern of spots, or reflections, is thus observed at the detector.  
The separations between reflections are related inversely to the lattice 113, hence it is 
named “the reciprocal lattice”.  From the measurement of spacings of the diffraction 
pattern, it is therefore possible to calculate the spacing of the lattice and infer its symmetry 




Figure 66 - Reciprocal lattice as observed via reflections measured on an image plate detector. 
This can be presented using the Ewald Construction (Figure 67).  It follows from 
observation that upon diffraction, the scattering vector    is equal to a reciprocal lattice 
vector  , a consequence of the orientation of the lattice parameters in the sample.  A 
sphere of radius 
 
 
 centred at the point of diffraction, will at its edge (the position of the 
detector) satisfy the Bragg equation for production of constructive interference.  When a 
lattice point on the reciprocal lattice is placed on this point (0,0,0), any other points in the 
lattice that overlay the surface of the sphere also satisfy the Bragg conditions for 
constructive interference and a reflection is observed.  It is then possible by rotating the 
orientation of the crystal and correspondingly the reciprocal lattice, to allow for the lattice 
points to be observed and have their intensities measured by the detector. 
 





Lattice points which cannot be rotated to intersect with the surface of the sphere cannot 
be observed as they cannot satisfy Bragg’s Law for the given wavelength of incident 
radiation.  To increase the number of reflections accessible, i.e. which are within the Ewald 
sphere, the incident wavelength must be decreased, giving access to measurements of 
lower d-spacings. 
The position of the reflections and their intensities contains the information both to 
calculate the dimensions and symmetry of the crystal lattice, and its contents within the 
unit cell.  The information on the unit cell contents is held within the intensities of the 
reflections in the reciprocal lattice, related to the electron density by Fourier transform.  
The observed diffraction pattern is the Fourier transform of the electron density and is 
defined in terms of the structure factor      at a defined reciprocal lattice point    . 
Equation 4 – The structure factor components (amplitude and phase) 
     |    |   
[     ] 
The structure factor consists of two components, amplitude |    | and phase      
(Equation 4), for each reflection and is calculated by summing the electron density      ) 
at every point in the unit cell multiplying by  [            )] and then integrating for the 
entire cell volume (Equation 5). 
Equation 5 – The structure factor as the Fourier transform of the electron density 
     ∫      )   
[            )]
 
    
   
In turn, the diffraction pattern is related by an inverse Fourier transform to the electron 
density (Equation 6), where   is the volume of the unit cell. 
Equation 6 - Electron density expressed as a reverse Fourier transform of the structure factor 
     )  
 
 
∑      
     
 [            )] 
From the experiment, the intensities can be measured directly by integration of the 
reflections, but the phase information is lost for each reflection.  Consequently it is not 
possible to directly perform a reverse Fourier transform of the diffraction pattern to 
directly view the electron density.  This is what is known as the “Phase Problem”.  The 
process of solving a crystal structure is a method of accurately estimating these missing 
phases in order to match a calculated structure to an observed structure as accurately as 
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possible, comparing Fourier transforms to form accurate electron density maps by atom 
assignment that can be justified by the observed reflections. 
2.3 Structure elucidation and refinement 
The phase problem is not trivial to solve and methods for doing so are necessarily iterative.  
Whilst originally computationally time consuming and expensive, they are now routinely 
employed with little effort as computational power has increased.  The most commonly 
used techniques for routine structure solution from experimental data are Patterson 
methods, Direct methods and Charge-Flipping (otherwise referred to as “Dual-Space 
methods”). 
2.3.1 Patterson Methods 
The Patterson method relies upon the basic principle that the observed amplitudes in the 
diffraction pattern, |    |, are squared, ignoring the phases initially, generating a map of 
peaks corresponding to inter-atomic vectors.  The magnitude of the peaks is proportional 
to the electron densities of the atoms and thus to the product of the atomic numbers of 
the two atoms involved.  This generates a set of interatomic vectors through the Patterson 
function,       (Equation 7).   
Equation 7 – The Patterson function 
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Once the phase information has been defined, it can be related to the cell origin.  The 
maxima on the Patterson maps, the Harker peaks, define the ends of the interatomic 
vectors.  The largest of the Harker peaks correspond to the vector of the largest atom with 
itself and are used to normalise all other vector magnitudes; interatomic vectors between 
larger, more electron rich atoms are easier to define.  Smaller atomic pairings are thus 
harder to define, being “lost” in the background.  This leads to the Patterson method 
sometimes being referred to as the “Heavy Atom method” and it is generally considered to 
be only practical if there are one or two heavy atoms in the asymmetric unit that differ 
significantly in electron density from the rest of the atoms present.  With the Patterson 
maxima identified, they can be interpreted to give some atomic positions and approximate 
phases can be generated.  These can be used to generate a reverse Fourier transform and 
thus generate a calculated map of electron density which, by comparison to the observed 
electron density map, serves as a first step for further refinement and interpretation as 
more atoms are identified and included in the calculation.   
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2.3.2 Direct Methods 
A more generalised approach to solving a structure, without the need to rely upon heavy 
atoms being present, is using “Direct Methods”.  The methods are termed “Direct” as they 
directly solve the phase problem by utilising the relationships between observed intensities 
of reflections.  The method is statistical in nature and relies on two fundamental principles: 
at any point in the crystal structure, the electron density cannot be negative, and electron 
densities are located in well-defined maxima, corresponding to atomic positions.  The Sayre 
equation, Equation 8, based on these principles, shows that the structure factor for a 
particular reflection,     , is a summation of the products of all pairs of reflections that 
contribute to it. 
Equation 8 - The Sayre Equation 
      ∑                        
      
 
As the structure factor relies upon all reflections relating to it, it is important that as much 
information is collected in the experiment as possible.  This includes harder-to-observe, 
high θ angle reflections, however as they are weaker, their contribution is less than the 
stronger, often smaller angle, reflections.  For cases where a pair of reflections that are 
both very strong are being utilised to calculate a third reflection that is also very strong, the 
relationship gives a good indication as to the phase of the structure factor; this is the triplet 
relationship.  For centrosymmetric structures it is reduced to assigning positive or negative 
values.  Three reflections,                , are related to each other by the following 
equality:               .  If the two reflections 210 and 111 are the same sign, 321 will 
be positive, a phase angle of 0°.  If they have opposite signs, 321 will be negative with a 
phase angle of 180°.   These initial relationships are set up for multiple sets of reflections, 
initially with random phases and a few strong reflections with definitively assigned phases, 
and changed in an iterative way to assign which is the most probable, and thus the 
remaining phases are determined approximately.  From the initial set of phases, an 
electron density map is generated, allowing visualisation of the results for identification 
and correction of any molecular shapes and atom assignments.  For non-centrosymmetric 
structures, the procedure is similar however the phase angle is not restricted simply to be 
positive or negative.  Direct methods are thus usually applied in an iterative, multisolution 
manner in which some strong reflections are given starting sets of phase angles and 
solutions corresponding to permutations of these are computed and evaluated. 
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Direct methods tend to work best with materials that have no more than about 300 non 
hydrogen atoms, as the probability of correctly determining a phase is inversely 
proportional to the square root of the number of atoms, N,  in the unit cell (Equation 9). 
2.3.3 Charge Flipping (Dual-Space Methods) 
Charge-flipping is considered a simpler yet considerably more computationally expensive 
method of solving a crystal structure than more traditional Patterson or Direct methods 
that has only become particularly useful in the past few years due to the greatly increased 
processing potential of modern computers117.  It is a method that uses both direct and 
reciprocal space to determine the phases and as thus is alternatively named “Dual-Space 
iterative methods”.  It is a method that relies upon several logical constraints upon the data 
which allow for construction of a meaningful set of phases for solution.  The constraints are 
outlined below in both direct and reciprocal space: 
Reciprocal Space Constraints: 
 Amplitude constraints – amplitudes observed in the experiment pose a constraint 
on the electron densities 
 Direct Space Constraints: 
 Positivity constraint – electron densities must always remain positive, negative 
electron densities are meaningless 
 Sparseness constraint – The unit cell will be mostly empty with a limited defined 
amount of positions of localised electron density 
The solution problem then becomes a matter of finding a suitable set of electron densities 
that comply with the amplitude constraints, and as closely as possible complying with some 
of the direct space constraints.  Any sets of electron densities that fulfil these constraints 
are called “constrained sets”.  Finding a correct set is a matter of finding a minimum where 
the constraints in both real and reciprocal space match up well, without falling into local 
minima.  The standard charge-flipping algorithm is outlined here116: 
1. All the experimental amplitudes are assigned random phases and all unobserved 
amplitudes are given a value of zero 
2. The electron density is calculated by inverse Fourier transform, from the observed 
amplitudes and assigned phases 
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3. The resulting electron densities are then modified by flipping the density of all 
points where the value of electron density is meaningless, i.e. below a set 
threshold, or is negative 
4. Structure factors are generated by Fourier transform of the modified electron 
density map 
5. A new set of structure factors are then obtained by using the observed 
experimental amplitudes with the calculated phases resultant from the flipping 
process, and these are iterated through the cycle from step 2 until the process 
converges between observed and calculated amplitudes. 
This method has the advantage of not relying upon knowledge of the symmetry in the unit 
cell before solution which at times can be ambiguous.  The symmetry is determined after 
the fact, as it can be observed in the calculated electron densities118.  The limit on the size 
of unit cell is only dependent upon computational power, with structures containing 
thousands of atoms in the unit cell known to be routinely solved by the method.  As the 
method relies upon a large amount of measured accurate amplitudes, it is not as suitable 
for use on an incomplete data set as Direct Methods. 
2.3.4 Structure completion and refinement 
Once a proportion of the atoms within the unit cell have been determined, the structure 
can be recycled through an iterative Fourier process, taking the forward Fourier transform 
of the new model produces a new set of calculated amplitudes and phases, and the 
previous set is discarded.  This can be repeated until all atoms are found.  Refinement of 
the structure most commonly is carried out using least-squares techniques, in which the 
atomic parameters in the model (for example, positions in the unit cell, and thermal 
parameters) are varied to give best agreement with the observed structure factor data set.  
Several cycles of refinement are typically required until the shifts in the parameter being 
varied are sufficiently minimal and the refinement is said to have converged.  The quality of 
the refinement is governed by the similarity between the two sets of structure factor 
values from the observed experimental data,   , and the calculated data from Fourier 
transform of the calculated electron density,   .  The R-factor is the term used to describe 
this quantification and is a calculation of the summation of the observed structure factors, 
  , minus the calculated structure factors   , normalised by the sum of the observed 
structure factors, usually expressed as a percentage (Equation 10). 
Equation 10 - Calculation of R-Factor 
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Weighting of error in the experiment must also be taken into consideration at this stage.  
For calculation of the R-factor, it is therefore important to state which reflections were 
actually used.  The most common way to decide which reflections are used are by taking 
only the structure factors that are greater than three times the error ( ) in the 
measurement of them,         ).  The weighted R-factor,    , is used to assess the 
quality of the weighted refinement (Equation 11). 
Equation 11 - Calculation of the weighted R-factor 
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The weighted R-factor is much more sensitive to smaller errors in the proposed model such 
as missing hydrogen atoms.  One further quantification of the structure similarity is the 
“goodness of fit”, S.  This, shown in Equation 12, is the sum of the difference in weighted 
structure factors divided by the number of reflections (m), minus the number of 
parameters (n) used to define the structure (or the over-determination of the structure).  
The goodness of fit is close to 1 for a correctly assigned structure. 
Equation 12 - Calculation of the goodness of fit 
  √
∑     
    
 )    
   
 
solved structures may have missing or inaccurate atom assignments.  Fourier methods are 
used to find other atoms or features contributing electron density that is not currently 
assigned.  In the early stages of structure completion, an “Fobs” Fourier can be calculated 
using the observed structure factor amplitudes with the set of phases calculated from the 
available partial model.  This normally reveals further atoms which can then be added to 
the model and the procedure repeated until all non-hydrogen atoms are found.  Towards 
the end of the structure determination, after initial refinement (see below), a Fourier map 
is calculated from the differences between the observed and calculated structure factors.  
This greatly highlights any areas where further assignments need to be made or modified 
to eliminate differences in the two sets of values.  In particular, assignment of hydrogen 
atoms is typically performed using this method where they can be reliably observed as 
peaks of residual unaccounted electron density.  However as they only have one electron 
and thus do not contribute much to the overall electron density, they are harder to observe 
and can sometimes be absent, requiring the assignment of “fixed” idealised hydrogen 
atoms to be generated. 
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Initially atoms in the calculated structure are defined using the x, y and z coordinates and a 
further parameter defining the radius of a sphere from that point to account for the spread 
of electron density originating from thermal or isotropic vibrations of the atom.  Although 
this is a convenient way to first model non-hydrogen atoms, it is not particularly realistic.  
This is therefore improved by assigning anisotropic displacement parameters; in total six 
parameters per atom114, defining an ellipsoidal shape (Figure 68).  This gives a better 
approximation of the atom thermal displacements.  Anisotropic thermal parameters are 
normally not applied to hydrogen atoms, since they have only one electron associated with 
them, which is, in addition, participating in covalent bonding to the parent atom in the 
molecule.   
 
Figure 68 - Anisotropic thermal ellipsoids showing 50% probability of electron density position 
2.3.5 Disorder and occupancy 
It is relatively common for crystals to exhibit disorder within their structure where a 
percentage of the cells within it, or an entire domain of the crystal is ordered differently 
from the bulk.  In cases where the long range order dominates and it is only a small portion 
of the structure that is disordered, it is usually possible to model the material with a 
generalised crystal structure representing the time-averaged arrangement of the material 
that is observed at the measured temperature and pressure114. 
The presence of disorder within a solved structure that has not been accounted for is 
usually detected by the appearances of irregularities in the structure, such as small or 
larger than normal isotropic parameters for atoms, or unusual elongated ellipsoids in 
anisotropic atom models. 
This can be accounted for in the crystal structure model by assigning partial atoms to 
positions of disorder to accurately model the electron density. 
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2.3.6 Interpretation and analysis of the structure 
Upon determination of the atom positions, it is possible to interpret the structure using 
visualisation software.  From the size, shape and positions of the thermal and vibrational 
displacement parameters, the interaction between the Wan der Waals radii and comparing 
them to known physical constants, it is possible to analyse the connectivity and behaviour 
of the molecules within the crystals.  In sufficiently high quality data, it is possible to 
measure the length and the angle of hydrogen bonds and their influence upon the local 
and global structure.  The standard visualisation tool for single crystal structures used here 
has been “Mercury” from the CCDC119 as it provides an effective and convenient array of 
features and abilities for analysing and displaying crystallographic information. 
2.5 Powder X-ray diffraction 
Powder X-ray diffraction (XRPD) is an extremely powerful characterisation tool used 
extensively throughout this research for medium throughput screening of crystalline 
samples, allowing for identification of new materials for further study.  
In powder diffraction, the sample is essentially an averaged mixture of single crystallites of 
the material in all possible orientations, giving the appearance of continuous rings of 
intensity, termed Debye-Scherrer rings (Figure 69). 
 
Figure 69 - Powder X-ray diffraction image clearly showing Debye-Scherrer rings around direct beam 
The observed rings are a result of the Bragg reflections generated from each individual 
single crystal, however the polycrystalline material produces multiple sets of Bragg 
reflections and the patterns appear overlaid on top of each other and rotated around the 




Figure 70 - Simulated observed reflections of a single crystal multiplied to represent crystallites rotated about 
the direct beam position 
The resultant image therefore generates a one dimensional data set corresponding to a 
cross section through the rings, with only the intensity of the rings and a measured angle, 
2θ, measured from the direct beam position, Figure 71.  As the rings are a result of the 
Bragg peak positions, their angle is proportional to the unit cell geometries and can be used 
to measure the dimensions of the cell via Rietveld refinement.  As these properties are 
characteristic of the crystal structure of the materials being analysed, they are extremely 




Figure 71 - Example X-ray powder diffraction pattern.  A one dimensional plot of the intensity measured in 
counts as a function of 2θ. 
When a mixture of materials is analysed, it is possible, if one or more of the components 
are known, to isolate the individual patterns corresponding to the each component and 
identify which materials are responsible for each of the Bragg peaks.  This allows for 
identification of new materials by subtraction of known peaks leaving only peaks 
corresponding to the un-matched material.  Although a full three dimensional structure 
cannot be obtained from such a method, it can be used to match it to a characterised 
material from single crystal data.  The intensities of the individual components making up a 
complete pattern also gives information as to the proportion of materials present, allowing 
for quantification, however, care must be taken as the intensity, being a consequence of 
the intensity of the individual Bragg reflections, is proportional to the electron densities of 
the atoms within the structure.  Single phase powder diffraction data of sufficiently high 
quality can also be used to solve the structure of a crystalline material.  There are two main 
approaches to solving structures from powder diffraction measurements.  The first of 
which is a more conventional approach where individual reflection intensities are extracted 
from the diffraction data and the structure is solved using Patterson or direct methods.  
This approach was used as early as 1948 by Zachariasen120 to solve the structure of α-
CrPO4.  This could be done due to the relatively simple systems involved with minimal peak 
overlap in the scattering pattern.  Where larger more complex samples are involved, it 
becomes a lot more difficult to be able to distinguish the individual peaks.  The second 
approach is a more recent development and is referred to as the “direct space” strategy.  It 
involves the calculation of a predicted structure and comparison of its calculated diffraction 
data to the measured diffraction data.  The similarity between the two sets of data is 
quantified and given a figure such as a profile R factor.  The simulated structure is then 
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modified in order to minimise the difference between the two sets of data until the 
structure is solved.  This is a “global optimisation” method, in which the techniques range 
from a simple grid search to more complex methods such as simulated annealing and 
genetic algorithms121.  This direct space method is based on the approach suggested by 
David is incorporated in computer software for this application such as DASH122.  These 
methods however could not be used in this research due to the varied interfering mixtures 
of materials possibly present in the samples being analysed. 
The main use of XRPD in this research will be by comparison of observed patterns to 
calculated patterns from known structures of starting materials in structural databases, 
where they exist, or by comparison to the raw or recrystallized starting materials.  This 
allows for rapid identification of whether a recrystallisation, reaction or cocrystallisation 
has occurred. 
2.6 Auto-statistical analysis of powder diffraction data 
As a consequence of the generation of vast quantities of X-ray powder diffraction data 
collected from the screening process, it was necessary for interpretation of the data within 
the contents of this research to use statistical analysis software in cases where the data 
was of sufficient quality for powder pattern matching.  The software used for this purpose 
was PolySNAP-3 123, for its qualitative and quantitative abilities, its phase compositional 
analysis features, as well as its adaptability to multiple forms of data including XRPD, DSC, 
Raman and IR.  It is able to take a collection of sample powder patterns and through 
provision of the starting material powder patterns, can identify the individual sample 
patterns corresponding to starting materials, clustering them together as similar patterns, 
separating those which have no remaining starting materials as new materials as well as 
identifying those which are a mixture and which are amorphous.  With mixed component 
patterns, it is further able to separate patterns within the sample pattern that correspond 
to known phases or materials and give a percentage compositional analysis, identifying 
unknown phases also present and estimating a percentage composition for those also.  
Unlike some other programs with similar features, PolySNAP-3 is capable of full profile 
pattern matching as well as matching by comparison of the most intense Bragg peaks.  This 
has obvious benefits of being able to generate more comprehensive matches of multi-
components mixtures, inclusion of weaker peaks from the “fingerprint region” of the 
patterns, as well as the ability to choose to match by intense peaks only, when the 
background in the samples are too high even after the software’s inbuilt background 
subtraction has attempted correction.  The patterns are matched by a numerical 
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assignment of “similarity” which is generated by comparing every sample pattern to every 
other within the data set and assigning a weighted mean of correlation coefficients to each 
pairing.  Those with a high correlation coefficient are clustered together and are given a 
similarity ranking.  The results are then able to be viewed numerically or visually using 
various graphical outputting options, the most useful of which, is the dendrogram (Figure 
72). 
 
Figure 72 - An example PolySNAP-3 dendrogram output with samples clustered according to similarity 
Limitations, however, were encountered when in utilising this software when comparing 
data from different diffractometers.  Characteristic features in the diffraction patterns 
specific to each instrument lead to lower than expected similarity figures when comparing 
data from two different sources, leading to clustering of data from different 
diffractometers.  In essence the issue is oversensitivity of the technique.  This was partially 
overcome by only matching data within certain, characteristic free, regions within the 
patterns and preparation of data by background subtraction by other software before 
inputting it into the PolySNAP software.  More reliably, identification of phases was verified 
by visual comparison of the samples to their components as in some cases, use of the 
software was limited by the systematic errors in the collection. 
New compounds identified by the statistical analyses are highlighted for further study, for 
example by isolation for single crystal characterisation methods.  These methods 
complement each other well, as the compositional analysis and quantification can give an 
assessment of how much decomposition has occurred or how much starting material 
remains after each experiment has taken place. 
2.7 Raman and infrared spectroscopy 
In certain circumstances, X-ray diffraction is not a suitable choice for analysis and 
spectroscopic methods may be used to study the materials.  Although they are not as 
definitive and unambiguous as single crystal X-ray diffraction, they can provide much useful 
information on bond interactions in non-crystalline materials as well as phase identification 
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by comparison to reference spectra and libraries.  Both infrared and Raman spectroscopy 
were employed to aid characterisation of new compounds. 
2.7.1 Infrared Spectroscopy 
Infrared spectroscopy (IR) utilises the absorption of EM radiation by molecules at 
characteristic resonant frequencies that are directly related to the connectivity of the 
atoms within the compound and hence characteristic of functional groups and often 
associated with individual bond vibrations.  The wavelengths of radiation absorbed by each 
chemical bond within the structure are a direct consequence of the bond strength and the 
masses of the atoms that are bonded, as well as their molecular environment.  Many 
functional groups can be identified by their vibrational frequencies expressed as peaks in 
an IR spectrum and thus compound identification may be achieved without the need for 
crystallisation, or even solidity. The characteristic peaks, corresponding to vibrations within 
the molecules (normal modes), are exhibited in the infrared region of the electromagnetic 
spectrum between 4000cm-1 and 400cm-1 124. 
 
Figure 73 - Example IR spectrum of a compound showing a broad O-H peak at 3400cm
-1
. 
Typically solid samples are placed in a coherent IR beam tuned to the area of the spectrum 
wishing to be studied.  Absorption of IR radiation at a frequency corresponding to the 
energy of a vibrational mode is registered as an absorbance by comparison of the 
transmitted beam to a reference beam.   
Fourier transform IR (FTIR) can increase the sensitivity IR measurements by employing a 
Michaelson interferometer to simultaneously irradiate the sample with the entire required 
range of radiation, as opposed to a standard scanning method through the range.  The 
interference pattern generated by recombination with the reference beam can then be 
converted by Fourier transform to produce a plot that is very similar to a standard IR 
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spectrum.  It has the benefit of decreasing the needed sample size and allowing a more 
rapid collection of a spectrum with a decreased sample preparation. 
Hydrogen bonds effects are observed within an IR spectrum by analysis of the O-H or the  
N-H bands which characteristically appear at the high frequency end of the spectrum as a 
result of the low mass of the hydrogen atom.  The strength of a hydrogen bond may be 
observed by analysis of the frequency of these bands.  A stronger hydrogen bond will 
increase the O-H or N-H bond length, lowering the vibration frequency, leading to a 
broader, more intense adsorption band.   
2.7.2 Fourier Transform Raman Spectroscopy 
Fourier transform Raman spectroscopy is a similar yet complementary technique to 
infrared spectroscopy.  As before noted, electromagnetic radiation is incident on a 
molecule it interacts with the vibrational modes of that molecule.  As a result of the Raman 
Effect, a photon of the specific frequency may excite the electronic state of a molecule 
from a ground state to a higher energy state.  Upon relaxation it emits a photon of a 
different energy and consequently returns to a different rotational or vibrational state than 
the original ground state.  As a result, a percentage of the photons scattered by the sample 
will exhibit a change in frequency. 
If the system returns to a more energetic state than that of the original state, a photon of a 
lower frequency will be emitted from the sample.  This is termed as a Stokes shift.  If it is 
less energetic, the frequency of the emitted photon will be higher, causing an anti-Stokes 
shift to be observed.  The Raman scattering intensity is determined by the observed change 
in polarisability between the two states. 
Similarly to X-ray powder diffraction, Raman scattering provides fingerprint information on 
small samples by analysing peak positions and comparing them to pure references.  It is a 
very powerful tool for determining the presence of very small changes between samples, 
such as in differentiation between two polymorphs of the same material by observing 
changes in the intermolecular frequencies and also changes in hydrogen bonding within the 
structure125 which can be further investigated through other complementary techniques 
such as single crystal X-ray diffraction. 
2.8 Electron microscopy 
Scanning Electron Microscopy (SEM) is a visual tool for observation and measurement of 
particles within samples.  Like an optical microscope with photons, an electron beam may 
be used to create a magnified image of an object, however in place of optical lenses and 
mirrors, a beam of electrons may be bent by a magnetic field allowing scanning of the 
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surface of a sample.  This has the effect of knocking off electrons from the surface which 
are collected in a positively charged anode which modulates the electron beam in a 
cathode ray tube, synchronous with the scanning beam on the sample.  The result is the 
production of a greatly magnified image of the target with a typical resolution of 
approximately 10nm which may be used for measurements of particle size or microscopic 
features126. 
2.9 Thermal analysis 
Two thermal analysis techniques – differential scanning calorimetry (DSC) and hot stage 
microscopy – were used to study the materials collected in order to identify the existence 
of new products and to aid characterisation of mixed component materials. 
2.9.1 Differential Scanning Calorimetry 
DSC is an extremely useful screening technique for identification of new materials and 
analysis of mixed phase materials.  It is an analytical technique that relies on the thermo-
chemical properties of the material being analysed and may be used for identification of 
melting points, phase transitions and solid to solid transitions of single or multi component 
samples in the solid state.   
 
Figure 74 - Diagrammatic display of standard Heat-flux DSC equipment
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In heat-flux DSC, a sample (S), be it amorphous or crystalline, is incrementally heated or 
cooled in a temperature controlled furnace as a function of time, at a chosen programmed 
rate along with a reference pan (R) (Figure 74). The difference in heat flow required to 
maintain the two pans at the same temperature is recorded and thus the thermal 
behaviour of the sample is observed by comparison.  When the sample undergoes a 
transition between phases, there will be a change in the heat required to maintain the pans 
at the same temperature, a result of either exothermic or endothermic transitions.  An 
endothermic transition would thus give a negative heat flow peak, indicating a phase 
transition possibly corresponding to a melt.  On a cooling cycle and occasionally on a 
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heating cycle, re-crystallizations show a peak in the positive heat flow direction, 
representative of an exothermic transition such as a recrystallisation (Figure 75).  
The areas under these observed peaks give a direct measure of the enthalpy of transition 
between phases.  DSC can be utilised to detect multiple phases in a sample, such as starting 
materials, products or polymorphs, as a DSC plot of a mixed phase sample would show 
individual thermal events corresponding to the separate materials, or a unique new melting 
point, belonging to a new material such as a cocrystal, in general distinct from the melting 
points of the starting materials128.  Normally, a sample plot would be compared to a 
reference DSC plot of the starting materials to allow identification of the thermal events.   
  
Figure 75 - DSC plot showing exothermic cooling transitions with an upward pointing positive heat flow and 
endothermic melting with a downward pointing negative heat flow
127
. 
DSC is able to distinguish individual polymorphs of a single material, as they will normally 
have different melting points due to different intermolecular interactions.  A more stable 
polymorph will have stronger interactions and thus be more thermally stable, resulting in a 
higher melting point.  It is also possible through DSC to observe transitions between 
polymorphs using the same principle, observing melting, crystallisations and further 
melting on a single scan.  This relatively rapid technique is particularly useful for screening 
a large number of samples to identify compounds of interest for further analysis and for 
providing stability information on materials formed from crystallisation experiments. 
2.9.2 Hot-stage microscopy 
Hot stage microscopy, similarly to DSC, provides information of transitions in phases by 
thermally modifying the environment whilst making observations upon physical changes in 
the material, determining the thermodynamic landscape for a system.   It is a form of 
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thermoptometry as a small sample is placed within a calibrated furnace and heated 
through a chosen programmed temperature cycle whilst making visual observations of the 
material as it is recorded with an optical microscope129.  Changes in the material at thermal 
events may be observed visually; for example, the melting of the material can be directly 
observed.  This is an excellent complementary thermal technique to DSC as the thermal 
events observed in DSC can be targeted with the temperature regime and studied in order 
to ascertain the behaviour of the material that results in the thermal event129.  This can 
help combat occasionally ambiguous DSC result interpretations that can lead to confusion 
in conclusions30.  It is possible using this technique easily to observe evolution of solvent 
from porous crystalline materials130 and also to watch transitions in polymorphs as they 
occur.  By application of the “mixed fusion method” it is also an effective way to identify 




3. Techniques and instrumentation 
3.1 Sample preparation 
Several different crystallisation methods were used throughout this research with the aim 
of creating stable molecular complexes of reactive materials and studying their behaviour 
with additional chosen components.  These methods each have their own advantages and 
disadvantages, which are outlined in this section.  These techniques form the basic 
standard procedure followed throughout the majority of the research detailed here and 
any modification to these core methods will be stipulated in the specific experiment 
descriptions. 
3.1.1 Temperature controlled medium throughput crystallisation 
The main technique used for preparation of new materials was that of temperature 
controlled evaporative crystallisation on a medium throughput scale.  This is a standard 
approach used to produce crystalline products for structural elucidation in small molecule 
crystallography and one that is commonly used within the crystallographic community.  In 
particular, the methods employed here can be classed as combinatorial self-assembly of 
multi component crystals.  It is the most flexible method and can be easily adapted to 
direct a crystallisation towards a particular structure or polymorph of interest132.  Aside 
from its adaptability, the overwhelming advantage of this method is its simplicity and 
hence repeatability, allowing for parallel batches of crystallisations with small adaptations 
to each sample to be initiated within a short time scale. 
The general procedure for generating a batch of crystallisation experiments, whether 
involving single or multiple components, is as follows: 
 A set of experiment parameters is decided upon for a combinatorial or single 
component crystallisation, generally consisting of 10-20 individual experiments, each 
with a differing set of environmental variables, such as an array of different solvents 
and temperatures of crystallisation, maximising the possibility of obtaining the desired 
complex and optimising crystal growth.  The choice of solvent is dependent on the 
reactivity and solubility of the target materials. 
 Into a clean, new, 7ml glass vial, typically of order 0.00025 moles of the reactive 
material is weighed accurately along with the relevant molar quantity of the co-
component (if required), depending on the target component ratio in the product (it 
should be noted that the resulting molar ratio in the crystallised product does not 
necessarily reflect the stoichiometry of the initial solution preparation).  It is important 
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that a clean new sample vial is used to eliminate contamination by any extraneous 
components, which could lead to the degradation of the reactive material, and to 
eliminate scratches and other nucleation points from within the vessel, leading to 
growth of fewer, less flawed individual crystals for analysis. 
 The chosen solvent is added slowly to each vial and dissolution is encouraged by 
several methods. 
o Stirring/vortex mixing – the vial is quickly agitated by a motor / magnetic stirrer 
creating a vortex within the sample 
o Sonication – sound energy is transferred into the sample through the vial, 
which is partially immersed within a bath of water, greatly agitating any 
particulate matter within it, aiding dissolution 
o Heating – the sample may be heated gently on a hot plate with a constantly 
controlled temperature, by gently warming with the palm of a hand through 
the glass vial, or by raising the temperature of the sonication bath.  Great care 
must be taken with the materials studied here, due to the reactivity of the 
materials and their tendency to decompose at relatively low temperatures. 
o In some cases where the solubility of a material is very limited, the addition of 
a few drops of a second solvent in which it is more soluble may be required to 
aid dissolution. 
In all cases, the volume of the solvent level is kept to the absolute minimum, no more 
than 6ml, to allow faster supersaturation once sufficient evaporation has occurred.  
Dissolution may be checked by transmission of a low intensity laser, such as a laser 
pointer, through the sample vial.  If the sample is completely dissolved, no specular 
reflection beam will be observed.  If complete dissolution cannot be achieved due to 
impurities, filtration may be attempted before the crystallisation is allowed to proceed 






Figure 76 - Cutaway diagram of sample preparation and crystal growth procedure for medium throughput 
temperature controlled crystallisations, from left to right: pre-dissolution – solvent is added to the solid 
materials; plastic lid of vial is perforated to allow for evaporation and placed in a heating well to control 
temperature; crystals are formed in the vial upon evaporation of the solvent past the supersaturation point. 
 Once the sample is completely dissolved (Figure 76), the plastic lid is perforated and 
the sample vial is placed within a multi-well heating unit, set at a controlled 
temperature (Figure 77), left in a fridge or left at ambient temperature for the duration 
of the crystallisation.  The crystals (which in this work are often subject to 
decomposition) are to some extent protected from the atmosphere during the 
crystallisation by the evaporating solvent, which displaces any air from the vial.  The 
solvent is allowed to evaporate completely.  Once the solvent has become 
supersaturated, crystallisation will occur as the reducing solvent can no longer retain 
the quantity of material, releasing crystallite seeds from which larger crystals will grow 
as more of the material assembles on the surface of the seeds. 
 
Figure 77 - Samples are placed in temperature controlled hot plates set at a constant temperature with 
custom made blocks for the duration of the crystallisation. 
 Once all solvent is evaporated, the vial containing the solid product material is 
removed from the temperature controlled environment and stored at ambient 
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conditions until analysis (Figure 78).  If single crystals have been formed, these are 
analysed by single crystal X-ray diffraction, while representative samples of all resulting 
compounds are analysed by X-ray powder diffraction. 
 
Figure 78 - Crystallised experiment samples produced from the medium throughput crystallisation technique 
awaiting analysis at ambient temperature. 
This method represents a simple self-assembly approach to synthesising the desired 
crystalline molecular complexes.  In the context of the present work, it also avoids adding 
excessive amounts of energy to the sample, thus limiting decomposition or reactivity.  If a 
desired crystal form cannot be obtained by the initial set of conditions chosen, the 
experiment can be easily altered by changing the chosen temperatures and solvents.  As 
reactive materials were being studied, the scale of this method also meets the need to use 
only small amounts of material, limiting possible unforeseen reactivity that may be 
hazardous. 
In cases where experiments were better suited to a smaller scale crystallisation, 1.5ml scale 
solvent crystallisations were carried out in a Reactarray Microvate Solo (Figure 79), with 
temperatures available from -30°C to 150°C in 12 independently controlled rows of 4 cells, 




Figure 79 - Reactarray Microvate Solo. 
This piece of apparatus was extremely useful as a temperature gradient could also be set 
for each row before reaching the set crystallisation holding temperature, allowing a cooling 
supersaturation to be reached in a crystallisation, preventing crashing out of starting 
materials immediately upon rapid cooling. 
If larger crystals of a material were needed for study, seeding crystallisation, where a small 
crystal is placed in a saturated solution of the same material to promote growth of a 
particular crystal or form, was utilised.  This has the effect of greatly accelerating the 
nucleation rate determining step of the crystallising process, and the seeding method is 
extremely useful in competitive processes, where it can be used to select a favoured solid 
form.  Intentional seeding with one polymorph is often the most successful way of 
preferentially producing that form rather than any others.  However, in general this was 
avoided where possible as extra steps in preparation of the sample can lead to 
contamination of the materials and exposure to atmosphere leading to further 
decomposition of the reactive component.  For the majority of cases, the standard 
crystallisation method was sufficient for the creation of suitable materials for analysis. 
3.1.2 Mechanochemical grinding and solvent drop grinding 
When use of solvents must be avoided, either due to incompatibility or insolubility of 
components, the mechanochemical grinding method may be employed.  First highlighted 
as a useful synthesis technique for the formation of hydrogen bonded co-crystals of picric 
acid by Rastogi133 in 1963, it is an underused yet incredibly powerful method of achieving 
crystalline forms of compounds of interest that are unachievable through normal solution 
methods.  An explanation of this phenomenon, proposed by Braga134, is that the heat 
generated in the course of a mechanochemical process can induce localised melting of the 
crystal, thus the reaction takes place in the liquid phase although solid products are 
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eventually recovered 134.  This can be observed in the application of the method where 
often the mixture of samples can become sticky during the grinding process before 
returning to a solid. 
The method can be performed manually, with a mortar and pestle, or by a ball mill.  Both of 
these have proved effective, however throughout this research, only the manual method 
has been employed (Figure 80).  The relatively simple general procedure for the method is 
as follows: 
 The raw material components are weighed out accurately in equimolar quantities into 
a mortar; 
 The components are gently mixed to homogenise the sample; 
 A timer is started and the materials are manually ground with a pestle constantly for 
three minutes, ensuring all material is equally treated; 
 The resulting powder is removed from the mortar and placed in a sealed glass vial until 
analysis. 
 
Figure 80 - Apparatus required for a mechanochemical solvent free grinding experiment. 
There are several modifications to the method that may aid complex formation, including 
the addition of catalytic amounts of a suitable solvent before grinding, which can increase 
the success of compound formation.  This would suggest a second solution phase synthesis 
route to the target compounds. 
The sample produced is characterised primarily by X-ray powder diffraction methods which 
easily identify the presence of new materials, but fully characterising the new material can 
prove difficult due to the microcrystalline state of the sample.  As proposed in Figure 81 by 
Braga, once a polycrystalline material has been created and confirmed, it may be used to 
seed a solution based crystallisation of the reagents, leading to growth of larger crystals 





Figure 81 - Solvent free grinding as an approach to producing larger cocrystals of a complex of interest
134
. 
Due to the energetic instability of the peroxide compounds studied here, however, any 
solvent free or solvent assisted grinding must be done in a carefully controlled environment 
and with small quantities in order to avoid energising the material to the point of 
decomposition. 
3.2 Instrumentation 
3.2.1 Single crystal X-ray diffraction 
Generating a fully characterised crystal structure of a material necessitates the selection of 
a high quality crystal.  Often this requires several trial crystals to be screened.  First, these 
are examined by microscope under a polarising filter to ensure the crystal is single and to 
detect any flaws that may cause be indicative of the presence of a multiple crystal or of 
twinning, which would adversely affect the diffraction experiment.  Secondly unit cell 
screening is run on a diffractometer.  An ideal crystal should be on average be between 
0.2mm and 0.5mm in multiple dimensions, appear transparent and clear with well-defined 
edges.  When viewed through a polarised microscope, the entire crystal should appear as 
one domain with no obvious flaws or cracks and when it is rotated 90°, light passing 
through it should extinguish completely in one motion.  Though several mounting methods 
are possible, in this research, single crystals were mounted on a glass fibre using either 
Fomblin®, a high-viscosity oil, or with vacuum grease for loading into a single crystal 
diffractometer. 
Three laboratory based single crystal X-ray diffractometers were used in this research.  
These are outlined here: 
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3.2.1.1 Rigaku R–axis Rapid diffractometer 
The main diffractometer used was a Rigaku R-axis Rapid diffractometer, using a 
molybdenum X-ray tube with a Kα radiation of wavelength 0.71073 Å, using a fine focus 
graphite monochromator.  The diffractometer was fitted with a curved image plate 
detector set at 127.4mm from the crystal (Figure 82), allowing simultaneous collection of 
data over a large area of reciprocal space in a single image.  The diffractometer was 
equipped with an Oxford Cryosystems 700 series liquid nitrogen cooled Cryostream, 
allowing for data collection temperatures between 80K and 400K using laminar flow of 
cooled N2 gas from the cold head directly over the crystal.  Unless otherwise stated, 
screening and collection was carried out at 100K.  The operation of the hardware and the 
interpretation of the images is carried out through the Rigaku CrystalClear 2.0 software 
environment135. 
 
Figure 82 - Rigaku R-axis Rapid single crystal X-ray diffractometer. 
The crystal is placed upon the glass fibre mount on a goniometer and centred directly in the 
path of the X-ray beam.  The Cryostream rapidly cools the temperature of the crystal to 
100K (or other chosen temperature) ready for collection of images.  An initial set of 
typically four images is collected for determination of the unit cell of the material.  The 
image exposure time is chosen dependent on multiple factors: the diffracting strength of 
the material under study, the size of the crystal and the intensity of the X-ray radiation.  A 
typical exposure time for a single image of an organic material can be anywhere between 1 
and 5 minutes.  From the matrix of collected images, the spot positions are determined and 
a preliminary unit cell is calculated and refined.  The unit cell may then be compared to 
those of the starting materials to see if it is a recrystallized reagent, or whether it is a 
crystal of a new material or new form.  If the unit cell does not match those of starting 
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materials or known products, the unit cell may then be searched for in the Cambridge 
Structural Database136 to see if it has previously been encountered.  The initial images will 
also give an indication of poor crystallinity that has not been identified through microscopy, 
such as twinning, poor mosaicity and diffuse scattering.  These will represent themselves in 
the image respectively as double peaks, spread out intensities and as broad features or 
additional peaks. 
At this point if the crystal has been determined to have a previously unknown unit cell and 
a full data collection is required, a data collection strategy is calculated by the CrystalClear 
software by using the preliminary unit cell of the structure and optimising the collection by 
application of the knowledge of its lattice symmetry.  The optimised collection strategy 
typically has a minimum d-spacing resolution of 0.7 Å, with a redundancy of five.  The 
images, as with the matrix, can be exposed for typically between 10 and 30 minutes to 
collect full sets of reflections of sufficiently high intensity compared to the background.  
Once the data have been collected, the images are integrated using the CrystalClear 
software, producing a list of reflections and corresponding intensities.  The data are 
corrected for background contribution, and an absorption correction applied using the 
multi-scan absorption correction method ABSCOR137.  This information is then passed to 
the crystal solution software for determination of the structure. 
3.2.1.2 Bruker Kappa APEX II 
The second single crystal X-ray diffractometer used was a Bruker Kappa Apex II, 4-circle 
geometry diffractometer fitted with a Molybdenum sealed tube X-ray source with a Kα 
radiation of 0.71073 Å directed through a fine focus graphite monochromator and an APEX 
II charge-coupled device (CCD) detector.  Measurement temperatures of 28K-100K are 
accessible using Helium gas and 100K-300K using a nitrogen generator with the equipped 




Figure 83 - Bruker Kappa APEX II single crystal X-ray diffractometer with Oxford Cryosystems N-HeliX 
cryostat. 
The experimental procedure adopted is very similar to that used on the Rigaku R-axis Rapid 
diffractometer with obvious differences as a result of the different detector type.  The APEX 
II CCD detector collects a much smaller area of reciprocal space in a single image and thus a 
much greater number of images must be obtained in order to collect a complete data set.  
The Bruker AXS APEX II software suite138, uses on average 36 images during the matrix 
collection for unit cell determination in comparison to the four used on the Rigaku.  
However the collection time for each image is much shorter with exposure times between 
10 and 30 seconds per image.  Unlike the Rigaku however, the detector may be moved and 
the sample-detector distance altered to best suit the desired collection strategy.  The data 
are integrated in a similar way with the Bruker AXS software and corrected using the 
SADABS139 multi-scan absorption correction method.  
3.2.1.3 Bruker-Nonius KappaCCD 
The third single crystal X-ray diffractometer employed is the Bruker-Nonius KappaCCD 
diffractometer (Figure 84), which is the older predecessor of the Bruker Kappa APEX II and 
again uses a molybdenum sealed tube X-ray source with Kα radiation of 0.71073 Å, 





Figure 84 - Bruker-Nonius KappaCCD diffractometer. 
The instrument used was fitted with an Oxford Cryosystems 500 series liquid nitrogen 
cooled Cryostream, allowing for data collection temperatures between 80K and 400K.  The 
data were collected in an almost identical way to that employed on the APEX II, but with 
the COLLECT140, HKL Denzo and Scalepack software141.  Absorption correction was 
performed with SADABS139. 
The data obtained by these three diffractometers was interpreted through the WinGX 
interface142 utilising SHELXS-97142, SHELXS-86143 or SIR-92144 to solve the structure by direct 
methods, or SUPERFLIP145 to solve using dual-space methods.  All structures were refined 
using SHELXL-97146. 
3.2.2 Powder X-ray diffraction 
Powdered materials were analysed primarily by powder X-ray powder diffraction (XRPD).  
XRPD was used to determine whether product material was crystalline, and whether it 
represented a previously unknown unit cell or a recrystallisation or decomposition product.  
XRPD patterns are more representative of the whole sample, but in consequence can 
represent the diffraction from several components that may be present.  This can make the 
patterns more difficult to isolate and interpret. 
The procedure for collection of a XRPD pattern on any of the three diffractometers used 
(see below) is as follows: a representative sample of the material is placed within a mortar 
and pestle and gently ground to homogenise the sample, reducing the microcystallites 
present within the sample to an average size and evenly distributing the components, 
assuming more than one component is present.  The sample is then loaded, typically, into a 
0.7mm glass capillary (0.3mm, 0.5mm and 1.0mm capillaries were also used where 
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appropriate).  If a sample was sticky and proved impossible to load by this method, it was 
rolled onto a thin glass fibre which was mounted instead of a capillary.  Samples once 
loaded were placed on a goniometer and centred in the X-ray beam of the diffractometer.  
The sample is rotated during the data collection in order to minimise any preferred 
orientation effects on the diffraction pattern. 
Samples were subjected to fast screening in which the diffraction was measured in the 2θ 
range from 5° and 50°.  A standard sample scan speed employed was 2° per minute which 
in most cases gave a reasonable pattern for analysis.  Weakly diffracting materials were 
given a longer exposure of 1° per minute, increasing where necessary up to 0.5° per 
minute, giving an improved peak intensity to background ratio. 
3.2.2.1 Bruker D8 Advance 
The primary powder X-ray diffractometer used was a Bruker D8 Advance (Figure 10), using 
a Cu sealed tube source providing Kα radiation of 1.54056 Å, equipped with a VANTEC-1 X-
ray detector.  The samples were measured in capillary stage transmission geometry with a 
1mm anti-divergence slit on the beam. 
 
Figure 85 - Bruker D8 Advance X-ray powder diffractometer with VANTEC-1 detector in transmission 
geometry with capillary stage in use. 
The hardware was controlled by the Bruker DIFFRACplus XRD Commander software 
environment147, outputting the diffraction patterns as .raw files for analysis. 
Two of these diffractometers were used over the course of this research.  This presented a 
problem as one of the diffractometers exhibited a much higher background with a 
distinctive profile compared to the other. 
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3.2.2.2 PANalytical X’pert Pro 
The second type of X-ray diffractometer used was a PANalytical X’pert Pro (Figure 11), 
again with a Cu sealed tube source providing Kα radiation of 1.54056Å.  The X’pert was 
fitted with a scintillation counter detector and set to transmission geometry when required 
for capillary sample stage setup.  Similarly to the Bruker D8, a 1mm slit size was used to 
limit the width of the beam. 
 
Figure 86 - PANalytical X'pert Pro in transmission geometry 
The hardware was operated during collection by the PANalytical X’pert “Data Collector” 
control software, outputting .xrdml files for analysis by the PANalytical Highscore Plus 
interpretation software148. 
3.2.2.3 BTX Benchtop XRD 
A small number of samples were analysed by a “BTX Benchtop XRD” compact X-ray 
diffraction / X-ray fluorescence system (Figure 87).  This small diffractometer, equipped 
with a Cobalt source scanned from 5°-55° in 2θ and was able to analyse a ~20mg organic 
sample via an integrated sample chamber, vibrated to randomise the orientation of the 
crystallites. 
 
Figure 87 - BTX Benchtop XRD with vibrating sample stage
149
. 
The Benchtop XRD was unable to accommodate capillary geometry and was used on a trial 
basis to allow comparison with sample materials collected on the other powder X-ray 
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diffractometers.  Any data collected on this instrument that is discussed will be specifically 
indicated. 
The analysis of XRPD data was found to be best interpreted using the PANalytical Highscore 
Plus software148 and the PolySNAP3123 statistical analysis software due to their adaptability 
to different data file types output by the different types of diffractometer.   
3.2.3 Thermal Analysis 
3.2.3.1 Differential Scanning Calorimetry 
DSC was carried out on selected samples on a TA Instruments Q20 Tzero differential 
scanning calorimeter, using heat flux based measurement (Figure 88).  5mg – 15 mg of 
material, representative of the entire sample being studied, was weighed accurately and 
hermetically sealed into a Tzero aluminium pan with a Tzero lid and press.  Using a cleaned 
set of tweezers, the sample pan was placed manually into the temperature cell on the 
sample mount along with a blank, empty reference pan.  The sample was then sealed into 
the cell and subjected to a temperature regime as described in the experiment to slightly 
above the melting point of the most thermally stable starting material present.  The 
samples were analysed using the TA Instruments Universal Analysis 2000 data analysis 
tool150  supplied with the calorimeter. 
 
Figure 88 - TA Instruments Q20 DSC. 
3.2.3.2 Hot-Stage microscopy 
Hot stage microscopy was performed using a Leica DM2700 M microscope fitted with an 
Infinity 2 CCD camera for optically recording videos of thermal events.  The samples, either 
single crystals or small amounts of powder, were prepared on a slide and subjected to a 
temperature regime dependent on the sample composition, similar to that used in a DSC 
experiment, as described above.  This was carried out in a Mettler-Toledo FP900 
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thermosystem utilising a FP82HT hot stage transmission oven controlled by a FP90 
processor (Figure 89). 
 
Figure 89 – Leica DM2700 M microscope with Mettler-Toledo FP900 thermosystem hot stage. 
A limiting factor of the hot stage microscopy technique is that the samples chosen for 
mounting on the slide within the oven are not always fully representative of the entire bulk 
of the material.  This results in the need for multiple measurements when 100% purity 
cannot be verified. 
3.2.4 Spectroscopy 
Small representative samples were analysed by Infrared and Raman spectroscopy where 
required.  Sample size was no larger than 3-5 mg. 
3.2.4.1 Infrared spectroscopy 
The infrared spectra of samples were collected on one of several Thermo Scientific infrared 
spectrometers fitted with an ATR accessory allowing for analysis of very small samples and 
without preparation, aside from mixing to ensure a the sample was representative of the 
bulk of the material.  Samples spectra are recorded several times and an average is taken 
to remove anomalous features in the spectra.  A background scan was subtracted from all 
spectra to remove the background produced by the apparatus and produce a flattened 
baseline. 
3.2.4.2 Raman optical microscopy 
Raman spectra were collected on a HORIBA LabRAM HR confocal microscope (Figure 90).  
Standard scan parameters utilised a Ventus 532 laser system, 100mW 532.17nm laser set 
at 25% optical density to ensure the organic samples were not destroyed.  The confocal 
aperture was set to 100μm and 600x, 50x and 10x objective lenses were available for 
observation by a Synapse CCD detection system.  The best spectra resulted when studying 
a single crystal sample of a pure material.  Sampling at different positions on a slide of a 
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material with a mixture of components provided different spectra corresponding to the 
different individual materials.  Multiple measurements were thus made within a sampling 
to ensure the spectra were representative of the bulk of the sample. 
 
Figure 90 - HORIBA LabRAM HR confocal microscope. 
Both IR and Raman samples were later analysed using the PolySNAP3 software, allowing 
background removal and statistical analysis, including the clustering of similar spectra. 
3.2.5 Electron Microscopy 
For imaging by scanning electron microscopy, a small portion of each sample was dusted 
onto a sample holder and coated before placing in the SEM chamber of a Philips/FEI XL30 
ESEM (Figure 91), offering a magnification of between 10x and 40000x with a resolution of 
3.5nm.  The samples were coated with a gold/palladium coating using a Polaron SC7640 
sputter coater to avoid melting and dispersion in the high vacuum chamber by the electron 
beam. 
 
Figure 91 - Philips/FEI XL30 ESEM 
Images produced by the SEM were analysed visually for features within the sample and 
measurements of artefacts and pore sizes. 
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4. Crystallisation of Reactive Materials 
Working with reactive materials requires care in understanding all aspects of the behaviour 
of the molecule under study.  Very little previous research has been conducted in the solid 
state properties of the extremely reactive organic peroxyacids and doubtless this is a result 
of their inherent instability, not only on their own in their pure form, but also with solvents 
in which dissolution may be attempted, pH conditions, temperature and ultimately any 
secondary materials into which they are brought into contact.  This places limitations on 
the type of materials used in attempting to stabilise reactive peroxyacids, but with no 
complete understanding of these molecules available, selecting the correct environment 
for crystallisation of these materials must involve a broad screening process.  Systems that 
do not retain the molecule’s efficacy must be eliminated and systems that initially maintain 
its stability pursued. 
In particular with the highly reactive organic peroxyacids, as observed in the crystal data 
that is available from Feeder and Jones14, there has been shown to be a need to re-
crystallise the phthalimidoperoxyaliphatic acids of interest in order to collect more 
accurate data to determine the behaviour of the terminal peroxyacid hydrogen, which was 
missing from the original data, and to re-discover the reaction conditions utilised to isolate 
the stable solid crystalline form in the first instance.  The literature corresponding to these 
materials only states that the crystals were provided by an external source to the 
crystallographer14 and thus the method of crystallising these materials, without allowing 
them to decompose to the parent acid, was confirmed in this work. 
The model material meta-chloroperbenzoic acid also had to be isolated and crystallised in 
order to understand its hydrogen bonding motifs, allowing assessment and potential 
manipulation of any prevalent motifs to bring forward into a crystal engineering strategy 
for co-crystallisation of the molecule.  It was also important to gather this information as it 
was likely that the recrystallised material may occur regularly in analysis of resulting 
materials, therefore a structure and powder pattern of the recrystallised pure MCPBA 
would be necessary. 
The solubilities and single crystal structures of the second class of materials under study – 
agrichemicals – were already known and therefore this step was not required. 
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4.1 Solvent effects on reactive materials 
4.1.1 Meta-chloroperbenzoic acid 
In order to find a suitable crystallisation environment for meta-chloroperbenzoic acid 
(MCPBA) and to obtain crystals suitable for single crystal X-ray diffraction, an array of 
solvents were selected for preliminary assessment of the stability of the material and used 
in a set of evaporative crystallisation experiments with MCPBA in its delivered form, 








Figure 92 - Molecular structure of meta-chloroperbenzoic acid (MCPBA). 
4.1.1.1 Overview of solvents chosen for screening 
Initially, a standard array of frequently used lab solvents was chosen for crystallisation of 
MCPBA.  Methanol, ethanol and propanol were selected due to the observed solubility of 
the material in these solvents and their relative inertness.  To this selection, acetone was 
added as a standard laboratory use solvent.  Acetone in particular was highlighted as a 
potential solvent which could not be oxidised, supported by evidence from existing 
crystallographic data14 where carbonyl groups within a solid-state structure were known to 








Methanol Ethanol Isopropanol Acetone
 
Figure 93 - Initial solvents chosen for dissolution and crystallisation study with MCPBA by evaporative 
crystallisation. 
These solvents were used to dissolve the MCPBA and the solutions allowed to slowly 
evaporate at both room temperature to assess the stability under ambient conditions, and 
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a reduced temperate of 4°C to decrease the available energy available to the system for 
decomposition. 
4.1.1.2 Statistical analysis of resulting compounds 
The resulting solids were analysed by X-ray powder diffraction and analysed for similarity in 
PolySNAP3123.  All patterns obtained may be found in Appendix 1.  The powder data 
collected shows evidence of clustering of the X-ray powder patterns into two distinct 
categories (Figure 94). 
  
Figure 94 – PolySNAP 3 clustering analysis of x-ray powder patterns of materials collected from the 
attempted recrystallisation of MCPBA in selected solvents. 
The yellow cluster indicated in the dendrogram (Figure 94) corresponds to the samples 
resulting from MCPBA recrystallized in methanol at 4°C, AM01_02i, ethanol and 
isopropanol at ambient room temperature and 4°C, AM01_03 to AM01_06 respectively.  
The yellow clustered patterns correlate at greater than a 78.0% similarity match.  The 
comparison of these patterns (Figure 95) confirms their excellent match to one another. 
                                                          
i
 For convenience, sample codes indicated are as used in the synthesis / crystallisation experiments.  




Figure 95 - Overlay of X-ray powder patterns from the identified yellow cluster (AM01_02 - AM01_06). 
The red coded sample, identified as 1 in the dendrogram, corresponds to AM01_01 – 
MCPBA recrystallised in methanol at room temperature.  Although the pattern is only at 
greatest, a 55.8% similarity match to the patterns within the yellow cluster, upon visual 
examination and comparison (Figure 96) the sample shows a very close match to the main 
peaks of the yellow clustered samples but with a much greater background noise resulting 
from a greater amorphous content.  This sample can therefore, for qualitative analysis, be 
clustered with the yellow coded samples. 
 
Figure 96 - Comparison of samples AM01_01 and AM01_05 – MCPBA crystallised in MeOH at room 
temperature and in propanol at room temperature. 
The patterns from the yellow cluster match closely to that of the meta-chloroperbenzoic 
acid decomposition material, the parent acid, 3-chlorobenzoic acid as shown by a 
comparison with a representative sample from the set (Figure 97).  These solvents were 
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Figure 97 - A representative XRPD scan of the yellow cluster (AM01_02) compared with a reference pattern 
for 3-chlorobenzoic acid. 
The green cluster (7 and 8 in Figure 94) represents samples AM01_07 and AM01_08, where 
the meta-chloroperbenzoic acid was crystallised in acetone at room temperature and 4°C 
respectively.  These samples match with 80.4% similarity.  The patterns do not show any 
resemblance to the decomposition product, 3-chlorobenzoic acid and may correspond to 
the recrystallised peroxyacid.  Upon isolation of a single crystal of this material, it was 
analysed by single crystal X-ray diffraction and identified as the target meta-
chloroperbenzoic acid, the structure of which is not recorded in the CSD46.  Comparison of 
the simulated XRPD pattern from the single crystal structure generated to the samples 
within the green cluster show an excellent match with a slight shift in peak positions 
resulting from the decrease in unit cell size from cryogenic cooling of the single crystal at 
100K, thus confirming the successful recrystallisation of MCPBA from acetone at both room 
temperature and 4°C (Figure 98). 
 
Figure 98 - Comparison of clustered room temperature XRPD patterns of recrystallised MCPBA samples 
(AM01_07 and AM01_08) to a simulated XRPD pattern generated from the solved structure of MCPBA from 
single crystal XRD data at 100K. 
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From the initial results, acetone is the only solvent in which the target peroxyacid 
crystallised successfully.  From the comparison with the simulated MCPBA XRPD patterns, 
all peaks correspond to peaks that should be present within the with the exception of the 
addition of a few small peaks in AM01_07 (Figure 98).  Comparing this sample to the 
reference XRPD pattern for 3-chlorobenzoic acid, it appears that a small amount of 
decomposition has in fact taken place in the room temperature acetone recrystallisaiton as 
these extra peaks match the strongest peaks observed in crystalline 3-chlorobenzoic acid 
(Figure 99). 
 
Figure 99 - XRPD pattern of AM01_07 compared to a reference pattern for 3-chlorobenzoic acid. 
This would be consistent with the fact that the starting material is in equilibrium with the 
parent acid.  This effect appears also to be present within the 4°C crystallisation, but to a 
smaller extent. 
The study of MCPBA solvent interaction was subsequently extended to methanol at 4°C 
and room temperature with the addition of hydrogen peroxide to the solution.  It was 
hoped that this would aid in the stabilisation of the MCPBA by pushing the decomposition 
equilibrium in a reverse direction, towards the formation of the peroxyacid, preventing, or 
at least making unfavourable, the formation of the parent 3-chlorobenzoic acid.  It was 
already observed that these crystallisation conditions, in the absence of hydrogen 
peroxide, produce only the parent acid as a product, thus any retention of MCPBA would 
be a direct result of the addition of the hydrogen peroxide. 
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Figure 100 - AM35_06 and AM35_07, MCPBA recrystallised in methanol at 4°C and room temperature 
respectively with the addition of HOOH, compared with MCPBA. 
As can be seen in Figure 100, this had a minimal effect, if any upon the samples from 
recrystallisation in methanol, with the addition of hydrogen peroxide insufficient to 
effectively minimise the decomposition in the polar methanol solvent.  The application of a 
small excess of HOOH to a crystallisation is, however, a logical step and was therefore 
utilised in most subsequent crystallisations. 
4.1.1.3 Analysis of isolated structures 
For the samples obtained from the small scale solvent screening of meta-chloroperbenzoic 
acid, the majority of the crystallisations resulted in decomposition to 3-chlorobenzoic acid.  
However that was not the only solvent interaction observed, with .reaction products also 
obtained under certain conditions.  One frequent such product was TATP – triacetone-
triperoxide, also discussed here. 
3-Chlorobenzoic acid 
Although the structure of 3-chlorobenzoic acid is known, for which two data sets exist 
within the CSD, both were collected at room temperature.  The structure was therefore 
recollected at 100K, in line with the standard collection temperature for single crystal X-ray 
diffraction in this research, and in the research group as a whole. 
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Figure 101 - Crystal structure asymmetric unit of 3-chlorobenzoic acid. 
A crystal structure of 3-chlorobenzoic acid (Figure 101) was obtained from a single crystal 
representative of the bulk of the sample, isolated from the recrystallisation of MCPBA in 
methanol at 4°C, AM01_02, and determined by single crystal X-ray diffraction at a 
temperature of 100K.  The structure of the material was reconfirmed to be monoclinic with 
a space group P21/c (  
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Table 4).  The asymmetric unit of the crystal structure comprises one full 3-chlorobenzoic 
acid molecule, and thus there are four molecules present within the unit cell.  As would be 
expected, the acidic group of the molecule is protonated.  Disorder of the chlorine atom on 
the 3 position of the benzene ring was observed, and modelled in terms of a 180° rotation 
of the aromatic part of the molecule resulting in two possible positions of the chlorine 
atom, alternating from the 3 to a 5 position.  When the disorder is modelled, it leads to a 
94% occupancy of the chlorine atom at the 3 position and a resulting 6% occupancy at the 5 
position.  This, however, has no real relevance to the hydrogen bonding motifs observed 




Table 4 - Crystal structure collection data for 3-chlorobenzoic acid. 
Compound 3-Chlorobenzoic acid 
Formula C7H5O2Cl 
Crystallisation Conditions MCPBA, Methanol at 4°C 
Molecular weight / gmol-1 156.56 
Temperature (K) 100 
Space Group P21/c 
a (Å) 3.7649(6) 
b (Å) 15.991(3) 
c (Å) 11.0242(18) 
α (o) 90 
β (o) 94.056(9) 
γ (o) 90 
Volume (Å3) 662.04(19) 
Z 4 
Z’ 1 
θ range/˚ 2.25-34.58 
Reflections Collected 22577 
Independent 2695 
Refln (obs.I>2theta(I)) 2299 
Rint 0.0593 
Parameters 107 
GooF on F2 1.068 
R1 (Observed) 0.0420 
R1 (all) 0.0491 
wR2 (all) 0.1198 
 
The primary interaction within the structure is the predictable and familiar R22(8) carboxylic 
acid dimerization motif (Figure 102), associating two carboxylic acid molecules via two 
moderate strength hydrogen bonds at an O···H-O distance of 2.652(2)Å and an angle of 
178(3)°, with the hydrogen atom clearly associated with O2, being at a distance of 0.86(3)Å 
to the donor and 1.79(3)Å to the acceptor O1.  The two dimerised 3-chlorobenzoic acid 
molecules associate such as to create a planar arrangement of the two molecules, with an 




Figure 102 - 3-chlorobenzoic acid dimerisation motif with associated hydrogen bond distances. 
O1 additionally interacts with the aromatic hydrogen at the 4 position on the aromatic ring, 
H2, creating a weak C-H···O interaction at an overall acceptor to acceptor distance of 
3.368(2)Å and an angle of 148(2)° (Figure 103). 
 
Figure 103 - 3-chlorobenzoic acid dimer interaction with aromatic hydrogen H2 parallel with the main dimer. 
This O1···H2 interaction is close to being planar with the main dimer but neighbouring 
molecules are displaced by 0.819Å to each other, produces a stepping arrangement of 
dimers alternating orientation to form infinite chains (Figure 104) stacking on top of each 
other down the a-axis. 
 




Figure 105 - Alternating dimers of 3-chlorobenzoic acid arranged along the stepping chains viewed down the 
direction of the a-axis. 
As viewed down the a-axis (Figure 105), the alternating orientation of the dimers along the 
infinite stepping chains can be appreciated.  These chains stack directly on top of each 
other down the a-axis thus generating sheets of hydrogen bonded molecules. 
 
Figure 106 - Chlorine interactions within 3-chlorobenzoic acid. 
The chlorine atoms in the molecule are not involved in significant intermolecular 
interactions (Figure 105).  They lie within the structure at a distance of 3.8703(7)Å to each 
other, greater than the sum of their van der Waals radii.  This is also true of their closest 
intermolecular interaction with the aromatic hydrogen at the 2 position, which has a 
distance of 3.38(2)Å.  The only interactions in which the van der Waals radii do overlap, are 
intramolecular, such as with the neighbouring hydrogen atoms within the aromatic ring. 
 
Figure 107 - Planes generated by stacked from symmetry equivalent benzene rings of 3-chlorobenzoic acid 




The aforementioned stacking of the sheets is facilitated by π-π stacking at a distance of 
3.442Å between the planes generated by stacked molecules (Figure 105).  The π-π stacking 
arrangement between the sheets is skewed as shown in Figure 108, where two adjacent 
sheets are coloured red and blue.  There are no obvious voids or channels within the 
structure aside from between the π-π interacting sheets. 
 
 
Figure 108 - Skewed stacking of two sheets (red and blue) of 3-chlorobenzoic acid. 
Triacetone-triperoxide (TATP) 
One unexpected side reaction that occurred frequently, not necessarily within the solvent 
screening process, but when acetone was used as a solvent to crystallise MCPBA or any of 
the other peroxyacids, was the formation of the highly energetic material triacetone-
triperoxide – TATP.  TATP is a highly unstable molecule which is very sensitive to concussion 
and ignition, and is used a primary and main charge explosive151.  The danger associated 
with the occurrence of this material as a by-product of crystallisations was limited by the 
crystallisation technique used, with each sample isolated in an individual reaction vessel on 




















Figure 109 - Standard reaction scheme for synthesis of triacetone-triperoxide. 
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The standard synthesis of triacetone-triperoxide is by reaction of hydrogen peroxide 
solution with acetone in the presence of a sulphuric acid catalyst (Figure 109).  Within the 
course of this research however, these reaction conditions are not present, and instead the 
acetone must react with hydrogen peroxide released from decomposition of the 
peroxyacid.  The formation of TATP was noted mainly in cases where the co-component 
was a carboxylic acid, thus the synthesis seems to be catalysed also by much weaker 
carboxylic acids.  The side reaction under the crystallisation conditions within acetone is 























Figure 110 - Synthesis of TATP under crystallisation conditions for MCPBA. 
TATP is a highly polymorphic material, with at least 6 known forms recorded151.  The form 
observed in the reaction conditions here, however consistently has reduced unit cell 
parameters of polymorph b described in the CSD, although the CSD entry for that form is in 
space group Cmca, whereas the structure collected here was better solved as P21/c.  Also, 
in disagreement with the provided description, this polymorph was previously obtained by 
thermal conversion over a course of weeks at 20°C, whereas the crystals collected here 
were all the result of a temperature controlled evaporative crystallisation in acetone. 
 





Table 5 - Crystal structure collection data for Triacetone-triperoxide 
Compound Triacetone-triperoxide 
Formula C9H18O6 
Crystallisation Conditions Side product from crystallisation of 2-chlorobenzoic acid 
in acetone at 4°C with peroxyacetic acid 
Molecular weight / gmol-1 222.24 
Temperature (K) 100 
Space Group P21/c 
a (Å) 15.9136(6) 
b (Å) 10.5446(4) 
c (Å) 15.5134(6) 
α (o) 90 
β (o) 118.4660(10) 
γ (o) 90 
Volume (Å3) 2288.46(14) 
Z 8 
Z’ 2 
θ range/˚ 1.46-24.7 
Reflections Collected 43772 
Independent 3834 
Refln (obs.I>2theta(I)) 2980 
Rint 0.0562 
Parameters 415 
GooF on F2 1.180 
R1 (Observed) 0.0629 
R1 (all) 0.0793 
wR2 (all) 0.1712 
 
In the chosen unit cell setting, P21/c (Table 5), there exist two independent molecules of 
TATP within the asymmetric unit.  Both of the molecules are considered to be in the right 
handed D3 conformation (Figure 111), as described by Reany et al.
151, with all oxygen bonds 
in a downward stepping orientation when the ring of the molecule is followed clockwise 
resulting in a right handed D3 molecular symmetry and a right handed helical arrangement 
of the structure. 
 
Figure 112 - Stable conformers of TATP
151
. 
There is also indication that there may be a small amount of disorder in the molecule 
between the conformers, which generates residual electron density not fully accounted for 
by this model, particularly noticeable around the oxygen positions, and also apparent by re-
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orientation of the methyl groups resulting from alternating between step-up and step-
down geometry of the O-O bonds. 
 
Figure 113 - Hydrogen bonding present in collected structure of TATP, polymorph b. 
There are 4 unique intermolecular hydrogen bonds within this structure (Figure 112).  They 
span between adjacent TATP molecules in pairs, linking inverted molecules in a chain 
perpendicular to the b-axis.  Each of the bonds are methyl C-H···O interactions.  C16-
H35···O1 has an overall bond distance of 3.639(4)Å and an angle of 177(4)°, which is paired 
with a complementary bond C4-H17···O9 of 3.575(4)Å (166(4)°).  This creates a weakly 
bonded R22(10) motif between the two inverted molecules.  The other set of interactions 
are on the other side of the molecules and are slightly stronger than their counterparts.  
Again both are C-H···O interactions.  The C12-H29···O5 bond distance is measured at 
3.522(6)Å (167(4)°) and complemented by the strongest of the interactions C9-H23···O7 at 
a distance of 3.460(6)Å (173(4)°).  This produces a second ring motif with a R22(8) 
configuration.  The chains of TATP molecules stack on top of each other, with two layers 
per unit cell, thus the distance between the planes generated by the chains is 5.2725(4)Å – 
half the distance of the b-axis (Figure 114). 
 
Figure 114 – Extended structure of TATP viewed along the c-axis showing planes generated by hydrogen 





Figure 115 - Three layers of TATP chains viewed down the b-axis of the collected TATP structure. 
Viewed down the direction of the b-axis (Figure 115), it can be observed that the molecules 
stack on top of each other in two distinct arrangements.  The first type, the “snowflake” 
arrangement is created when the molecules stack directly above each other rotated 180°, 
giving the appearance of a circular centre of oxygen atoms with six protruding equally 
spaced methyl group pairs.  This gives the appearance of channels extending the length of 
the b-axis, however at a channel size of approximately 3Å, the void is almost completely 
filled by Van der Waals radii of the oxygen atoms, leaving very little space for any inclusion.  
In the second stacking arrangement, the molecules do not overlay directly, however are 
still rotated by 180° with each consecutive layer.  In the second arrangement, the methyl 
groups at one “point” of the molecule overlays with the void of the next creating an overall 
larger footprint than the snowflake, when viewed from this direction. 
To an extent the oxygen atoms are isolated from any significant interactions by the 
arrangement of the methyl groups, which by arranging the molecules into chains 
introduces bands of methyl hydrogens.  This is particularly evident in Figure 113, where 
bands of hydrogens between the layers introduce a significant separating gap into the 
structure. 
As this material is highly polymorphic, it makes sense for all polymorphs of this material to 
be referenced to when using acetone as a solvent for crystallisation of peroxyacids.  This is 
easily achieved by looking for the presence of the corresponding XRPD patterns of these 
polymorphs in the sample X-ray powder diffraction patterns – in contexts such as this, the 
value of using pattern matching software such as PolySNAP3 is obvious. 
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4.1.2 6-Phthalimidoperoxyhexanoic acid 
There is little published information on the main material under study, 6-
phthalimidoperoxyhexanoic acid (PAP), and as mentioned in the introduction, the position 
of the peroxy hydrogen atom was not determined in previous studies14.  Similarly to 
MCPBA, the stability of PAP in solvent environments as for crystallisation experiments was 
not known, and a similar screening process for solvents was required. 
4.1.2.1 Overview of solvents chosen for screening 
As this was the main target material under study, a broader screen of solvents was chosen 
for study to maximise the potential of finding a compatible solvent to work with 
throughout the co-crystallisation experiments.  As with the screening of meta-
chloroperbenzoic acid, an initial two temperature regime was also adhered to in order to 
minimise the available energy in the system which may lead to activation of a 
decomposition reaction.  The standard room temperature re-crystallisation was 
supplemented by a 4°C recrystallisation for each solvent, with the exception of morpholine, 
which is a solid at this temperature. 
The solvents chosen for recrystallisation of PAP were: methanol, ethanol, isopropanol, 
acetone, methyl acetate, ethyl acetate, diethyl ether, chloroform, morpholine and dioxane.  
This included an array of standard lab solvents, as well as the use of acetates, which are 
known to be used during the synthesis of the material, and as such were expected to 
favour its stability. 
Drawing parallels with the MCPBA screening, the use of acetone as a solvent was expected 
to produce positive results in this screening, leading to recrystallisation of the PAP.  A wider 
range of recrystallisation conditions for acetone were thus prepared.  Also in line with the 
previous screening, the introduction of hydrogen peroxide to selected recrystallisations 
was attempted in order to maintain the equilibrium of the peroxyacid/parent acid in favour 
of the production or retention of the target material.  
An overview for the selection of solvents and conditions for the recrystallisation of PAP is 






Table 6 - Solvent screening recrystallisation parameters for 6-phthalimidoperoxyhexanoic acid 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM24_01 Methanol 4°C 1 
AM24_02 Methanol Room temperature 2 
AM24_03 Ethanol 4°C 3 
AM24_05 Isopropanol 4°C 4 
AM24_06 Isopropanol Room temperature 5 
AM24_07 Chloroform 4°C 6 
AM24_08 Chloroform Room temperature 7 
AM24_09 Acetone 4°C 8 
AM24_10 Acetone Room temperature 9 
AM24_11 Diethyl Ether 4°C 10 
AM24_12 Diethyl Ether Room temperature 11 
AM24_13 Ethyl Acetate 4°C 12 
AM24_14 Ethyl Acetate Room temperature 13 
AM24_16 Morpholine Room temperature 14 
AM24_17 1,4-Dioxane 4°C 15 
AM24_18 1,4-Dioxane Room temperature 16 
AM32_03 Acetone 4°C 17 
AM32_04 Acetone 4°C 18 
AM32_05 Acetone Room temperature 19 
AM32_06 Acetone Room temperature 20 
AM32_07 Acetone 30°C 21 
AM32_08 Acetone 50°C 22 
AM32_09 Methyl Acetate 4°C 23 
AM32_10 Methyl Acetate Room temperature 24 
AM32_11 Methyl Acetate 30°C 25 
AM32_12 Methanol and HOOH 4°C 26 
AM32_14 Methanol and HOOH 30°C 27 
AM32_15 Ethanol and HOOH 4°C 28 
AM32_16 Ethanol and HOOH Room temperature 29 
AM32_17 Ethanol and HOOH 30°C 30 
 
4.1.2.2 Statistical analysis of resulting compounds 
The resulting solids collected from the recrystallisations were analysed by X-ray powder 
diffraction methods and analysed statistically using the PolySNAP 3 software.  All XRPD 




Figure 116 – PolySNAP 3 clustering analysis of X-ray powder patterns of materials collected from the 
attempted recrystallisation of 6-phthalimidoperoxyhexanoic acid in selected solvents as described in Table 6 
with the cluster cut level set to 72% similarity. 
The dendrogram presented from the analysis of the XRPD data (Figure 116), where the scan 
number corresponds to the system used for recrystallisation as detailed under the column 
“PolySNAP ID” in Table 6, when the percentage similarity cut off level is set to 72%, as 
suggested by the analysis, shows several distinct groupings amongst the materials.  The 
first group, clustered as red and referred to as group A, consists of 11 samples, detailed in 
Table 7. 
Table 7 - Resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid clustered within group A 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM24_01 Methanol 4°C 1 
AM24_10 Acetone Room temperature 9 
AM24_11 Diethyl Ether 4°C 10 
AM32_03 Acetone 4°C 17 
AM32_04 Acetone 4°C 18 
AM32_05 Acetone Room temperature 13 
AM32_06 Acetone Room temperature 20 
AM32_07 Acetone 30°C 21 
AM32_09 Methyl Acetate 4°C 23 
AM32_10 Methyl Acetate Room temperature 24 
AM32_11 Methyl Acetate 30°C 25 
 
When the patterns in group A are analysed (Figure 117), they appear to all have the same 
main component peaks, with the exception of the least similar pattern in the grouping, 
corresponding to sample AM32_05.  All scans however show a similar presence of the main 




Figure 117 - XRPD patterns of collected materials from recrystallisation of 6-phthalimidoperoxyhexanoic acid 
clustered in group A. 
When compared to a simulated powder X-ray diffraction pattern of the known crystal 
structure of PAP (Figure 118), confirmed by the assignment of the majority of the peaks 
that this is the main component within group A samples.  Thus for the crystallisation 
conditions corresponding to this group, the peroxyacid is successfully recrystallised.  Figure 
118 shows the comparison of a representative pattern from group A and the simulated 
pattern, from which it can be observed that there are two peaks that are not 
representative of the reference pattern.  These peaks, at 14.9° and 28.0°, do not 
correspond to any other known pattern, including those of 6-phthalimidohexanoic acid or 
any of the known forms of TATP.  However, the sample that features these peaks most 
strongly is AM32_05, recrystallisation of PAP with acetone at room temperature, exactly 
the same conditions as AM35_06, in which these peaks are much smaller.  It is possible is 
that these peaks could be the result of the presence of a small amount of an impurity in the 






































batch of PAP provided.  This would be consistent with the fact that a small amount is 
present in all XRPD patterns of recrystallisations, albeit at different levels. 
 
Figure 118 - Comparison of a XRPD sample representative of cluster group A with a simulated XRPD pattern 
from the reference crystal structure of 6-phthalimidoperoxyhexanoic acid. 
These results from cluster group A show that the PAP is most stable in acetone, methyl 
acetate and, quite surprisingly, methanol at 4°C.  The successful recrystallisation in 
methanol is unexpected as the model compound MCPBA showed fairly complete 
conversion to the parent acid under these conditions. 
The second set of groupings, B and C – yellow and green respectively in Figure 116 – 
correspond to the samples outlined by the crystallisation conditions in Table 8 (with the 
colour coding retained). 
Table 8 - Resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid clustered within groups B 
and C. 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM24_02 Methanol Room temperature 2 
AM24_14 Ethyl Acetate Room temperature 13 
 
These conditions produced materials which show all the major peak correlations to 
recrystallised PAP, but as the samples were substantially more amorphous, their similarity 
was indicated to be less (Figure 119) at only 65%.  Again it can be noted that in sample 
AM24_14, recrystallisation in ethyl acetate at room temperature, the unidentified peaks 
are of a greater intensity. 
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Figure 119 - XRPD patterns collected of samples in cluster groups B and C compared with the reference 
simulated XRPD pattern of 6-phthalimidoperoxyhexanoic acid. 
Cluster group D, light blue (Figure 116), consists of nine samples, all with a similarity to 
each other greater than 79% with their crystallisation conditions as detailed in Table 9. 
Table 9 - Resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid clustered within group D 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM24_06 Isopropanol Room temperature 5 
AM24_07 Chloroform 4°C 6 
AM24_08 Chloroform Room temperature 7 
AM24_09 Acetone 4°C 8 
AM24_12 Diethyl Ether Room temperature 11 
AM24_13 Ethyl Acetate 4°C 12 
AM24_17 1,4-Dioxane 4°C 15 
AM24_18 1,4-Dioxane Room temperature 16 
AM32_08 Acetone 50°C 22 
 
Cluster group D represents samples with a mixture of materials, which as a result have 
patterns similar to each other.  The samples identified all show the presence of the 
impurity peak, as well as possible evidence of PAP within the sample in combination with 
the parent acid “decomposed PAP” – 6-phthalimidohexanoic acid or its hydrated crystal 
form (Figure 120).  As such these crystallisation conditions, and their unpredictability for 
retention of the peroxyacid, are unsuitable for crystallisation of PAP, with perhaps the 
exception of AM24_09 – recrystallisation in acetone at 4°C, which by analysis of the XRPD 
pattern shows more retention of the peroxyacid with only minor decomposition to the 
parent acid.  
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Figure 120 - XRPD patterns resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid 
clustered within group D compared to 6-phthalimidoperoxyhexanoic acid, its parent acid and a hydrate of the 
parent acid. 
Cluster group E, dark blue, consists of four patterns with greater than 80% similarity.  These 
samples, with their crystallisation conditions shown in Table 10 and their XRPD patterns 
shown in Figure 121 all have an excellent similarity to the simulated XRPD pattern of the 
known crystal structure of the decomposed PAP breakdown product 6-
phthalimidohexanoic acid hydrate152. 
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Table 10 - Resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid clustered within group E 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM24_03 Ethanol 4°C 3 
AM24_05 Isopropanol 4°C 4 
AM32_12 Methanol and HOOH 4°C 26 
AM32_16 Ethanol and HOOH Room temperature 29 
 
 
Figure 121 - XRPD patterns resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid 
clustered within group E compared to the simulated XRPD pattern of the known crystal structure of the 
decomposed PAP form 6-phthalimidohexanoic acid monohydrate. 
Cluster group F, in magenta, consists of two samples, AM32_14 and AM32_17.  Both of 
these samples are from crystallisation of PAP in an alcohol with the addition of hydrogen 
peroxide at 30°C (Table 11).  These samples both result in a decomposition of the material 
to the parent acid, with AM32_14 producing a high purity of 6-phthalimidohexanoic acid 
monohydrate and AM32_17 producing a mixture of the same hydrate and as well as the 
anhydrous crystal form (Figure 122).  There is no remaining peroxyacid in either of these 
samples. 
Table 11 - Resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid clustered within group F 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM32_14 Methanol and HOOH 30°C 27 
AM32_17 Ethanol and HOOH 30°C 30 
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Figure 122 - XRPD patterns resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid 
clustered within group F compared to the simulated XRPD pattern of the known crystal structure of 
decomposed PAP forms 6-phthalimidohexanoic acid monohydrate and 6-phthalimidohexanoic acid. 
The remaining cluster group, G, in orange is another small cluster of two samples: 
AM24_16 and AM32_15, both of which are from seemingly unrelated crystallisation 
conditions (Table 12).  Both of these samples, however, show the presence of a new 
material, which does match any of the other known or expected decomposition products. 
Table 12 - Resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid clustered within group G 
Sample ID Recrystallisation solvent Temperature PolySNAP3 ID 
AM24_16 Morpholine Room temperature 14 
AM32_15 Ethanol and HOOH 4°C 28 
 
Figure 123 - XRPD patterns resultant materials recrystallised from 6-phthalimidoperoxyhexanoic acid 
clustered within group G compared to the simulated XRPD pattern of a new polymorph of 6-
phthalimidohexanoic acid monohydrate. 
The new product was analysed by single crystal X-ray diffraction and identified to be a new, 
unknown polymorph of the decomposed PAP product 6-phthalimidohexanoic acid 
monohydrate, which was an excellent match for the XRPD patterns of these two samples 
(Figure 123). 
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4.1.2.3 Analysis of isolated structures 
As noted in the previous section, there were several materials isolated by the solvent 
screening process of 6-phthalimidoperoxyhexanoic acid identified by X-ray powder 
diffraction methods.  These structures are described here with their characteristic 
crystallographic packing: 
6-Phthalimidohexanoic acid 
The main decomposition product of PAP, this material was encountered regularly 
throughout this research.  As this compound has already been studied by Feeder and 
Jones153, and recorded within the CSD, a recollection of the structure was not required for 
production of a simulated XRPD pattern for the analysis and assessment of decomposition 
products of the peroxyacid.  It is, however, appropriate at this point to study the structure 
and interactions of the kwown structure of his material (CSD ref. code VUNZEJ10153). 
 
Figure 124 - Known crystal structure of 6-phthalimidohexanoic acid
153
 
The structure of 6-phthalimidoperoxyhexanoic acid is likely to share interaction 
characteristics with the parent acid (6-phthalimidohexanoic acid), due to the high similarity 
between the two molecules.  The phthalimido group and the aliphatic chain remain 
unchanged from the peroxyacid molecule with the same interaction sites.  The only change 
in the structure is the loss of the basic oxygen atom from the peroxyacid functional group 
and resulting change in position of the terminal hydrogen onto the acidic oxygen, forming 
the parent carboxylic acid.  As would be expected with the carboxylic acid functional group 
and synthons being present, the carboxylic acid R22(8) motif once again is the dominant 
interaction within the structure.  This occurs between the two unique molecules of 6-
phthalimidohexanoic acid in the asymmetric unit of the P21/c structure.  The two primary 
hydrogen bonds are formed between O4-H···O7 and O8-H···O3 with bond distances, from 
oxygen to oxygen, of 2.61(2)Å and 2.62(2)Å respectively (Figure 124).  Upon closer 
inspection (Figure 125), it can be observed that the bond lengths between the C-O covalent 
bonds are not equivalent in the two molecules.  The distances C28-O7 and C28-O8 in one 
molecule are equal at 1.21(2)Å, which would be unexpected for a carboxylic acid group.  
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Such an arrangement would usually only be present in a deprotonated carboxylic acid 
where the residual charge is delocalised over the entire O-C-O group.  This leads to 
ambiguities as to the existence and, if present, the positioning of the acidic hydrogen atom 
on the molecule.  By analysis of the second molecule the observed distances of the C-O 
bonds , 1.18(2)Å and  1.21(3)Å are not significantly different within the measured 3σ error 
and thus cannot be verified  as to having double or single bond character. 
 
Figure 125 - R
2
2(8) ring motif present between the two unique molecules of 6-phthalimidohexanoic acid in 
the asymmetric unit. 
 
Figure 126 - 6-phthalimidohexanoic acid as viewed down the b-axis. 
The two hydrogen bonds of moderate strength, as defined by Jeffrey21, associate the two 
unique molecules of 6-phthalimidohexanoic acid together to form dimers which alternate 




Figure 127 - Interactions between neighbouring paired 6-phthalimidoheaxanoic acid dimers. 
Between neighbouring pairs of molecules, there are interactions from the aliphatic chain to 
both the phthalimido group and the carboxylic acid of the next dimer (Figure 127).  The two 
interactions are along the plane of the c-axis and are mirrored in the two dimers to 
produce four interactions.  The strongest of these interactions is C26-H26···O1, an aliphatic 
C-H from third carbon in the chain interacting with the phthalimido carbonyl measuring 
3.43(2)Å between non hydrogen atoms.  The second pair of interactions are again between 
the third carbon of the aliphatic chain, but of the second molecule, C12, and the single 
bonded oxygen, O4, of a symmetry equivalent molecule.  This forms a C12-H11···O4 bond 
of overall distance 3.52(2)Å. 
 
Figure 128 - Second set of interactions between the 6-phthalimidohexanoic acid dimers. 
The second set of interactions between the dimers occurs along the same plane, however 
to the dimer set above the previous, resulting in the interaction to the second side of the 
dimer.  As shown in Figure 128, there are three specific interactions, of C-H···O type, one 
between the carbonyl O6 of the phthalimido group and an aromatic C-H of the phthalimido 
group on a neighbouring dimer, C4-H3···O6 at a distance of 3.29(2)Å.  The remaining set of 
interactions is present between O1, the phthalimido carbonyl of the second dimer and two 
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aliphatic C-H groups and the second and fourth carbon atoms of the chain, C27 and C25.  
These interactions are of approximately similar strength, at 3.65(2)Å and 3.61(2)Å 
respectively.  As in the previous dimer, these three interactions are mirrored at the other 
end of the dimer pairs, resulting in six interactions between them.  The last set of 
interactions between the dimers is as shown in Figure 129. 
 
Figure 129 - Highlighted interactions between the dimers of 6-phtalimidohexanoic acid. 
 
O5, a phthalimido carbonyl, exhibits two C-H···O interactions with C11 and C13, both at an 
overall distance of 3.43(2)Å.  There is also an interaction between phthalimido carbonyl O2 
and C18 at a distance of 3.34(2)Å and a further interaction to the unassigned hydroxyl 
carbon of the carboxylic acid dimer group, C26-H25···O8 at a distance of 3.66(2)Å.  All of 
these are relatively weak interactions. 
 
Figure 130 - Unit cell of 6-phthalimidohexanoic acid viewed down the b-axis (left) and down the c-axis (right). 
The phthalimido ends of the molecule align along the c-axis, however when viewed down 
this axis, it can be seen that the arrangement of the groups shows no direct overlay of the 




Figure 131 - Angles measured between planes generated by phthalimido groups in 6-phthalimidohexanoic 
acid. 
The angle between the aligned phthalimido groups is equivalent in all molecular pairings 
within the unit cell at an angle of 103.25° (Figure 130) forming a “point to face” interaction 
between each molecule forming a “zipper” arrangement of phthalimido groups down the 
b-axis (Figure 132). 
 
Figure 132 - "Zipper" arrangement of phthalimido groups present along the b-axis of 6-phthalimidohexanoic 
acid 
This arrangement results in a skewed π-π stacking of the phthalimido rings at distances of 






Table 13 - Details of the crystal structure of 6-phthalimidohexanoic acid
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Compound 6-Phthalimidohexanoic acid 
Formula C14H15N1O4 
Molecular weight / gmol-1 261.27 
Temperature (K) 283-303 
Space Group P21/c 
a (Å) 21.055(8) 
b (Å) 4.662(1) 
c (Å) 28.067(9) 
α (o) 90 
β (o) 105.22(3) 
γ (o) 90 
Volume (Å3) 2658.380 
Z 8 
Z’ 2 
R1 (Observed) 0.08 
 
The primary driving force in the packing arrangement is evidently the hydrogen bonding of 
the carboxylic acid group, however the flexibility of the aliphatic chain allows for this whilst 
permitting efficient packing of the phthalimido group. 
6-Phthalimidohexanoic acid hydrate 
The statistical analysis also showed the presence of a PAP decomposition product as a 
monohydrate with two distinct crystal forms.  The first form was already isolated by Feeder 
and Jones152 and recorded in the CSD, however the XRPD pattern of the second material is 
distinctly different, and is identified as 6-phthalimidohexanoic acid monohydrate form II, 
with the previously recorded structure designated form I (Figure 133). 
 
Figure 133 – XRPD patterns of 6-phthalimidohexanoic acid monohydrate forms I and II. 
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 6-Phthalimidohexanoic acid Monohydrate  Form I
 6-Phthalimidohexanoic acid Monohydrate Form II
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Crystals of Form II were isolated from crystallisation using morpholine as a solvent via slow 
evaporative crystallisation at room temperature.  The details of the structure and data 
collection parameters are compared between forms in Table 14. 
Table 14 – Crystal structure collection data of 6-phthalimidohexanoic acid monohydrate forms I and II 
Compound 6-Phthalimidohexanoic acid 
monohydrate Form I 152 
6-Phthalimidohexanoic acid 
monohydrate Form II 
Formula C14H15N1O4 – H2O C14H15N1O4 – H2O 
Crystallisation Conditions Crystallisation from acetic 
acid at room temperature 
Decomposition of 6-
phthalimidoperoxyhexanoic 
acid from crystallisation in 
morpholine at room 
temperature 
Molecular weight / gmol-1 279.1 279.1 
Temperature (K) 295 100 
Space Group P21/c P-1 
a (Å) 8.771(3) 6.9672(5) 
b (Å) 22.553(5) 8.5418(7) 
c (Å) 7.257(2) 12.4428(9) 
α (o) 90 109.156(6) 
β (o) 99.33(6) 94.369(5) 
γ (o) 90 95.813(6) 
Volume (Å3) 1417 689.31(9) 
Z 4 2 
Z’ 1 1 
θ range/˚ 8-12 1.75-22.79 
Reflections Collected 4362 11037 
Independent 4126 1862 
Refln (obs.I>2theta(I)) 1734 1487 
Rint 0.031 0.0717 
Parameters 199 248 
GooF on F2 unknown 1.134 
R1 (Observed) 0.054 0.0492 
R1 (all) Unknown 0.0681 
wR2 (all) 0.054 0.1124 
 
The two forms are chemically identical, with very similar structural features and motifs, 
both consisting of one molecule of 6-phthalimidohexanoic acid and one water molecule in 




Figure 134 - Asymmetric units of 6-phthalimidohexanoic acid monohydrate forms I (left) and II (right). 
The molecules show slight differences in geometry, likely a result of packing characteristics 
and the different temperatures of data collection. 
 
Figure 135 - Structures of 6-phthalimidohexanoic acid monohydrate overlaid with form I in blue, and form II 
in red. 
Both forms of the monohydrate are similar in the fact that they exhibit a short moderate 
strength hydrogen bond to the water molecule from the hydroxyl hydrogen of the 
carboxylic acid functional group.  These are of a similar length: in form I the distances 
measured between O(141)-H(141)···O(1) is 2.595(4)Å and O(1)-H(201)···O(140) is 2.769(4)Å, 
forming a water-incorporated ring motif with a R44(12) arrangement (Figure 136).  The 
water molecules, O(1), form further hydrogen bonds to O(8) of the phthalimido group at an 




Figure 136 - Hydrogen bonding motif present in Form I of 6-phthalimidohexanoic acid monohydrate. 
 
Figure 137 - Hydrogen bonding motif present in Form II of 6-phthalimidohexanoic acid monohydrate. 
The motif in Form II is similar, with only minor differences (Figure 137).  The distances 
measured between O(3)-H(15)···O(5) is 2.5932(2)Å (171(3)°) and O(5)-H(16)···O(4) is 
2.7556(2)Å (168(6)°), forming a water-incorporate ring motif with a R44(12) arrangement.  
The water molecules, O(5), form further hydrogen bonds to O(1) of the phthalimido group 
at an oxygen to oxygen distance of 2.747(2)Å (168(5)°). 
The differences in the structures arise from the arrangement of these groups with each 
other, seen through differing orientations of the phthalimido groups. 
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Figure 138 – Stacking of phthalimido groups in 6-phthalimidohexanoic acid in form I viewed down the a-axis 
(top left), c-axis (top right) and an expanded view down the a-axis (bottom). 
In Form I, the phthalimido groups stack on top of each other with the aliphatic chains 
progressing in the same direction, the groups only rotating partially such as the chains are 
always to the same side of the stacked molecules.  The phthalimido groups are at a vertical 
spacing of 3.629(4)Å. 
         
Figure 139 - Stacking of phthalimido groups in 6-phthalimidohexanoic acid in form II as viewed down the b-




Figure 140 - Stacking of phthalimido groups in 6-phthalimidohexanoic acid in form II as viewed down the b-
axis. 
In form II however the phthalimido groups alternate in orientation so that the aliphatic 
chains change side and direction.  As a result the phthalimido groups themselves are 
stacked at 180° to each other at spacings of 3.458Å and 3.386Å.  This dramatic change in 
packing causes the difference in crystal structure between the two polymorphs. 
4.2 Acidic and basic effects on reactive peroxides 
The effects of addition of excess strong acid and strong base in a solvent that has proven 
instability with the crystallised peroxyacid material was also investigated.  Both MCPBA and 
PAP were crystallised in methanol and ethanol in the presence of both hydrochloric acid 
and sodium hydroxide to assess the amount of decomposition of the target material that 
occurred under each condition. 
4.2.1 Effect of introduction of hydrochloric acid and sodium hydroxide on MCPBA 
Addition of hydrochloric acid to attempted recrystallisations of MCPBA in methanol and 
ethanol, conditions which in absence of the strong acid have been observed to allow 
decomposition of the material, was explored to assess whether introduction of acidic 
conditions would allow for better retention of the peroxyacid.  The XRPD patterns of 





Figure 141 - XRPD patterns collected of crystallisations of MCPBA in methanol (red) and ethanol (green) with 
the addition of hydrochloric acid at room temperature, compared to sample patterns of MCPBA (blue) and 3-
chlorobenzoic acid (magenta). 
As can be noted from the XRPD patterns, both of the samples recrystallized from methanol 
and ethanol have resulted in a complete conversion to the parent acid, 3-
chlorobenzobenzoic acid.  It is evident from the scans that no traces of MCPBA are retained 
in the final product. 
 
Figure 142 - XRPD patterns collected of crystallisations of MCPBA in methanol at room temperature (blue) 
and ethanol at 4°C (grey) and room temperature (brown) with the addition of sodium hydroxide, compared 
to sample patterns of MCPBA (blue) and 3-chlorobenzoic acid (magenta). 
With the addition of sodium hydroxide to the same crystallisation conditions, formation of 
an entirely new material is observed.  This material seems to be present in absence of 
peaks from either MCPBA and 3-chlorobenzoic acid (Figure 142), but the samples have 
poor crystallinity and it may be the case that other materials present in the representative 
samples are more amorphous or weakly diffracting in comparison.  The crystalline material 
present was identified by manual powder pattern recognition (from comparison to known 
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materials in the ICSD154) to be sodium carbonate monohydrate.  As shown in Figure 143, 
there is a very strong correlation between this XRPD pattern and the samples recorded.  
 
Figure 143 - XRPD patterns collected of crystallisations of MCPBA in methanol at room temperature (purple) 
and ethanol at 4°C (blue, second from top) and room temperature (green) with the addition of sodium 
hydroxide, compared a simulated XRPD pattern from the crystal structures of sodium carbonate 
monohydrate (red) and sodium carbonate heptahydrate (blue, bottom). 
The samples also all contained varying amounts of sodium hydroxide heptahydrate (Figure 
143).  This material was isolated from a later complementary screening under the same 
conditions with PAP, however indications of its strongest peaks are present in the samples 
of recrystallised MCPBA to which sodium hydroxide had been added. 
4.2.2 Effect of introduction of hydrochloric acid and sodium hydroxide on 6-
phthalimidoperoxyhexanoic acid 
A similar screening process was performed upon 6-phthalimidoperoxyhexanoic acid (PAP), 
adding hydrochloric acid and sodium hydroxide to the recrystallisations in methanol and 
ethanol at both 4°C and room temperature. 
The results from the experiments with the hydrochloric acid addition are interesting.  The 
first of the samples, with the target material crystallised in methanol at 4°C, is a very good 
match to the PAP decomposition product 6-phthalimidohexanoic acid monohydrate form I, 
thus under these conditions not only is there decomposition of the target material, but also 
water has been incorporated into the structure (Figure 144). 
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Figure 144 - XRPD patterns collected of crystallisation of 6-phthalimidoperoxyhexanoic acid in methanol at 
4°C with the addition of hydrochloric acid (red) compared with a simulated XRPD pattern from the crystal 
structure of 6-phthalimidohexanoic acid monohydrate form I (grey). 
The other three resultant materials, however, do not match this pattern (Figure 145).  
Recrystallisation of the peroxyacid in methanol at room temperature, as well as in ethanol 
at both 4°C and room temperature, with hydrochloric acid added, has resulted in a material 
where the XRPD pattern does not match the target material, its parent acid or either of the 
two decomposed PAP hydrates. 
 
Figure 145 - XRPD patterns of 6-phthalimidoperoxyhexanoic acid in methanol at room temperature 
(AM33_02; purple), and in ethanol at 4°C (AM33_03; blue) and room temperature (AM33_04; green upper), 
all with the addition of hydrochloric acid, compared with those from 6-phthalimidoperoxyhexanoic acid (light 
blue), 6-phthalimidohexaanoic acid (dark red) and its two hydrates (grey, and green lower) 
The pattern most closely resembles that of 6-phthalimidohexanoic acid, but it is clear that 
it is not a good match.  This material may therefore be either another undiscovered 
polymorph of 6-phthalimidohexanoic acid or its hydrates, or a chloride salt of the parent 
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acid.  It can be concluded that in each circumstance, addition of a strong acid is a detriment 
to the retention of the peroxyacid. 
When crystallised in the presence of sodium hydroxide, again a transformation is found to 
have taken place in the material.  Collected powder X-ray diffraction patterns of 
representative samples show no presence of the peroxyacid of any of its known 
decomposition products in their known forms (Figure 146). 
 
Figure 146 - XRPD patterns of 6-phthalimidoperoxyhexanoic acid with the addition of sodium hydroxide in 
methanol and ethanol at room temperature (AM33_06 (red upper) & AM33_08; red middle), and in ethanol 
at 4°C (AM33_07; red lower) compared with 6-phthalimidoperoxyhexanoic acid (light blue), 6-
phthalimidoheaxanoic acid (dark red) and its two hydrates (grey and light green). 
The XRPD patterns of these materials, although showing a high background level, have 
primary peaks at a very high angle, suggestive of a small unit cell.  It is evident that the two 
recrystallisations at room temperature have produced the same material which again 
closely resembles sodium carbonate monohydrate, whereas the crystallisation at 4°C has 
produced a different material which could not be identified.   
From the recrystallisation of PAP in MeOH at 4°C with NaOH present, single crystals were 
obtained that were suitable for single crystal X-ray diffraction.  The following structure 
solution was obtained from data collected on the Rigaku Single crystal X-ray diffractometer 
at 100K using an Oxford Cryosystems Cryostream (Table 15). 
 
Position [°2Theta] (Copper (Cu))























 Decomposed PAP Hydrate Form I
 Decomposed PAP Hydrate Form II
158 
 
Table 15 - Crystal structure data for sodium carbonate heptahydrate 
Compound Sodium Carbonate Heptahydrate 
Formula C1 H14 Na2 O10 
Crystallisation Conditions Recrystallisation of  
6-phthalimidoperoxyhexanoic acid in MeOH 
at 4°C with NaOH present 
Molecular weight / gmol-1 232.10 
Temperature (K) 100K 
Space Group P b c a 
a (Å) 6.97960(10) 
b (Å) 14.49430(10) 
c (Å) 19.3246(2) 
α (o) 90 
β (o) 90 
γ (o) 90 
Volume (Å3) 1954.95(4) 
Z 8 
θ range/˚ 2.108- 27.603 
Reflections Collected 32142 
Independent 2238 
Refln (obs.I>2theta(I)) 2119 
Rint 0.1172 
Parameters 161 
GooF on F2 1.0095 
R1 (Observed) 0.0179 
R1 (all) 0.0192 
wR2 (all) 0.0560 
 
Sodium carbonate heptahydrate is commonly known as “soda ash” and is most commonly 
synthesised using the Solvay Process155, from sodium chloride and calcium carbonate, but 
as neither of these components are present in the crystallisation, it must follow a different 
reaction mechanism.  The sodium must originate from the sodium hydroxide, however the 
presence of the carbonate molecule must be from a decomposition of the target material, 
or more likely a reaction of the methanol solvent.  The methanol is likely oxidised by the 
liberated hydrogen peroxide from the decomposition of the PAP to oxygenate the carbon 
of the methanol molecule, transforming it to a tertiary oxidised carbon, the negatively 
charged carbonate ion.  This then crystallises with two positively charged sodium ions and 
the remaining water molecules are either taken from the solution as a result of the 
decomposing peroxyacid, the used hydrogen peroxide, or absorbed from the atmosphere 
into the crystal structure.  This proposed reaction mechanism would also hold for the 




Figure 147 - Unit cell of the collected structure of sodium carbonate heptahydrate from the recrystallisation 
of 6-phthalimidoperoxyhexanoic acid in methanol at 4°C with the addition of NaOH. 
The crystal structure of this material, determined for confirmation, has no real implications 
to this research and did not merit further structural investigation. 
4.3 Crystal structure of meta-chloroperbenzoic acid 
The crystal structure of meta-chloroperbenzoic acid, was obtained from samples obtained 
from an evaporative crystallisation in acetone at 4°C.  The crystals themselves were very 
plate-like and consequently it was difficult to select a sufficiently high quality crystal for a 
detailed un-twinned collection and subsequent structure solution.  The following structure 
represents the best of the isolated crystals analysed by X-ray diffraction. 
4.3.1 Summary of diffraction experiment and data 
This X-ray crystal structure (Table 16) was collected on a Bruker AXS Apex II single crystal X-
ray diffractometer at a collection temperature of 100K.  The crystals were clear and 




Table 16 - Crystal structure collection data for meta-chloroperbenzoic acid 
Compound Meta-chloroperbenzoic acid 
Formula C7H5O3Cl1 
Crystallisation Conditions Crystallised by slow evaporation in acetone at 4°C 
Molecular weight / gmol-1 172.57 
Temperature (K) 100 
Space Group P21/c 
a (Å) 3.9254(17) 
b (Å) 5.920(2) 
c (Å) 30.427(11) 
α (o) 90 
β (o) 93.31(2) 
γ (o) 90 
Volume (Å3) 705.9(5) 
Z 4 
Z’ 1 
θ range/˚ 1.34-28.12 
Reflections Collected 17385 
Independent 1678 
Refln (obs.I>2theta(I)) 1406 
Rint 0.346 
Parameters 120 
GooF on F2 1.073 
R1 (Observed) 0.1040 
R1 (all) 0.1175 
wR2 (all) 0.2491 
 
The final R-factor is rather high for this structure, but the data quality is sufficient for 
determination of both non-hydrogen and hydrogen positions, allowing a structural analysis 
of the material.  The heavily twinned nature of these crystals and difficulty in producing a 
sufficiently high quality crystal are possible reasons for the lack of an existing X-ray crystal 
structure for this material. 
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4.3.2 Analysis of the structure and interactions of MCPBA 
 
Figure 148 - Crystal structure of meta-chloroperbenzoic acid (MCPBA). 
The crystal structure of meta-chloroperbenzoic acid (MCPBA) is monoclinic with a space 
group of P21/c.  The asymmetric unit of the structure contains only one molecule of MCPBA 
in the asymmetric unit, with a fully protonated peroxyacid group identified (Figure 148). 
 
Figure 149 - MCPBA molecule viewed along the plane of the aromatic ring 
The molecule itself is almost planar, with only a rotation of 8.3(7)° of the peroxyacid 
functional group from the plane of the benzene ring and the chlorine atom (Figure 149). 
 
Figure 150 - Hydrogen bonding of peroxyacid group in MCPBA viewed along a-axis 
When viewed perpendicular to the plane defined by the molecules, the hydrogen bonding 
motif can be observed.  The basic oxygen of the peroxide group, O3, forms an asymmetric 
bifurcated hydrogen bond motif comprising a weaker bond with the basic oxygen of the 
neighbouring molecule, also O3, and a stronger hydrogen bond with the carbonyl of the 
same neighbouring molecule, O1 (Figure 150).  The interaction with the carbonyl is the 
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stronger of the two, at a distance of 2.712(6)Å (O3-H5···O1); the bent nature of this 
hydrogen bond (O-H-O angle 158(9)°) allows the formation of the second interaction 
making the bond bifurcated.  The second interaction, O3-H5···O3, has an overall distance of 
3.033(6)Å.  As the direction of the motif is the same as is observed with the other 
peroxyacids, forming a C1
1(5) chain (O3-H5-O1-C5-O2), it may be the case that this second 
interaction with the basic oxygen occurs in other cases where the hydrogen position is not 
determined in those published structures. 
 
Figure 151 - Chains of MCPBA as viewed down the a-axis. 
The hydrogen bonded chains are aligned along the b-axis of the structure, which can be 
seen clearly from the view down the a-axis (Figure 151), forming hydrogen bonded 
peroxyacid channels, enclosed by aromatic groups and ultimately chlorine atoms.  This 
gives an overall distance between the chlorine atoms of successive molecules of 5.920(3)Å. 
 
Figure 152 - MCPBA with planes generated by aromatic rings of hydrogen bonded molecules. 
When the structure is rotated 90°, it can be observed that the planes generated by the 





Figure 153 – π-π stacking present in the crystal structure of MCPBA. 
The structure is stacked along the a-axis, producing skewed π-π stacking at a distance of 
3.393(7)Å between the rings and subsequently generated planes of molecules, measured 
from the closest atom contacts between two neighbouring planes. 
 
Figure 154 - Chlorine interactions in MCPBA. 
The chlorine interactions form a chlorine channel with a distance of 3.437(2)Å, within the 
distance of the sum of the Van der Waals radii, and 4.477(2)Å (Figure 154).  
This furthers the evidence that in the solid state, Swern’s proposed dimerisation of 
peroxyacid molecules is contradicted, with the structure following the pattern of 
interactions of the basic oxygen and terminal hydrogen to carbonyl oxygen atoms of other 
peroxyacid molecules, forming a catemeric structure.  There is also no evidence of 
intramolecular interaction within the molecule. 
4.4 Crystal structure of 6-phthalimidoperoxyhexanoic acid 
The crystal structure of 6-phthalimidoperoxyhexanoic acid (PAP) was obtained from a 
recrystallisation of the supplied material, marked with 71% purity, in acetone.  The crystals 
were obtained by slow evaporation at a constant controlled temperature of 30°C using a 
temperature controlled hot plate and exist as very small, clear, colourless plate-like 
crystals.  The data was of sufficient quality to model all H atoms from a Fourier difference 
map and the positions and thermal parameters were subsequently refined.  This allowed 
for the refinement of all non-hydrogen atoms anisotropically, and all hydrogen atoms 
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isotropically, including the terminal hydrogen on the peroxyacid functional group, resolving 
the previous ambiguities in its location. 
 
Figure 155 - The asymmetric unit of the crystal structure of 6-phthalimidoperoxyhexanoic acid. 
4.4.1 Summary of diffraction experiment and data 
Data were collected on a Bruker AXS, APEX II diffractometer at a collection temperature of 
100K, but also subsequently repeated and confirmed on a Rigaku RAPID image plate 
diffractometer.  The APEX-determined structure was solved to a final R-factor of 3.34%. 
Table 17 - Crystal structure collection data for 6-phthalimidoperoxyhexanoic acid 
Compound 6-Phthalimidoperoxyhexanoic acid 
Formula C14H15N1O5 
Crystallisation Conditions Evaporative crystallisation from acetone at 30°C 
Molecular weight / gmol-1 277.28 
Temperature (K) 100 
Space Group P21/c 
a (Å) 18.814(4) 
b (Å) 4.5065(10) 
c (Å) 15.508(4) 
α (°) 90 
β (°) 90.959(9) 
γ (°) 90 
Volume (Å3) 1314.7(5) 
Z 4 
θ range(˚) 1.082-18.981 
Reflections Collected 13414 
Independent 1050 
Refln (obs.I>2theta(I)) 849 
Rint 0.057 
Parameters 186 
GooF on F2 1.0683 
R1 (Observed) 0.0334 
R1 (all) 0.0464 
wR2 (all) 0.0837 
4.4.2 Analysis of the structure and interactions of 6-phthalimidoperoxyhexanoic acid 
It is immediately clear from the structure that the OH hydrogen position is not as well 
defined as the others.  This could either be a result of bifurcation of the hydrogen bond, or 
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simply the inherent flexibility of the terminal OH compared to the other atoms.  However a 
Fourier difference map only shows evidence of a single, slightly diffuse, peak when the 
residual electron density is viewed, with the assigned hydrogen removed.  
 
Figure 156 – Hydrogen bonding of peroxyacid groups in 6-phthalimidoperoxyhexanoic acid. 
The hydrogen of the peroxyacid group is directed between the terminal oxygen and the 
carbonyl of a neighbouring peroxyacid group, forming a hydrogen bond with an O–H···O 
distance of 2.713(4)Å forming a familiar C1
1(5) chain (Figure 156).  There is also a second, 
weaker interaction, similar to that observed with MCPBA, between the peroxy hydrogen 
and the terminal peroxy oxygen of the neighbouring molecule, with a O···H-O distance of 
2.937(4)Å.  The hydrogen is directed more towards carbonyl due to the stronger hydrogen 
bond, indicated by its shorter distance, however the moderate strength hydrogen bonding 
interaction with the neighbouring terminal oxygen in this bifurcated interaction reduces 
the bind angle at oxygen to 97(2)° as opposed to a standard angle of 104.45° as predicted 
by VSEPR theory.  Statistical analysis of known crystal structures of peroxide oxygen, not 
limited to peroxy acids, indicates that this reduction in angle is not uncommon.  It is, 
however, outside the known range for peroxyacids (99.7° – 112.2°), of which there are only 
five.  The second interaction is significant and at least partially directing the hydrogen 
bond, which is echoed by the Fourier difference map, which shows only one electron 
density peak corresponding to the hydrogen. 
 
The angling of the neighbouring phthalimido rings allows C-H···O interactions from the 
phthalimido carbonyl to an aromatic hydrogen and from the carbonyl on the other side of 




Figure 157 - Intermolecular interactions between 6-phthalimidoperoxyhexanoic acid molecules. 
The C···O distances corresponding to these interactions (Figure 157, A and B), are 3.306(5)Å 
and 3.492(4)Å respectively and these are therefore relatively weak hydrogen bonds.  Also 
shown in Figure 157 as C, is an oxygen - aliphatic hydrogen bond between carbon 5 of the 
chain and the terminal oxygen of the peroxy group.  This is also a relatively weak hydrogen 
bond with an oxygen to carbon distance of 3.461(4)Å. 
 
Figure 158 - Phthalimido packing arrangement in 6-phthalimidoperoxyhexanoic acid. 
The phthalimido arrangement is such that the aromatic planes of adjacent molecules are at 
a distance greater than 3.8Å and are therefore defined to be too distant for the π – π 
stacking to be significant.  The intermolecular interactions are thus predominantly from the 
strong hydrogen bonding interactions observed around the peroxy acid group and the 







Figure 159 - Unit cell of PAP viewed along the b-axis. 
As can be observed from viewing the structure along the b-axis, Figure 159, PAP molecules 
pack in rows of phthalimido groups interacting with each other, defined here as being at 
the top and bottom of the shown unit cell, with the peroxy acid groups interacting only 
with other peroxy acid groups, at the centre of the cell.  This has the effect of creating rows 
of aromatic interactions separated by the aliphatic chain from conventional hydrogen 
bonding channels at the functional oxidising end of the molecule.   
 
Figure 160 - 6-phthalimidoperoxyhexanoic acid oriented to view interactions between stacked molecules on 
the a-b-axis. 
It can also be observed from Figure 160, further shown in Figure 161, that the phthalimido 
groups are not all stacked in the same direction.  Neighbouring 6-
phthalimidoperoxyhexanoic acid molecules lie with the planar phthalimido rings almost 
perpendicular to each other, at approximately averaged 80°, creating a saw tooth effect on 
the aromatic stacking motif.  The flexibility of the number 6 carbon on the aliphatic chain 
allows the rest of the molecule to lie in an almost parallel alignment in the intersecting 
plane between the two rings.  This allows for the reactive end of the molecules to lie 





Figure 161 - Planes generated from phthalimido groups on neighbouring 6-phthalimidoperoxyhexanoic acid 
molecules. 
4.5  Summary 
From the evidence collected, it is clear that the molecules under study are indeed highly 
unstable, reacting under normally inert crystallisation conditions such as with standard 
laboratory solvents.  Solvent selection has a major part to play in the retention of the 
peroxyacid character and production of crystals of these reactive materials.  The solvent 
that offered the greatest success with recrystallisation of the target materials was acetone.  
However, as can be seen in the production of TATP, even the solvents in which the 
materials are relatively stable, reactions can take place that can be potentially hazardous.  
Attempts to use more extreme conditions to stabilise these reactive materials were 
unsuccessful.  The use of strong acids and bases as additives in crystallisation environments 
that already proved to be unstable had only a negative effect, producing more side 
products. 
From the crystallographic data collected, it has been confirmed that the peroxyacid group 
has propensity to interact through hydrogen bonding to carbonyl groups, and is stable in 
their presence.  As such, any motif designed to interact with the peroxyacid functional 
group itself should include a strong hydrogen bond acceptor such as, or similar to, a 
carbonyl, or instead should be designed to react with other functionalities of the target 
molecule, such as the aromatic or phthalimido rings.  The aliphatic chain of the PAP 
molecule allows for greater conformational flexibility than with meta-chloroperbenzoic 
acid, and this could perhaps be utilised for selective interaction with only one part of the 





5. Multicomponent Molecular Complexes of Reactive Materials 
Introducing a secondary material into the crystallisation process, as outlined in the 
introduction, could serve as a viable way of bringing together the target reactive material 
with a second component, potentially reducing its reactivity.  The principle is similar to that 
adopted in other co-crystallisation approaches to physical property tuning – for example it 
is used to enhance the solubility of an insoluble active ingredient by coupling with a co-
component with inherent solubility in the solvent used.  The parallel here is that the 
inherent stability of the co-component offers stability to the reactive material when the 
complex is formed.  The results outlined in this chapter represent the collected data from 
such attempts, assessing the suitability of each secondary component.   
5.1 Carboxylic acids and peroxyacids 
Given observed common interactions in the pure peroxyacid functionalised molecules, 
providing a strongly electron donating carbonyl with which the terminal peroxy hydrogen 
can interact seems a logical design strategy for creating a multi-component material.  The 
fully oxidised carbonyl group is inherently stable in the presence of peroxyacids and could 
be a main feature in any synthons designed.  The peroxyacid group itself has similarity with 
the carboxylic acid group, in terms of size and hydrogen bonding capability, a factor that 
tends to favour the formation of a hydrogen bonded co-crystal.  In addition the weaker 
organic acids will be less likely to decompose the peroxyacids and their similarity to the 
decomposition products, the parent acids, could also potentially help maintain the 
equilibrium of the decomposition reaction in favour of the retention of the peroxyacid.  A 
series of carboxylic acid molecules were thus selected as possible secondary components, 
as described below . 
5.1.1 Peroxyacetic acid and carboxylic acids 
Peroxyacetic acid (Figure 162), a liquid at room temperature, was added to carboxylic acid 






Figure 162 - Peroxyacetic acid - PAA 
In all experiments, the acid was dissolved in the selected solvents with the addition of the 
peroxyacetic acid, from a 39% peroxyacetic acid solution, in a 1:1 molar ratio to attempt to 
grow a 1:1 molecular complex.  The method of preparation was that of temperature 
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controlled evaporative crystallisation.  The full XRPD patterns for each resulting product 





Figure 163 - 2-Chlorobenzoic acid 
Peroxyacetic acid was crystallised with 2-chlorobenzoic acid (Figure 163) in acetone, 
methanol, ethanol, isopropanol and chloroform at 4°C and room temperature (Table 18). 
Table 18 - Crystallisation conditions of peroxyacetic acid (PAA) and 2-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM01_01 PAA 2-chlorobenzoic acid Acetone 4°C 8 
AM01_03 PAA 2-chlorobenzoic acid Methanol 4°C 7 
AM01_04 PAA 2-chlorobenzoic acid Methanol Room temperature 6 
AM01_05 PAA 2-chlorobenzoic acid Ethanol 4°C 5 
AM01_06 PAA 2-chlorobenzoic acid Ethanol Room temperature 4 
AM01_07 PAA 2-chlorobenzoic acid Isopropanol 4°C 3 
AM01_08 PAA 2-chlorobenzoic acid Isopropanol Room temperature 2 
AM01_09 PAA 2-chlorobenzoic acid Chloroform 4°C 1 
 
 
Figure 164 - Dendrogram of similarity of XRPD patterns collected from samples isolated from crystallisations 
of PAA and 2-chlorobenzoic acid. 
All XRPD patterns of samples collected from the crystallisations have a greater than 75% 
similarity with the only exception being AM02_08 (Figure 164 – Sample 2 (yellow)).  This 
represents a crystallisation of the two components in isopropanol at room temperature, 




Figure 165 - XRPD patterns collected from crystallisations of PAA and 2-chlorobenzoic acid (red) compared 
with a reference pattern for 2-chlorobenzoic acid (blue). 
On visual comparison, the collected XRPD patterns all show excellent correlation to the 
reference pattern for 2-chlorobenzoic acid with all peaks assigned.  The peroxyacid has thus 
not formed a complex with the 2-chlorobenzoic acid. 
3-Chlorobenzoic acid 
 
Figure 166 - 3-chlorobenzoic acid 
A similar experiment was performed with 3-chlorobenzoic acid (Figure 166).  The acid was 
dissolved in acetone, methanol, ethanol and isopropanol, to which peroxyacetic acid was 
added in a 1:1 acid to peroxyacid molar ratio and crystallised in a controlled temperature 
environment at both room temperature and 4°C (Table 19). 
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Table 19 - Crystallisation conditions of peroxyacetic acid (PAA) and 3-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM03_01 PAA 3-chlorobenzoic acid Acetone 4°C 1 
AM03_02 PAA 3-chlorobenzoic acid Acetone 4°C  
AM03_03 PAA 3-chlorobenzoic acid Methanol 4°C 2 
AM03_04 PAA 3-chlorobenzoic acid Methanol Room temperature 3 
AM03_05 PAA 3-chlorobenzoic acid Ethanol 4°C 4 
AM03_06 PAA 3-chlorobenzoic acid Ethanol Room temperature 5 
AM03_07 PAA 3-chlorobenzoic acid Isopropanol 4°C 6 
 
The dendrogram representation of the statistical analysis from the XRPD patterns of the 
products shows that all patterns match at a minimum 60% correlation (Figure 167).  The 
choice of a lower correlation level allows inclusion of those samples which upon visual 
identification contain the same Bragg peaks but have a larger amorphous background, 
reducing the correlation calculated in PolySNAP-3. 
 
Figure 167 - Dendrogram of similarity of XRPD patterns collected from samples isolated of crystallisation of 
PAA and 3-chlorobenzoic acid. 
 
Figure 168 - XRPD patterns collected from crystallisations of PAA and 3-chlorobenzoic acid (red) compared 
with a reference pattern of 3-chlorobenzoic acid (blue). 
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All collected XRPD samples are an excellent match to the reference XRPD pattern of 3-
chlorobenzoic acid (Figure 168) and thus no new crystalline forms are present in the 




Figure 169 - 4-chlorobenzoic acid 
In a similar manner to the previous experiments, 4-chlorobenzoic acid (Figure 169) was 
used under the crystallisation conditions outlined in Table 20. 
Table 20 - Crystallisation conditions of peroxyacetic acid (PAA) and 4-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM04_01 PAA 4-chlorobenzoic acid Acetone 4°C 1 
AM04_02 PAA 4-chlorobenzoic acid Acetone Room temperature 2 
AM04_03 PAA 4-chlorobenzoic acid Methanol 4°C 3 
AM04_04 PAA 4-chlorobenzoic acid Methanol Room temperature 4 
AM04_06 PAA 4-chlorobenzoic acid Ethanol Room temperature 5 
AM04_07 PAA 4-chlorobenzoic acid Isopropanol 4°C 6 
AM04_08 PAA 4-chlorobenzoic acid Isopropanol Room temperature 7 
 
 
Figure 170 - Dendrogram of similarity of XRPD patterns collected from samples isolated from crystallisations 
of PAA and 4-chlorobenzoic acid. 
As for 2 and 3-chlorobenzoic acid, the recrystallization attempts of 4-chlorobenzoic acid 
with peroxyacetic acid yield the same product in each crystallisation environment.  The 
XRPD pattern show >74% similarity (Figure 170).  By comparison of the patterns to the 
reference pattern of 4-chlorobenzoic acid (Figure 171), it can be seen that there are no 




Figure 171 - XRPD patterns collected from crystallisations of PAA and 4-chlorobenzoic acid (red) compared 
with a reference pattern of 4-chlorobenzoic acid (blue). 
2-Picolinic acid 
 
Figure 172 - 2-picolinic acid 
Peroxyacetic acid and 2-picolinic acid (Figure 172) were mixed in 1:1 molar solution, which 
then underwent slow evaporation.  The introduction of a second electron rich group was 
proposed to provide a second site for interaction with the terminal hydrogen of the 
peroxyacid group, providing the opportunity for a stronger, possibly bifurcated synthon.  
The crystallisation conditions which produced solid products suitable for XRPD analysis are 
detailed in Table 21. 
Table 21 - Crystallisation conditions of peroxyacetic acid (PAA) and 2-picolinic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM05_01 PAA 2-picolinic acid Acetone 4°C 1 
AM05_02 PAA 2-picolinic acid Acetone Room temperature 2 
AM05_03 PAA 2-picolinic acid Chloroform 4°C 3 
AM05_04 PAA 2-picolinic acid Chloroform Room temperature 4 
AM05_06 PAA 2-picolinic acid Ethyl Acetate Room temperature 5 
 
From the XRPD patterns, it is evident that formation of a new crystalline material has taken 
place, and the statistical analysis identified four distinct powder pattern types (Figure 173). 
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Figure 173 - Statistical analysis dendrogram of the crystallisation products of PAA and 2-picolinic acid. 
The samples crystallised from acetone (red) can be identified by XRPD comparison to be 
mainly composed of 2-picolinic acid (Figure 174). 
 
Figure 174 - XRPD patterns of PAA and 2-picolinic acid crystallised in acetone at 4°C (top) and room 
temperature (middle) compared to the reference XRPD pattern of 2-picolinic acid (bottom). 
 
Figure 175 - XRPD of PAA crystallised with 2-picolinic acid in ethyl acetate (AM05_06; top) compared with 
reference patterns for 2-picolinic acid (middle) and 2-picolinic acid chloride (bottom). 
The sample identified as 5 in the dendrogram (Figure 173) corresponds to the 
crystallisation from ethyl acetate at room temperature.  As evidenced in Figure 175, this 
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sample comprises a mixture of the 2-picolinic acid starting material, with a chlorinated salt 
of the picolinic acid.  The source of the chlorine in the formation of this material is 
proposed to be from contamination of the sample. 
 
Figure 176 - XRPD patterns of PAA and 2-picolinic acid crystallised in chloroform at 4°C (black) and room 
temperature (light blue) compared to the reference XRPD pattern of 2-picolinic acid chloride (magenta), and 
a hydrated form (green). 
The remaining samples were isolated from chloroform solution, which appears to have 
reacted to evolve chlorine which has then complexed with the picolinic acid in both the 
anhydrous form, as seen in the room temperature crystallisation, and the hydrated 
chloride, which is present almost exclusively in the 4°C sample and as a component in the 
room temperature sample.  The shift in expected peak positions is due to the difference in 
the temperature of data acquisition between the 100K 2-picolinic acid hydrated chloride 
salt, and the room temperature XRPD patterns of the two samples. 
No molecular complex of the peroxyacetic acid is formed under the chosen conditions. 
1-Naphthaleneacetic acid 
 
Figure 177 - 1-naphthaleneacetic acid 
To bring a larger molecule into the crystallisation attempts, as well as a more developed π 
structure, 1-naphthaleneacetic acid was used in the cocrystallisation environment in the 
same equimolar approach as for the previous samples.  The crystallisation conditions 
chosen for these cocrystallisations are detailed in Table 22. 
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Table 22 - Crystallisation conditions of peroxyacetic acid (PAA) and 1-naphthaleneacetic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM06_01 PAA 1-Naphthaleneacetic acid Acetone 4°C 1 
AM06_02 PAA 1-Naphthaleneacetic acid Acetone Room temperature 2 
AM06_03 PAA 1-Naphthaleneacetic acid Chloroform 4°C 3 
AM06_05 PAA 1-Naphthaleneacetic acid Diethyl ether 4°C 4 
AM06_07 PAA 1-Naphthaleneacetic acid Ethyl acetate 4°C 5 
AM06_08 PAA 1-Naphthaleneacetic acid Ethyl Acetate Room temperature 6 
AM06_09 PAA 1-Naphthaleneacetic acid Acetonitrile 4°C 7 
 
 
Figure 178 - Statistical analysis dendrogram of the crystallisation products of PAA and 1-naphthaleneacetic 
acid. 
As shown by the statistical analysis, the samples analysed by XRPD all show a high 
correlation, at similarity of >65%, with the only differences resulting from gradual 
differences in the background levels of the scans. 
 
Figure 179 - XRPD patterns collected from crystallisations of PAA and 1-naphthaleneacetic acid (red) 
compared with a reference pattern of 1-naphthaleneacetic acid (blue). 
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When compared to the reference pattern of the 1-napthalene acetic acid starting material, 
the XRPD patterns show an excellent match with all Bragg peaks accounted for.  The 
peroxyacetic acid has thus not formed a complex with the 1-napthalene acetic acid. 
2-Hydroxybenzoic acid (salicylic acid) 
 
Figure 180 - Salicylic acid 
Peroxyacetic acid was cocrystallised using the above procedure with salicylic acid (Figure 
180), a secondary component with two hydrogen bond donors present which can provide a 
double donor motif on one side of the molecule, or a donor and acceptor within close 
proximity.  This capability offers the opportunity for interaction through the terminal 
peroxyacid hydrogen, one of the two available peroxyacid oxygen atoms, or the peroxyacid 
carbonyl.  This would provide a two hydrogen bond synthon with additional interaction 
strength.  The crystallisation conditions chosen are outlined in Table 23. 
Table 23 - Crystallisation conditions of peroxyacetic acid (PAA) and salicylic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM08_01 PAA Salicylic acid Acetone 4°C 1 
AM08_02 PAA Salicylic acid Acetone Room temperature 2 
AM08_03 PAA Salicylic acid Chloroform 4°C 3 
AM08_04 PAA Salicylic acid Chloroform Room temperature 4 
AM08_05 PAA Salicylic acid Diethyl Ether 4°C 5 
AM08_06 PAA Salicylic acid Diethyl Ether Room temperature 6 
AM08_07 PAA Salicylic acid Ethyl Acetate 4°C 7 
AM08_08 PAA Salicylic acid Ethyl Acetate Room temperature 8 
AM08_09 PAA Salicylic acid Acetonitrile 4°C 9 
AM08_10 PAA Salicylic acid Acetonitrile Room temperature 10 
 
 
Figure 181 - Statistical analysis dendrogram of the crystallisation products of PAA and salicylic acid. 




Figure 182 - Comparison of a representative sample of the XRPD patterns collected from the crystallisation of 
PAA with salicylic acid (red) with the reference XRPD pattern of the salicylic acid starting material (green). 
As shown by the comparison of the XRPD pattern of a sample from the crystallisation 
experiments with a reference pattern of salicylic acid, it can be seen that no new crystalline 
materials have formed in any of the crystallisations. 
3-hydroxybenzoic acid 
 
Figure 183 - 3-hydroxybenzoic acid 
Following on from the methodology set out with salicylic acid of introducing a second 
hydrogen bond donor, 3-hydroxybenzoic acid (Figure 183) was also introduced with 
peroxyacetic acid, under the crystallisation conditions outlined in Table 24. 
 
Table 24 - Crystallisation conditions of peroxyacetic acid (PAA) and 3-hydroxybenzoic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM09_01 PAA 3-hydroxybenzoic acid Acetone 4°C 1 
AM09_02 PAA 3-hydroxybenzoic acid Acetone Room temperature 2 
AM09_05 PAA 3-hydroxybenzoic acid Diethyl Ether 4°C 3 
AM09_06 PAA 3-hydroxybenzoic acid Diethyl Ether Room temperature 4 
AM09_07 PAA 3-hydroxybenzoic acid Ethyl Acetate 4°C 5 
AM09_08 PAA 3-hydroxybenzoic acid Ethyl Acetate Room temperature 6 
AM09_09 PAA 3-hydroxybenzoic acid Acetonitrile 4°C 7 
AM09_10 PAA 3-hydroxybenzoic acid Acetonitrile Room temperature 8 
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Figure 184 - Statistical analysis dendrogram of the crystallisation products of PAA and 3-hydroxybenzoic acid. 
The statistical analysis of the XRPD patterns indicated that there are two distinct crystalline 
forms.  The patterns for the most common form, Figure 184 (red), have >75% similarity.  
Examination of the XRPD patterns of the samples in this cluster identify them to be 3-
hydroxybenzoic acid Form I with a high degree of purity (Figure 185). 
 
Figure 185 - XRPD patterns of a representative sample of the red main cluster of the crystallisation of PAA 
and 3-hydroxybenzoic acid (red) compared to the reference XRPD pattern of 3-hydroxybenzoic acid Form I 
(blue). 
The second cluster consists of two samples, both room temperature crystallisations, 
AM09_02 and AM09_06, from acetone and diethyl ether respectively.  These samples are 
confirmed to be predominantly 3-hydroxybenzoic acid Form II, as confirmed by XRPD 
analysis and comparison to the reference (Figure 186).  Only starting materials have thus 
recrystallized. 
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Figure 186 - XRPD patterns of a representative sample of the yellow cluster of the crystallisation of PAA and 





Figure 187 - Malonic acid 
With two hydrogen bond donors and two acceptors and the added flexibility of the three 
carbon single bonded backbone of the molecule providing rotation, malonic acid (Figure 
187) is an extremely versatile hydrogen bonding material, providing the opportunity for 
several hydrogen bonding motifs.  Malonic acid was thus brought into a cocrystallisation 
environment with peroxyacetic acid in the conditions shown in  
Table 25. 
Table 25 - Crystallisation conditions of peroxyacetic acid (PAA) and malonic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM18_01 PAA Malonic acid Acetone 4°C 1 
AM18_02 PAA Malonic acid Acetone Room temperature 2 
AM18_03 PAA Malonic acid Chloroform 4°C 3 
AM18_04 PAA Malonic acid Chloroform Room temperature 4 
AM18_05 PAA Malonic acid Diethyl Ether 4°C 5 
AM18_06 PAA Malonic acid Diethyl Ether Room temperature 6 
AM18_07 PAA Malonic acid Ethyl Acetate 4°C 7 
AM18_08 PAA Malonic acid Ethyl Acetate Room temperature 8 
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Figure 188 - Statistical analysis dendrogram of the crystallisation products of PAA and malonic acid. 
As can be seen from the dendrogram in Figure 188, all the scans of the resultant materials 
show excellent correlation to each other with similarity >79%.  As observed with all 
previous results using this methodology, all samples matched the co-component starting 
material (Figure 189). 
 
Figure 189 - XRPD pattern of a sample representative of all crystallisation products from PAA and malonic 




Figure 190 - Oxalic acid 
Oxalic acid (Figure 190) has similar conformational flexibility to malonic acid and was thus 
also used as a secondary component for crystallisation with peroxyacetic acid, under the 
conditions shown in Table 26. 
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Table 26 - Crystallisation conditions of peroxyacetic acid (PAA) and oxalic acid 
Sample ID Component A Component B Solvent Temperature PolySNAP ID 
AM19_01 PAA Oxalic acid Acetone Room temperature 1 
AM19_02 PAA Oxalic acid Acetone 4°C 2 
AM19_05 PAA Oxalic acid Diethyl Ether Room temperature 3 
AM19_06 PAA Oxalic acid Diethyl Ether 4°C 4 
AM19_07 PAA Oxalic acid Ethyl Acetate Room temperature 5 
 
These materials showed >60% similarity in correlation of their XRPD patterns, not 
particularly high for a PolySNAP 3 analysis.  Manual analysis, however, confirmed that all 
samples are the same crystalline material, which matches pure oxalic acid dihydrate (Figure 
191). 
 
Figure 191 - XRPD patterns of all samples collected from the crystallisation of PAA and oxalic acid (red) 
compared to the reference pattern for oxalic acid dihydrate (blue). 
 
5.1.2 Meta-chloroperbenzoic acid and carboxylic acids 
The second peroxyacid to be subjected to this method is the larger solid molecule, meta-
chloroperbenzoic acid (MCPBA).  Expected solid products could thus include mixtures of 
MCPBA, 3-chlorobenzoic acid and residual secondary component starting materials, ras 
well as possible molecular complexes of the MCPBA or 3-chlorobenzoic acid and the 
secondary material.  As with peroxyacetic acid, consideration of molecular recognition led 
to the choice of carboxylic acids as candidates for interaction with the MCPBA.  Compared 
with peroxyacetic acid, MCPBA is of a more similar size to the secondary materials chosen 
and thus may be more likely to form molecular complexes. 
The experiments were carried out by self-assembly through small scale evaporative 
crystallisation in temperature controlled environments and in a 1:1 peroxyacid to 
carboxylic acid ratio, to promote generation of 1:1 molecular complexes. 
Position [°2Theta] (Copper (Cu))
























 Oxalic acid dihydrates
184 
 
With so many possible outcomes from these experiments, and the high proportion of 
samples that resulted in a mixture of several crystalline materials, unambiguous statistical 
analysis proved difficult.  Manual analysis by comparison to reference data proved more 
reliable in some cases.  This is reflected in the results of the experiments detailed in this 
section. 
2-chlorobenzoic acid, 3-chlorobenzoic acid, 4-chlorobenzoic acid and MCPBA are very 
similar molecules, providing similar packing and stacking interactivity and well matched 
hydrogen bond capabilities.  They should thus provide a good basis for interaction between 
the two molecules in the cocrystallisations. 
2-Chlorobenzoic acid 
2-chlorobenzoic acid and MCPBA were combined in 1:1 molar ratio and dissolved in the 
solvent and temperature controlled environment as outlined in Table 27. 
 Table 27 - Crystallisation conditions of MCPBA and 2-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature Analysis Group 
AM10_01 MCPBA 2-chlorobenzoic acid Acetone Room temperature A 
AM10_02 MCPBA 2-chlorobenzoic acid Acetone 4°C amorphous 
AM10_03 MCPBA 2-chlorobenzoic acid Chloroform Room temperature A 
AM10_04 MCPBA 2-chlorobenzoic acid Chloroform 4°C A 
AM10_05 MCPBA 2-chlorobenzoic acid Diethyl ether Room temperature B 
AM10_06 MCPBA 2-chlorobenzoic acid Diethyl ether 4°C B 
AM10_07 MCPBA 2-chlorobenzoic acid Ethyl acetate Room temperature A 




Figure 192 - XRPD patterns of samples crystallised from MCPBA and 2-chlorobenzoic acid defined as group A 
(red), compared to the reference patterns of 2-chlorobenzoic acid (blue) and 3-chlorobenzoic acid (green). 
The samples from the crystallisation conditions defined in Table 27 as analysis group A, 
consist of all samples crystallised from acetone, chloroform and ethyl acetate at both room 
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temperature and 4°C, with the exception of the cocrystallisation in acetone at 4°C which is 
amorphous.  As seen in Figure 192, these samples show good correlation to a combination 
of the Bragg peaks of the secondary starting material 2-chlorobenzoic acid and the 
decomposition product 3-chlorobenzoic acid, the parent acid of MCPBA.  No other peaks 
are noticeably present in these samples and thus no recrystallised MCPBA remains.  All 
crystalline MCPBA has been decomposed to the parent acid 3-chlorobenzoic acid and no 
new molecular complex formed. 
 
Figure 193 - XRPD patterns of samples crystallised from MCPBA and 2-chlorobenzoic acid defined as group B 
(purple), compared to the reference patterns of 2-chlorobenzoic acid (blue), 3-chlorobenzoic acid (green) and 
MCPBA (grey). 
The remaining two samples, crystallised from diethyl ether at room temperature and 4°C, 
produce a second composition of materials.  The XRPD patterns collected from these 
materials show the same peak profile as a combination of the three crystalline materials 2-
chlorobenzoic acid, 3-chlorobenzoic acid and MCPBA (Figure 193), indicating that although 
some decomposition has taken place, a large proportion of crystalline MCPBA remains.  As 
all peaks can be assigned, it can be taken that there have been no new materials formed. 
3-Chlorobenzoic acid 
3-Chlorobenzoic acid was cocrystallised with MCPBA in a 1:1 molar ratio under the same 
crystallisation environments as the experiment with 2-chlorobenzoic acid, as outlined in 
Table 28.  The cocrystallisation of these materials is slightly different from the other 
chlorobenzoic acids in the fact that the secondary material is itself the decomposition 
product of the peroxyacid.  This could aid retention of the peroxyacid within the 
equilibrium between the peroxyacid and the parent acid.  The large excess of the parent 
acid should push the equilibrium in the direction of the formation of the peroxyacid, thus 
limiting its decomposition. 
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Table 28 - Crystallisation conditions of MCPBA and 3-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature 
AM11_01 MCPBA 3-chlorobenzoic acid Acetone Room temperature 
AM11_02 MCPBA 3-chlorobenzoic acid Acetone 4°C 
AM11_03 MCPBA 3-chlorobenzoic acid Chloroform Room temperature 
AM11_04 MCPBA 3-chlorobenzoic acid Chloroform 4°C 
AM11_05 MCPBA 3-chlorobenzoic acid Diethyl ether Room temperature 
AM11_06 MCPBA 3-chlorobenzoic acid Diethyl ether 4°C 
AM11_07 MCPBA 3-chlorobenzoic acid Ethyl acetate Room temperature 
AM11_08 MCPBA 3-chlorobenzoic acid Ethyl acetate 4°C 
 
From the collected XRPD data of the resultant compounds, with the exception of AM11_03 
– crystallisation of the two components in chloroform at room temperature – which is 
amorphous, it can be seen that all samples contain large amounts of 3-chlorobenzoic acid, 
as would be expected, with the presence of varying amounts of MCPBA.  Crystalline MCPBA 
is present in small quantities in the acetone and chloroform samples but it is present in 
greater quantities in those samples crystallised from diethyl ether and ethyl acetate (Figure 
194).
 
Figure 194 - XRPD patterns of samples crystallised from MCPBA and 3-chlorobenzoic acid (red) compared to 
the reference patterns of 3-chlorobenzoic acid (green) and MCPBA (grey). 
4-Chlorobenzoic acid 
Following the series of chlorobenzoic acids, 4-chlorobenzoic acid was cocrystallised under 
the same conditions with MCPBA (  
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Table 29 - Crystallisation conditions of MCPBA and 4-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature 
AM12_01 MCPBA 3-chlorobenzoic acid Acetone Room temperature 
AM12_02 MCPBA 3-chlorobenzoic acid Acetone 4°C 
AM12_03 MCPBA 3-chlorobenzoic acid Chloroform Room temperature 
AM12_04 MCPBA 3-chlorobenzoic acid Chloroform 4°C 
AM12_05 MCPBA 3-chlorobenzoic acid Diethyl ether Room temperature 
AM12_06 MCPBA 3-chlorobenzoic acid Diethyl ether 4°C 
AM12_07 MCPBA 3-chlorobenzoic acid Ethyl acetate Room temperature 
AM12_08 MCPBA 3-chlorobenzoic acid Ethyl acetate 4°C 
 
Cocrystallisation with 4-chlorobenzoic acid results in the recrystallisation of the 4-
chlorobenzoic acid in all cases, together with the MCPBA decomposition product 3-
chlorobenzoic acid, with all scans showing the characteristic 3-chlorobenzoic acid Bragg 
peak at 13.6° in 2θ (Figure 195).  The samples show only trace amounts of MCPBA, while 
recrystallisation in ethyl acetate at 4°C produced a sample that was significantly more 
amorphous than the other samples. 
 
Figure 195 - XRPD patterns of samples crystallised from MCPBA and 4-chlorobenzoic acid (red), compared to 
the reference patterns of 3-chlorobenzoic acid (green) and 4-chlorobenzoic acid (brown). 
None of the chlorobenzoic acids have proven to be effective in cocrystallising with MCPBA 
to produce a new solid phase material. 


































As with the peroxyacetic acid experiments, 1-naphthaleneacetic acid was cocrystallised 
with MCPBA in a 1:1 molar ratio under controlled temperature conditions with selected 
solvents as outlined in Table 30. 
Table 30 - Crystallisation conditions of MCPBA and 1-naphthaleneacetic acid 
Sample ID Component A Component B Solvent Temperature 
AM13_01 MCPBA 1-naphthaleneacetic acid Acetone Room temperature 
AM13_02 MCPBA 1-naphthaleneacetic acid Acetone 4°C 
AM13_03 MCPBA 1-naphthaleneacetic acid Chloroform Room temperature 
AM13_04 MCPBA 1-naphthaleneacetic acid Chloroform 4°C 
AM13_05 MCPBA 1-naphthaleneacetic acid Diethyl ether Room temperature 
AM13_06 MCPBA 1-naphthaleneacetic acid Diethyl ether 4°C 
AM13_07 MCPBA 1-naphthaleneacetic acid Ethyl acetate Room temperature 
AM13_08 MCPBA 1-naphthaleneacetic acid Ethyl acetate 4°C 
 
All crystallisations analysed with XRPD are shown in Figure 196 with the reference patterns 
for 3-chlorobenzoic acid and 1-naphthaleneacetic acid for comparison.  It is clear that all 
features in XRPD patterns, which are identical for all crystallisations, are a combination of 
the powder patterns of the decomposed material, 3-chlorobenzoic acid, and 1-
naphthaleneacetic acid.  The results suggest complete decomposition of the peroxyacid 
and conversion to the parent acid and neither MCPBA nor its parent acid has interacted 
with the 1-naphthaleneacetic acid to form a new crystalline material. 
 
Figure 196 - XRPD patterns of samples crystallised from MCPBA and 1-naphthaleneacetic acid (red), 
compared to the reference patterns of 1-naphthaleneacetic acid (blue) and 3-chlorobenzoic acid (green). 
Position [°2Theta] (Copper (Cu))

































2-Hydroxybenzoic acid (salicylic acid) 
Following the methodology proposed for peroxyacetic acid, salicylic acid was introduced 
into cocrystallisations with MCPBA in order to take advantage of its hydrogen bond donor 
and acceptor features.  The salicylic acid was dissolved in a 1:1 equimolar ratio with 
MCPBA, despite its multiple hydrogen bonding capabilities, and crystallised using the same 
slow evaporative crystallisation technique.  The solvent and temperature parameters for 
these crystallisations are outlined in Table 31. 
Table 31 - Crystallisation conditions of MCPBA and 2-hydroxybenzoic acid 
Sample ID Component A Component B Solvent Temperature 
AM14_01 MCPBA 2-hydroxybenzoic acid Acetone Room temperature 
AM14_02 MCPBA 2-hydroxybenzoic acid Acetone 4°C 
AM14_03 MCPBA 2-hydroxybenzoic acid Chloroform Room temperature 
AM14_04 MCPBA 2-hydroxybenzoic acid Chloroform 4°C 
AM14_05 MCPBA 2-hydroxybenzoic acid Diethyl ether Room temperature 
AM14_06 MCPBA 2-hydroxybenzoic acid Diethyl ether 4°C 
AM14_07 MCPBA 2-hydroxybenzoic acid Ethyl acetate Room temperature 
AM14_08 MCPBA 2-hydroxybenzoic acid Ethyl acetate 4°C 
 
 
Figure 197 - XRPD patterns of samples crystallised from MCPBA and 2-hydroxybenzoic acid (red), compared 
to the reference patterns of 2-hydroxybenzoic acid (brown), 3-chlorobenzoic acid (green) and MCPBA (grey). 









































The collected XRPD patterns of this cocrystallisation screening result in patterns that 
consist only of a combination of salicylic acid and 3-chlorobenzoic acid (Figure 197).  Trace 
amounts of MCPBA can possibly be found particularly in the region around 15° 2θ, however 
this area is also characteristic of peaks corresponding to salicylic acid.  It is not possible to 
completely confirm that all MCPBA has been decomposed in the cocrystallisations.  The 
cocrystallisation product from diethyl ether at room temperature is significantly more 
amorphous than the other samples, with no 3-chlorobenzoic acid present.  It is possible in 
this case that the 3-chlorobenzoic acid did not crystallise in these conditions and is present 
as an amorphous background. 
3-Hydroxybenzoic acid 
3-Hydroxybenzoic acid was also crystallised with MCPBA in the same crystallisation solvent 
and temperature conditions as 2-hydroxybenzoic acid.  The crystallisation parameters are 
outlined in Table 32. 
Table 32 - Crystallisation conditions of MCPBA and 3-hydroxybenzoic acid 
Sample ID Component A Component B Solvent Temperature Analysis group 
AM15_01 MCPBA 3-hydroxybenzoic acid Acetone Room temperature A 
AM15_02 MCPBA 3-hydroxybenzoic acid Acetone 4°C A 
AM15_03 MCPBA 3-hydroxybenzoic acid Chloroform Room temperature B 
AM15_04 MCPBA 3-hydroxybenzoic acid Chloroform 4°C B 
AM15_05 MCPBA 3-hydroxybenzoic acid Diethyl ether Room temperature A 
AM15_06 MCPBA 3-hydroxybenzoic acid Diethyl ether 4°C A 
AM15_07 MCPBA 3-hydroxybenzoic acid Ethyl acetate Room temperature A 
AM15_08 MCPBA 3-hydroxybenzoic acid Ethyl acetate 4°C A 
 
Figure 198 - XRPD patterns of samples crystallised from MCPBA and 3-hydroxybenzoic acid defined as group 
A (red), compared to the reference powder patterns of 3-chlorobenzoic acid (brown) and 3-hydroxybenzoic 
acid form II (purple). 
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The results collected from the XRPD patterns suggest two distinct pattern types, analysis 
groups A and B.  Analysis group A consists of all samples crystallised from acetone, diethyl 
ether and ethyl acetate.  By comparison to the reference patterns (Figure 198), it can be 
determined that group A corresponds to a mixed component sample containing 3-
chlorobenzoic acid and 3-hydroxybenzoic acid form II.  No MCPBA is present in the patterns 
and it can be taken that it has all converted to 3-chlorobenzoic acid. 
The remaining samples, crystallised from chloroform at 4°C and room temperature, contain 
the same mixture of components, but with the additional presence of a large amount of 
crystalline MCPBA (Figure 199).  It appears that with 3-hydroxybenzoic acid in chloroform, 
MCPBA does not decompose to its parent acid; however there is still no indication of any 
molecular complex formation, with no new peaks corresponding to unknown crystalline 
products. 
 
Figure 199 - XRPD patterns of samples crystallised from MCPBA and 3-hydroxybenzoic acid defined as group B 
(blue), compared to the reference powder patterns of MCPBA (grey), 3-chlorobenzoic acid (brown) and  
3-hydroxybenzoic acid form II (purple). 
None of the recrystallisation experiments with MCPBA and 3-hydroxybenzoic acid show the 
presence of Form I of 3-hydroxybenzoic acid. 
Malonic Acid 
MCPBA was crystallised in a 1:1 molar ratio with malonic acid in order to take advantage of 
its flexibility of geometry and hydrogen bonding motifs.  The crystallisation conditions for 
these experiments which yielded solid materials suitable for study are outlined in Table 33. 
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Table 33 - Crystallisation conditions of MCPBA and malonic acid 
Sample ID Component A Component B Solvent Temperature 
AM22_01 MCPBA Malonic acid Acetone Room temperature 
AM22_02 MCPBA Malonic acid Acetone 4°C 
AM22_03 MCPBA Malonic acid Chloroform Room temperature 
AM22_04 MCPBA Malonic acid Chloroform 4°C 
AM22_05 MCPBA Malonic acid Diethyl ether Room temperature 
AM22_06 MCPBA Malonic acid Diethyl ether 4°C 
AM22_07 MCPBA Malonic acid Ethyl acetate Room temperature 
AM22_08 MCPBA Malonic acid Ethyl acetate 4°C 
 
Figure 200 - XRPD patterns of samples crystallised from MCPBA and malonic acid (red), compared to the 
reference patterns of malonic acid (blue) and 3-chlorobenzoic acid (brown). 
All XRPD patterns represent a mixed composition of malonic acid and the parent acid 3-
chlorobenzoic acid, from decomposition of MCPBA (Figure 200). 
Oxalic Acid 
As a natural progression from the use of malonic acid, oxalic acid was cocrystallised with 
MCPBA under the same crystallisation conditions and parameters, detailed in Table 34. 
Table 34 - Crystallisation conditions of MCPBA and oxalic acid 
Sample ID Component A Component B Solvent Temperature 
AM23_01 MCPBA Oxalic acid Acetone Room temperature 
AM23_02 MCPBA Oxalic acid Acetone 4°C 
AM23_03 MCPBA Oxalic acid Chloroform Room temperature 
AM23_04 MCPBA Oxalic acid Chloroform 4°C 
AM23_05 MCPBA Oxalic acid Diethyl ether Room temperature 
AM23_06 MCPBA Oxalic acid Diethyl ether 4°C 
AM23_08 MCPBA Oxalic acid Ethyl acetate 4°C 
 
The XRPD patterns collected from these crystallisation experiments show presence of 
primarily oxalic acid dihydrate with smaller amounts of the decomposition product 3-
chlorobenzoic acid; no crystalline MCPBA is present.  It is worthy of note that the sample 
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AM23_08, crystallisation from ethyl acetate at 4°C, has produced significantly more 
crystalline 3-chlorobenzoic acid than oxalic acid dehydrate (Figure 201).  Either more 
decomposition of MCPBA has occurred in these conditions, or the oxalic acid dihydrate 
does not crystallise well in such an environment.  There is no indication of molecular 
complex formation. 
 
Figure 201 - XRPD patterns of samples crystallised from MCPBA and oxalic acid (red), compared to the 




Figure 202 - Chloranilic acid 
Although not a carboxylic acid, 2,5-dichloro-3,6-dihydroxybenzoquinone (chloranilic acid) 
shares many of the characteristics of a carboxylic acid, including a carbonyl and a hydroxyl 
group in relatively close proximity.  It therefore shows complementarities with MCPBA that 
could possibly be utilised for hydrogen bond interactions.  In particular the carbonyl 
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oxygen, which is deshielded by the aromaticity of the ring, may prove to be more attractive 
to the peroxy hydrogen, making a hydrogen bond between the two more likely. 
Chloranilic acid, despite its two sets of hydrogen bond donors and acceptors, was 
crystallised in a 1:1 ratio with MCPBA under the solvent and controlled temperature 
conditions set out in Table 35.  Only samples for which the preparation led to materials 
suitable for powder diffraction have been included. 
Table 35 - Crystallisation conditions of MCPBA and chloranilic acid 
Sample ID Component A Component B Solvent Temperature 
AM64_01 MCPBA Chloranilic acid Acetone 4°C  
AM64_02 MCPBA Chloranilic acid Acetone Room temperature 
AM64_04 MCPBA Chloranilic acid Methyl acetate Room temperature 
AM64_05 MCPBA Chloranilic acid Ethyl acetate 4°C  
AM64_07 MCPBA Chloranilic acid Diethyl ether 4°C  
 
 
Figure 203 - XRPD patterns of collected materials from the cocrystallisations of MCPBA and chloranilic acid 
(red) compared with reference patterns of chloranilic acid (grey) and 3-chlorobenzoic acid (blue). 
From the XRPD data (Figure 203), all samples contain high amounts of 3-chlorobenzoic acid 
with no indications of any MCPBA or chloranilic acid present.  It is likely that all the MCPBA 
has decomposed to the parent acid.  The lack of crystalline chloranilic acid may suggest a 
further reaction has taken place as, in general, chloranilic acid crystallises well in many 
conditions and is usually a reliable co-component for the formation of co-crystals with 
carboxylic acids. 
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Figure 204 - Bromanilic acid 
Complexes of bromanilic acid are typically isostructural to those of chloranilic acid and it 
can in some cases be substituted as a molecular complex component in a cocrystallisation 
experiment.  It has the same interaction capabilities and was thus used for cocrystallisation 
with MCPBA in the same conditions as chloranilic acid. 
Table 36 - Crystallisation conditions of MCPBA and bromanilic acid 
Sample ID Component A Component B Solvent Temperature 
AM65_01 MCPBA Bromanilic acid Acetone 4°C  
AM65_02 MCPBA Bromanilic acid Acetone Room temperature 
AM65_03 MCPBA Bromanilic acid Methyl acetate 4°C  
AM65_04 MCPBA Bromanilic acid Methyl acetate Room temperature 
AM65_05 MCPBA Bromanilic acid Ethyl acetate 4°C  
AM65_06 MCPBA Bromanilic acid Ethyl acetate Room temperature 
AM65_07 MCPBA Bromanilic acid Diethyl ether 4°C  
AM64_08 MCPBA Bromanilic acid Diethyl ether Room temperature 
 
 
Figure 205 - XRPD patterns of collected materials from the cocrystallisations of MCPBA and bromanilic acid 
(red) compared with reference patterns of bromanilic acid (green) and 3-chlorobenzoic acid (blue). 
As can be seen from the collected XRPD patterns of the materials (Figure 205), there is no 
indication of any bromanilic acid present in the cocrystallisation products.  All the MCPBA 
has decomposed to the parent 3-chlorobenzoic acid, with no other Bragg peaks present. 
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5.1.3 6-Phthalimidoperoxyhexanoic acid and carboxylic acids 
Following from the MCPBA experiments, the largest target peroxyacid studied, 6-
phthalimidoperoxyhexanoic acid (PAP) was subjected to the same cocrystallisation 
conditions as the other peroxyacids, with the same choices of co-molecules selected.  The 
π-π interacting character of the phthalimido group present in PAP offers additional 
interaction possibilities to those of the peroxyacid group of the molecule.  It is therefore 
possible that PAP, may take on some of the characteristics of both a π-π stacking molecule 
those of the other peroxyacids studied.  The aliphatic chain separates these two 
components, and thus they can be targeted for interaction separately.  The carboxylic acids 
cocrystallised with PAP were specifically targeted at the peroxyacid end of the molecule in 
keeping with the aims of the other two peroxyacid cocrystallisations. 
2-Chlorobenzoic acid 
PAP was cocrystallised in a 1:1 equimolar ratio with 2-chlorobenzoic acid by the same 
evaporative crystallisation method as used for the other solid peroxyacid, MCPBA, with the 
aim to generating molecular complexes through interaction between the peroxyacid 
functional group and the carboxylic acid.  The solvents chosen for crystallisation were 
methanol, ethanol, acetone and ethyl acetate, solvents in which PAP has demonstrated 
stability.  The crystallisation parameters for each sample are detailed in Table 37. 
Table 37 - Crystallisation conditions of PAP and 2-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature Analysis Group 
AM26_01 PAP 2-Chlorobenzoic acid Methanol 4°C  A 
AM26_02 PAP 2-Chlorobenzoic acid Methanol Room temperature  A 
AM26_03 PAP 2-Chlorobenzoic acid Methanol 30°C  B 
AM26_04 PAP 2-Chlorobenzoic acid Ethanol 4°C  C 
AM26_05 PAP 2-Chlorobenzoic acid Ethanol Room temperature  D 
AM26_06 PAP 2-Chlorobenzoic acid Ethanol 30°C  D 
AM26_07 PAP 2-Chlorobenzoic acid Acetone 4°C  E 
AM26_08 PAP 2-Chlorobenzoic acid Acetone Room temperature  E 
AM26_09 PAP 2-Chlorobenzoic acid Acetone 30°C  E 
AM26_11 PAP 2-Chlorobenzoic acid Ethyl Acetate Room temperature  E 
AM26_12 PAP 2-Chlorobenzoic acid Ethyl Acetate 30°C  E 
 
The collected XRPD patterns of the resultant materials show high amounts of amorphous 
background leading to difficulty in isolating which compositions of materials are present in 
each sample.  From the powder patterns however, five distinct mixtures have been 
identified and their composition identified.  For convenience these have been grouped, as 
shown in Table 37, and can be analysed as follows. 
Group A consist of two samples crystallised from methanol at 4°C and room temperature, 




Figure 206 - XRPD patterns of collected materials from the cocrystallisations of PAP and 2-chlorobenzoic acid 
from analysis group A (red) compared with reference patterns of 6-phthalimidohexanoic acid hydrate Form II 
(brown), 2-chlorobenzoic acid (green) and 6-phthalimidohexanoic acid (red). 
Samples in group A consist of a mixture of the parent acid of PAP, its newly found hydrated 
form (Form II) and 2-chlorobenzoic acid.  The PAP has thus decomposed and has not 
interacted with the secondary component. 
Group B, consists of a single pattern AM26_03, crystallised from methanol at 30°C.  
Although this is also highly amorphous, it can be identified by XRPD (Figure 207) to consist 
of a mixture of the Form II hydrate of the parent acid, and PAP itself, with no other 
crystalline materials present. 
 
























Figure 207 - XRPD patterns of collected materials from the cocrystallisations of PAP and 2-chlorobenzoic acid 
from analysis group B (black) compared with reference patterns of 6-phthalimidohexanoic acid hydrate Form 
II (brown) and PAP (blue). 
Analysis group C, another single sample, is from the crystallisation from ethanol at 4°C.  It 
consists primarily of the Form II hydrate of decomposed PAP, and 2-chlorobenzoic acid 
(Figure 208). 
 
Figure 208 - XRPD patterns of collected materials from the cocrystallisations of PAP and 2-chlorobenzoic acid 
from analysis group C (purple) compared with reference patterns of 6-phthalimidohexanoic acid hydrate 
Form II (brown) and 2-chlorobenzoic acid (green). 
Group D, representing the samples crystallised from ethanol at room temperature and 
30°C, show a similar composition to one another.  They both appear to be comprised of a 
mixture of decomposed PAP – 6-phthalimidohexanoic acid – and Form I of its hydrate 
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(Figure 209).  There appears to be no crystalline 2-chlorobenzoic acid present in these 
samples. 
 
Figure 209 - XRPD patterns of collected materials from the cocrystallisations of PAP and 2-chlorobenzoic acid 
from analysis group D (violet) compared with reference patterns of 6-phthalimidohexanoic acid hydrate Form 
I (green) and 6-phthalimidohexanoic acid (red). 
Finally the remaining samples, all from acetone and ethyl acetate solution, are show clearly 
by XRPD to be comprised entirely of recrystallised PAP peroxyacid and 2-chlorobenzoic acid 
(Figure 210).  Although the PAP has been retained in these crystallisations, there is no 
indication of the formaionof a molecular complex. 
 
Figure 210 - XRPD patterns of collected materials from the cocrystallisations of PAP and 2-chlorobenzoic acid 
from analysis group E (violet) compared with reference patterns of 2-chlorobenzoic acid (green) and PAP 
(blue). 
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3-chlorobenzoic acid was crystallised with PAP under the same conditions as for as 2-
chlorobenzoic acid (Table 38). 
Table 38 - Crystallisation conditions of PAP and 3-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature Analysis Group 
AM25_01 PAP 3-Chlorobenzoic acid Methanol 4°C  A 
AM25_02 PAP 3-Chlorobenzoic acid Methanol Room temperature  amorphous 
AM25_03 PAP 3-Chlorobenzoic acid Methanol 30°C  A 
AM25_05 PAP 3-Chlorobenzoic acid Ethanol Room temperature  A 
AM25_06 PAP 3-Chlorobenzoic acid Ethanol 30°C  A 
AM25_07 PAP 3-Chlorobenzoic acid Acetone 4°C  A 
AM25_08 PAP 3-Chlorobenzoic acid Acetone Room temperature  A 
AM25_09 PAP 3-Chlorobenzoic acid Acetone 30°C  A 
AM25_10 PAP 3-Chlorobenzoic acid Ethyl Acetate 4°C  A 
AM25_11 PAP 3-Chlorobenzoic acid Ethyl Acetate Room temperature  A 
AM25_12 PAP 3-Chlorobenzoic acid Ethyl Acetate 30°C  A 
 
 
Figure 211 - XRPD patterns of collected materials from the cocrystallisations of PAP and 3-chlorobenzoic acid 
(red) compared with reference patterns of 6-phthalimidoperoxyhexanoic acid - PAP (blue) and 3-
chlorobenzoic acid (brown). 
The resulting samples were analysed by XRPD (Figure 211) and, with the exception of the 
sample from methanol at room temperature which appears to be completely amorphous, 
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all appear to be comprised of recrystallised 6-phthalimidoperoxyhexanoic acid and 3-
chlorobenzoic acid only.  There are no indications of any other materials present. 
4-Chlorobenzoic acid 
4-chlorobenzoic acid was cocrystallised with PAP under the same conditions.  From the 
XRPD analysis of the collected materials, they can be categorised into three groups as 
defined by their analysis group in Table 39. 
Table 39 - Crystallisation conditions of PAP and 4-chlorobenzoic acid 
Sample ID Component A Component B Solvent Temperature Analysis Group 
AM27_01 PAP 4-Chlorobenzoic acid Methanol 4°C  A 
AM27_02 PAP 4-Chlorobenzoic acid Methanol Room temperature  A 
AM27_03 PAP 4-Chlorobenzoic acid Methanol 30°C  B 
AM27_04 PAP 4-Chlorobenzoic acid Ethanol 4°C C 
AM27_05 PAP 4-Chlorobenzoic acid Ethanol Room temperature  B 
AM27_06 PAP 4-Chlorobenzoic acid Ethanol 30°C  B 
AM27_07 PAP 4-Chlorobenzoic acid Acetone 4°C  C 
AM27_08 PAP 4-Chlorobenzoic acid Acetone Room temperature  B 
AM27_10 PAP 4-Chlorobenzoic acid Ethyl Acetate 4°C  B 
AM27_11 PAP 4-Chlorobenzoic acid Ethyl Acetate Room temperature  B 
AM27_12 PAP 4-Chlorobenzoic acid Ethyl Acetate 30°C  B 
 
 
Figure 212 – XRPD patterns of collected materials from the cocrystallisations of PAP and 4-chlorobenzoic acid 
from analysis group A (red) compared with reference patterns of 4-chlorobenzoic acid (green) and 6-
phthalimidohexanoic acid monohydrate Form I (dark green) 
Analysis group A, samples AM27_01 and AM27_02, crystallised from methanol consist of a 
combination of crystalline 4-chlorobenzoic acid and 6-phthalimidohexanoic acid 
monohydrate Form I (Figure 212).  It is worth noting that Form II was also found, from 
analysis of single crystals extracted from AM27_01, however they are not representative of 
the bulk of the sample. 
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Group B, as defined in Table 39, contains the majority of samples in the screening.  From 
comparison of the XRPD data with reference patterns, these samples consist of a mixture 
of 4-chlorobenzoic acid and 6-phthalimidohexanoic acid only (Figure 213). 
 
Figure 213 – XRPD patterns of collected materials from the cocrystallisations of PAP and 4-chlorobenzoic acid 
from analysis group B (blue) compared with reference pattern of 4-chlorobenzoic acid (green) and 6-
phthalimidohexanoic acid (red). 
The final two samples, defined as group C, crystallisations in ethanol and acetone at 4°C 
can be seen from the XRPD data (Figure 214) to be recrystallised 4-chlorobenzoic acid only.   
 
Figure 214 - XRPD patterns of collected materials from the cocrystallisations of PAP and 4-chlorobenzoic acid 
from analysis group C (orange) compared with reference patterns of 4-chlorobenzoic acid (green) and 6-
phthalimidohexanoic acid monohydrate Form I (dark green). 
1-Naphthaleneacetic acid 
PAP and 1-naphthaleneacetic acid have similar sized π conjugated systems as well as the 
peroxyacid and carboxylic acid similarities previously discussed.  Being closer in size and 
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features to PAP, there may be more likelihood of 1-naphthaleneacetic acid producing a 
molecular complex.  The crystallisation conditions chosen for the 1:1 equimolar 
cocrystallisations are outlined in Table 40. 
Table 40 - Crystallisation conditions of PAP and 1-naphthaleneacetic acid 
Sample ID Component A Component B Solvent Temperature 
AM28_01 PAP 1-Naphthaleneacetic acid Methanol 4°C  
AM28_03 PAP 1-Naphthaleneacetic acid Methanol 30°C  
AM28_04 PAP 1-Naphthaleneacetic acid Ethanol 4°C 
AM28_05 PAP 1-Naphthaleneacetic acid Ethanol Room temperature  
AM28_06 PAP 1-Naphthaleneacetic acid Ethanol 30°C  
AM28_07 PAP 1-Naphthaleneacetic acid Acetone 4°C  
AM28_08 PAP 1-Naphthaleneacetic acid Acetone Room temperature  
AM28_08 PAP 1-Naphthaleneacetic acid Acetone 30°C  
AM28_10 PAP 1-Naphthaleneacetic acid Ethyl Acetate 4°C  
AM28_11 PAP 1-Naphthaleneacetic acid Ethyl Acetate Room temperature  
AM28_12 PAP 1-Naphthaleneacetic acid Ethyl Acetate 30°C  
AM28_13 PAP 1-Naphthaleneacetic acid Diethyl Ether 4°C  
AM28_14 PAP 1-Naphthaleneacetic acid Diethyl Ether Room temperature  
AM28_15 PAP 1-Naphthaleneacetic acid Diethyl Ether 30°C  
 
 
Figure 215 - XRPD patterns of collected materials from each solvent in the cocrystallisations of PAP and 1-
naphthaleneacetic acid compared with reference patterns of 1-naphthaleneacetic acid (grey) and 6-
phthalimidohexanoic acid monohydrate Form I (dark green) 
From the collected XRPD data, it can be seen that all samples have created a mixed 
material of similar compositions containing only 1-naphthaleneacetic acid crystals and 
decomposed PAP in the form of its monohydrate (Form I) (Figure 215).  A representative 
sample from each solvent environment is shown.  Some small traces of PAP may be present 
in some of the samples by indication of the most intense Bragg peaks; however with such a 
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high background, most of which is removed in processing along with the hidden signal, it 
cannot be verified. 
2-Hydroxybenzoic acid (Salicylic acid) 
PAP was also crystallised with salicylic acid under the conditions outlined in Table 41, with a 
1:1 molar ratio of peroxyacid to carboxylic acid.  As with the other peroxyacids, it is 
possible that the additional hydrogen bond donor might aid in the formation of motifs 
creating a molecular complex with the peroxyacid functional group.  However, with the 
additional carbonyls present in the phthalimido group of PAP providing two additional 
hydrogen bond acceptors, an interaction could also be generated at the other end of the 
molecule. 
Table 41 - Crystallisation conditions of PAP and salicylic acid 
Sample ID Component A Component B Solvent Temperature 
AM29_01 PAP 2-Hydroxybenzoic acid Methanol 4°C  
AM29_02 PAP 2-Hydroxybenzoic acid Methanol Room Temperature 
AM29_03 PAP 2-Hydroxybenzoic acid Methanol 30°C  
AM29_04 PAP 2-Hydroxybenzoic acid Ethanol 4°C 
AM29_05 PAP 2-Hydroxybenzoic acid Ethanol Room temperature  
AM29_06 PAP 2-Hydroxybenzoic acid Ethanol 30°C  
AM29_07 PAP 2-Hydroxybenzoic acid Acetone 4°C  
AM29_08 PAP 2-Hydroxybenzoic acid Acetone Room temperature  
AM29_08 PAP 2-Hydroxybenzoic acid Acetone 30°C  
AM29_10 PAP 2-Hydroxybenzoic acid Ethyl Acetate 4°C  
AM29_11 PAP 2-Hydroxybenzoic acid Ethyl Acetate Room temperature  
AM29_12 PAP 2-Hydroxybenzoic acid Ethyl Acetate 30°C  
AM29_13 PAP 2-Hydroxybenzoic acid Diethyl Ether 4°C  
AM29_14 PAP 2-Hydroxybenzoic acid Diethyl Ether Room temperature  
AM29_15 PAP 2-Hydroxybenzoic acid Diethyl Ether 30°C  
 
The PAP has again decomposed and recrystallised as the hydrated parent acid (Form I), as 
shown by XRPD comparison to the reference patterns of the starting material and the 
decomposed PAP products (Figure 216).   From analysis of the pattern profiles, there 




Figure 216 - XRPD patterns of selected materials from the cocrystallisations of PAP and salicylic acid (red) 
compared with reference patterns of salicylic acid (blue) and 6-phthalimidohexanoic acid monohydrate Form 
I (dark green). 
3-Hydroxybenzoic acid 
PAP was also cocrystallised with the salicylic acid isomer 3-hydroxybenzoic acid.  As with 
MCPBA, it is expected that the two hydrogen bond donors are fully available for interaction 
with the acceptors of the peroxyacid.  3-hydroxybenzoic acid was cocrystallised with PAP in 
a 1:1 equimolar ratio with crystallisation environments as shown in Table 42. 
From the collected XRPD data of the resulting materials, the patterns can be categorised 
into 4 distinct analysis groups, as defined in the table.  The contents of each group are 
discussed below. 
Table 42 - Crystallisation conditions of PAP and 3-hydroxybenzoic acid 
Sample ID Component A Component B Solvent Temperature Analysis Group 
AM30_01 PAP 3-Hydroxybenzoic acid Methanol 4°C  A 
AM30_02 PAP 3-Hydroxybenzoic acid Methanol Room Temperature B 
AM30_03 PAP 3-Hydroxybenzoic acid Methanol 30°C  C 
AM30_04 PAP 3-Hydroxybenzoic acid Ethanol 4°C B 
AM30_05 PAP 3-Hydroxybenzoic acid Ethanol Room temperature  B 
AM30_06 PAP 3-Hydroxybenzoic acid Ethanol 30°C  C 
AM30_07 PAP 3-Hydroxybenzoic acid Acetone 4°C  D 
AM30_08 PAP 3-Hydroxybenzoic acid Acetone Room temperature  C 
AM30_09 PAP 3-Hydroxybenzoic acid Acetone 30°C  D 
AM30_10 PAP 3-Hydroxybenzoic acid Ethyl Acetate 4°C  A 
AM30_11 PAP 3-Hydroxybenzoic acid Ethyl Acetate Room temperature  A 
AM30_12 PAP 3-Hydroxybenzoic acid Ethyl Acetate 30°C  A 
AM30_13 PAP 3-Hydroxybenzoic acid Diethyl Ether 4°C  A 
AM30_14 PAP 3-Hydroxybenzoic acid Diethyl Ether Room temperature  A 
AM30_15 PAP 3-Hydroxybenzoic acid Diethyl Ether 30°C  A 
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The samples in group A, primarily samples from ethyl acetate and diethyl ether, but also 
methanol at 4°C, contain recrystallised form II of 3-hydroxybenzoic acid and recrystallised 
PAP.  There is no indication of molecular complex formation in the XRPD patterns (Figure 
217). 
 
Figure 217 – XRPD patterns of collected materials from the cocrystallisations of PAP and 3-hydroxybenzoic 
acid from analysis group A (red) compared with reference patterns of 3-hydroxybenzoic acid Form II (grey) 
and PAP (blue). 
Group B, indicated in orange, crystallised from methanol at room temperature and ethanol 
at 4°C and room temperature is represented by the XRPD patterns in Figure 218.  The 
products peaks can be attributed to the presence of both polymorphs of 3-hydroxybenzoic 
acid, as well as recrystallised PAP.  Again, however, all peaks can be assigned and no new 
crystalline complexes have been formed. 
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Figure 218 – XRPD patterns of collected materials from the cocrystallisations of PAP and 3-hydroxybenzoic 
acid from analysis group B (orange) compared with reference patterns of 3-hydroxybenzoic acid Form I (red), 
3-hydroxybenzoic acid form II (grey) and PAP (blue). 
The cocrystallisation products identified as analysis group C, from methanol and ethanol 
solutions at 30°C, and also acetone at room temperature, have a high degree of amorphous 
content and only weak XRPD scans could be obtained.  After removal of the large 
background, few features remain, and caution is required in their interpretation.  The 
smaller of the peaks observed in these samples appear to correspond to the strongest 
peaks of 3-hydroxybenzoic acid form II and recrystallised PAP.  The major feature in these 
three scans, however, is the high intensity peak at 27.5° in 2θ (Figure 219).  Aside from a 
large preferred orientation peak arising from 3-hydroxybenzoic acid form II, there are no 
known materials from the decomposition of PAP or the crystallisation of 3-hydroxybenzoic 
acid that would explain the presence of this very large peak in relation to the intensities of 
the other components present.  Further analysis would be required to determine the origin 
of this significant peak. 
The final two samples, group D (purple), contain the same combination of materials as 
group C, but with different proportions of the crystalline materials 3-hydroxybenzoic acid 
form II and PAP.  They also contain the anomalous peak at 27.5° in 2θ (Figure 220), but it is 
less prominent in group D, possibly as this material is more crystalline or there is a lesser 
content of the unknown component attributed to this peak.  The similarity with group C 
products is consistent with the fact that both sets of samples are crystallised from acetone. 
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Figure 219 - XRPD patterns of collected materials from the cocrystallisations of PAP and 3-hydroxybenzoic 
acid from analysis group C (blue) compared with reference patterns of all known crystal forms of the starting 
materials and their known decomposition products. 
 
Figure 220 - XRPD patterns of collected materials from the cocrystallisations of PAP and 3-hydroxybenzoic 
acid from analysis group D (purple) compared with reference patterns 3-hydroxybenzoic acid form II (grey) 
and PAP (blue). 
Malonic acid 
PAP was also cocrystallised in a 1:1 molar ratio with malonic acid from acetone at 4°C and 
room temperature (AM38_14 and AM38_15) with the addition of a small amount, around 5 
drops, of hydrogen peroxide in an attempt to buffer the decomposition of the peroxyacid.  
The crystallisation setup was otherwise similar to the previous experiments.  The resulting 
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materials were analysed by XRPD (Figure 221).  The collected XRPD data shows the 
presence of a high amorphous background in the samples; subtraction of this reveals the 
peaks shown.  These show the presence of malonic acid and the decomposed PAP parent 
acid.  The sample crystallised at 4°C shows the presence of an additional peak at 28° 2θ, but 
with such high background samples, this could be from a mis-correction of the data.  There 
is no evidence of an unknown crystalline product. 
 
Figure 221 - AM38_14 (blue) and AM38_15 (green), XRPD patterns of resultant materials from the 
cocrystallisation of malonic acid and PAP with HOOH, compared to the reference patterns for malonic acid 
(grey) and 6-phthalimidohexanoic acid (red). 
Oxalic acid 
Oxalic acid was also cocrystallised with PAP in a 1:1 molar ratio with malonic acid from 
acetone at 4°C and room temperature (AM38_16 and AM38_17) with the addition of a 
small amount, around 5 drops, of hydrogen peroxide in an attempt to buffer the 
decomposition of the peroxyacid under otherwise the same crystallisation procedure.  The 
resulting materials were analysed by XRPD. 
The XRPD patterns from these two samples again contained high levels of amorphous 
background scattering which had to be subtracted.  The resulting peaks were compared to 
those of known decomposition products and starting materials (Figure 222), indicating that 
the product contains the β form of oxalic acid, traces of PAP and a larger amount of 6-
phthalimidohexanoic acid monohydrate Form I.   The majority of the PAP has thus 
decomposed with no molecular complex formation indicated. 
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Figure 222 - XRPD patterns of resultant materials from the cocrystallisation of oxalic acid and PAP with 
HOOH, AM38_16 (purple) and AM38_17 (red), compared to the reference patterns for oxalic acid β form 
(green), 6-phthalimidohexanoic acid monohydrate form I (olive) and PAP (blue). 
Chloranilic acid 
Chloranilic acid was cocrystallised with PAP in a 1:1 equimolar ratio with the addition of 5 
drops of HOOH as an anti-decomposition buffer.  The crystallisation conditions, solvent and 
controlled crystallisation temperature, from which solid products were obtained, are given 
in Table 43. 
Table 43 - Crystallisation conditions of PAP and chloranilic acid 
Sample ID Component A Component B Solvent Temperature Analysis 
Group 
AM66_02 PAP Chloranilic acid Acetone Room temperature A 
AM66_03 PAP Chloranilic acid Methyl acetate 4°C B 
AM66_05 PAP Chloranilic acid Ethyl acetate 4°C  A 
AM66_06 PAP Chloranilic acid Ethyl acetate Room temperature A 
 
The resulting materials were analysed by XRPD and found to fall into two groups defined in 
Table 43 as A and B.  Analysis group A, consisting of both of the samples crystallised in ethyl 
acetate at 4°C and room temperature, as well as the sample crystallised from acetone at 
room temperature, share many similar features in their XRPD patterns (Figure 223).  The 
majority of these features correspond well and indicate a strong presence of the parent 
acid – 6-phthalimidohexanoic acid.  Chloranilic acid also may be present in these samples 
but in a much smaller quantity.  The peak at 28° in 2θ could only be assigned, however, by 
assuming a high degree of preferred orientation in the samples; it could also correspond to 
an unidentified component. 
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Figure 223 - XRPD patterns of collected materials from the cocrystallisations of PAP and chloranilic acid from 
analysis group A (red) compared with reference patterns of 6-phthalimidohexanoic acid (navy) and chloranilic 
acid (green). 
 
Figure 224 - XRPD patterns of collected material from the cocrystallisation of PAP and chloranilic acid from 
analysis group B (purple) compared with reference patterns of PAP (blue) and chloranilic acid (green). 
Group B is obtained from the cocrystallisation in methyl acetate at 4°C.  This sample had a 
high background content and the constituents of the sample are not particularly clear.  
Most peaks can be assigned by contributions from recrystallised PAP and the chloranilic 
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acid starting materials (Figure 224),but further study would be required on the 
cocrystallisations of PAP and chloranilic acid with HOOH added. 
Bromanilic acid 
Bromanilic acid was similarly crystallised with PAP in a 1:1 equimolar ratio in acetone at a 
constant temperature of 4°C (AM67_01) and room temperature (AM67_02) with the 
addition of 5 drops of hydrogen peroxide.  Both samples when analysed by XRPD proved to 
contain high quantities of amorphous material as seen in the background, leading to a 
limited amount of the information in the patterns. 
 
Figure 225 – XRPD patterns of collected materials from the cocrystallisation of PAP and bromanilic acid with 
the addition of HOOH in acetone at 4°C (green) and room temperature (red) compared to the reference 
patterns for PAP (blue), bromanilic acid (purple) and 6-phthalimidohexanoic acid (navy). 
The remaining peaks (Figure 225) indicate that the sample recrystallized at 4°C contains 
primarily the decomposed PAP parent acid (6-phthalimidohexanoic acid) and some 
bromanilic acid.  The sample crystallised at room temperature contains greater quantities 
of bromanilic acid and there may be some indication of PAP in the lower angle peaks. 
5.1.4 Unresolved materials 
Cocrystallisations were also performed between the following materials, all at 1:1 ratio: 
 Meta-chloroperbenzoic acid and picolinic acid 
 Meta-chloroperbenzoic acid and dipicolinic acid 
 6-phthalimidoperoxyhexanoic acid and picolinic acid 
 6-phthalimidoperoxyhexanoic acid and dipicolinic acid 
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Unit cell screening of single crystals extracted from the samples yielded only starting 
materials, which may or may not be representative of the bulk of the sample.  These 
crystallisation experiments have yet to be fully assessed along with the remaining materials 
from the noted acid cocrystallisations. 
5.2 π-π interacting materials, proton sponges and peroxyacids 
Through targeting the π bonded region of the target molecules, the secondary components 
within this section were brought together in a crystallisation environment in a 1:1 ratio 
with the target materials with the aim of forming π-π interactions, creating molecular 
complexes of a stacked nature.  This methodology was designed specifically not to interact 
with the peroxyacid functional group itself, as the peroxyacid functionality was too 
unstable to be a primary point of interaction in a cocrystallisation experiment.  Although 
the proton sponges used have the additional capability of inducing proton transfer from 
the target material, they are robust π bond containing aromatic materials and may be 
considered within this category as their π-π stacking interactions often form a major 
directing factor in their crystal structures. 
As with the carboxylic acid cocrystallisations, the experiments were carried out in a range 
of solvents under temperature controlled evaporative crystallisation, as will be described 
for each experiment set.  
5.2.1 Meta-chloroperbenzoic acid and π-π interacting materials 
With its aromatic ring, MCPBA is a prime candidate for π-π stacking interactions and as 
such was cocrystallised with second components of a similar molecular shape and size.  On 
addition to π stacking capacity, each of the selected co-molecules had hydrogen bond 





Figure 226 - 1,4-Dihydroxybenzene (hydroquinone) 
Hydroquinone (Figure 226), with its aromatic ring and two hydrogen bond donors in the 
form of hydroxyl groups, was chosen primarily for its π-π stacking interaction potential with 
MCPBA.  It was crystallised with MCPBA in a 1:1 equimolar ratio in a series of 
crystallisations.  A representative result of these experiments is shown in the XRPD pattern 
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in Figure 227, from AM68_02 – cocrystallisation in acetone at room temperature with the 
addition of a few drops of hydrogen peroxide.  
This indicates the presence of 3-chlorobenzoic acid only, with no or very little other 
crystalline materials present.  The majority of the crystalline MCPBA has thus been 
decomposed to the parent acid. 
 
 
Figure 227 - XRPD pattern of collected material from cocrystallisation of MCPBA and hydroquinone in 
acetone at room temperature (red) compared with the reference patterns of 3-chlorobenzoic acid (blue), 




Figure 228 - 2-hydroxybenzophenone 
With its twin aromatic ring arrangement and hydrogen bond donor and acceptor available, 
2-hydroxybenzophenone (Figure 228) was selected as a material with potential to stack 
with MCPBA or form hydrogen bonds to the peroxyacid group.  It was utilised in 1:1 
equimolar cocrystallisation experiments, similar solvents with hydrogen peroxide addition 
as for previous experiments at controlled temperatures of 4°C and room temperature.  
Those experiments for which XRPD data were collected are displayed in Table 44. 
Table 44 - Crystallisation conditions of MCPBA and 2-hydroxybenzophenone 
Sample ID Component A Component B Solvent Temperature 
AM80_01 MCPBA 2-Hydroxybenzophenone Acetone 4°C 
AM80_03 MCPBA 2-Hydroxybenzophenone Methyl acetate 4°C 
AM80_07 MCPBA 2-Hydroxybenzophenone Diethyl ether 4°C 
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As can be seen from the XRPD data (Figure 229), all patterns show distinctive peaks 
corresponding to 3-chlorobenzoic acid, particularly in the sample collected from acetone at 
4°C, in which all peaks can be attributed to 3-chlorobenzoic acid.  The samples crystallised 
from methyl acetate and diethyl ether at 4°C also show a large content of 3-chlorobenzoic 
acid, along with 2-hydroxybenzophenone.  Once again the MCPBA appears to have 
decomposed to the parent acid in all recorded samples. 
 
Figure 229 - XRPD patterns of collected materials from the cocrystallisation of PAP and  
2-hydroxybenzophenone with the addition of HOOH in acetone at 4°C (top red), methyl acetate at 4°C 
(middle red) and diethyl ether at 4°C (bottom red) compared to the reference patterns for 2-






Figure 230 – 3-hydroxybenzophenone 
3-hydroxybenzophenone (Figure 230) is a more attractive hydrogen bonding co-material 
for MCPBA, as the 3-hydroxyl group is unable to form an intramolecular hydrogen bond.  
This co-molecule was screened under the same 1:1 conditions as 2-hydroxybenzophenone.  
The crystallisation conditions for which XRPD data were obtained from the products are 
detailed in Table 45.  As with the previous experiments, a small amount of hydrogen 
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peroxide was added to the crystallisation to aid in the prevention of decomposition to the 
parent acid.  The resulting XRPD patterns were compared to those of the starting materials 
and known decomposition products (Figure 231). 
Table 45 - Crystallisation conditions of MCPBA and 3-hydroxybenzophenone 
Sample ID Component A Component B Solvent Temperature 
AM82_01 MCPBA 3-Hydroxybenzophenone Acetone 4°C 
AM82_03 MCPBA 3-Hydroxybenzophenone Methyl acetate 4°C 
AM82_05 MCPBA 3-Hydroxybenzophenone Ethyl acetate 4°C 
AM82_07 MCPBA 3-Hydroxybenzophenone Diethyl ether 4°C 
 
 
Figure 231 - XRPD patterns of collected materials from the cocrystallisation of MCPBA and  
3-hydroxybenzophenone with the addition of HOOH in acetone at 4°C (top red), methyl acetate at 4°C (2nd 
red), methyl acetate at 4°C (3rd red) and diethyl ether at 4°C (bottom red) compared to the reference 
patterns of 3-chlorobenzoic acid (blue) and 3-hydroxybenzophenone (green). 
From the XRPD pattern comparison it can be observed that the samples resulting from 
acetone and diethyl ether solution contain only crystalline 3-chlorobenzoic acid.  Any other 
materials present must be amorphous.  The samples from methyl acetate and ethyl acetate 
also show a strong presence of 3-chlorobenzoic acid but also recrystallised 3-
hydroxybenzophenone in trace amounts.  In all samples the MCPBA has decomposed to the 
parent acid without generation of a new molecular complex. 
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Figure 232 - 2-chlorobenzophenone 
The cocrystallisation of MCPBA and 2-chlorobenzophenone (Figure 232) with the addition 
of hydrogen peroxide crystallised in a 1:1 equimolar ratio from methyl acetate at room 
temperature produced a material that from XRPD analysis appears poorly crystalline 
(Figure 233). 
 
Figure 233 - XRPD pattern of material collected from the cocrystallisation of MCPBA and 2-
chlorobenzophenone crystallised from methyl acetate at room temperature compared with the reference 
patterns of 3-chlorobenzoic acid (blue) and 2-chlorobenzophenone (green) 
From the XRPD pattern comparison to starting materials and known decomposition 
products, the peaks present after removal of the background, can be attributed to a 
combination of 3-chlorobenzoic acid and 2-chlorobenzophenone.  It is thus likely that the 
MCPBA has decomposed to the parent acid. 
5.2.2 6-Phthalimidoperoxyhexanoic acid and π-π interacting materials 
When dealing with π-π interacting materials and PAP, the focus of the candidate 
interactions is primarily upon the phthalimido end of the molecule.  The planar phthalimido 
group can stack readily and has great conformational flexibility with respect to the 
hydrogen bonding head of the molecule as a result of the long aliphatic chain.  This should 

















allow it to pack effectively between molecules whilst separating the peroxyacid head from 
the area of π interaction; this is seen in the crystal structures of 6-phthalimidohexanoic acid 
and its family.  Introducing a second π-π stacking material into the crystallisation could thus 
create a new molecular complex with the peroxyacid through solely π interactions, 
removing the need to interact with the unstable peroxyacid functional group. 
To this end, PAP was cocrystallised with a range of selected aromatic materials, including 
those with hydrogen bonding potential and proton sponges. 
2-Hydroxybenzophenone 
2-Hydroxybenzophenone was cocrystallised with 6-phthalimidoperoxyhexanoic acid in a 
1:1 equimolar ratio in a selected range of solvents and crystallisation temperatures as set 
out in Table 46.  The resultant materials were analysed by XRPD for assessment of 
crystalline material content and indication of the formation of any new components in the 
crystallisation process.  The crystallisation was aided by the addition of 5 drops of hydrogen 
peroxide to buffer the equilibrium of the decomposition reaction of the peroxyacid. 
Table 46 - Crystallisation conditions of PAP and 2-hydroxybenzophenone 
Sample ID Component A Component B Solvent Temperature 
AM81_01 PAP 2-Hydroxybenzophenone Acetone 4°C 
AM81_03 PAP 2-Hydroxybenzophenone Methyl acetate 4°C 
 
 
Figure 234 - XRPD patterns of materials collected from the cocrystallisation of PAP and 2-
hydroxybenophenone (red) compared with the reference patterns of 6-phthalimidohexanoic acid (blue) and 
2-hydroxybenzophenone (purple) 
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From the two samples for which XRPD data could be collected (Figure 234, Table 46), it can 
be clearly determined that the resulting materials from both experiments are a 
combination of 2-hydroxybenzophenone and the PAP decomposition product 6-
phthalimidohexanoic acid.  The peroxyacid is thus decomposed to the parent acid under 
these conditions, with no indication of molecular complex formation. 
3-Hydroxybenzophenone 
PAP was also cocrystallised with 3-hydroxybenzophenone, under the same condition under 
an equimolar ratio and within a temperature controlled environment.  The crystallisation 
conditions for each experiment that resulted in a material that was analysed by XRPD are 
outlined in Table 47. 
Table 47 - Crystallisation conditions of PAP and 3-hydroxybenzophenone 
Sample ID Component A Component B Solvent Temperature Analysis Group 
AM83_01 PAP 3-Hydroxybenzophenone Acetone 4°C A 
AM83_02 PAP 3-Hydroxybenzophenone Acetone Room temperature B 
AM83_03 PAP 3-Hydroxybenzophenone Methyl Acetate 4°C A 
AM83_05 PAP 3-Hydroxybenzophenone Ethyl acetate 4°C B 
AM83_07 PAP 3-Hydroxybenzophenone Diethyl ether 4°C B 
 
From analysis of the collected XRPD data, the samples can be split into two categories, 
defined in the table as analysis groups A and B. 
 
Figure 235 - XRPD patterns from the cocrystallisation of PAP and 3-hydroxybenzophenone defined as analysis 
group A (red) compared to a reference pattern of 6-phthalimidohexanoic acid monohydrate Form I (green). 
The samples in analysis group A (Figure 235), from acetone and methyl acetate at 4°C, 
resulted in recrystallisation of 6-phthalimidohexanoic acid monohydrate (Form I), with no 
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 6-phthalimidohexanoic acid hydrate Form I
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unidentified Bragg peaks present.  The secondary component material, 3-
hydroxybenzophenone cannot be seen and is assumed to be amorphous.  The PAP in these 
crystallisations has decomposed to the parent acid. 
 
Figure 236 - XRPD patterns from the cocrystallisation of PAP and 3-hydroxybenzophenone defined as analysis 
group B (magenta) compared to a reference pattern of 3-hydroxybenzophenone (olive) and 6-
phthalimidohexanoic acid (navy) 
The remaining samples for which data were collected are defined as analysis group B.  
These materials all have peaks indicative of a composition containing both 6-
phthalimidohexanoic acid and 3-hydroxybenzoic acid (Figure 236).  All samples in this 





Figure 237 - 4-hydroxybenzophenone 
PAP was crystallised with 4-hydroxybenzophenone (Figure 237) in a 1:1 equimolar 
evaporative crystallisation under the same conditions as the previous two 
hyroxybenzophenones.  Although no XRPD data was collected from these materials, single 
crystal analysis of selected samples from the cocrystallisation from methanol at 30°C 
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revealed the presence of a reaction product, benzoic acid (Figure 238), an oxidation 
product of the 4-hydroxybenzophenone. 
 
Figure 238 - Benzoic acid 
The oxidising agents, either the PAP or the hydrogen peroxide, must therefore have 
oxidised the 4-hydroxybenzophenone molecule at the carbonyl, suggesting that the 
corresponding leaving group, 1-hydroxy-4-methylbenzene or a further oxidised material 
must also be present.  A crystal structure of this material was collected, however the data is 
not of higher quality to that of this molecule as recorded in the CSD46, 156. 
From analysis of the simulated XRPD pattern of this crystal structure with those of the 
products from the other hydroxybenzophenone cocrystallisations, no similarity is evident 
between the peak profiles and therefore this decomposition product cannot be a major 






Figure 239 - Benzimidazole 
Benzimidazole (Figure 239) is a planar molecule with an aromatic ring and an available 
electron rich nitrogen site for interaction.  This was selected cocrystallisation attempts, not 
only for its π-π interactions, but also for its ability to deprotonate co-components by 
forming a strong hydrogen bond by proton transfer to the heterocyclic nitrogen.  It could 
thus potentially strip the peroxyacid hydrogen from the basic oxygen forming a salt, 
completely changing the electronic nature of the peroxide chain of the peroxyacid and its 
resulting reactivity.  With respect to the characteristics of PAP, it shares a common size and 
shape with the phthalimido group, potentially aiding molecular recognition.  Benzimidazole 
was therefore crystallised with PAP in a 1:1 molar ratio under the conditions outlined in 
Table 48, and allowed to crystallise by slow evaporation. 
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Table 48 - Crystallisation conditions of PAP and Benzimidazole 
Sample ID Component A Component B Solvent Temperature 
AM31_02 PAP Benzimidazole Methanol Room temperature 
AM31_05 PAP Benzimidazole Ethanol Room temperature 
AM31_06 PAP Benzimidazole Ethanol 30°C 
AM31_07 PAP Benzimidazole Acetone 4°C 
AM31_08 PAP Benzimidazole Acetone Room temperature 
AM31_09 PAP Benzimidazole Acetone 30°C 
AM31_10 PAP Benzimidazole Ethyl acetate 4°C 
AM31_11 PAP Benzimidazole Ethyl acetate Room temperature 
AM31_12 PAP Benzimidazole Ethyl acetate 30°C 
AM31_13 PAP Benzimidazole Diethyl Ether 4°C 
AM31_14 PAP Benzimidazole Diethyl Ether Room temperature 
AM31_15 PAP Benzimidazole Diethyl Ether 30°C 
 
All XRPD patterns of the materials collected from the cocrystallisation experiments show a 
high degree of similarity, but they do not correspond to benzimidazole, PAP, or any of the 
known PAP decomposition products (Figure 240 Figure 162).  These products thus 






Figure 240 - Collected materials from the cocrystallisation of PAP and benzimidazole (red) compared to the 
reference patterns of 6-phthalimidohexanoic acid monohydrate Forms I (green) and II (brown), PAP (blue), 6-
phthalimidohexanoic acid (Navy) and benzimidazole (magenta). 
Suitable crystals for single crystal X-ray diffraction were extracted from sample AM31_11, 
crystallisation from ethyl acetate at room temperature, and were subsequently measured 
on the Rigaku R-Axis diffractometer at 100K.  The data collection details are shown in Table 
49. 
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Table 49 - Crystal structure collection data for 6-phthalimidohexanoic acid benzimidazole benzimidazol-1-ol 
(1:1:1) molecular complex 
Compound 6-phthalimidohexanoic acid benzimidazole benzimidazol-
1-ol (1:1:1) molecular complex 
Formula C28H27O4.4N5 
Crystallisation Conditions Reaction product from cocrystallisation of 6-
phthalimidoperoxyhexanoic acid and benzimidazole in 
ethyl acetate at room temperature 
Molecular weight / gmol-1 503.95 
Temperature (K) 100 
Space Group P-1 
a (Å) 5.3091(9) 
b (Å) 11.754(2) 
c (Å) 20.033(3) 
α (o) 87.840(6) 
β (o) 85.105(6) 
γ (o) 76.980(5) 
Volume (Å3) 1213.3(4) 
Z 2 
Z’ 1 
θ range/˚ 3.1-27.6 
Reflections Collected 26030 
Independent 5515 
Refln (obs.I>2theta(I)) 3786 
Rint 0.0514 
Parameters 458 
GooF on F2 1.042 
R1 (Observed) 0.0563 
R1 (all) 0.0877 
wR2 (all) 0.1368 
 
The determined structure is a molecular complex of the decomposed PAP parent acid (6-
phthalimidohexanoic acid) and benzimidazole.  There are three molecular species present, 
of which there are two chemically different moieties related to benzimidazole. 
 
Figure 241 - Asymmetric unit of benzimidazole, benzimidazol-1-ol and 6-phthalimidohexanoic acid. 
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As can be seen in Figure 241, the asymmetric unit not only contains a molecule of 
decomposed PAP, and a molecule of benzimidazole, but a partially oxidised benzimidazole 
derivative.  The cocrystallisation conditions have led to oxidisation of the available nitrogen 
on the benzimidazole molecule by the peroxyacid, producing benzimidizol-1-ol. 
 
Figure 242 - 6-phthalimidohexanoic acid dimer formed over the inversion centre (left), bond length 
measurements of short strong hydrogen bond between the two carboxylic acid functional groups (right) 
The peroxyacid itself is lost in the process, with its decomposition product 6-
phthalimidohexanoic acid retained in the structure as part of the molecular complex.  The 
decomposed PAP molecules are dimerised via a single short strong hydrogen bond 
between the carboxylic acid groups, with O···H-O distance 2.463(3)Å (Figure 242).  The 
hydrogen atom is situated on an inversion centre between the two molecules. 
 
Figure 243 - Moderate strength hydrogen bond between carboxylic acid and benzimidazole directed towards 
the hydroxyl oxygen of the group. 
The carboxylic acid of the decomposed PAP is also involved in a second, moderate strength, 
hydrogen bond of N-H···O distance 2.878(3)Å (170(2)°) between the unreacted 
benzimidazole molecule and the hydroxyl oxygen of the carboxylic acid group (Figure 243).  
The unreacted benzimidazole is further hydrogen bonded to the oxidized benzimidazole via 
a second moderate strength hydrogen bond with the oxidised benzimidazole amine with a 





Figure 244 - The moderate strength hydrogen bond between the lone pair of the nitrogen on the unreacted 
benzimidazole molecule and the amine hydrogen of the reacted benzimidazole 
The final molecule in the asymmetric unit is the partially oxidised benzimidazole molecule.  
The X-ray diffraction data suggest that the nitrogen of the benzimidazole molecule (N5) is 
disordered over two positions corresponding to an oxidised and non-oxidised form (Figure 
245).  The oxygen atom (O5) has 40% occupancy which corresponds to N5 at the N5B 
position; the hydroxyl group is thus associated with this nitrogen.  N5A is the un-oxidised 
nitrogen. 
 
Figure 245 - Partially oxidised benzimidazole / benzimidazol-1-ol molecule
 
Figure 246 - Two alternative hydrogen bond arrangements over the inversion centre between the two 
partially oxidised benzimidazole molecules. 
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The hydrogen H28 sits over the inversion centre and two hydrogen bonding arrangements 
are possible, depending on the disorder configuration.  If the molecules are oxidised, there 
is a short, strong O5···H28···O5 hydrogen bond at a distance of 2.391(6)Å, while if they are 
not oxidised, there is a N5A···H28··N5A moderate strength hydrogen bond of distance 
2.779(6)Å.  This alternating hydrogen bonding motif affects the atomic displacement 
parameters of the remaining non hydrogen atoms on the benzimidazole molecule, but only 
N5 can be fully split to two positions in the disorder model. 
 
Figure 247 - Stacking of benzimidazole molecules over the aliphatic chain and carboxylic acid dimer. 
The benzimidazole molecules stack directly over the aliphatic chains of the decomposed 
PAP hydrogen bonded dimer forming aliphatic C-H···π interactions at distances of 3.678(3)Å 
and 3.715(3)Å, packing between the closest atoms of the phthalimido groups of the two 
decomposed PAP molecules (Figure 247).  The non-oxidised benzimidazole further stacks in 
a skewed overlap with the oxidised benzimidazole molecule at a distance of 3.105(4)Å. 
 
Figure 248 - Alternating phthalimido groups forming hydrogen bonded squares.  The benzimidazole 
molecules contained within this square arrangement are omitted for clarity. 
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The phthalimido groups adopt an alternate arrangement creating two carbonyl to aromatic 
C-H···O hydrogen bonds at a distance of 3.311(2)Å (172(2)°) forming a hydrogen bonded 
square arrangement (Figure 248) around the benzimidazole molecules. 
 
Figure 249 - Skewed stack arrangement of phthalimido groups perpendicular to the stacking of the 
benzimidazole molecules 
Finally, the phthalimido groups also stack with each other in a skewed arrangement along 
the ab diagonal, with a π-π interaction distance of 3.432(3)Å forming an overlapping zigzag 
arrangement  (Figure 249). 
The simulated XRPD pattern generated by this structure is an excellent match to the 
patterns observed from all of the cocrystallisations in this experiment set and is thus fully 
representative of the bulk sample product (Figure 250). 
 
Figure 250 - XRPD pattern representative of all samples collected from the cocrystallisation of PAP and 
benzimidazole (red) compared to the simulated structure of the 6-phthalimidohexanoic acid benzimidazole 
benzimidizol-1-ol molecular complex (green). 
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5.2.3 Unresolved materials 
Cocrystallisations were also performed between the following materials, all in a 1:1 ratio:  
 Meta-chloroperbenzoic acid and Benzimidazole  
 Meta-chloroperbenzoic acid and DMAN “Proton Sponge” 
 Meta-chloroperbenzoic acid and 1,3-Dihydroxybenzene (Resorcinol)  
 Meta-chloroperbenzoic acid and 1,2-Dihydroxybenzene (Catechol) 
 Meta-chloroperbenzoic acid and 1-Chloro-2-nitrobenzene 
 Meta-chloroperbenzoic acid and 1-Chloro-3-nitrobenzene 
 Meta-chloroperbenzoic acid and 4,4-Bipyridine 
 Meta-chloroperbenzoic acid and 4-Hydroxybenzophenone 
 Meta-chloroperbenzoic acid and Naphthazerin 
 Meta-chloroperbenzoic acid and Tetrahydroxyquinone 
 6-phthalimidoperoxyhexanoic acid and 1,4-Dihydroxybenzene (Hydroquinone) 
 6-phthalimidoperoxyhexanoic acid and 1,3-Dihydroxybenzene (Resorcinol) 
 6-phthalimidoperoxyhexanoic acid and 1,2-Dihydroxybenzene (Catechol) 
 6-phthalimidoperoxyhexanoic acid and 1-Chloro-2-nitrobenzene 
 6-phthalimidoperoxyhexanoic acid and 1-Chloro-3-nitrobenzene 
 6-phthalimidoperoxyhexanoic acid and 4,4-Bipyridine 
 6-phthalimidoperoxyhexanoic acid and 2-Chlorobenzophenone 
 6-phthalimidoperoxyhexanoic acid and Tetrahydroxyquinone 
 6-phthalimidoperoxyhexanoic acid and Naphthazarin 
 6-phthalimidoperoxyhexanoic acid and DMAN “Proton sponge” 
Unit cell screening of single crystals extracted from the samples yielded only starting 
materials, which may or may not be representative of the bulk of the sample.  These 
crystallisation experiments have yet to be fully assessed along with the remaining 
unscreened materials from the noted π –π stacking directed cocrystallisations. 
 
5.3 Metals and peroxyacids 
The combination of the target peroxyacids with metal salts was also explored.  Using the 
same technique as with other cocrystallisation experiments the aim was to form either 
coordinated metal complexes with the peroxyacid as ligand, or crystalline salts with an 
altered reactivity.  The reactions with a metal centre, however, have the risk that 
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association may be a highly reactive process, or possibly irreversible, with no way to 
recover the peroxyacid after complex formation. 
This method was therefore explored in a limited way, allowing for a cautious approach.  As 
for the carboxylic acids and the π-π associating materials, the components were brought 
together for evaporative crystallisation in equimolar ratios, to favour a 1:1 association of 
the materials upon crystallisation in a series of solvents in temperature controlled 
environments as detailed for each experiment. 
5.3.1 Meta-chloroperbenzoic acid and metals 
MCPBA was crystallised in a 1:1 molar ratio with a range of acid salts in the presence of a 
small amount of hydrogen peroxide to buffer the retention of the peroxyacid.  The solvent 
and temperature was varied in order to maximise the chances of producing a complex 
containing the MCPBA.   
Magnesium Chloride 
The crystallisation conditions used are given in Table 50 
Table 50 - Crystallisation conditions of MCPBA and magnesium chloride 
Sample ID Component A Component B Solvent Temperature 
AM50_01 MCPBA Magnesium chloride Ethyl acetate 4°C 
AM50_04 MCPBA Magnesium chloride Chloroform 4°C 
AM50_08 MCPBA Magnesium chloride Acetone Room temperature 
AM50_10 MCPBA Magnesium chloride Diethyl ether 4°C 
AM50_13 MCPBA Magnesium chloride Dichloromethane 4°C 
AM50_14 MCPBA Magnesium chloride Dichloromethane Room temperature 
AM50_16 MCPBA Magnesium chloride Methanol 4°C 
AM50_20 MCPBA Magnesium chloride Methyl acetate Room temperature 
AM50_22 MCPBA Magnesium chloride Isopropanol 4°C 
AM50_25 MCPBA Magnesium chloride Ethanol 4°C 
AM50_26 MCPBA Magnesium chloride ethanol Room temperature 
 
From the XRPD data of the analysed samples, 3-chlorobenzoic acid is present in all samples 
that showed significant crystallinity (Figure 251).  All samples were very weakly diffracting, 
making further analysis very difficult and unreliable.  The crystallisations from acetone, 
methyl acetate and ethanol at room temperature all support the conclusion that the 
peroxyacid has decomposed and not formed a complex, through identification of 3-




Figure 251 - XRPD patterns of the products of cocrystallisation of MCPBA and magnesium chloride (red) 
compared with the reference pattern from 3-chlorobenzoic acid (black). 
Calcium Chloride 
The crystallisation conditions used are given in Table 51 
Table 51 - Crystallisation conditions of MCPBA and calcium chloride 
Sample ID Component A Component B Solvent Temperature 
AM53_01 MCPBA Calcium chloride Ethyl acetate 4°C 
AM53_02 MCPBA Calcium chloride Ethyl acetate Room temperature 
AM53_13 MCPBA Calcium chloride dichloromethane 4°C 
AM53_19 MCPBA Calcium chloride Methyl acetate 4°C 
AM53_22 MCPBA Calcium chloride isopropanol 4°C 
 
As with magnesium chloride, all samples analysed showed 3-chlorobenzoic acid as the only 
significant crystalline component present (Figure 252).  The peroxyacid has again 
decomposed to the parent acid without interaction with the metal. 
 
Figure 252 - XRPD patterns of the products of cocrystallisation of MCPBA and calcium chloride (red) 
compared with the reference pattern of 3-chlorobenzoic acid (black). 
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The crystallisation conditions used are given in Table 52. 
Table 52 - Crystallisation conditions of MCPBA and copper chloride 
Sample ID Component A Component B Solvent Temperature 
AM86_03 MCPBA Copper chloride Methyl acetate 4°C 
AM86_05 MCPBA Copper chloride Ethyl acetate 4°C 
AM86_07 MCPBA Copper chloride Diethyl ether 4°C 
 
Figure 253 - XRPD patterns of the products cocrystallisation of MCPBA and copper chloride (red) compared 
with 3-chlorobenzoic acid (black) and copper chloride (purple) reference patterns. 
The patterns from this series of experiments indicate the presence of 3-chlorobenzoic acid 
and copper chloride in the final materials (Figure 253).  The MCPBA has decomposed to the 
parent acid and no interaction is observed with the metal in the solid state. 
Copper Sulfate 
The crystallisation conditions used are given in Table 53 
Table 53 - Crystallisation conditions of MCPBA and copper sulfate 
Sample ID Component A Component B Solvent Temperature 
AM87_03 MCPBA Copper sulfate Methyl acetate 4°C 
AM87_05 MCPBA Copper sulfate Ethyl acetate 4°C 
AM87_07 MCPBA Copper sulfate Diethyl ether 4°C 
 
The samples collected from the crystallisation of MCPBA and copper sulfate that were 
analysed by XRPD all contain varying amounts of 3-chlorobenzoic acid (Figure 254).  The 
poorest match to the reference pattern is found for AM87_05, the material from ethyl 
acetate at 4°C.  The remaining peaks in the samples, however, do not correspond to any of 
the starting materials or decomposition products.  Further investigation is required the 
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Figure 254 - XRPD patterns of the products of cocrystallisation of MCPBA and copper sulfate in methyl 
acetate (red), ethyl acetate (blue) and diethyl ether (green) all at 4°C compared with the reference pattern 
for 3-chlorobenzoic acid (black). 
 
5.3.2 6-Phthalimidoperoxyhexanoic acid and metals 
PAP was crystallised in a 1:1 molar ratio with the following acid salts in the presence of a 
small amount of hydrogen peroxide to buffer the retention of the peroxyacid, as for 
MCPBA.  The solvent and temperature was varied in order to achieve the maximum 
possibility of creating a new material that included the peroxyacid.   
Magnesium Chloride 
The crystallisation conditions used are given in Table 54. 
Table 54 - Crystallisation conditions of PAP and magnesium chloride 
Sample ID Component A Component B Solvent Temperature Scan Group/s 
AM51_01 PAP Magnesium chloride Ethyl  acetate 4°C A 
AM51_02 PAP Magnesium chloride Ethyl  acetate Room temperature A 
AM51_04 PAP Magnesium chloride Chloroform 4°C A 
AM51_07 PAP Magnesium chloride Acetone 4°C B 
AM51_08 PAP Magnesium chloride Acetone Room temperature A 
AM51_10 PAP Magnesium chloride Diethyl ether 4°C A & B 
AM51_11 PAP Magnesium chloride Diethyl ether Room temperature A 
AM51_14 PAP Magnesium chloride Dichloromethane Room temperature A 
AM51_19 PAP Magnesium chloride Methyl acetate 4°C A 
AM51_25 PAP Magnesium chloride Ethanol 4°C B 
AM51_26 PAP Magnesium chloride Ethanol Room temperature A 
 
























From the analysed XRPD data, two product groups have been recognised, as defined in 
Table 54. 
 
Figure 255 – XRPD patterns of collected scans categorised as group A from the crystallisation of PAP with 
magnesium chloride and hydrogen peroxide (black), compared with the reference pattern of 6-
phthalimidohexanoic acid (red). 
Samples falling into category A, are those in which 6-phthtlaimidohexanoic acid is present 
in the pattern in differing proportions.  In some of these samples they are not the main 
component, however the pattern profiles indicate that that the strongest peaks are 
present.  This is particularly noted at around 17.5° in 2θ and in the region between 12° and 
15° 2θ where the characteristic peak profile can be seen (Figure 255).  
In samples categorised as group B, distinctive peaks originating from the profile of 6-
phthalimidohexanoic acid monohydrate Form I can be found; this is most evident at around 
25° 2θ (Figure 256).  These reference patterns account for some of the Bragg peaks found 
in the experimental patterns, however many are unaccounted for – in particular the peaks 
between 30° and 34° 2θ found in all of the samples cannot be assigned by any known 
pattern.  More study, particularly single crystal analysis, is needed on this material to 
attempt to find a structure of a known unit cell corresponding to these peaks.   










































Figure 256 - XRPD patterns of collected scans categorised as group B from the crystallisation of PAP with 
magnesium chloride and hydrogen peroxide (purple), compared with the reference pattern of 6-
phthalimidohexanoic acid monohydrate form I (black). 
Calcium Chloride 
The crystallisation conditions used are given in Table 55 
Table 55 - Crystallisation conditions of PAP and calcium chloride 
Sample ID Component A Component B Solvent Temperature Scan Group/s 
AM54_01 PAP Calcium chloride Ethyl  acetate 4°C A 
AM54_02 PAP Calcium chloride Ethyl  acetate Room temperature Amorphous 
AM54_04 PAP Calcium chloride Chloroform 4°C Amorphous 
AM54_05 PAP Calcium chloride Chloroform Room temperature Amorphous 
AM54_07 PAP Calcium chloride Acetone 4°C B 
AM54_10 PAP Calcium chloride Diethyl ether 4°C B 
AM54_13 PAP Calcium chloride Dichloromethane Room temperature Amorphous 
AM54_14 PAP Calcium chloride Dichloromethane 4°C Amorphous 
AM54_19 PAP Calcium chloride Methyl acetate 4°C C 
AM54_20 PAP Calcium chloride Methyl acetate Room temperature C 
AM54_22 PAP Calcium chloride Isopropanol 4°C Amorphous 
AM54_23 PAP Calcium chloride isopropanol Room temperature Amorphous 
 
Analysis of the resultant materials by XRPD proved to be very difficult as the samples were 
poorly crystalline, some showing no reflections at all.  These samples are marked on Table 
55 as amorphous.  The remaining samples were categorised into 3 groups, A, B and C. 
Group A is from ethyl acetate at 4°C, which by powder pattern comparison clearly indicates 
the presence of triacetone-triperoxide form I in the sample along with unidentified 
secondary materials (Figure 257 red).  This can only be from oxidation of the methyl 
acetate by the PAP or the hydrogen peroxide and subsequent formation of TATP crystals. 
Group B, from acetone and diethyl ether at 4°C, shows similarity with the primary peaks of 
the decomposed PAP product 6-phthalimidohexanoic acid, however the patterns are very 
weak so only the presence of the strongest reflections is observed (Figure 257 black). 























Figure 257 - XRPD patterns of materials from crystallisation of PAP with calcium chloride and hydrogen 
peroxide compared to matching reference patterns.  Analysis group A (red) with reference TATP (top red), 
analysis group B (black) with reference 6-phthalimidohexanoic acid monohydrate form II (top black) and 
analysis group C (blue) with reference 6-phthalimidohexanoic acid (top blue). 
The final group C again are represented by extremely weak patterns, but they do show 
some similarity to the strongest features in the pattern profile of the decomposed PAP 
product 6-phthalimidohexanoic acid (Figure 257 blue). 
There is no clear indication in any of the samples analysed that would suggest that PAP has 
been retained or that a new complex has formed, other than the reaction product TATP. 
Copper Chloride 
The crystallisation conditions used are given in Table 56 
Table 56 - Crystallisation conditions of PAP and copper chloride 
Sample ID Component A Component B Solvent Temperature 
AM88_01 PAP Copper chloride Acetone 4°C 
AM88_03 PAP Copper chloride Methyl acetate 4°C 
AM88_05 PAP Copper chloride Ethyl acetate 4°C 
 
From the collected XRPD data of the samples, it can be seen by comparison to the 
reference materials powder patterns that the composition of all three of the samples is a 
mixture of copper chloride and the decomposed PAP parent acid – 6-phthalimidohexanoic 
acid monohydrate (form I) as is shown in Figure 258.  There is no indication of PAP in the 
samples or that any new complexes have formed. 
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Figure 258 - XRPD patterns of materials collected from the crystallisation of PAP and copper chloride with 
hydrogen peroxide (red) compared to reference patterns of copper chloride (purple) and 6-
phthalimidohexanoic acid monohydrate form I (magenta). 
Copper Sulfate 
6-phthalimidoperoxyhexanoic acid was also crystallised with copper sulfate with the 
addition of hydrogen peroxide under similar conditions, however at the time of writing, no 
results have been obtained for analysis. 
5.4 Conclusions 
Utilising carboxylic acids as secondary materials for cocrystallisation conditions has yielded 
no positive results in terms of complex formation with the target peroxyacids.  Addition of 
many of the carboxylic acids has led to the complete decomposition of the peroxyacids and 
recrystallization of the co-component, favouring self-association rather than molecular 
association with the target material or its decomposition products.  It is unexpected that 
there is no evidence of complex formation between the parent acids and the carboxylic 
acid secondary materials.  This could possibly be a result of the equilibrium reaction in play 
throughout the crystallisation preventing molecular recognition as a result of constantly 
interchanging functionality between a carboxylic acid and peroxyacid group.  It seems 
however that the carboxylic acid functionality is incompatible for interaction with the 
peroxyacid group, and no new materials have been formed. 
With the non-carboxylic acid functionalised materials, such as the π-π interacting materials 
there also has been little to no success in creating a new material complex.  In the majority 
of cases, decomposition to the parent acid of the peroxyacid is the normal outcome, with 
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few exceptions to the rule.  The new molecular complex between the parent acid and 
benzimidazole leads to a supposition that molecular similarity to the largest part of the 
molecule could be a potential route to reliably creating molecular complexes with PAP, but 
this requires more investigation.  A possible future direction would be to use a non-
functionalised, or fully oxidised functionality within phthalimido molecules, where no 
chemical reactions can take place during the crystallisation process. 
The crystallisation with metals has yielded no new complexes.  If this approach is to work 
more effectively, a more directed synthesis methodology would perhaps be better suited 
rather than soft molecular recognition and salt formation. 
Addition of hydrogen peroxide to crystallisation experiments throughout the research 
seems to have had the effect of producing fewer crystalline or more amorphous materials.  
This could possibly be explained by the effect of the equilibrium reaction and subsequent 
functional group changes in disturbing the molecular recognition step in the crystallisation 
process.  This could be equally the case for the secondary material, as the presence of 
hydrogen peroxide may instigate an oxidation of any carboxylic acid group present in these 





6. Hosting Reactive materials 
This Chapter discusses a different approach to stabilising the target reactive materials 
which focusses upon trying to design systems in which the highly reactive and unstable 
target molecules would interact in molecular complexes with selected co-components 
using the principles of crystal engineering and molecular recognition.  The technique 
discussed here instead involves bringing the material into a larger, more stable structure, 
which could lead to protection of the molecules within a hosted environment and an 
overall reduction in their reactivity. 
As described in the introduction, there are several ways in which this could be achieved: 
through assembly of a host structure around the molecules, such as with urea complexes, 
or by utilising pre-assembled hosts, such as the large and highly stable cyclodextrins, to 
host the target reactive materials within their structure. 
Another area explored is that of potential hosting within layered materials.  In particular 
the montmorillonite clay Bentonite was used in an attempt to allow the inclusion of the 
target reactive material 6-phthalimidoperoxyhexanoic acid (PAP) within its layered 
arrangement. 
6.1 Urea based hosting 
The ability of urea to create channelled networks around secondary guest materials90 
proposed a possible strategy for molecularly encapsulating reactive peroxyacids into a 
larger structure that may possibly add stability to the guest material.  Both urea and 
thiourea, which has larger structural footprint and porosity as noted earlier, were studied 
as a way of enclosing the target peroxyacid molecules within a protective molecular shell. 
Both materials, urea and thiourea, were first tested with hydrogen peroxide in a range of 
typical crystallisation conditions to determine if the channelled structures could first be 
created under such reactive conditions.  As noted in the previous chapter, inclusion of 
hydrogen peroxide into the crystallisation environment has in general decreased 
crystallinity in the final sample but as the urea based molecules are not directly interacting 
with the functional group of the target molecules, this may not pose an issue in this case. 
6.1.1 Urea and hydrogen peroxide 
Urea was crystallised an a range of solvents at 4°C and room temperature as detailed in 
Table 57, and the collected crystalline materials analysed by XRPD and single crystal unit 
cell analysis.  
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Table 57 - Crystallisation of Urea in selected solvents with hydrogen peroxide 
Sample HOOH Solvent Temperature Analysis group 
AM39_01 5 Drops Methanol 4°C A 
AM39_02 5 Drops Methanol Room temperature A 
AM39_03 5 Drops Ethanol 4°C B 
AM39_04 5 Drops Ethanol Room temperature A 
AM39_05 5 Drops Acetone 4°C A 
AM39_06 5 Drops Acetone Room temperature B 
AM39_07 5 Drops Methyl Acetate 4°C A 
AM39_08 5 Drops Methyl Acetate Room temperature A 
AM39_09 5 Drops Ethyl Acetate 4°C A 
AM39_10 5 Drops Ethyl Acetate Room temperature A 
AM39_11 5 Drops Chloroform 4°C A 
AM39_12 5 Drops Chloroform Room temperature A 
AM39_13 5 Drops Dichloromethane 4°C A 
AM39_14 5 Drops Dichloromethane Room temperature A 
 
 
Figure 259 - XRPD clustering dendrogram showing three pattern types present. 
The XRPD data was clustered using PolySNAP3123 and found to contain three clustered 
pattern types.  The largest of the three clusters, defined as group A and shown as red in 
Figure 259, corresponds to the recrystallisation of the starting material urea on its own, as 




Figure 260 - XRPD pattern representative of group A (red) compared to the reference pattern of the urea 
starting material (magenta). 
XRPD pattern comparison for the second cluster, denoted B and shown as yellow in Figure 
259, shows the presence of the same recrystallised starting material as shown in group A 
but with the addition of a second material.  This is a hydrogen peroxide:urea complex 
(Figure 261) previously determined and recorded in the CSD157. 
 
Figure 261 - XRPD patterns of group B (orange) compared to the reference patterns of the urea starting 
material (magenta) and the urea:hydrogen peroxide complex (olive). 
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The third cluster denoted C and shown as yellow in the dendrogram (Figure 259) is a good 
match for group A by manual analysis of the XRPD pattern.  However a much higher 
background and poorer crystallinity results in a less good match, leading to a separate 
clustering of this group. 
 
Figure 262 - Urea:HOOH cocrystal structure as viewed down the c-axis 
Thy hydrogen peroxide:urea 1:1 complex structure157 is not a tunnelled complex but a 1:1 
structure featuring a zigzag motif (Figure 262).  However it is stable and proves urea to be 
unreactive in the presence of strong oxidising agents.  This complex was also proved to be 
present in samples from both methyl acetate and ethyl acetate solution at room 
temperature as confirmed by single crystal analysis.  However these crystals are not 
sufficiently abundant to form the bulk of the sample as determined by XRPD. 
6.1.2 Thiourea and hydrogen peroxide 
The same experimental procedure was performed with thiourea.  In this case, however, 
upon addition of the oxidising agent, the thiourea reacted violently, likely a result of the 
strong sulfur-oxygen affinity.  Any recrystallisations of peroxyacids in thiourea would likely 
result in a similar reaction and consequently this direction was not pursued. 
6.1.3 Urea and 6-phthalimidoperoxyhexanoic acid 
With urea proving to be stable in the presence of peroxyacids,  
6-phthalimidoperoxyhexanoic acid (PAP) was added to urea in the presence of a small 
amount of hydrogen peroxide with the aim of creating either a hosted material or a 
molecular complex between the two.  They were prepared in equimolar quantities and 
cocrystallised in a selected range of solvents at both 4°C and room temperature.  Those for 
which XRPD data were collected for are shown, along with their crystallisation conditions, 
in Table 58. 
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Table 58 - Crystallisation of urea with PAP in selected solvents with hydrogen peroxide 
Sample Component A Component B HOOH Solvent Temperature 
AM41_01 Urea PAP 5 Drops Methanol 4°C 
AM41_03 Urea PAP 5 Drops Ethanol 4°C 
AM41_05 Urea PAP 5 Drops Acetone 4°C 
AM41_07 Urea PAP 5 Drops Methyl Acetate 4°C 
AM41_08 Urea PAP 5 Drops Methyl acetate 4°C 
AM41_09 Urea PAP 5 Drops Ethyl Acetate 4°C 
AM41_11 Urea PAP 5 Drops Chloroform 4°C 
 
These samples that were analysed by XRPD indicated that the urea had recrystallised in all 
cases with the decomposed PAP parent acid 6-phthalimidoperoxyhexanoic acid present in 
trace amounts in all samples.  The sample produced from methanol, however, shows a 
significantly increased amount of the parent acid as can be seen in Figure 263. 
 
Figure 263 - XRPD patterns of resultant material from cocrystallisations of urea and PAP with hydrogen 
peroxide (red) compared to the reference structure of urea (magenta) and 6-phthalimidohexanoic acid (grey). 
Suitable crystals from AM41_08 were analysed by single crystal XRD and found to consist of 
the urea:HOOH cocrystal described above.  
The combination of these results would seem to suggest that the PAP molecule has 
decomposed to a significant extent, and partially recrystallised as the parent acid, 
irrespective of the recrystallisation behaviour of the urea.  A small percentage of the HOOH 
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present in the crystallisation or resulting of the decomposition of the PAP, crystallises with 
the urea to create a known molecular complex. 
6.1.4 Urea and meta-Chloroperbenzoic acid 
Following the experiments with urea and PAP, MCPBA was crystallised under the same 
conditions.  In this case, hydrogen peroxide was excluded from the crystallisation in order 
not to compete with the peroxyacid as a target for the urea.  The crystallisation conditions 
for which XRPD data were obtained are detailed in Table 59. 
Table 59 - Crystallisation of urea with MCPBA in selected solvents with hydrogen peroxide 
Sample Component A Component B Solvent Temperature 
AM41_01 Urea MCPBA Acetone 4°C 
AM41_03 Urea MCPBA Methyl Acetate 4°C 
AM41_05 Urea MCPBA Ethyl Acetate 4°C 
AM41_07 Urea MCPBA Diethyl Ether 4°C 
 
The resultant materials were analysed by XRPD and found to be comprised of the urea 
starting material and the urea:hydrogen peroxide complex in smaller amounts (Figure 264).  
This confirms decomposition of the peroxyacid to supply the urea with hydrogen peroxide 
that must be available to form the complex. 
 
Figure 264 - XRPD patterns of crystallisation products of urea and MCPBA (red) compared with reference 
patterns of the urea starting material (magenta) and the urea:HOOH complex (green). 
6.1.5 Summary 
Crystallisation with urea and thiourea has failed to produce a channelled complex around 
the peroxyacid molecules, with thiourea reacting quite violently with the strongly oxidising 
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materials making it wholly incompatible with them.  Urea did form a molecular complex 
with hydrogen peroxide in several systems and proves to be stable in the presence of the 
reactive materials.  However it may be aiding in the decomposition of the peroxyacid group 
by removing liberated hydrogen peroxide from the environment, thus accelerating the 
decomposition equilibrium.   
Finding the correct conditions for producing a channelled structure around the peroxyacids 
without decomposition of the functional group could still potentially lead to the formation 
of a clathrate structure hosting a peroxyacid.  More success may be achieved with the 
aliphatic peroxyacids, such as peroxypelagonic acid, which would better suit hosting of the 
peroxyacid in the relatively small dimensions of the channels. 
6.2 Hosting within cyclodextrins 
Hosting with cyclodextrins and cyclodextrin derived molecules is a potential way of creating 
a robust cage structure around guest molecules that physically encapsulates them.  This 
could prevent them from reacting readily with molecules external to the structure.  
Cyclodextrins are stable molecules and as such were not expected to react with the 
oxidising peroxyacids and offered a potential route for stabilisation.  Crystallisations were 
prepared of α-, β- and triacetyl-β-cyclodextrin with the peroxyacids under study.  Some of 
these crystallisations were carried out with the addition of hydrogen peroxide, and bases 
such as sodium and potassium hydroxide.  This follows  the work on “edible MOF’s” by 
Smaldone96 as a synthesis methodology for trapping molecules. 
Prior to experiments with the peroxyacids, it was confirmed that recrystallisation of the 
cyclodextrins was possible, with formation of the β-cyclodextrin metal frameworks 
successfully achieved in the absence of peroxyacid as confirmed by single crystal diffraction 
and unit cell determination. 
6.2.1 meta-chloroperbenzoic acid and β-cyclodextrin potassium framework 
A cocrystallisation experiment using MCPBA and β-cyclodextrin with the addition of 
potassium hydroxide in water produced single crystal samples.  These were confirmed to 
be an unknown crystal structure by evaluation of the unit cell parameters against those in 
the CSD136.  Single crystal X-ray data from these crystals were therefore collected on the 
Rigaku R-axis image plate diffractometer to determine the structure of the new material 




Table 60 - Crystal structure collection data for potassium β-cyclodextrin 3-chlorobenzoic acid clathrate  
Compound 3-Chlorobenzoic acid potassium-β-cyclodextrin clathrate 
Formula C105H141O98Cl3K3 
Crystallisation Conditions MCPBA, β-cyclodextrin and potassium hydroxide in water at 30°C 
Molecular weight / gmol
-1
 3194.9 
Temperature (K) 100 
Space Group P1 
a (Å) 14.9575(17) 
b (Å) 15.7246(18) 















θ range/˚ 3.06 – 27.48 
Reflections Collected 44410 
Independent 28565 






R1 (Observed) 0.0978 
R1 (all) 0.1337 
wR2 (all) 0.3057 
 
 
Flack Parameter 0.04(7) 
 
From the determined crystal structure, it can be seen that the cocrystallisation experiment 
has resulted in the formation of a cyclodextrin/potassium host structure with a 3-
chlorobenzoic acid guest.  The latter is decomposed from the MCPBA peroxy-acid starting 
material and subsequently included in the structure (Figure 265). 
 
Figure 265 - Asymmetric unit of the beta-cyclodextrin potassium 3-chlorobenzoic acid clathrate. 
The crystal structure may be dissected into three constituent parts, the 
cyclodextrin/potassium frame, the intercalated 3-chlorobenzoic acid molecules, and the 
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crystallised solvent water molecules throughout the structure.  The latter is a consequence 
of crystallisation in water as a solvent and is common for cyclodextrin structures.  The 
number of water molecules in the structure is not always well defined as they are freely 
situated within voids generated by the large and inefficiently packed structure.  The 
included water molecules are hydrogen bonded to the abundant hydroxyl groups on the 
external side of the cyclodextrin rings.  There are nine independent oxygen atoms 
determined in the structure and each of these is assumed to be water molecules.  However 
the size of the structure and the disorder present precludes determination of the solvent 
water hydrogen atoms (Figure 266). 
 
Figure 266 - The asymmetric unit of the K-β-cyclodextrin framework only as viewed from side on and top 
down orientations showing external facing hydroxyl groups available for hydrogen bonding to H2O. 
The cyclodextrin framework is the largest component of the structure and directs the 
structure with its connectivity.  The β-cyclodextrin molecules, as observed regularly in the 
literature85, 96, form the familiar barrel arrangement (Figure 267 left), creating a hollow in 
which large guest materials may be hosted, with an approximately 3Å average separation 
between the oxygen atoms of the two molecules.  This has the effect of creating a void that 
is approximately 12Å wide at the centre point of the barrel and 10Å at either end, 
measured from atom centre points.  In this structure however, the β-cyclodextrin 
molecules are bridged by two potassium ions, one forming three short contacts and the 
other forming one ordered contact and a two-position disordered contact, resulting in 





Figure 267 - Common barrel arrangement of -cyclodextrin molecules within the framework (left).  Two 
bridging potassium ions and one top mounted potassium ion in the structure (right) 
The β-cyclodextrin molecules are then further connected through the potassium ions to 
water molecules, which bridge the gap via hydrogen bonding at the widest points between 
the molecules.  The molecules are also further connected with extensive hydrogen bonding 
networks between the barrels themselves, aligning all the molecules on the same axis, 
creating channels of pores (Figure 268 left). 
  
Figure 268 – the β-cyclodextrin framework is linked together with ionic interactions and extensive hydrogen 
bonding (left).  The cyclodextrin molecules overlap leaving only internal voids in the framework (right). 
The hydrogen bonded molecules are in sufficiently close proximity to overlap the van der 
Waals radii of the neighbouring barrels, leaving only the internal voids available for 
secondary molecules (Figure 268 right).  Inside the voids of the barrels, there are three 3-
chlorobenzoic acid molecules (Figure 269 left), two of which are ordered and orientated 
inside the cyclodextrin rings, in plane with the length of the void, and a third molecule 
located in the gap between the two sides of the barrel arrangement, disordered between 





Figure 269 - Three 3-chlorobenzoic acid molecules located inside the core of the barrel arrangement of -
cyclodextrin (left).  The three 3-chlorobenzoic acid molecules, two are static, one is disordered (right). 
The two ordered molecules are at an aromatic C-H···π stacking distances of 3.82(1)Å and 
4.04(2)Å to the disordered centre molecule, with their chlorine atoms clustered around a 
single area with Cl···Cl distances between 3.111(9)Å and 4.657(6)Å depending on which site 
is assigned to the disordered molecule. 
The disordered molecule itself is situated over two positions, each at about 50% 
occupancy.  The molecules can be separated from each other, as shown in Figure 270, with 
the atom positions and hydrogen locations assigned for each molecule.  In the disordered 
configuration, the molecule flips orientation, moving the position of the chlorine atom by 
2.10(2)Å , with rotation of the carboxylic acid group about 120° around the centre point of 
the two molecules.  This disorder either induces or is induced by the disorder in the 
bridging potassium ions between the cyclodextrins. 
 
Figure 270 - 50/50% disordered 3-chlorobenzoic acid molecule at the centre of the cyclodextrin barrel, with 
connectivity of individual disordered components highlighted in blue and orange for clarity. 
The resulting material can therefore be described as a 3:2:3 potassium : cyclodextrin L 3-
chlorobenzoic acid complex. 
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Given the ability of this complex to host the peroxy-acid decomposition product 3-
chlorobenzoic acid, it may be possible either to crystallise MCPBA into the structure if the 
correct conditions are found for retention, or to re-functionalise the peroxyacid after 
formation of the complex by reacting with hydrogen peroxide.  Hydrogen peroxide itself, as 
a result of its small size, may be able to enter into the pore along with the 3-chlorobenzoic 
acid and re-functionalise the acid group. 
6.2.2 Summary 
More of the materials set up and crystallised in this area need to be studied in more detail, 
particularly those containing MCPBA, to assess whether a condition has been isolated in 
which the peroxyacid has been crystallised into the clathrate with the peroxyacid 
functionality retained.  The host framework may also be compatible with inclusion of the 
larger PAP molecule.  The probability of this being possible appears high, with a 
cyclodextrin based PAP already on the market and sold as Cavamax® W7/Eureco®158, with 
no crystal structure recorded.  However, due to time constraints it was not possible to 
pursue this further in this project. 
6.3 Hosting within clays 
Montmorillonite based materials such as Bentonite are known to have a semi-stable 
layered structure in which the pore sizes are constant throughout the material.  They have 
a general composition of [Al2(OH)2(Si2O5)2]
13  159 and their texture properties are dependent 
on the contents of the layers, the charge of the intercalated material and any mechanical 
working of the layered material itself.  However, the porosity is not yet fully understood159.  
The pore sizes of the materials are known to change as a result of saturation and hydration, 
and it has been shown to be possible to place a desired material into the intercalant pores 
in literature precedents160.   
The proposed and generally accepted mechanism of intercalation is that with the hydration 
of the layered material, the pores or layers separate, allowing inclusion of the solvent, and 
thus any material present in the solvent (Figure 271).  As the material is dehydrated, the 
pore or layer returns to a smaller dimension, with the deposition of the solvated target 





Figure 271 - intercalation of a material into a layered montmorillonite
161
. 
The effect of this upon the montmorillonite structure is an observed increase in the size of 
the spacing between the layers, termed the “basal” spacing, corresponding to the increase 
in space needed for the intercalant to be hosted within the material.  This can be measured 
from powder X-ray diffraction data as a low angle peak which can give a direct 
measurement as to the average physical size of the spacing throughout the material as 
shown in Figure 272. 
 
Figure 272 - Schematic of intercalation layer distances in a Montmorillonite clay
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6.3.1 Intercalation of materials into clays by solid grinding 
To investigate the use of this material as a potential host for the target peroxy-acids, 
solvent free grinding of the reactive component with the bentonite clay was achieved by 
manually grinding the bentonite clay and PAP together in initial weight per weight 
measurements under completely dry conditions.  This led to the formation of 
unremarkable dry powders as could be expected.  This was repeated for acetic acid, 
peroxyacetic acid and meta-chloroperobenzoic acid.  These samples were analysed by 
XRPD and the patterns collected showed no change in the position of the basal peak in all 
samples except that prepared with PAP (Figure 273) where a significant shift of this 





Figure 273 - Basal spacing change measured in XRPD patterns of Bentonite-intercalate grinding with 
solely Bentonite (red), acetic acid (blue), peroxyacetic acid (green) meta-chloroperbenzoic acid 
(grey) and 6-phthalimidoperoxyhexanoic acid (PAP; brown). 
 
To confirm and characterise further this result observed with PAP, the experiment was 
repeated and the pattern of the resulting material was analysed immediately by XRPD.  This 
initial pattern showed no difference to that of the recorded powder pattern of the clay 
alone.  However, when the sample was left for a period of a week to a month and analysed 
for a second time, a significant change in position of the the broad peak was observed.  This 
shift correspnds to the previously observed shift in basal spacing between a blank grind and 
a grind with the PAP present (Figure 274).  In addition to the structural effects, there is thus 
a kinetic effect evident, with a significant structural change in the clay structure as a 
function of time. 





















 AM45_03 Short Blank Bentonite Grind
 AM47_03 Short Acetic acid and bentonite
 AM49_03 Short Peroxyacetic acid and bentonite
 AM59_03 short MCPBA and bentonite




Figure 274 - Bentonite and PAP XRPD patterns:  blank Bentonite (red); that resulting from a pattern 
determined immediately following the grinding of Bentonite and PAP (blue) and a later re-scan of the same 
system (green). 
With the initial rough volume for volume experiment, there was an increase in basal 
spacing from 14.7Å to 17.7Å, as can be seen in the XRPD (Figure 273).  This is consistent 
with the possibility of intercalation of a guest (possibly PAP) into the host clay material by 
slow solvation which could be aided by hygroscopic solvation of PAP by atmospheric water.  
The change in basal spacing corresponds to an inter-layer spacing increase in 3Å, more than 
sufficient to incorporate a PAP molecule oriented along the plane of the spacing.  As such 
the material and this preparation method was further investigated.  
The initial observation was shown to be repeatable by a second experiment via solvent 
drop grinding.  A manual grinding technique was utilised, with a mortar and pestle, and 
grinding the material for no longer than three minutes in the presence of a catalytic 
amount of acetone (several drops, enough to wet the material out).  Acetone was chosen 
as the solvent catalyst due to the believed balance of stability and solubility displayed by 
PAP in this solvent.  This was also repeated with MCPBA to assess if direct solvation-
assisted grinding would have the same effect upon that peroxyacid.  As can be noted from 
Figure 275, the solvent drop sample with MCPBA did not initiate an increase in the basal 
spacing.   
 














 AM45_03 Short Blank Bentonite Grind
 AM60_03 PAP and bentonite immediate scan
 AM60_03 PAP and bentonite Rescan
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The repeat PAP grinding experiment upon near immediate analysis by XRPD of the resulting 
dry material, it was noted that the clay had once again expressed a shift in the basal 
spacing observed upon immediate analysis and as such a solvating effect was confirmed to 
be a requirement of the process.  The proposed mechanism is that the target material is 
dissolved on the microscopic scale and forced into the layers or pores of the hosting 
material, depositing itself, and remaining after the solvent has been removed, thus forcing 
the layers to remain open as determined by the spacing increase. 
 
Figure 275 - Bentonite three-minute grind blank (red) compared with MCPBA solvent drop grind (light blue) 
and PAP solvent drop grind (dark blue). 
In order to achieve a better understanding of the physical changes in these materials, SEM 
images were taken of the resulting products. 
In the first set of images (Figure 276) it can be seen that dry grinding of Bentonite and PAP 
has resulted in the production of small crystallites and non-crystalline features appearing 
throughout the material.  These non-crystalline features were measured to be up to 10 
microns in diameter. 
















 AM45_03 Short Blank Bentonite Grind
 AM61_01 MCPBA and bentonite acetone drop




Figure 276 – SEM images of dry ground Bentonite with PAP showing distinct crystalline and non-crystalline 
features within the sample. 
However, if a sample is dry ground and analysed within 1 hour, a completely different set 
of images is observed (Figure 277).  In these images, taken at similar magnifactions, no 
crystallites or substantial non-crystalline features are observed. 
   
Figure 277 – SEM images of dry ground Bentonite and PAP observed within one hour of grinding. 
When solvent drop grinding is used, again the crystallites and substantial non-crystalline 
features are observed within the structure of the intercalating material immediately (Figure 
278). 
   
Figure 278 - SEM images of solvent drop ground Bentonite and PAP. 
This mirrors the XRPD analysis of the ground materials, where the developed dry-ground 
and solvent drop-ground  resultant materials show a change in basal spacing, whereas the 
dry-ground samples analysed immediately, do not. 
In order to assess the effect that the quantity of PAP ground with the Bentonite would have 
on the basal spacing, measured quantities of the clay and the PAP were manually ground 
together with acetone drops added, for 3 minutes each.  Details of the ratios used are 
listed in Table 61 and varied from 10:1 to 1:2 Bentonite:peroxyacid ratio, in 0.01g steps.  
The basal spacing was calculated by first smoothing the peak and then peak picking using 
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X’pert Highscore Plus148 to determine the maximum in 2θ, which was subsequently 
converted to a d-spacing. 
Table 61 - Bentonite and PAP measurements added to grinding experiments with corresponding basal spacing 
Sample Bentonite (g) PAP (g) Grind time (s) Basal Spacing (Å) 
AM102_01 0.10 0.01 180 15.92 
AM102_02 0.10 0.02 180 16.25 
AM102_03 0.10 0.03 180 16.47 
AM102_04 0.10 0.04 180 16.64 
AM102_05 0.10 0.05 180 17.21 
AM102_06 0.10 0.06 180 17.02 
AM102_07 0.10 0.07 180 17.63 
AM102_08 0.10 0.08 180 17.60 
AM102_09 0.10 0.09 180 17.55 
AM102_10 0.10 0.10 180 17.80 
AM102_11 0.10 0.11 180 17.18 
AM102_12 0.10 0.12 180 17.35 
AM102_13 0.10 0.13 180 17.50 
AM102_14 0.10 0.14 180 17.32 
AM102_15 0.10 0.15 180 17.32 
AM102_16 0.10 0.16 180 17.33 
AM102_17 0.10 0.17 180 17.49 
AM102_18 0.10 0.18 180 17.72 
AM102_19 0.10 0.19 180 17.60 
AM102_20 0.10 0.20 180 17.87 
Blank 0.10 0.00 180 14.93 
Visually from the powder patterns (Figure 280), the increase in d-spacing appears to follow 
a linear trend, levelling off at around a 1:1 wt./wt. ratio of PAP to Bentonite.  The peak 
fitting results, although showing a more irregular peak position, bear out the overall trend 
of increase until the spacing of approximately 17.5Å is achieved.  There is a noticeable with 
a change in gradient from 0.7g of PAP onwards.  Samples corresponding to 0.07g, 0.10g and 
0.18g of PAP were analysed by XRPD scans to 50° 2θ.  These were chosen as representative 
of the start of gradient change, maximum shift of basal spacing, and beyond the maximum 
shift (Figure 279).  
 
Figure 279 – Full XRPD patterns of Bentonite ground for three minutes (navy), Bentonite and PAP grinds with 
acetone samples AM102_07, AM102_10 and AM102_18 respectively (black top, middle and bottom) and of 
PAP ground for three minutes (green). 
Position [°2Theta] (Copper (Cu))


























Figure 280 - XRPD patterns of collected samples from weight/weight incrementing solvent drop grind of 
Bentonite and PAP with acetone.  The increase in PAP added proceeds downwards from AM102_01 being the 
smallest amount to AM102_20 being the largest. 
Position [°2Theta] (Copper (Cu))















































The XRPD (Figure 279) shows, in comparison to the reference patterns for PAP and 
Bentonite ground individually for three minutes that almost no crystalline PAP is observed 
with the 0.07g addition.  Upon reaching the maximum d-spacing change, small traces of 
PAP may be observed, and by the addition of 0.18g, PAP is clearly visible in its crystalline 
state.  These results may be suggestive that the PAP is being intercalated until the point 
where maximum d-spacing shift has occurred (approx. 1:1 wt./wt.), and after that point, 
excess PAP is crystallised alongside the formed material.  This suggests a limit to the 
quantity of PAP able to be intercalated into the spacings.  Patterns beyond this point are 
essentially meaningless as the quantity of PAP prevents precise determination of the basal 
spacing. 
A plot of the data is seen to plateau, at a point where the basal spacing no longer increases 
with an increase in PAP (Figure 281).  As noted above, some of the data points deviate from 
the indicated trend – this is probably the result of the manual and therefore incomplete 
grinding technique employed, which may leave excess material not intercalated. 
 
Figure 281 - Plot of basal spacing with respect to the mass of PAP added to the solvent assisted grind with a 
guide line drawn to indicate the trend. 
This experiment was repeated with decomposed PAP ground into Bentonite clay.  Samples 







































mass of PAP  (g/0.1g off Bentonite) 
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Table 62 below.  Mass has been corrected for the altered molecular weights of the 
decomposed PAP used to correspond to the same molar ratio with respect to the 0.1g of 
clay used as used for the PAP-clay grinding experiments. 






Time (s) Corrected mass(g) 
d spacing 
(Å) 
AM115_01 0.1030 0.0022 180 0.0021 15.15 
 
AM115_02 0.1012 0.0111 180 0.0109 16.19 
AM115_03 0.1063 0.0254 180 0.0238 16.46 
AM115_04 0.1021 0.0333 180 0.0326 16.38 
AM115_05 0.1007 0.0426 180 0.0423 16.78 
AM115_06 0.1021 0.0555 180 0.0543 16.84 
AM115_07 0.1006 0.0633 180 0.0629 16.96 
AM115_08 0.1006 0.0715 180 0.0710 16.68 
AM115_09 0.1032 0.0821 180 0.0795 17.36 
AM115_10 0.1020 0.0933 180 0.0914 17.40 
AM115_11 0.1027 0.1059 180 0.1031 17.58 
AM115_12 0.1055 0.1137 180 0.1077 17.31 
AM115_13 0.1008 0.1243 180 0.1233 17.40 
AM115_14 0.1001 0.1341 180 0.1339 17.53 
AM115_15 0.1000 0.1437 180 0.1437 17.27 
AM115_16 0.1010 0.1565 180 0.1549 17.85 
AM115_17 0.1040 0.1665 180 0.1600 17.78 
 
 
Figure 282 - Plot of basal spacing with respect to the mass of 6-phthalimidohexanoic acid added to the 



































Mass of 6-phthalimidohexanoic acid added (g/0.1g of Bentonite) 
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The results give a better logarithmic fit and show the same or similar characteristic curve 
that is observed with PAP where the trend plateaus.  The points on the graph fit better to a 
trend than the less accurately measured PAP results.  Again, however, the scatter in the 
points likely stems from inconsistencies in the grinding method.  Localised areas of the 
sample with less material worked into it than others could lead to an uneven distribution of 
basal spacing throughout the sample. 
The fact that 6-phthalimidohexanoic acid added in the same way to the grinding process 
has a similar effect on the spacing as the PAP indicates that it is not the peroxyacid itself 
reacting with the clay to chemically change it, but the whole molecule that is having a 
physical effect on the Bentonite spacing.  This is supported by the previous findings of a 
lack of change in samples ground with MCPBA or peroxyacetic acid, which may be too small 
to have significant effect on the basal spacing even if intervalated.   
This does not, however, confirm that the material inside the spacing is in fact a peroxyacid 
or whether it has decomposed.  It is known from the full length XRPD scans that in the 
presence of PAP in excess of the mass required to reach the plateauing effect on the clay 
basal spacing, further addition of PAP is crystallised around the material.  However there is 
no indication from these structural measurements that the functionality has been retained 
inside the clay host material. 
When the Bentonite and PAP grind samples are analysed by Raman spectroscopy, using the 
Horiba spectrometer, there is no similarity between the final sample and the spectrum 
collected for PAP alone (Figure 283).  The presence of the clay prevents the analysis of the 
intercalated material and only a background signal is seen, matching that of the pure clay 
itself.  Comparison of the IR spectra does indicate the presence of the molecule (Figure 
284), however the limitation on the technique itself prevents the explicit detection of the 
O-O peroxide bond due to the lack of a dipole in the bond.  Thus, the IR results would be 
consistent with the presence of the peroxyacid or of the parent acid. 
 




Figure 284 - IR spectra overlay of PAP (red) and the ground sample of Bentonite with PAP (blue) 
The use of spectroscopy to determine the contents of the clay is hindered by the presence 
of both the clay itself, and by the remaining PAP external to the clay, which could give a 
false indication of what is inside the host-guest material of interest.  An alternative testing 
method therefore had to be sought. 
6.3.2 Reactivity testing 
Upon advice given by the industrial collaborator, it was learned that certain dyes within 
household products discolour in the presence of PAP.  In particular “Ariel Excel Gel” 
(Procter and Gamble), a blue coloured liquid laundry detergent, will turn green on reaction 
with PAP. 
Testing of the materials created by the first Bentonite grind of PAP was therefore 
undertaken with the gel.  Before the addition of materials., the gel is seen to be blue and 
translucent (Figure 285).   
 
Figure 285 - Testing gel before addition of materials in wells I, II and III (left to right). 
To well I was added de-ionised water only.  Unground PAP and a small amount of water 
were added to well II, while sample AM102_09 (90% PAP / 100% clay), a sample from 
before clay saturation, plus some water was added to well III.  No immediate change was 
observed but when left overnight, the PAP on its own in well II had changed the colour of 
the mixture to green, indicating oxidation had occurred (Figure 286). 
 
Figure 286 - Testing gel after 24 hours of materials added in wells I, II and III (left to right). 
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The sample in well III of Bentonite with intercalated PAP has shown no colour change, 
indicating that the material is not oxidising the gel.  This could be a result of the clay locking 
the reactivity of PAP in the mixture, or that the material has decomposed prior to addition 
into the clay or during the process. 
 
Figure 287 - Testing gel after 24 hours of materials added in wells IV, V and VI (left to right). 
Three more samples in the series of experiments were tested, corresponding to 20% PAP to 
Bentonite, 110% PAP to Bentonite and 190% PAP to Bentonite.  Testing reveals the 20% 
sample does not oxidise the gel, however the other two show signs of darkening indicating 
that PAP is present and free to react with the indicator, either from residual un-intercalated 
material, or from the re-introduced PAP from the intercalated spacings. 
6.3.3 Summary 
It is clear that PAP or its decomposed product the parent 6-phthalimidohexanoic acid, 
interacts with Bentonite to increase the pore size in the clay, removing the ability of the 
added peroxy-acid to oxidise secondary materials, up to a point where the quantity of PAP 
is greater than the point at which the Bentonite basal spacing will no longer expand.  Below 
this point there is no oxidation of secondary materials from the intercalated sample and 
this method may therefore have achieved the goal of stabilisation of the reactive PAP 
peroxy-acid.  Further investigation into defining the nature of the material intercalated is 
needed, as well as further testing of reactivity to define a condition at which the 
intercalated material is released. 
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7. Molecular complexes of agrichemicals 
One of the aims of this research was to forming new molecular complexes involving 
agrichemicals (also sometimes known as Active Agrichemical Ingredients, or AAIs) as a way 
of changing the physical properties of the materials, for better dispersion, a change in 
solubility, modified melting point, and better stability.  The latter is of particular relevance 
in the context of the related work on reactive peroxyacids presented earlier, and many 
agrochemical materials have a high degree of intrinsically reactivity to aid their function.  
To this end the two agrichemicals, 2,4-dichlorophenoxyacetic acid - 2,4-D (Figure 10) and 
3,4-dichlorophenoxyacetic acid – 3,4-D (Figure 11) were cocrystallised with a range of 
secondary components with the aim of creating new molecular complexes in which the 
interactions of the agrichemical could be studied for a better understanding of their 




Cl Cl  






Figure 289 – Molecular structure of 3,4-Dichlorophenoxyacetic acid (3,4-D). 
 
The two molecules 2,4-D and 3,4-D have a near identical molecular structure, with only a 
rearrangement of one chlorine position on the benzene ring and they share the same 
primary hydrogen bonding interactions.  Both molecules should therefore be able to form 
similar motifs with secondary materials introduced into the crystallisation environment as 
potential co-components in molecular complexes. 
The primary potential hydrogen bond interaction point on 2,4-D and 3,4-D is focussed 
around the carboxylic acid group, which in previous studies has been shown not to 
dimerise, but instead dissociate, particularly in the presence of a strong electron rich donor 
site on the co-molecule106, 107.  As such, the present research on these molecules focussed 
on interaction between these molecules and secondary components containing amine 
groups, primarily imidazole based molecules. 
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7.1 Chlorophenoxyacetic acids and Imidazole 
NNH
 
Figure 290 – Molecular structure of imidazole 
2,4-D and 3,4-D were cocrystallised with imidazole (Figure 290) in a 1:1 equimolar ratio in 
methanol, ethanol, acetone, ethyl acetate and diethyl ether, both at room temperature 
and 30°C in the attempt to create molecular complexes for study by X-ray diffraction.  The 
experiments were successful in growing crystals from both sets of cocrystallisations 
suitable for study by single crystal X-ray diffraction on the Rigaku R-axis image plate 
diffractometer. 
7.1.1 2,4-Dichlorophenoxyacetic acid and Imidazole 
Slow evaporation of 2-4-dichlorophenoxyacetic acid and imidazole dissolved in methanol 
and held at a constant crystallisation temperature of 30°C yielded a new material, as 
identified by a previously undetermined unit cell from single crystal X-ray diffraction.  The 
unit cell did not correspond to either of the starting materials, and was thus subjected to a 




Table 63 - Crystal structure collection data for 2,4-Dichlorophenoxyacetate imidazolium complex. 
Compound 2,4-Dichlorophenoxyacetate imidazolium complex 
Formula C8H5O3Cl2: C3H5N2 
Crystallisation Conditions Cocrystallisation of 2,4-D and imidazole in methanol at 30°C 
Molecular weight / gmol
-1
 289.114 
Temperature (K) 100 
Space Group P21/c 
a (Å) 4.897(3) 
b (Å) 12.641(7) 















θ range/˚ 7.58-53.70 
Reflections Collected 16436 
Independent 2810 






R1 (Observed) 0.0509 
R1 (all) 0.0689 
wR2 (all) 0.1346 
 
 
Figure 291 - Asymmetric unit of 2,4-D Imidazolium complex consisting of one acetate ion and one amide. 
Analysis of the crystal structure reveals that in the asymmetric unit (Figure 291), there is a 
1:1 composition of 2,4-D and imidazole.  The 2,4-D has been deprotonated at the carboxylic 
acid, forming an acetate ion, with the hydrogen atom transferred to the available lone pair 





Figure 292 - Primary moderate strength hydrogen bonds situated between the amide and acetate functional 
groups N2-H8···O2 and N1-H10···O3. 
The primary hydrogen bonds between the molecules are located between the acetate 
functional group and the amide group, N2-H8···O2, at an overall distance of 2.696(4)Å 
(166(4)°), and N1-H10···O3, at a distance of 2.609(4)Å (171(6)°), making them both 
moderate strength hydrogen bonds as defined by Jeffrey21 (Figure 292).  The C4-O2 
covalent bond is slightly shorter than the C4-O3 covalent bond at respective distances of 
1.247(4)Å and 1.256(4)Å. The hydrogens are clearly located from the Fourier peaks on the 
axis of the bonds, bonded to the nitrogen atoms.  This creates a C22(8) chain motif along the 
b-axis of the structure, alternating between imidazolium and phenoxyacetate molecules 
(Figure 293). 
 
Figure 293 - Phenoxyacetate - imidazolium C
2
2(8) motif along b-axis of the crystal structure. 
The acetate group is further associated via O3 to Cl1 via a interaction of distance 3.067(3)Å, 




Figure 294 - View of 2,4-D molecules only along the b-axis showing the Cl2···Cl2 interaction and the C10-
H4···O2 interactions. 
Also along the b-axis is a chlorine···chlorine interaction at a distance of 3.290(2)Å and a 
R22(16) ring motif generated by the C10-H4···O2 aromatic hydrogen bond at a C···O distance 
of 3.270(5)Å. 
 
Figure 295 – packing of aromatic rings in 2,5-D imidazolium complex as viewed down the c-axis. 
Finally, there is an an aliphatic C-H···O hydrogen bond between C5 and acetate oxygen O3 
(Figure 295), at an overall C···O distance of 3.318(5)Å, linking the parallel packed 2,4-D 
molecules along the direction of the a-axis.  Neither the 2,4-D nor the the imidazolium ion 
show direct π-π stacking arrangements as they do not sit over each other.  At their closest 
non hydrogen distances, the 2,4-D molecules are 3.709(4)Å apart, while imidazolim 
molecules are slightly closer to each other, at 3.480(6)Å. 
7.1.2 3,4-Dichlorophenoxyacetic acid and Imidazole 
3,4-D and imidazole cocrystallised in acetone at room temperature also produced crystals 
of a new material suitable for study by single crystal X-ray diffraction and therefore 
received a full data collection.  The details of the data collection and the crystal structure 
parameters are outlined in Table 64. 
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Table 64 - Crystal structure collection data for 2,4-Dichlorophenoxyacetate imidazolium complex  
Compound 3,4-Dichlorophenoxyacetate imidazolium complex 
Formula C8H5O3Cl2: C3H5N2 
Crystallisation Conditions Cocrystallisation of 3,4-D and imidazole in acetone at room 
temperature 
Molecular weight / gmol
-1
 289.114 
Temperature (K) 100 
Space Group P-1 
a (Å) 9.207(3) 
b (Å) 11.157(3) 















θ range/˚ 3.02 – 27.47 
Reflections Collected 28129 
Independent 5639 






R1 (Observed) 0.0271 
R1 (all) 0.0302 




Figure 296 - Asymmetric unit of the 3,4-D Imidazolium complex showing the hydrogen bond interactions 
between the two ion pairs. 
The collected structure was identified to be a 1:1 3,4-dichlorophenoxyacetate imidazolium 
complex, comprising of two pairs of ions within the asymmetric unit, paired by hydrogen 
bonds originating from the amine groups of the imidazolium ions to the acetate groups of 
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the 3,4-D molecules.  The distances of the interactions are 2.658(2)Å (N3-H16···O5) 
(167(2)°) and 2.656(2)Å (N2-H5···O2) (167(2)°), making them both moderate strength 
interactions (Figure 296).  These interactions are continued through the imidazolium 
molecules to the next acetate group of the symmetrically equivalent molecule of the next 
cell, with the hydrogen bonds originating from the opposite sides of the imidazole 
molecules generating a further two slightly weaker hydrogen bonds at a distance of 
2.665(2)Å (176(2)°) (N4-H19···O6) and 2.683(2)Å (176(2)°) (N1-H3···O3) as highlighted in 
Figure 297. 
 
Figure 297 - 3,4D and imidazolium ion chains generated along the a-axis. 
As seen along the a-axis there are two distinct chlorine-oxygen interactions, Cl4···O3 and 
Cl2···O6, at similar distances of 3.061(1)Å and 3.092(1)Å, respectively (Figure 297).  This has 
the effect of generating two C22(8) chains, (N1···O3---O2···N1; Figure 298) and (N4···O6---
O5···N3; Figure 299), with interweaving aromatic groups.  This results in the formation of 
columns along the a-axis with an end to face zig-zag orientation of the aromatic groups.  
The symmetry equivalent aromatic groups are distant from each other at over 7Å and do 





Figure 298 - 3,4-D and imidazolium (N1···O3---O2···N1) chains. 
 
 
Figure 299 - 3,4-D and imidazolium (N1···O3---O2···N1) chains. 
The end to face stacked aromatic rings are further connected via an aromatic hydrogen to 
chlorine and an aromatic hydrogen to oxygen interaction, at the overall distances, 
3.632(2)Å (C14···O5), 3.767(1)Å (C13···Cl1), 3.634(2)Å (C22···O2) and 3.835(2)Å (C21···Cl3).  
These interactions are highlighted in Figure 300. 
 
Figure 300 - End to face stacking interactions and consequent contacts in the crystal structure of 3,4-D 
imidazolium complex. 
The chains of imidazolium molecules stack in a skewed arrangement on top of each other 
in the direction of the c-axis, parallel with the ab plane, creating channels of stacked 




Figure 301 - Sandwiched aromatic sheets present in 3,4-D imidazolium complex on the ab plane. 
7.1.3 Thermal analysis of 2,4-D and 3,4-D imidazolium complexes 
The new 2,4-D and 3,4-D imidazolium complexes were analysed by DSC and compared to 
the scans of their respective starting materials to assess whether the new forms offer this 
aspect of modified physical properties as set out in the project aims. 
In the 2,4-dichlorophenoxyacetate imidazolium complex, only one thermal event can be 
seen in the sample scan, at 130-137 °C (Figure 302), corresponding to a product melting 
transition.  This event does not correspond to any of the starting materials and is a 6°C 
decrease from that observed in pure 2,4-D.  This molecular complex is thus less thermally 
stable than the starting material. 
 
Figure 302 - DSC scans of 2,4-Dichlorophenoxyacetic acid (green), imidazole (brown) and the 2,4-D 
imidazolium complex (blue). 
The DSC scan of the 3,4-dichlorophenoxyacetate imidazolium complex (Figure 303) has 
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very broad event at 98-103 °C and a smaller event at 116-118 °C, none of which correspond 
to either of the starting materials, and one exothermic event from 60-57 °C.  This possibly 
suggests that this material may be polymorphic, with several forms which are transitioned 
through the heating cycle, reaching a final melting point, and then recrystallizing on the 
cooling cycle at the original crystal form.  These other forms should be investigated, ideally 
by higher temperature single crystal X-ray diffraction to determine if a change in the crystal 
structure is observed.  All exothermic transitions, however, are at a much lower 
temperature than the 3,4-D melting point at 140-142 °C, and this complex is therefore also 
less thermally stable. 
 
Figure 303 - DSC scans of 3,4-Dichlorophenoxyacetic acid (green), imidazole (brown) and the 3,4-D 
imidazolium complex (blue). 
7.2 Chlorophenoxyacetic acids and 4(5)-methylimidazole 
N NH
CH3  
Figure 304 - Molecular structure of 4(5)-methylimidazole. 
Both 2,4-D and 3,4-D were further studied by cocrystallising with a slightly larger methyl 
substituted analogue of imidazole, 4(5)-methylimidazole (Figure 304).  Under the same 
slow evaporative crystallisation method, crystallisations were performed in methanol, 
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with the imidazole crystallisations, suitable crystals for study by single crystal X-ray 
diffraction were found amongst both sets of experiments. 
7.2.1 2,4-Dichlorophenoxyacetic acid and 4(5)-methylimidazole 
Slow evaporative crystallisation of 2-4-dichlorophenoxyacetic acid and 4(5)-
methylimidazole dissolved in ethyl acetate and held at a constant crystallisation 
temperature of 30°C yielded a new material which was subjected to a full data collection, 
detailed in Table 65. 
 
 
Table 65 - Crystal structure collection data for 2,4-Dichlorophenoxyacetate 4(5)-methylimidazolium 
monohydrate 
Compound 2,4-Dichlorophenoxyacetate 4(5)-methylimidazolium monohydrate  
Formula C8H5O3Cl2: C4H7N2:H2O 
Crystallisation Conditions 2,4-D and 4(5)-methylimidazole crystallised in ethyl acetate at 30°C 
Molecular weight / gmol
-1
 321.15 
Temperature (K) 100 
Space Group P212121 
a (Å) 4.7865(5) 
b (Å) 12.7296(14) 















θ range/˚ 3.03 – 27.48 
Reflections Collected 19031 
Independent 3309 






R1 (Observed) 0.0321 
R1 (all) 0.0368 
wR2 (all) 0.0723 





Figure 305 - Asymmetric unit of 2,4-D 4(5)-methylimidazole monohydrate. 
The asymmetric unit of the 2,4-D 4(5)-methylimidazole monohydrate structure contains 
one of each of the three components with the proton of the 2,4-D relocated to the 
available nitrogen of the methylimidazolium molecule (Figure 305). 
 
Figure 306 - Hydrogen bonding network forming a chain flowing through 2,4-D back to 4(5)-
methylimidazolium molecules. 
The two larger molecules form a chain of acetate to amine hydrogen bonds, all of 
moderate strength, originating from either side of the methylimidazolium ion at distances 
2.690(2)Å (175(3)°) (N2-H9···O2) and 2.648(2)Å (164(2)°) (N1-H7···O1) creating an entirely 
moderate strength C22(8) chain motif (Figure 306). 
 
 
Figure 307 - 2,4-D molecules hydrogen boned to linear chain of alternating water molecules in the structure. 
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Also hydrogen bonded to the acetate functional group are the water molecules at a 
distance of 2.777(2)Å (175(3)°) (O4-H13···O2), bound with moderated strength interactions 
to themselves forming an alternating orientation one dimensional chain of water molecules 
running throughout the structure with a 2.760(3)Å (176(3)°) hydrogen bond linking the 
chain (O4-H14···O4; Figure 307). 
 
Figure 308 - Weaker aromatic hydrogen bonds from 2,4-D molecule to chain water molecules. 
The water molecules are further held in place by much weaker aromatic C-H···O 
interactions originating from the aromatic 5 and 6 positions, with respective distances of 
3.361(3)Å and 3.681(3)Å.  These contacts are at the limit of a hydrogen bond interaction, 
however they are directed towards the oxygen atom of the water molecules and thus 
probably have a weak stabilising effect (Figure 308). 
 
Figure 309 - 2,4-D with 4(5)-methylimidazolium hidden showing chlorine oxygen interaction chain. 
The chlorine atoms on the 2,4-D molecule interact with the neighbouring 2,4D molecule 
with a Cl···Cl distance of 3.1010(1)Å; these are the only interactions between the molecules 




Figure 310 - C-HO and C-HCl interactions from 4(5)-methylimidazolium ion to chlorine and oxygen on 2,4-
D. 
The methylimidazolium ion also has C-HO and C-HCl interactions with the 2,4-D 
molecule, as shown in Figure 310.  The chlorine interaction is the weaker of the two, and as 
a result the C-H bond is directed more towards the lone pair of O3, the chain oxygen with a 
C11···O3 distance of 3.394(2)Å; this is still a  very weak interaction. 
 
Figure 311 - packing of 2,4-D aromatic rings viewed perpendicular from the plane of the ring (left) and looking 
down the planes of the rings (right). 
Finally, the 3,4-D molecules pack on top of each other at a closest interatomic distance of 
3.476(3)Å (Figure 311; right).  This is within the range of π-π stacking interaction with the 
molecules stacked in a skewed arrangement.  The chain oxygen with its lone pairs sit above 
the π cloud (Figure 312; left) reinforcing the structure through π-σ interactions. 
7.2.2 3,4-Dichlorophenoxyacetic acid and 4(5)-methylimidazole 
Cocrystallisation of 3-4-dichlorophenoxyacetic acid and 4(5)-methylimidazole dissolved in 
acetone and held at a constant crystallisation temperature of 30°C yielded a new material 










Table 66 - Crystal structure collection data for 3,4-Dichlorophenoxyacetate 4(5)-methylimidazolium molecular 
complex 
Compound 3,4-Dichlorophenoxyacetate 4(5)-methylimidazolium complex 
Formula C8H5O3Cl2: C4H7N2 
Crystallisation Conditions 3,4-D crystallised with 4(5)-methylimidazole in acetone at 30°C 
Molecular weight / gmol
-1
 303.14 
Temperature (K) 100 
Space Group P21/c 
a (Å) 6.9895(6) 
b (Å) 24.7289(17) 















θ range/˚ 3.07 – 27.48 
Reflections Collected 154.01 
Independent 2947 






R1 (Observed) 0.0376 
R1 (all) 0.0505 
wR2 (all) 0.1074 
 
 
Figure 312 – Planar hydrogen bonding network of the 3,4-D 4(5)-methylimidazolium structure. 
The structure of the 3,4-D methylimidazolium complex is predominantly planar, with all 
aromatic molecules lying in a sheet, with only the methyl hydrogens and CH2 hydrogens 
protruding from this.  Similar to the other structures with imidazole based co-molecules, 
the two protonated amine groups propagate a hydrogen bonded chain throughout the 
structure (Figure 312).  The two main interactions are both associated with O2 – one of the 
acetate oxygens – with distances 2.662(2)Å (174(2)°) and 2.702(2)Å (167(3)°) from N1 and 
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N2, respectively.  Yet again these are moderate strength hydrogen bonds, with a similar 
distance as seen in the previous structures. 
The second acetate oxygen, O3 is directed towards H10, with an overall C10···O3 distance 
of 3.223(3)Å forming a very weak aromatic hydrogen bond.  This is further supported by 
the 5 position aromatic hydrogen directed with a very weak interaction towards the chain 
oxygen, and the 3.810(2)Å Cl2···H12-C3 interaction.  O3 also forms a second interaction 
with H3 at an overall distance (O3···C8) of 3.039(2)Å (132(7)°). 
 
Figure 313 - C-H to chlorine interactions observed between 3,4-D and 4(5)-methylimidazolium ions. 
The 3,4-D molecules have several chlorine interactions with the methylimidazolium 
molecule and the neighbouring 3,4-D molecule (Figure 313).  Cl1 and Cl2 both interact with 
the bulky methyl group at distances of 3.534(2)Å and 3.438(2)Å respectively, whilst Cl2 also 
is very close to interaction range, at 3.810(2)Å to H12 (measured distance from Cl2···C3), an 
aromatic hydrogen,  The C-H contact with Cl1 is more distant, at 4.174(2)Å, and less likely 
to make a significant contribution to the packing. 
 
Figure 314 - Planes of molecules of alternating orientation 2,4-D and methylimidazolium ions. 
Finally, the planes stack at a measured distance of 3.230(2)Å (Figure 314) forming a zig-zag 
arrangement of alternating units along the b-axis, creating ribbons with chlorine and 





Figure 315 - Planes forming narrow ribbons down a-axis edged by chlorine atoms and methyl groups. 
 
7.2.3 Thermal analysis of  2,4-D and 3,4-D  4(5)-methylimidazolium complexes 
The 2,4-D and 3,4-D 4(5)-methylimidazolium molecular complexes were analysed by DSC 
and compared to their respective reference scans to assess physical property modification. 
 
Figure 316 - DSC scans of 2,4-Dichlorophenoxyacetic acid (blue), 4(5)-methylimidazole (green) and the 2,4-D 
4(5)-methylimidazolium complex (brown). 
The DSC scan of the 2,4-D complex, which was recognised to be a hydrated structure, 
showed multiple thermal events upon heating (Figure 316).  Two broad events at 70-85 °C 
and 110-120°C are evident that do not correspond to either of the starting materials.  It 
could be the case that the first of these events, is from the evolution of the water from the 
structure, and the second is the melting point of the structure.  Both of these events 
however are below the point at which the 2,4-D shows its melting peak, and thus the 
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Figure 317 - DSC scans of 3,4-dichlorophenoxyacetic acid (blue), 4(5)-methylimidazole (green) and the 3,4-D 
4(5)-methylimidazolium complex (brown). 
The DSC scan of the 3,4-D complex is much sharper.  The new complex (Figure 317; brown) 
is clearly experiencing one melting transition, which is situated between the melting points 
of the two starting materials at about 97-100 °C.  Both new molecular complexes discussed 
in this section are thus less thermally stable than their agrichemical component in the pure 
form. 
7.3 Chlorophenoxyacetic acids and benzimidazole 
N NH
 
Figure 318 - Molecular structure of benzimidazole. 
With a similar behaviour and functionality to that of the imidazoles, benzimidazole (Figure 
318) was the next material to be crystallised with 2,4-D and 3,4-D with the aim of creating a 
more stable molecular complex.  Benzimidazole itself has a significantly higher thermal 
stability than imidazole, and it was hoped than it would lend itself to the molecular 
complexes formed.  This touched on work previously explored by Liu106 in which a 2,4-D 
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interaction was known, however the crystallisation was screened to see if an anhydrous 
form could be found.  As such, slow evaporative cocrystallisation experiments were 
performed as before with methanol, ethanol, acetone, ethyl acetate and diethyl ether as 
solvents, both at room temperature and 30°C.  This yielded two more new materials, one 
from the 2,4-D experiments, and one from 3,4-D. 
7.3.1 2,4-Dichlorophenoxyacetic acid and benzimidazole 
Crystallisation of 2-4-dichlorophenoxyacetic acid and benzimidazole dissolved in acetone 
and held at room temperature for crystallisation yielded a new material which was 
subjected to a full data collection, detailed in Table 67. 
Table 67 - Crystal structure collection data for 2,4-Dichlorophenoxyacetate benzimidazolium complex 
Compound 2,4-Dichlorophenoxyacetate benzimidazolium complex 
Formula C8H5O3Cl2: C775N2 
Crystallisation Conditions 2,4-D crystallised with benzimidazole in acetone at room temperature 
Molecular weight / gmol
-1
 339.17 
Temperature (K) 100 
Space Group Pbca 
a (Å) 30.342(2) 
b (Å) 11.3122(4) 















θ range/˚ 3.08 – 27.48 
Reflections Collected 32095 
Independent 3324 






R1 (Observed) 0.0283 
R1 (all) 0.0333 





Figure 319 - Asymmetric unit of 2,4-D and benzimidazolium ions forming R
2
2(7) motif. 
The asymmetric unit of the 2,4-D benzimidazolium structure collected contains one of each 
molecule, interacting in an R22(7) motif between one side of the amine head of the 
benzimidazolium molecule and the acetate group of the 2,4-D (Figure 319).  The motif is 
formed by a moderate strength hydrogen bond originating from the amine group with a 
distance of 2.648(1)Å (179(2)°) between N1···O2.  This is supported by a weaker interaction 
from the benzimidazole head hydrogen to O3, with a measured distance from the head 
carbon to O3 of 3.062(2)Å.  This is confirmed to be a weak interaction by a very slight 
bending of the C-H electron density towards O3. 
 
Figure 320 - Larger 2(2,4-D) 2(benzimidazolium) R
4
4(16) motif. 
As with the other imidazole based molecules, the other side of the benzimidazolium forms 
hydrogen bonds through a second interaction to acetate oxygen O3, with another 
moderate strength distance of 2.666(1)Å (149(2)°) (N2···O3).  This has the effect of 




Figure 321 - Position 2 chlorine on 2,4-D has two short contacts with aromatic hydrogens on two 
benzimidazolium molecules. 
The 2-position chlorine on the 2,4-D (Figure 321) makes two contacts with different 
benzimidazolium molecules at distances of 3.535(1)Å (ClH-C) and 3.418(1)Å (ClN), aiding 
the stacking of the molecules, which is at 3.268(2)Å planar separation measure between 
the distance of the closest atoms in the planes. 
 
Figure 322 – Packed molecules sit indirectly over each other (left), forming echelon arrangements (right). 
The skewed stacking of the molecules again prevents π interaction, with distances between 
stacking molecules between 3.41-3.54 Å for 2,4-D molecules and 3.25-3.55 Å for 
imidazolium molecules.  The indirect stacking forms an inverting echelon pattern as can be 
seen in Figure 322 (right). 
7.3.2 3,4-Dichlorophenoxyacetic acid and benzimidazole 
2-4-dichlorophenoxyacetic acid and benzimidazole were dissolved in ethyl acetate and held 
at 30°C for crystallisation yielded a new material which was subjected to a full data 







Table 68 - Crystal structure collection data for 3,4-Dichlorophenoxyacetate benzimidazolium molecular 
complex 
Compound 3,4-Dichlorophenoxyacetate benzimidazolium complex 
Formula C8H5O3Cl2: C7H5N2 
Crystallisation Conditions 3,4-D crystallised with benzimidazole in ethyl acetate at 30°C 
Molecular weight / gmol
-1
 339.17 
Temperature (K) 100 
Space Group Pc 
a (Å) 13.8047(7) 
b (Å) 4.8070(3) 















θ range/˚ 3.18 – 27.48 
Reflections Collected 21677 
Independent 9813 






R1 (Observed) 0.0346 
R1 (all) 0.0637 
wR2 (all) 0.0886 
Flack parameter -0.01(4) 
 
 
Figure 323 - Symmetry inequivalent molecules in the 3,4-D benzimidazolium structure, showing the extended 
hydrogen bonding network. 
The 3,4-D and benzimidazolium structure is more irregular than the other structures.  It 
follows the same imidazolium hydrogen bonding chain motif, however the molecules are 
slightly out of arrangement, seen most prominently at the shared acetate oxygen O5, 
which is hydrogen bonded from both N2 and N5 (Figure 323).  As can be seen in Table 69, 
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the N-H···O hydrogen bonding distances are all of moderate strength, which has come to be 
expected from the other structures. 
Table 69 – hydrogen bond distances in the 3,4-D benzimidazolium structure 
Atom 1 Atom 2 Length Angle 
N1 O3 2.590(3) 161(3)° 
N4 O7 2.690(3) 161(3)° 
N5 O5 2.668(3) 172(3)° 
N2 O5 2.781(3) 176(3)° 
N6 O8 2.622(3) 169(4)° 
N3 O1 2.624(3) 171(4)° 
 
 
Figure 324 - Aromatic hydrogen to chlorine interactions in the 3,4-D benzimidazolium structure. 
On the other sides of the molecules, the chlorine atoms experience a similar skewing of 
their average bond lengths, as seen in Figure 324, and shown in Table 70. 
Table 70 – chlorine interaction distances in the 3,4-D benzimidazolium structure 
Atom 1 Atom 2 Length 
Cl2 C36 3.328(3) 
Cl3 C40 3.415(3) 
Cl1 C37 3.354(3) 
Cl5 C45 3.732(4) 
Cl6 C31 3.659(3) 
Cl6 C7 3.694(3) 




Figure 325 - Irregular packing in 3,4-D benzimidazolium structure. 
Together, this creates an irregular packing pattern (Figure 325).  This may not be the most 
stable form of the structure, as it does not conform with the normal arrangements through 
the rest of the more regularly arranged structural motifs in the series.  This molecular 
complex should be screened for possible polymorphism. 
7.3.3 Thermal analysis of  2,4-D and 3,4-D  benzimidazolium complexes 
The thermal analysis of the 2,4-D and 3,4-D benzimidazolium complexes is very clear.  Both 
materials show only one endothermic transition that does not correspond to either starting 
material. 
 
Figure 326 - DSC scans of 2,4-Dichlorophenoxyacetic acid (green), benzimidazole (brown) and the 2,4-D 
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The 2-4-D sample shows an endothermic event at 131-134 °C (Figure 326; blue) that 
appears before the melting points of the starting materials.  The new molecular complex is 
therefore less thermally stable than either of the starting materials. 
The 3,4-D complex shows only one transition peak (Figure 327) but at a much lower 
temperature (about 30° lower).  This is likely a result of the much poorer ordering of the 
structure than its 2,4-D isomer.  The endothermic peak observed for the complex is at 98-
102 °C and is also significantly lower than the melting points of either of its starting 
materials. 
 
Figure 327 - DSC scans of 3,4-Dichlorophenoxyacetic acid (green), benzimidazole (brown) and the 3,4-D 
benzimidazolium complex (blue). 




Figure 328 - Molecular structure of 1-methylbenzimidazole 
1-methylbenzimidazole (Figure 328), with one of its available hydrogen bonding sites 
essentially blocked off entirely by the methyl group, should offer the potential for 
significantly different hydrogen bonding motifs to those found for  benzimidazole.  It was 
therefore studied under equimolar cocrystallisation conditions with 2,4-D and 3,4-D in 
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30°C, with the aim to generate molecular complexes for study.  Single crystals suitable for 
study were found from the 2,4-D experiments and studied by single crystal X-ray 
diffraction: 
7.4.1 2,4-Dichlorophenoxyacetic acid and1-methylbenzimidazole 
Single crystals were recovered from the crystallisation of 2,4-D and 1-methylbenzimidazole 
and upon identification that a new material had been formed, were subjected to a full data 
collection on the image plate diffractometer.  The details of the collection and subsequent 
crystal structure solution are outlined in Table 71. 
Table 71 - Crystal structure collection data for 2,4-Dichlorphenoxyacetate 1-methylbenzimidazolium 
molecular complex 
Compound 2,4-Dichlorphenoxyacetic acid 1-methylbenzimidazole complex 
Formula C8H6O3Cl2:C8H8N2 
Crystallisation Conditions 2,4-D crystallised with 1-methylbenzimidazole in acetone at room 
temperature 
Molecular weight / gmol
-1
 353.19 
Temperature (K) 100 
Space Group P21/c 
a (Å) 14.495(4) 
b (Å) 11.082(3) 















θ range/˚ 3.44 – 27.48 
Reflections Collected 8946 
Independent 3669 






R1 (Observed) 0.0882 
R1 (all) 0.153 





Figure 329 - Asymmetric unit of the 2,4-D 1-methylbenzimidazole structure featuring the short strong N-HO 
hydrogen bond. 
With the removal of one of the hydrogen bonding sites from the benzimidazole molecule 
the hydrogen bond strength of the main hydrogen bonding interaction, as seen in the 
asymmetric unit of the 2,4-D 1-methylnezimidazole (Figure 329), is seen to increase making 
the N1-H6-O2 interaction a short, strong hydrogen bond at an NO distance of 2.515(6)Å 
(176(6)°).  With the electron density associated with the hydrogen modelled at distances of 
1.24(7)Å (H6-O2) and 1.27(7)Å (H6-N1), the error on the distance makes the association of 
the hydrogen to either of the molecules indeterminate, being close to centre within error.  
However, it is slightly closer to the oxygen and for convenience the complex will be 
discussed in non-deprotonated terms. 
 
 
Figure 330 – 1-methylbenzimidazole stacking forming asymmetric unit dimers. 
The 1-methylbenzimidazole molecules stack with a medium strength π-π stacking 
interaction at 3.457(7)Å, with overlapping 5 and 6 membered rings (Figure 330).  This has 
the effect of producing a π-π bonded dimer of the molecules that are hydrogen bonded in 
the asymmetric unit to two 2,4-D molecules.  The “asymmetric unit dimer” thus orientates 
the 2,4-D molecules perpendicular to the plane of the methylbenzimidazole molecules, 
forming in directions favourable to the available π-π interaction.  This feature is utilised 
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further in the structure, with π-π interactions forming between 2,4-D groups at a distance 
of 3.463(8)Å, with the appearance of creating a π-π stacked chain of asymmetric unit 
dimers (Figure 331). 
 
Figure 331 - stacking of 2,4-D molecules forming a - stacking chain. 
 
Figure 332 - 2,4-D molecules in the complex, with 1-methylbenzimidazole molecules hidden, showing chlorine 
and aromatic hydrogen interactions. 
The dimers are further supported by a network of chlorine interactions between the 2,4-D 
molecules along the plane of their aromatic rings (Figure 332) with a Cl1···Cl2 distance 
measured at 3.469(2)Å and an additional contact to the aromatic C-H on the 3 position of 
the benzene ring with Cl2C3 distance.  There is also a very weak C-HO interaction 
involving the chain oxygen O1 with C3O1 distance of 4.009(7)Å. 
 
Figure 333 - 2,4-D 1-methylbenzimidazole structure viewed down the a, b and c axes (left, centre and right). 
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The overall motif of the packed structure is well ordered, with a tight zig-zag arrangement 
visible viewed down the a-axis (Figure 333; left) and sandwich planes with 3,4-D edges and 
1-methylbenzimidazole centres seen when viewed down the b and c axes (Figure 333; 
middle and right). 
7.4.2 3,4-Dichlorophenoxyacetic acid and 1-methybenzimidazole 
Crystallisations of 3,4-dichlorophenoxyacetic acid and 1-methylbenzimidazole have 
produced no crystals suitable for single crystal X-ray diffraction purposes at the time of 
writing.  However, samples were isolated which were suitable for DSC analysis, the results 
of which may be found in the following thermal analysis section. 
7.3.3 Thermal analysis of 2,4-D and possible 3,4-D  1-methylbenzimidazole 
complexes 
The final 2,4-D complex studied, that with benzimidazole, was analysed by DSC and found 
to contain two thermal events, one of which corresponds to the melting point of the 1-
methylbenzimidazole, while  the other is at 100-102°C (Figure 334; brown).  This would 
suggest that the new complex co-exists with some residual methylbenzimidazole present in 
the product.  The melting transition of the new complex is again found to be less than that 
of 2,4-D and therefore less thermally stable than the parent agrichemical. 
 
Figure 334 - DSC scans of 2,4-Dichlorophenoxyacetic acid (blue), 1-methylbenzimidazole (green) and the 2,4-D 
1-methylbenzimidazolium complex (brown). 
The DSC of the material collected from the crystallisation experiment of 3,4-D and 1-
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corresponding to the 1-methylbenzimidazole starting material, and a further melt at 
around 78-81 °C (Figure 335; brown).  This would suggest that this material too has formed 
a new complex, which should be analysed by single crystal X-ray diffraction when suitable 
crystals are found. 
 
Figure 335 - DSC scans of 3,4-Dichlorophenoxyacetic acid (blue), 1-methylbenzimidazole (green) and the 
unresolved sample from the crystallisation of 3,4-D and 1-methylbenzimidazole (brown). 
7.5 Unresolved materials 
Several other crystallisations of 2,4-D and 3,4-D were initiated, but due to time constraints, 
have not as yet been analysed.  These were as follows: 
 2,4D and DMAN 
 2,4-D and α-cyclodextrin 
 2,4-D and β-cyclodextrin 
 2,4-D and tri-acetyl-β-cyclodextrin 
 2,4-D and Hydroxyethyl-β-cyclodextrin 
 
7.6 Summary 
New structures were produced with 2,4-D and 3,4-D with several imidazole based 
molecules, the majority of which showed similar imidazolium – N-H double hydrogen bond 
motifs to deprotonated carboxylic acid functional groups, forming chains throughout the 
structures of moderate hydrogen bond strength.  This motif was lost however when one of 
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All molecular complexes formed were showed to be less thermally stable than the 
component agrichemical when analysed by DSC.  This is likely to mean that they would be 
more soluble as a result, based on the frequent correlation between these two parameters; 
dissolution testing of these materials is planned within the group in future. 
The resultant product from the cocrystallisation of 3-4-D and 1-methylbenzimidazole has 
been identified as a new material by DSC and should be further characterised to determine 
its content and structure, along with the analysis of the materials that have not yet been 
studied by structural methods. 
8. Conclusions 
8.1 Reactive materials 
Working with reactive materials has proven to be very challenging.  Their high degree of 
reactivity resulting from the energetics of their molecular structures leads to a high degree 
of incompatibility with a wide range of secondary components normally exploited in 
molecular complex formation.  This drastically limits the available conditions in which the 
target materials can be used, with respect to solvent, additives, atmospheric considerations 
and consequently storage and application.  However, as reactive materials form some of 
the most useful and important chemicals for vital functions in many industries, finding a 
way to control them effectively is an area which merits research.  With this in view, the 
research outlined in this work into finding new methods of working with these materials, 
and finding new ways to add stability to them in a reliable and functional way that does not 
prevent them for from being used in their desired application, has driven the multi-faceted 
approach used to try and achieve the goal of a stabilised reactive material. 
The use of crystallography as a tool for this goal is a valid approach, with due time and 
diligence given to screening desired targets for a more complete understanding of their 
individual reactivities, compatibilities and incompatibilities, with different types of 
materials.  This is targeted at the design of a method for stabilising them to suit the 
individual needs of the chemical or series of chemicals through targeting individual reactive 
sites on the concerned molecule itself.  The use of a crystal engineering methodology to 
achieve this is well suited to the aim, as it too requires understanding and targeting of 
molecular features in order to achieve desired material of multiple components, and 
creating a new material in the solid state, with its own characteristic features and physical 
properties, which may be more suitable for potential application. 
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In some cases crystallising the target reactive materials in single component form has even 
proved to be a delicate procedure, requiring extensive screening with an array of many 
different conditions to find one that best suits the reactive material under study.  Where 
databases exist with detailed information on the likely reactivity and compatibility of these 
reactive materials, this can be achieved easily through identification of patterns.  However, 
this is seldom the case for highly reactive materials, and empirical research must be 
performed in order to provide a full understanding of the target reactive compound that is 
to be stabilised. 
8.2 Organic peroxyacids 
Working with organic peroxyacids is an extremely delicate procedure, and throughout this 
research there have been many pitfalls whilst trying to find a reliable way to stabilise these 
materials.  Being the most reactive of all the organic peroxides, they are notoriously 
incompatible with a wide range of materials, forming equally if not more hazardous 
energetic outcomes if not treated carefully.  Successfully working with these materials is 
possible, however, and a range of studies of the target materials used as a basis for this 
research have been successful. 
8.2.1 Screening and crystallisation of organic peroxyacids 
8.2.1.1 Solvents for peroxyacids 
The screening process for finding optimal conditions for crystallisation of reactive peroxides 
has involved trialling a medium to wide range of solvents, many of which resulted in the 
decomposition of the peroxyacids to the parent acids.  This occurred either through 
absorption of water into the solvent and thus making it available for use in the 
decomposition reaction below (Figure 336), or by directly reacting with the solvent itself to 











Figure 336 - Reversed reaction of formation of a peroxyacid, or the “decomposition reaction”. 
Recrystallisation attempts of the peroxyacid meta-chloroperbenzoic acid, led to 
decomposition that reliably formed its parent acid, 3-chlorobenzoic acid (Figure 101), 
which although very structurally similar to the peroxyacid from which it decomposes, 




Figure 337 - Crystal structure asymmetric unit of 3-chlorobenzoic acid. 
Also, reaction of the peroxyacid MCPBA or its other decomposition product, hydrogen 
peroxide, with acetone readily forms the unstable energetic material triacetone 























Figure 338 - Synthesis of TATP under crystallisation conditions for MCPBA. 
Production of the TATP material in this manner is not the standard approach, and the 
crystal structure was collected and solved for completeness (Figure 115). 
 
Figure 339 - 3 layers of TATP chains viewed down the b-axis of the collected TATP structure 
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What was unexpectedly encountered however is that the solvent that so readily reacts with 
peroxides to form TATP – acetone – was the one in which MCPBA was most stable, as 
determined at both 4°C and room temperature, and a crystal structure of the MCPBA 
reactive material was achieved from these conditions. 
With the second, larger, peroxyacid, 6-phthalimidoperoxyhexanoic acid (PSP), a similar 
outcome was encountered with decomposition to the parent acid – 6-phthalimidohexanoic 
acid, and to its hydrate, a new polymorph of which was discovered (Figure 134). 
 
Figure 340 - Asymmetric unit of 6-phthalimidohexanoic acid monohydrate Form II. 
A selection of solvent conditions were found in which PAP could crystallise without 
decomposing, and this was taken forward to the succeeding crystallisations (Table 72). 
Table 72 - Solvent conditions from which PAP was successfully recrystallised 
Sample ID Recrystallisation solvent Temperature 
AM24_01 Methanol 4°C 
AM24_10 Acetone Room temperature 
AM24_11 Diethyl Ether 4°C 
AM32_03 Acetone 4°C 
AM32_04 Acetone 4°C 
AM32_05 Acetone Room temperature 
AM32_06 Acetone Room temperature 
AM32_07 Acetone 30°C 
AM32_09 Methyl Acetate 4°C 
AM32_10 Methyl Acetate Room temperature 
AM32_11 Methyl Acetate 30°C 
 
8.2.1.2 Additiives in peroxyacid recrystallisations 
Adding components to the crystallisation process, in particular hydrochloric acid and 
sodium hydroxide to change the acidity and basicity of the crystallisation, as well as 
hydrogen peroxide proved to be unsuccessful in retaining the peroxyacid functionality. 
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The addition of hydrochloric acid to crystallisations of peroxyacids seems to expedite the 
decomposition of the peroxyacid in all cases.  The hydrogen ion reacts readily with the 
peroxyacid group to create a water molecule, decomposing the peroxyacid to its parent 
carboxylic acid. 
Crystallisation with the addition of sodium hydroxide resulted in the crystallisation of “soda 
ash” or sodium carbonate heptahydrate, a common material in which the peroxyacid 
oxidises a solvent to produce a carbonate for the salt to be formed with. 
The addition of hydrogen peroxide, with the aim of reversing the decomposition 
equilibrium, had the more curious effect of preventing recrystallisation, making resulting 
materials more amorphous.  It is suggested  that this may be a result of the functional 
group exchanging back and forward from carboxylic acid to peroxyacid, preventing its use 
in molecular association with the primary or secondary materials. 
8.2.1.3 Crystal structures of target materials 
The crystal structure of MCPBA was obtained from acetone recrystallisations and proved to 
have a similar hydrogen bonding motif in its functional group as the known peroxyacids.  
With the determination of the presence of the hydrogen atom, the pairing relationship 
between two peroxyacids could be properly defined as a catemeric arrangement, and not 
the previously proposed dimeric arrangement11, 12 (Figure 150). 
 




Figure 342 - Asymmetric unit of the crystal structure of 6-phthalimidoperoxyhexanoic acid (PAP). 
This was further confirmed by the determination of the structure of 6-
phthalimidoperoxyhexanoic acid, PAP (Figure 342), in which the peroxyacid functional 
group head also showed the same catemeric motif (Figure 156). 
 
Figure 343 – Hydrogen bonding of peroxyacid groups in 6-phthalimidoperoxyhexanoic acid. 
 
8.2.2  Using carboxylic acids for cocrystallisation with peroxyacids 
Crystallisation of peroxyacids with carboxylic acids proved unsuccessful, not only leading to 
decomposition of the peroxyacids to the parent acids, but even the resulting parent acids 
did not undergo molecular complex formation with the secondary acid components in the 
crystallisation.  The peroxyacids were not only incompatible chemically with then explored 
conditions, but some unknown factor is preventing association of the carboxylic acid group. 
No new complexes were formed with peroxyacids and carboxylic acids. 
8.2.3 Using π-π interacting materials for crystallisation with peroxyacids 
Cocrystallisation with larger molecules with a strong π-interacting character also proved 
unsuccessful in producing peroxy-acid molecular complexes, with decomposition of both 
the peroxyacids and the secondary materials evident.  For example, 4-
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hydroxybenzophenone was oxidised by the peroxyacid to form a crystalline structure of 
benzoic acid. 
Crystallisation of PAP with benzimidazole formed a new crystalline material, which was 
found to be a partially oxidised/nonoxidised benzimidazole – 6-phthalimidohexanoic acid 
complex, in which one of the two benzimidazole molecules in the asymmetric unit has been 
oxidised at 40% occurrence to form a hydroxyl group on the available amine (Figure 241). 
 
Figure 344 - Asymmetric unit of oxidised benzimidazole, benzimidazole and 6-phthalimidohexanoic acid 
 
8.2.4 Crystallising reactive materials with metals 
Crystallisation of reactive peroxyacids with metals resulted in decomposition in the 
majority of cases, to form the parent acids with no other new materials formed.  However 
the analysis of these materials is by no means complete and the collected samples await 
further analytical investigations in future. 
8.2.5 Hosting reactive materials 
The concept of locking the reactive material inside a larger, more stable, structure led to 
the investigation of several host-guest combination methodologies, including urea 
channelling, the use of cyclodextrins and layered materials such as montmorillonite clays. 
8.2.5.1 Hosting in Urea based structures 
Hosting with urea based structures, that is urea channels and thiourea, proved to be 
unsuccessful.  Thiourea was violently reactive with the organic peroxides and thus entirely 
excluded from consideration.  Urea tended to recrystallise on its own as the starting 
material, or in the presence of hydrogen peroxide, forming a known hydrogen peroxide 
urea 1:1 cocrystal, as determined by single crystal XRD – unit cell analysis and X-ray powder 
diffraction methods.  No new materials aside from this previously known cocrystal were 
found for analysis. 
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8.2.5.2 Hosting in cyclodextrins 
Hosting materials within cyclodextrins proved to be more successful.  A crystalline host 
structure with organic peroxyacid contained inside was not obtained, however a structure 
of a β-cyclodextrin potassium framework with the MCPBA parent acid (3-chlorobenzoic 
acid) intercalated into its barrel shaped structure was achieved, with two ordered and one 
disordered guest molecules (Figure 269). 
 
Figure 345 - Three 3-chlorobenzoic acid molecules located inside the core of the barrel arrangement of -
cyclodextrin (left).  Of the three 3-chlorobenzoic acid molecules, two are ordered, one is disordered (right). 
It is proposed that with additional research, this could prove to be a possible solution to 
the hosting approach of a peroxyacid, given the correct conditions for retaining the 
peroxyacid are found, in which this structural arrangement also assembles. 
8.2.5.3 Hosting within layered materials  
Hosting the peroxyacids within the montmorillonite clay Bentonite proved to be 
unsuccessful for smaller molecules and MCPBA, however with PAP a significant change in 
the structure of the hosting material was observed.  This corresponded to an increase in 
the interlayer spacing by more than 3Å upon application of the peroxyacid through solvent 
assisted grinding techniques.  This was quantified and found to be scalable to a point at 
which the clay can no longer accept any more of the material.  Determination of the 
contents of the material once the spacing increase (and the intercalation of the guest) had 
occurred proved difficult.  The same effect is observed with the PAP parent acid and as 
such the effect is not limited to the peroxyacid functionalised material.  Testing of the 
intercalated material revealed limited oxidising ability on a test material up to the point of 
saturation of the pores in the clay.  After that point the testing material is strongly oxidised, 
possibly due to the present of remaining peroxyacid outside the clay.  It is clear that under 
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these intercalation conditions the peroxyacid is encouraged not to decompose, a positive 
outcome that can be pursued in future work. 
8.3 Agrochemicals 
Cocrystallisation with agrochemicals was another direction focussed in this research in an 
attempt to change their physical properties to better suit the need of the end application.  
The high reactivity of many active agrichemical ingredients (AAIs) provides a clear link to 
the work on reactive materials.  To this end the target materials 2,4-dichlorophenoxyacetic 
acid (2,4-D) and 3,4-dichlorophenoxyacetic acid (3,4-D) were cocrystallised with imidazole 
based materials with a good degree of success. 
8.3.1 Cocrystallising with imidazole based components 
New molecular complexes were formed between 2,4-D and imidazole, 4(5)-
methylimidazole, benzimidazole and 1-methylbenzimidazole, and between 3,4-D and 
imidazole, 4(5)-methylimidazole and benzimidazole.  A common recurring motif throughout 
the crystallisations and the resulting molecular complexes was the generation of an 
imidazolium based ion with two of the nitrogen atoms on the molecules protonated.  This 
then generated moderate strength hydrogen bonds to the acetate groups created on the 
chlorophenoxyacetic acid molecules as a result of the deprotonation (Figure 299).   
 
Figure 346 - 3,4-D and imidazolium (N1···O3-O2···N1) chains. 
The 1-methyl benzimidazole complex, however, did not generate this motif due to the 
occupation of one of the nitrogen sites by the methyl group.  Instead an interesting π-
stacking driven structure was formed (Figure 331), with only one hydrogen bond existing 
between the 2,4-D and the 1-methylbenzimidazole nitrogen atom which, as a short, strong 
N-H-O hydrogen bond, is significantly stronger than the moderate strength chain 




Figure 347 - stacking of 2,4-D molecules with 1-methylbenzimidazole forming a π-π stacking chain. 
8.3.2 Thermal analysis of crystal structures 
The thermal analysis of these new materials all showed that the melting points of the 
generated molecular complexes were at a lower temperature than those of the 
agrichemical used in synthesis of the complex.  The new materials were therefore less 
thermally stable than the original compounds. 
The thermal analysis also revealed one sample for which a new material has likely formed 
but for which no crystal structure exists.  This is the result of crystallisation between 3,4-
dichlorophenoxyacetic acid and 1-methylbenzimidazole.  This should be investigated and 
fully characterised to complete the series of molecules investigated. 
8.4 Forward look 
Although the outcome of many of the experiments was unsuccessful in creating a stabilised 
molecular complex, a lot of new information was gathered about the target materials 
which may be used to further understand the interactions and limitations of these.  As such 
further investigation of these materials will be aided by this information, and finding a 
hosting method or a crystal engineering strategy which will perform the task needed for 
stabilisation is just a process of tuning the conditions and materials until the correct 
method is found. 
The solvent selection for crystallisation needs to be widened to find more possible 
environments for crystallisation of the peroxyacids as well as more in depth temperature 
screening, with more low temperature experiments to reduce available free energy in the 
systems. 
The crystallisation in host materials showed the most promise, with the cyclodextrin cage 
structures stable in presence of peroxyacids, and able to incorporate molecules of the 
correct size.  Further investigation needs to be carried out on these with greatly expanded 
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experimental conditions tested for inclusion of the materials with retention of the 
peroxyacid.  Again, finding the correct conditions for this to be achieved should be a 
process of elimination and then fine tuning until the target is achieved. 
The positive results on clays also propose a very promising direction for further work.  The 
intercalation of reactive materials into the pores of the material cannot only be limited to 
one target reactive molecule and this method may be applicable to reactive materials other 
than PAP. 
The agrichemical studies yielded many new structures clearly offers a rich vein for 
producing molecular complexes.  It was noted during the research into the 
chlorophenoxyacetic acids that no crystals exist with these materials in their protonated 
state, which in the work proved to create a much stronger hydrogen bond.  As such efforts 
should be made to direct the crystallisations towards retention of the carboxylic acid 
functionality of these materials for assessment of the change in physical properties. 
The most lacking feature in this research was time.  Given enough time, more complete 
investigations of the materials formed could be achieved, with many crystallisations and 
samples still requiring analysis.  One of the most important things to realise is that in this 
type of exploratory research every sample was a different experiment, with each of them 
are as important as the next; complete analysis of all samples is required for the full 
understanding to be achieved.  The answer may already be in a vial of crystals that hasn’t 
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APPENDICES – Experimental Data 
Appendix 1 –Crystallisation of Reactive Materials 
X-ray Powder Diffraction (XRPD) data 
 
Meta-chloroperbenzoic acid (MCPBA) 
 
AM01_01 – MCPBA + Methanol crystallised at room temperature 
 






Position [°2Theta] (Copper (Cu))
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AM01_03 – MCPBA + Ethanol crystallised at room temperature 
 
AM01_04 – MCPBA + Ethanol crystallised at 4°C 
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AM01_06 – MCPBA + Isopropanol crystallised at 4°C 
 
AM01_07 – MCPBA + Acetone crystallised at room temperature 
 
AM01_08 – MCPBA + Acetone crystallised at 4°C  
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AM35_06 – MCPBA + Methanol with hydrogen peroxide crystallised at 4°C 
 
 
AM35_07 - MCPBA + Methanol with hydrogen peroxide crystallised at room temperature 
 
 
AM34_01 – MCPBA + Methanol with hydrochloric acid crystallised at 4°C 
 
 
Position [°2Theta] (Copper (Cu))















AM34_04 – MCPBA + methanol with sodium hydroxide crystallised at room temperature 
 
 
AM34_06 – MCPBA + ethanol with hydrochloric acid crystallised at room temperature 
 
 
AM34_07 – MCPBA + ethanol with sodium hydroxide crystallised at 4°C 
 
 
Position [°2Theta] (Copper (Cu))
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6-Phthalimidoperoxyhexanoic acid (PAP) 
 
AM24_01 – 6-phthalimidoperoxyhexanoic acid + Methanol crystallised at 4°C 
 
 
AM24_02 – 6-phthalimidoperoxyhexanoic acid + Methanol crystallised at room 
temperature 
 
AM24_03 – 6-phthalimidoperoxyhexanoic acid +Ethanol crystallised at 4°C 
 
Position [°2Theta] (Copper (Cu))










AM24_05 – 6-phthalimidoperoxyhexanoic acid + isopropanol crystallised at 4°C 
 
 











AM24_07 – 6-phthalimidoperoxyhexanoic acid + chloroform crystallised at 4°C 
 
 
AM24_08 – 6-phthalimidoperoxyhexanoic acid + chloroform crystallised at room 
temperature 
 




AM24_10 – 6-phthalimidoperoxyhexanoic acid + acetone crystallised at room temperature 
 
AM24_11 – 6-phthalimidoperoxyhexanoic acid + diethyl ether crystallised at 4°C 
 





AM24_13 – 6-phthalimidoperoxyhexanoic acid + ethyl acetate crystallised at 4°C 
 
AM24_14 – 6-phthalimidoperoxyhexanoic acid + ethyl acetate crystallised at room 
temperature 
 





AM24_17 – 6-phthalimidoperoxyhexanoic acid + 1,4-dioxane crystallised at 4°C 
 
AM24_18 – 6-phthalimidoperoxyhexanoic acid + 1,4-dioxane crystallised at room 
temperature 
 
AM32_03 and AM32_04 – Repeat of 6-phthalimidoperoxyhexanoic acid + Acetone 
crystallised at 4°C 
 Position [°2Theta] (Copper (Cu))














AM32_05 and AM32_06 – Repeat of 6-phthalimidoperoxyhexanoic acid + acetone 
crystallised at room temperature 
 
AM32_07 – 6-phthalimidoperoxyhexanoic acid + Acetone crystallised at 30°C 
AM32_08 – 6-phthalimidoperoxyhexanoic acid +Acetone crystallised at 50°C 
 
Position [°2Theta] (Copper (Cu))














Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM32_09 – 6-phthalimidoperoxyhexanoic acid + methyl acetate crystallised at 4°C 
 
AM32_10 – 6-phthalimidoperoxyhexanoic acid + methyl acetate crystallised at room 
temperature 
 
AM32_11 – 6-phthalimidoperoxyhexanoic acid + methyl acetate crystallised at 30°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








AM32_12 – 6-phthalimidoperoxyhexanoic acid + methanol with hydrogen peroxide 
crystallised at 4°C 
 
AM32_14 – 6-phthalimidoperoxyhexanoic acid + methanol with hydrogen peroxide 
crystallised at 30°C 
 
AM32_15 – 6-phthalimidoperoxyhexanoic acid + ethanol with hydrogen peroxide 
crystallised at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM32_16 – 6-phthalimidoperoxyhexanoic acid + ethanol with hydrogen peroxide 
crystallised at room temperature 
 
 
AM32_17 – 6-phthalimidoperoxyhexanoic acid + ethanol with hydrogen peroxide 
crystallised at 30°C 
 
  
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







AM33_01 – 6-phthalimidoperoxyhexanoic acid + methanol with hydrochloric acid 
crystallised at 4°C 
 
AM33_02 – 6-phthalimidoperoxyhexanoic acid + methanol with hydrochloric acid 
crystallised at room temperature 
 
AM33_03 – 6-phthalimidoperoxyhexanoic acid + ethanol with hydrochloric acid crystallised 
at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM33_04 – 6-phthalimidoperoxyhexanoic acid + ethanol with hydrochloric acid crystallised 
at room temperature 
 
AM33_06 – 6-phthalimidoperoxyhexanoic acid + methanol with sodium hydroxide 
crystallised at room temperature 
 
AM33_07 – 6-phthalimidoperoxyhexanoic acid + ethanol with sodium hydroxide 
crystallised at 4°C 
 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM33_08 – 6-phthalimidoperoxyhexanoic acid + ethanol with sodium hydroxide 
crystallised at room temperature 
 
  
Position [°2Theta] (Copper (Cu))













Cocrystallisations with carboxylic acids 
Peroxyacetic acid and 2-chlorobenzoic acid 
 
AM02_01 – PAA + 2-chlorobenzoic acid crystallised in acetone at 4°C 
 






Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))









AM02_04 – PAA + 2-chlorobenzoic acid crystallised in methanol at room temperature 
 
 
AM02_05 – PAA + 2-chlorobenzoic acid crystallised in ethanol at 4°C 
 
AM02_06 – PAA + 2-chlorobenzoic acid crystallised in ethanol at room temperature 
 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM02_07 – PAA + 2-chlorobenzoic acid crystallised in isopropanol at 4°C 
 
 
AM02_08 – PAA + 2-chlorobenzoic acid crystallised in isopropanol at room temperature 
 
AM02_09 – PAA + 2-chlorobenzoic acid crystallised in chloroform at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Peroxyacetic acid and 3-chlorobenzoic acid 
 
AM03_01 PAA + 3-chlorobenzoic acid crystallised in acetone at 4°C 
 
AM03_03 PAA + 3-chlorobenzoic acid crystallised in methanol at 4°C 
 
AM03_04 PAA + 3-chlorobenzoic acid crystallised in methanol at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








AM03_05 PAA + 3-chlorobenzoic acid crystallised in ethanol at 4°C 
 
 
AM03_06 PAA + 3-chlorobenzoic acid crystallised in ethanol at room temperature 
 
 
AM03_07 PAA + 3-chlorobenzoic acid crystallised in isopropanol at 4°C 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









Peroxyacetic acid and 4-chlorobenzoic acid 
 
AM04_01 PAA + 4-chlorobenzoic acid crystallised in acetone at 4°C 
 
AM04_02 PAA + 4-chlorobenzoic acid crystallised in acetone at room temperature 
 
AM04_03 PAA + 4-chlorobenzoic acid crystallised in methanol at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







AM04_04 PAA + 4-chlorobenzoic acid crystallised in methanol at room temperature 
 
 
AM04_06 PAA + 4-chlorobenzoic acid crystallised in ethanol at room temperature 
 
 
AM04_07 PAA + 4-chlorobenzoic acid crystallised in isopropanol at 4°C 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM04_08 PAA + 4-chlorobenzoic acid crystallised in isopropanol at room temperature 
 
 
Peroxyacetic acid and 2-picolinic acid 
AM05_01 PAA + 2-picolinic acid crystallised in acetone at 4°C 
 
AM05_02 PAA + 2-picolinic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







AM05_03 PAA + 2-picolinic acid crystallised in chloroform at 4°C 
 
 
AM05_04 PAA + 2-picolinic acid crystallised in chloroform at room temperature 
 
 
AM05_06 PAA + 2-picolinic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








Peroxyacetic acid and 1-naphthaleneacetic acid 
AM06_01 PAA + 1-Naphthaleneacetic acid crystallised in acetone at 4°C 
 
 
AM06_02 PAA + 1-Naphthaleneacetic acid crystallised in acetone at room temperature 
 
 
AM06_03 PAA + 1-Naphthaleneacetic acid crystallised in chloroform at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







AM06_05 PAA + 1-Naphthaleneacetic acid crystallised in diethyl ether at 4°C 
 
 
AM06_07 PAA + 1-Naphthaleneacetic acid crystallised in ethyl acetate at 4°C 
 
 
AM06_08 PAA + 1-Naphthaleneacetic acid crystallised in ethyl acetate at room 
temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))













Peroxyacetic acid and Salicylic acid 
AM08_01 PAA + Salicylic acid crystallised in acetone at 4°C 
 
AM08_02 PAA + Salicylic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))










AM08_03 PAA + Salicylic acid crystallised in chloroform at 4°C 
 
 
AM08_04 PAA + Salicylic acid crystallised in chloroform at room temperature 
 
 
AM08_05 PAA + Salicylic acid crystallised in diethyl ether at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM08_06 PAA + Salicylic acid crystallised in diethyl ether at room temperature 
 
 
AM08_07 PAA + Salicylic acid crystallised in ethyl acetate at 4°C 
 
 
AM08_08 PAA + Salicylic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM08_09 PAA + Salicylic acid crystallised in acetonitrile at 4°C 
 
 
AM08_10 PAA + Salicylic acid crystallised in acetonitrile at room temperature 
 
 
Peroxyacetic acid and 3-hydroxybenzoic acid 
AM09_01 – PAA + 3-hydroxybenzoic acid crystallised in acetone at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM09_02 – PAA + 3-hydroxybenzoic acid crystallised in acetone at room temperature 
 
 
AM09_05 – PAA + 3-hydroxybenzoic acid crystallised in diethyl ether at 4°C 
 
 
AM09_06 – PAA + 3-hydroxybenzoic acid crystallised in diethyl ether at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM09_07 – PAA + 3-hydroxybenzoic acid crystallised in ethyl acetate at 4°C 
 
 
AM09_08 – PAA + 3-hydroxybenzoic acid crystallised in ethyl acetate at room temperature 
 
 
AM09_09 – PAA + 3-hydroxybenzoic acid crystallised in acetonitrile at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM09_10 – PAA + 3-hydroxybenzoic acid crystallised in acetonitrile at room temperature 
 
 
Peroxyacetic acid and Malonic acid 
AM18_01 – PAA + Malonic acid crystallised in acetone at 4°C 
 
AM18_02 – PAA + Malonic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM18_03 – PAA + Malonic acid crystallised in acetone at 4°C 
 
 
AM18_04 – PAA + Malonic acid crystallised in acetone at room temperature 
 
 
AM18_05 – PAA + Malonic acid crystallised in acetone at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM18_06 – PAA + Malonic acid crystallised in acetone at room temperature 
 
 
AM18_07 – PAA + Malonic acid crystallised in acetone at 4°C 
 
 
AM18_08 – PAA + Malonic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))









Peroxyacetic acid and oxalic acid 
AM19_01 – PAA + oxalic acid crystallised in acetone at room temperature 
 
 
AM19_02 – PAA + oxalic acid crystallised in acetone at 4°C 
 
M19_05 – PAA + oxalic acid crystallised in diethyl ether at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))







AM19_06 – PAA + oxalic acid crystallised in diethyl ether at 4°C 
 
 
AM19_07 – PAA + oxalic acid crystallised in ethyl acetate at room temperature 
 
MCPBA and 2-chlorobenzoic acid 
AM10_01 MCPBA + 2-chlorobenzoic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM10_02 MCPBA + 2-chlorobenzoic acid crystallised in acetone at 4°C 
 
 
AM10_03 MCPBA + 2-chlorobenzoic acid crystallised in chloroform at room temperature 
 
AM10_04 MCPBA + 2-chlorobenzoic acid crystallised in chloroform at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM10_05 MCPBA + 2-chlorobenzoic acid crystallised in diethyl ether at room temperature 
 
AM10_06 MCPBA + 2-chlorobenzoic acid crystallised in diethyl ether at 4°C 
 
AM10_07 MCPBA + 2-chlorobenzoic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM10_08 MCPBA + 2-chlorobenzoic acid crystallised in ethyl acetate at 4°C 
 
MCPBA and 3-chlorobenzoic acid 
AM10_01 MCPBA + 2-chlorobenzoic acid crystallised in acetone at room temperature 
 
AM10_02 MCPBA + 2-chlorobenzoic acid crystallised in acetone at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM10_03 MCPBA + 2-chlorobenzoic acid crystallised in chloroform at room temperature 
 
 
AM10_04 MCPBA + 2-chlorobenzoic acid crystallised in chloroform at 4°C 
 
 
AM10_05 MCPBA + 2-chlorobenzoic acid crystallised in diethyl ether at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM10_06 MCPBA + 2-chlorobenzoic acid crystallised in diethyl ether at 4°C 
 
AM10_07 MCPBA + 2-chlorobenzoic acid crystallised in ethyl acetate at room temperature 
 
 
AM10_08 MCPBA + 2-chlorobenzoic acid crystallised in ethyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









MCPBA and 4-chlorobenzoic acid 
AM12_01 – MCPBA + 4-chlorobenzoic acid crystallised in acetone at room temperature 
 
AM12_02 – MCPBA + 4-chlorobenzoic acid crystallised in acetone at 4°C 
 
AM12_03 – MCPBA + 4-chlorobenzoic acid crystallised in chloroform at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM12_04 – MCPBA + 4-chlorobenzoic acid crystallised in chloroform at 4°C 
 
AM12_05 – MCPBA + 4-chlorobenzoic acid crystallised in diethyl ether at room 
temperature 
 
AM12_06 – MCPBA + 4-chlorobenzoic acid crystallised in diethyl ether at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM12_07 – MCPBA + 4-chlorobenzoic acid crystallised in ethyl acetate at room 
temperature 
 
AM12_08 – MCPBA + 4-chlorobenzoic acid crystallised in ethyl acetate at 4°C 
 
MCPBA and 1-napthaleneacetic acid 
AM13_01 – MCPBA + 1-naphthaleneacetic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))









AM13_02 – MCPBA + 1-naphthaleneacetic acid crystallised in acetone at 4°C 
 
AM13_03 – MCPBA + 1-naphthaleneacetic acid crystallised in chloroform at room 
temperature 
 
AM13_04 – MCPBA + 1-naphthaleneacetic acid crystallised in chloroform at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))












AM13_06 – MCPBA + 1-naphthaleneacetic acid crystallised in diethyl ether at 4°C 
 
  
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM13_07 – MCPBA + 1-naphthaleneacetic acid crystallised in ethyl acetate at room 
temperature 
 
AM13_08 – MCPBA + 1-naphthaleneacetic acid crystallised in ethyl acetate at 4°C 
 
  
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







MCPBA and 2-hydroxybenzoic acid 
AM14_01 – MCPBA + salicylic acid crystallised in acetone at room temperature 
 
AM14_02 – MCPBA + salicylic acid crystallised in acetone at 4°C 
 
AM14_03 – MCPBA + salicylic acid crystallised in chloroform at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM14_04 – MCPBA + salicylic acid crystallised in chloroform at 4°C 
 
AM14_05 – MCPBA + salicylic acid crystallised in diethyl ether at room temperature 
 
AM14_06 – MCPBA + salicylic acid crystallised in diethyl ether at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))









AM14_07 – MCPBA + salicylic acid crystallised in ethyl acetate at room temperature 
 
AM14_08 – MCPBA + salicylic acid crystallised in ethyl acetate at 4°C 
 
MCPBA and 3-hydroxybenzoic acid 
AM15_01 – MCPBA + 3-hydroxybenzoic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM15_02 – MCPBA + 3-hydroxybenzoic acid crystallised in acetone at 4°C 
 
AM15_03 – MCPBA + 3-hydroxybenzoic acid crystallised in chloroform at room 
temperature 
 
AM15_04 – MCPBA + 3-hydroxybenzoic acid crystallised in chloroform at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))










AM15_05 – MCPBA + 3-hydroxybenzoic acid crystallised in diethyl ether at room 
temperature 
 
AM15_06 – MCPBA + 3-hydroxybenzoic acid crystallised in diethyl ether at 4°C 
 
AM15_07 – MCPBA + 3-hydroxybenzoic acid crystallised in ethyl acetate at room 
temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM15_08 – MCPBA + 3-hydroxybenzoic acid crystallised in ethyl acetate at 4°C 
 
MCPBA and malonic acid 
AM22_01 – MCPBA + malonic acid crystallised in acetone at room temperature 
 
AM22_02 – MCPBA + malonic acid crystallised in acetone at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








AM22_03 – MCPBA + malonic acid crystallised in chloroform at room temperature 
 
AM22_04 – MCPBA + malonic acid crystallised in chloroform at 4°C 
 
AM22_05 – MCPBA + malonic acid crystallised in diethyl ether at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM22_06 – MCPBA + malonic acid crystallised in diethyl ether at 4°C 
 
AM22_07 – MCPBA + malonic acid crystallised in ethyl acetate at room temperature 
 
AM22_08 – MCPBA + salicylic acid crystallised in ethyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








MCPBA and oxalic acid 
AM23_01 – MCPBA + oxalic acid crystallised in acetone at room temperature 
 
AM23_02 – MCPBA + oxalic acid crystallised in acetone at 4°C 
 
AM23_03 – MCPBA + oxalic acid crystallised in chloroform at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))










AM23_04 – MCPBA + oxalic acid crystallised in chloroform at 4°C 
 
AM23_05 – MCPBA + oxalic acid crystallised in diethyl ether at room temperature 
 
AM23_06 – MCPBA + oxalic acid crystallised in diethyl ether at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM23_08 – MCPBA + oxalic acid crystallised in ethyl acetate at 4°C 
 
MCPBA and chloranilic acid 
AM64_01 – MCPBA + chloranilic acid crystallised in acetone at 4°C 
 
AM64_02 – MCPBA + chloranilic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))










AM64_04 – MCPBA + chloranilic acid crystallised in methyl acetate at room temperature 
 
 
AM64_05 – MCPBA + chloranilic acid crystallised in ethyl acetate ether at 4°C 
 
AM64_07 – MCPBA + chloranilic acid crystallised in diethyl ether at 4°C 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









MCPBA and bromanilic acid 
AM65_01 – MCPBA + bromanilic acid crystallised in acetone at 4°C 
 
AM65_02 – MCPBA + bromanilic acid crystallised in acetone at room temperature 
 
AM65_03 – MCPBA + bromanilic acid crystallised in methyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))










AM65_04 – MCPBA + bromanilic acid crystallised in methyl acetate at room temperature 
 
AM65_05 – MCPBA + bromanilic acid crystallised in ethyl acetate at 4°C 
 
AM65_06 – MCPBA + bromanilic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM65_07 – MCPBA + bromanilic acid crystallised in diethyl ether at 4°C 
 
AM65_08 – MCPBA + bromanilic acid crystallised in diethyl ether at room temperature 
 
PAP and 2-chlorobenzoic acid 
AM26_01 – PAP + 2-chlorobenzoic acid crystallised in methanol at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM26_02 – PAP + 2-chlorobenzoic acid crystallised in methanol at room temperature 
 
AM26_03 – PAP + 2-chlorobenzoic acid crystallised in methanol at 30°C 
 
AM26_04 – PAP + 2-chlorobenzoic acid crystallised in ethanol at 4°C 
 







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








AM26_05 – PAP + 2-chlorobenzoic acid crystallised in ethanol at room temperature 
 
AM26_06 – PAP + 2-chlorobenzoic acid crystallised in ethanol at 30°C 
 
AM26_07 – PAP + 2-chlorobenzoic acid crystallised in acetone at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM26_08 – PAP + 2-chlorobenzoic acid crystallised in acetone at room temperature 
 
AM26_09 – PAP + 2-chlorobenzoic acid crystallised in acetone at 30°C 
 
AM26_11 – PAP + 2-chlorobenzoic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM26_12 – PAP + 2-chlorobenzoic acid crystallised in ethyl acetate at 30°C 
 
PAP and 3-chlorobenzoic acid 
AM25_01 – PAP + 3-chlorobenzoic acid crystallised in methanol at 4°C 
 
AM25_02 – PAP + 3-chlorobenzoic acid crystallised in methanol at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM25_03 – PAP + 3-chlorobenzoic acid crystallised in methanol at 30°C 
 
AM25_05 – PAP + 3-chlorobenzoic acid crystallised in ethanol at room temperature 
 
AM25_06 – PAP + 3-chlorobenzoic acid crystallised in ethanol at 30°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM25_07 – PAP + 3-chlorobenzoic acid crystallised in acetone at 4°C 
 
AM25_08 – PAP + 3-chlorobenzoic acid crystallised in acetone at room temperature 
 
AM25_09 – PAP + 3-chlorobenzoic acid crystallised in acetone at 30°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM25_10 – PAP + 3-chlorobenzoic acid crystallised in ethyl acetate at 4°C 
 
AM25_11 – PAP + 3-chlorobenzoic acid crystallised in ethyl acetate at room temperature 
 
AM25_12 – PAP + 3-chlorobenzoic acid crystallised in ethyl acetate at 30°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








PAP and 4-chlorobenzoic acid 
AM27_01 – PAP + 4-chlorobenzoic acid crystallised in methanol at 4°C 
 
AM27_02 – PAP + 4-chlorobenzoic acid crystallised in methanol at room temperature 
 
AM27_03 – PAP + 4-chlorobenzoic acid crystallised in methanol at 30°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))










AM27_04 – PAP + 4-chlorobenzoic acid crystallised in ethanol at 4°C 
 
AM27_05 – PAP + 4-chlorobenzoic acid crystallised in ethanol at room temperature 
 
AM27_06 – PAP + 4-chlorobenzoic acid crystallised in ethanol at 30°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM27_07 – PAP + 4-chlorobenzoic acid crystallised in acetone at 4°C 
 
AM27_08 – PAP + 4-chlorobenzoic acid crystallised in acetone at room temperature 
 
AM27_10 – PAP + 4-chlorobenzoic acid crystallised in ethyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM27_11 – PAP + 4-chlorobenzoic acid crystallised in ethyl acetate at room temperature 
 
AM27_12 – PAP + 4-chlorobenzoic acid crystallised in ethyl acetate at 30°C 
 
PAP and 1-naphthaleneacetic acid 
AM28_01 – PAP + 1-naphthaleneacetic acid crystallised in methanol at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







AM28_03 – PAP + 1-naphthaleneacetic acid crystallised in methanol at 30°C 
 
AM28_04 – PAP + 1-naphthaleneacetic acid crystallised in ethanol at 4°C 
 
AM28_05 – PAP + 1-naphthaleneacetic acid crystallised in ethanol at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM28_06 – PAP + 1-naphthaleneacetic acid crystallised in ethanol at 30°C 
 
AM28_07 – PAP + 1-naphthaleneacetic acid crystallised in acetone at 4°C 
 
AM28_08 – PAP + 1-naphthaleneacetic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM28_09 – PAP + 1-naphthaleneacetic acid crystallised in acetone at 30°C 
 
AM28_10 – PAP + 1-naphthaleneacetic acid crystallised in ethyl acetate at 4°C 
 
AM28_11 – PAP + 1-naphthaleneacetic acid crystallised in ethyl acetate at room 
temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM28_12 – PAP + 1-naphthaleneacetic acid crystallised in ethyl acetate at 30°C 
 
AM28_13 – PAP + 1-naphthaleneacetic acid crystallised in diethyl ether at 4°C 
 
AM28_14 – PAP + 1-naphthaleneacetic acid crystallised in diethyl ether at room 
temperature 
 
Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM28_15 – PAP + 1-naphthaleneacetic acid crystallised in diethyl ether at 30°C 
 
PAP and Salicylic acid 
AM29_01 – PAP + salicylic acid crystallised in methanol at 4°C 
 
AM29_02 – PAP + salicylic acid crystallised in methanol at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








AM29_03 – PAP + salicylic acid crystallised in methanol at 30°C 
 
AM29_04 – PAP + salicylic acid crystallised in ethanol at 4°C 
 
AM29_05 – PAP + salicylic acid crystallised in ethanol at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM29_06 – PAP + salicylic acid crystallised in ethanol at 30°C 
 
AM29_07 – PAP + salicylic acid crystallised in acetone at 4°C 
 
AM29_08 – PAP + salicylic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM29_09 – PAP + salicylic acid crystallised in acetone at 30°C 
 
AM29_10 – PAP + salicylic acid crystallised in ethyl acetate at 4°C 
 
AM29_11 – PAP + salicylic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM29_12 – PAP + salicylic acid crystallised in ethyl acetate at 30°C 
 
AM29_13 – PAP + salicylic acid crystallised in ethyl acetate at 4°C 
 
AM29_14 – PAP + salicylic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM29_15 – PAP + salicylic acid crystallised in ethyl acetate at 30°C 
 
PAP and 3-hydroxybenzoic acid 
AM30_01 – PAP + 3-hydroxybenzoic acid crystallised in methanol at 4°C 
 
AM30_02 – PAP + 3-hydroxybenzoic acid crystallised in methanol at room temperature 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM30_03 – PAP + 3-hydroxybenzoic acid crystallised in methanol at 30°C 
 
AM30_04 – PAP + 3-hydroxybenzoic acid crystallised in ethanol at 4°C 
 
AM30_05 – PAP + 3-hydroxybenzoic acid crystallised in ethanol at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))










AM30_06 – PAP + 3-hydroxybenzoic acid crystallised in ethanol at 30°C 
 
AM30_07 – PAP + 3-hydroxybenzoic acid crystallised in acetone at 4°C 
 
AM30_08 – PAP + 3-hydroxybenzoic acid crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








AM30_09 – PAP + 3-hydroxybenzoic acid crystallised in acetone at 30°C 
 
AM30_10 – PAP + 3-hydroxybenzoic acid crystallised in ethyl acetate at 4°C 
 
AM30_11 – PAP + 3-hydroxybenzoic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))










AM30_12 – PAP + 3-hydroxybenzoic acid crystallised in ethyl acetate at 30°C 
 
AM30_13 – PAP + 3-hydroxybenzoic acid crystallised in ethyl acetate at 4°C 
 
AM30_14 – PAP + 3-hydroxybenzoic acid crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







AM30_15 – PAP + 3-hydroxybenzoic acid crystallised in ethyl acetate at 30°C 
 
PAP and malonic acid 
AM38_14 – PAP + Malonic acid with hydrogen peroxide crystallised in acetone at 4°C 
 
AM38_15 – PAP + Malonic acid with hydrogen peroxide crystallised in acetone at room 
temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








PAP and oxalic acid 
AM38_17 – PAP + Malonic acid with hydrogen peroxide crystallised in acetone at 4°C 
 
AM38_18 – PAP + Malonic acid with hydrogen peroxide crystallised in acetone at room 
temperature 
 
PAP and chloranilic acid 
AM66_02 – PAP + chloranilic acid with hydrogen peroxide crystallised in acetone at room 
temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM66_03 – PAP + chloranilic acid with hydrogen peroxide crystallised in methyl acetate at 
4°C 
 
AM66_05– PAP + chloranilic acid with hydrogen peroxide crystallised in ethyl acetate at 4°C 
 
AM66_06 – PAP + chloranilic acid with hydrogen peroxide crystallised in ethyl acetate at 
room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









PAP and bromanilic acid 
AM67_01 – PAP + bromanilic acid with hydrogen peroxide crystallised in acetone at 4°C 
 




Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))










Cocrystallisations with π-π interacting materials 
MCPBA and 1,4-Dihydroxybenzene 
AM68_02 – MCPBA + 1,4-dihydroxybenzene with hydrogen peroxide crystallised in acetone 
at room temperature 
 
MCPBA and 2-hydroxybenzophenone 
AM80_01 – MCPBA + 2-hydroxybenzophenone with hydrogen peroxide crystallised in 
acetone at 4°C 
 
AM80_03 – MCPBA + 2-hydroxybenzophenone with hydrogen peroxide crystallised in 
methyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM80_07 – MCPBA + 2-hydroxybenzophenone with hydrogen peroxide crystallised in 
diethyl ether at 4°C 
 
MCPBA and 3-hydroxybenzophenone 
AM82_01 – MCPBA + 3-hydroxybenzophenone with hydrogen peroxide crystallised in 
acetone at 4°C 
 
AM82_03 – MCPBA + 3-hydroxybenzophenone with hydrogen peroxide crystallised in 
methyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))









AM82_05 – MCPBA + 3-hydroxybenzophenone with hydrogen peroxide crystallised in ethyl 
acetate at 4°C 
 
AM82_07 – MCPBA + 3-hydroxybenzophenone with hydrogen peroxide crystallised in 
diethyl ether at 4°C 
 
MCPBA and 2-chlorobenzophenone 
AM104_05 – MCPBA + 2-chlorobenzophenone with hydrogen peroxide crystallised in 
methyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))


















PAP and 2-hydroxybenzophenone 
AM81_01 – PAP + 2-hydroxybenzophenone with hydrogen peroxide crystallised in acetone 
at 4°C 
 
AM81_03 - PAP + 2-hydroxybenzophenone with hydrogen peroxide crystallised in methyl 
acetate at 4°C 
 
PAP and 3-hydroxybenzophenone 
AM83_01 – PAP + 3-hydroxybenzophenone with hydrogen peroxide crystallised in acetone 
at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







AM83_02 - PAP + 3-hydroxybenzophenone with hydrogen peroxide crystallised in acetone 
at room temperature 
 
AM83_03 - PAP + 3-hydroxybenzophenone with hydrogen peroxide crystallised in methyl 
acetate at 4°C 
 
AM83_05 - PAP + 3-hydroxybenzophenone with hydrogen peroxide crystallised in ethyl 
acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))










AM83_07 - PAP + 3-hydroxybenzophenone with hydrogen peroxide crystallised in diethyl 
ether at 4° 
 
PAP and Benzimidazole 
AM31_02 – PAP + Benzimidazole crystallised in methanol at room temperature 
 
AM31_05 – PAP + Benzimidazole crystallised in ethanol at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))










AM31_06 – PAP + Benzimidazole crystallised in ethanol at 30°C 
 
AM31_07 – PAP + Benzimidazole crystallised in acetone at 4°C 
 
AM31_08 – PAP + Benzimidazole crystallised in acetone at room temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM31_09 – PAP + Benzimidazole crystallised in acetone at 30°C 
 
AM31_10 – PAP + Benzimidazole crystallised in ethyl acetate at 4°C 
 
AM31_11 – PAP + Benzimidazole crystallised in ethyl acetate at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM31_12 – PAP + Benzimidazole crystallised in ethyl acetate at 30°C 
 
AM31_13 – PAP + Benzimidazole crystallised in diethyl ether at 4°C 
 
AM31_14 – PAP + Benzimidazole crystallised in diethyl ether at room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM31_15 – PAP + Benzimidazole crystallised in diethyl ether at 30°C 
 
Crystallisations with metals 
MCPBA and magnesium chloride 
AM50_01 – MCPBA + magnesium chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
AM50_04 – MCPBA + magnesium chloride with hydrogen peroxide in chloroform at 4°C 
 
Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))









AM50_08 – MCPBA + magnesium chloride with hydrogen peroxide in acetone at room 
temperature 
 
AM50_10 – MCPBA + magnesium chloride with hydrogen peroxide in diethyl ether at 4°C 
 
AM50_13 – MCPBA + magnesium chloride with hydrogen peroxide in dichloromethane at 
4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM50_14 – MCPBA + magnesium chloride with hydrogen peroxide in dichloromethane at 
room temperature 
 
AM50_16 – MCPBA + magnesium chloride with hydrogen peroxide in methanol at 4°C 
  
AM50_22 – MCPBA + magnesium chloride with hydrogen peroxide in isopropanol at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM50_25 – MCPBA + magnesium chloride with hydrogen peroxide in ethanol at 4°C 
 
AM50_26 – MCPBA + magnesium chloride with hydrogen peroxide in ethanol at room 
temperature 
 
MCPBA and calcium chloride 
AM53_01 – MCPBA + calcium chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))















AM53_02 – MCPBA + calcium chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
AM53_13 – MCPBA + calcium chloride with hydrogen peroxide in dichloromethane at 4°C 
 
AM53_19 – MCPBA + calcium chloride with hydrogen peroxide in methyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))







AM53_22 – MCPBA + calcium chloride with hydrogen peroxide in isopropanol at 4°C 
 
MCPBA and copper chloride 
AM86_03 – MCPBA + copper chloride with hydrogen peroxide in methyl acetate at 4°C 
 
AM86_0 5– MCPBA + copper chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))









AM86_07 – MCPBA + copper chloride with hydrogen peroxide in diethyl ether at 4°C 
 
MCPBA and Copper sulfate 
AM87_03 – MCPBA + copper sulfate with hydrogen peroxide in methyl acetate at 4°C 
 
AM87_0 5– MCPBA + copper sulfate with hydrogen peroxide in ethyl acetate at 4°C 
 
Position [°2Theta] (Copper (Cu))














Position [°2Theta] (Copper (Cu))









AM87_07 – MCPBA + copper sulfate with hydrogen peroxide in diethyl ether at 4°C 
 
PAP and magnesium chloride 
AM51_01 – PAP + magnesium chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
AM51_02 – PAP + magnesium chloride with hydrogen peroxide in ethyl acetate at room 
temperature 
 
Position [°2Theta] (Copper (Cu))
















Position [°2Theta] (Copper (Cu))








AM51_04 – PAP + magnesium chloride with hydrogen peroxide in chloroform at 4°C 
 
AM51_07 – PAP + magnesium chloride with hydrogen peroxide in acetone at 4°C 
 
AM51_08 – PAP + magnesium chloride with hydrogen peroxide in acetone at room 
temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM51_10 – PAP + magnesium chloride with hydrogen peroxide in diethyl ether at 4°C 
 
AM51_11 – PAP + magnesium chloride with hydrogen peroxide in diethyl ether at room 
temperature 
 
AM51_14 – PAP + magnesium chloride with hydrogen peroxide in dichloromethane at 
room temperature 
 
Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








AM51_19 – PAP + magnesium chloride with hydrogen peroxide in methyl acetate at 4°C 
 
AM51_25 – PAP + magnesium chloride with hydrogen peroxide in ethanol at 4°C 
 
AM51_26 – PAP + magnesium chloride with hydrogen peroxide in ethanol at room 
temperature 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))

















PAP and calcium chloride 
AM54_01 – PAP + calcium chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
AM54_07 – PAP + calcium chloride with hydrogen peroxide in acetone at 4°C 
 
AM54_10 – PAP + calcium chloride with hydrogen peroxide in diethyl ether at 4°C 
 
Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))








AM54_19 – PAP + calcium chloride with hydrogen peroxide in methyl acetate at 4°C 
 
AM54_20 – PAP + calcium chloride with hydrogen peroxide in methyl acetate at room 
temperature 
 
PAP and copper chloride 
AM88_01 – PAP + copper chloride with hydrogen peroxide in acetone at 4°C 
 
Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








AM88_03 – PAP + copper chloride with hydrogen peroxide in methyl acetate at 4°C 
 
AM88_05 – PAP + copper chloride with hydrogen peroxide in ethyl acetate at 4°C 
 
  
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Appendix 3 –Hosting Reactive Peroxides in Layered Materials 
XRPD Data 
 
Urea based hosting 




Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))














Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))













Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))












Position [°2Theta] (Copper (Cu))







Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))











Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))











Urea and 6-phthalimidoperoxyhexanoic acid 
 
Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))











Position [°2Theta] (Copper (Cu))






Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))











Urea and meta-chloroperbenzoic acid 
 
Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))












Position [°2Theta] (Copper (Cu))








Position [°2Theta] (Copper (Cu))





Position [°2Theta] (Copper (Cu))















Position [°2Theta] (Copper (Cu))





600  AM45_03 - Bentonite 3 minute grind full







 AM45_03 Short Blank Bentonite Grind












Position [°2Theta] (Copper (Cu))






400  AM49_03 Bentonite and Peroxacetic acid







 AM49_03 Short Peroxyacetic acid and bentonite
Position [°2Theta] (Copper (Cu))



















 am55_03 short MCPBA 3 minute grind
Position [°2Theta] (Copper (Cu))


















1500  am56_03 Short PAP 3 minute grind
Position [°2Theta] (Copper (Cu))






 AM59_03 Long MCPBA and bentonite


















 AM60_03 PAP and bentonite immediate scan
Position [°2Theta] (Copper (Cu))





 AM60_03 PAP and bentonite longer scan




















 am60_03 Short PAP and Bentonite








 AM61_01 MCPBA and bentonite acetone drop







 AM61_03 PAP and bentonite acetone drop
450 
 
Bentonite and 6-phthalimidoperoxyhexanoic acid incrementing PAP:Bentonite 
ratio 
 













































































































Bentonite and 6-phthalimidohexanoic acid incrementing Acid:Bentonite ratio 
 





































































































Appendix 4 – Cocrystallisation of Agrichemicals 






















40 60 80 100 120 140 160 180
Temperature (°C)
Sample: AM_24D
Size:  5.9000 mg
Method: Alan SM heat and cool




Run Date: 22-Jan-2013 14:55
Instrument: DSC Q20 V24.10 Build 122

















40 60 80 100 120 140 160
Temperature (°C)
Sample: AM_34D
Size:  5.4000 mg
Method: Alan SM heat and cool




Run Date: 22-Jan-2013 15:41
Instrument: DSC Q20 V24.10 Build 122


























40 60 80 100 120 140 160
Temperature (°C)
Sample: AM_IMIDAZOLE
Size:  5.4000 mg
Method: Alan SM heat and cool




Run Date: 22-Jan-2013 16:15
Instrument: DSC Q20 V24.10 Build 122


















20 40 60 80 100 120
Temperature (°C)
Sample: AM_METHYLIMIDAZOLE
Size:  6.8000 mg
Method: Alan SM heat and cool




Run Date: 22-Jan-2013 17:45
Instrument: DSC Q20 V24.10 Build 122























40 60 80 100 120 140 160 180 200
Temperature (°C)
Sample: AM_BENZIMIDAZOLE
Size:  3.4000 mg
Method: Alan SM heat and cool




Run Date: 22-Jan-2013 17:04
Instrument: DSC Q20 V24.10 Build 122


















20 40 60 80 100 120
Temperature (°C)
Sample: AM_1METHYlBENZIMIDAZOLE
Size:  7.6000 mg
Method: Alan SM heat and cool




Run Date: 22-Jan-2013 18:38
Instrument: DSC Q20 V24.10 Build 122
Exo Up Universal V4.5A TA Instruments
460 
 
DSC of collected products 
2,4-Dichlorophenoxyacetic acid and Imidazole 
 


















20 40 60 80 100 120 140 160 180 200
Temperature (°C)
Sample: AM120_04
Size:  4.9000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM120_04.001
Operator: AlanM
Run Date: 24-Jan-2013 16:20
Instrument: DSC Q20 V24.10 Build 122


















20 40 60 80 100 120 140 160 180
Temperature (°C)
Sample: AM121_05
Size:  5.0000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM121_05.001
Operator: AlanM
Run Date: 24-Jan-2013 17:02
Instrument: DSC Q20 V24.10 Build 122
Exo Up Universal V4.5A TA Instruments
461 
 
2,4-Dichlorophenoxyacetic acid and 4(5)-methylimidazole 
 


















20 40 60 80 100 120 140 160 180 200
Temperature (°C)
Sample: AM124_09
Size:  4.4000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM124_09.001
Operator: AlanM
Run Date: 25-Jan-2013 14:31
Instrument: DSC Q20 V24.10 Build 122

















0 50 100 150 200 250
Temperature (°C)
Sample: AM125_05
Size:  4.2000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM125_05.001
Operator: AlanM
Run Date: 25-Jan-2013 15:24
Instrument: DSC Q20 V24.10 Build 122
Exo Up Universal V4.5A TA Instruments
462 
 
2,4-Dichlorophenoxyacetic acid and benzimidazole 
 



















0 50 100 150 200 250
Temperature (°C)
Sample: AM122_06
Size:  3.2000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM122_06.001
Operator: AlanM
Run Date: 24-Jan-2013 17:40
Instrument: DSC Q20 V24.10 Build 122



















0 50 100 150 200 250
Temperature (°C)
Sample: AM123_09
Size:  5.9000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM123_09.001
Operator: AlanM
Run Date: 24-Jan-2013 18:24
Instrument: DSC Q20 V24.10 Build 122
Exo Up Universal V4.5A TA Instruments
463 
 
2,4-Dichlorophenoxyacetic acid and1-methylbenzimidazole 
 



















0 50 100 150 200 250
Temperature (°C)
Sample: AM126_05
Size:  4.9000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM126_05.001
Operator: AlanM
Run Date: 25-Jan-2013 16:13
Instrument: DSC Q20 V24.10 Build 122

















20 40 60 80 100 120 140 160 180 200
Temperature (°C)
Sample: AM127_10
Size:  5.1000 mg DSC
File: C:...\Desktop\Work\Agro DSC\AM127_10.001
Operator: AlanM
Run Date: 25-Jan-2013 17:17
Instrument: DSC Q20 V24.10 Build 122
Exo Up Universal V4.5A TA Instruments
